FORM 10-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
|
|
|
(Mark One)
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
|
For the fiscal year ended December 31, 2008
|
OR
|
o
|
|
TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
|
For the transition period
from to
|
Commission File Number 1-11239
HCA INC.
(Exact Name of Registrant as
Specified in its Charter)
|
|
|
Delaware
|
|
75-2497104
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer Identification No.)
|
One Park Plaza
Nashville, Tennessee
|
|
37203
(Zip Code)
|
(Address of Principal Executive
Offices)
|
|
|
Registrants telephone number, Including Area Code:
(615) 344-9551
Securities Registered Pursuant to Section 12(b) of the Act:
None
Securities Registered Pursuant to Section 12(g) of the Act:
Common Stock, $0.01 Par Value
Indicate by check mark if the Registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes o No þ
Indicate by check mark if the Registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the Registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the Registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
(§ 229.405 of this chapter) is not contained herein,
and will not be contained, to the best of Registrants
knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this
Form 10-K
or any amendment to this
Form 10-K. þ
Indicate by check mark whether the Registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer o
|
|
Accelerated filer o
|
|
Non-accelerated filer þ
|
|
Smaller reporting company o
|
|
|
|
|
(Do not check if a smaller reporting company)
|
|
|
Indicate by check mark whether the Registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ
As of February 25, 2009, there were approximately
94,371,400 shares of Registrants common stock
outstanding. There is not a market for the Registrants
common stock; therefore, the aggregate market value of the
Registrants common stock held by non-affiliates is not
calculable.
DOCUMENTS INCORPORATED BY REFERENCE
None.
PART I
General
HCA Inc. is one of the leading health care services companies in
the United States. At December 31, 2008, we operated 166
hospitals, comprised of 160 general, acute care hospitals; five
psychiatric hospitals; and one rehabilitation hospital. The 166
hospital total includes eight hospitals (seven general, acute
care hospitals and one rehabilitation hospital) owned by joint
ventures in which an affiliate of HCA is a partner, and these
joint ventures are accounted for using the equity method. In
addition, we operated 105 freestanding surgery centers, eight of
which are owned by joint ventures in which an affiliate of HCA
is a partner, and these joint ventures are accounted for using
the equity method. Our facilities are located in 20 states
and England. The terms Company, HCA,
we, our or us, as used
herein, refer to HCA Inc. and its affiliates unless otherwise
stated or indicated by context. The term affiliates
means direct and indirect subsidiaries of HCA Inc. and
partnerships and joint ventures in which such subsidiaries are
partners. The terms facilities or
hospitals refer to entities owned and operated by
affiliates of HCA and the term employees refers to
employees of affiliates of HCA.
Our primary objective is to provide a comprehensive array of
quality health care services in the most cost-effective manner
possible. Our general, acute care hospitals typically provide a
full range of services to accommodate such medical specialties
as internal medicine, general surgery, cardiology, oncology,
neurosurgery, orthopedics and obstetrics, as well as diagnostic
and emergency services. Outpatient and ancillary health care
services are provided by our general, acute care hospitals,
freestanding surgery centers, diagnostic centers and
rehabilitation facilities. Our psychiatric hospitals provide a
full range of mental health care services through inpatient,
partial hospitalization and outpatient settings.
The Company was incorporated in Nevada in January 1990 and
reincorporated in Delaware in September 1993. Our principal
executive offices are located at One Park Plaza, Nashville,
Tennessee 37203, and our telephone number is
(615) 344-9551.
On November 17, 2006, HCA Inc. completed its merger (the
Merger) with Hercules Acquisition Corporation,
pursuant to which the Company was acquired by Hercules Holding
II, LLC (Hercules Holding), a Delaware limited
liability company owned by a private investor group comprised of
affiliates of Bain Capital Partners (Bain), Kohlberg
Kravis Roberts & Co. (KKR), Merrill Lynch
Global Private Equity (MLGPE) (each a
Sponsor) and affiliates of HCA founder,
Dr. Thomas F. Frist Jr., (the Frist Entities,
and together with the Sponsors, the Investors), and
by members of management and certain other investors. The
Merger, the financing transactions related to the Merger and
other related transactions are collectively referred to in this
annual report as the Recapitalization. The Merger
was accounted for as a recapitalization in our financial
statements, with no adjustments to the historical basis of our
assets and liabilities. As a result of the Recapitalization, our
outstanding capital stock is owned by the Investors, certain
members of management and key employees and certain other
investors. On April 29, 2008, we registered our common
stock pursuant to Section 12(g) of the Securities Exchange
Act of 1934, as amended, thus subjecting us to the reporting
requirements of Section 13(a) of the Securities Exchange
Act of 1934, as amended. Our common stock is not traded on a
national securities exchange.
Available
Information
We file certain reports with the Securities and Exchange
Commission (the SEC), including annual reports
on
Form 10-K,
quarterly reports on
Form 10-Q
and current reports on
Form 8-K.
The public may read and copy any materials we file with the SEC
at the SECs Public Reference Room at
100 F Street, N.E., Washington, DC 20549. The public
may obtain information on the operation of the Public Reference
Room by calling the SEC at
1-800-SEC-0330.
We are an electronic filer, and the SEC maintains an Internet
site at
http://www.sec.gov
that contains the reports and other information we file
electronically. Our website address is www.hcahealthcare.com.
Please note that our website address is provided as an inactive
textual reference only. We make available free of charge,
through our website, our annual report on
Form 10-K,
quarterly reports on
Form 10-Q
and current reports on
Form 8-K,
and all amendments to those reports filed or furnished pursuant
to Section 13(a) of the Exchange Act as soon as reasonably
practicable after such material is electronically filed with or
furnished to the SEC. The
3
information provided on our website is not part of this report,
and is therefore not incorporated by reference unless such
information is specifically referenced elsewhere in this report.
Our Code of Conduct is available free of charge upon request to
our Corporate Secretary, HCA Inc., One Park Plaza, Nashville,
Tennessee 37203.
Business
Strategy
We are committed to providing the communities we serve high
quality, cost-effective health care while complying fully with
our ethics policy, governmental regulations and guidelines and
industry standards. As a part of this strategy, management
focuses on the following principal elements:
|
|
|
|
|
maintain our dedication to the care and improvement of human
life;
|
|
|
|
maintain our commitment to ethics and compliance;
|
|
|
|
leverage our leading local market positions;
|
|
|
|
expand our presence in key markets;
|
|
|
|
continue to leverage our scale;
|
|
|
|
continue to develop enduring physician relationships; and
|
|
|
|
become the health care employer of choice.
|
Health
Care Facilities
We currently own, manage or operate hospitals; freestanding
surgery centers; diagnostic and imaging centers; radiation and
oncology therapy centers; comprehensive rehabilitation and
physical therapy centers; and various other facilities.
At December 31, 2008, we owned and operated 153 general,
acute care hospitals with 38,014 licensed beds, and an
additional seven general, acute care hospitals with 2,267
licensed beds are operated through joint ventures, which are
accounted for using the equity method. Most of our general,
acute care hospitals provide medical and surgical services,
including inpatient care, intensive care, cardiac care,
diagnostic services and emergency services. The general, acute
care hospitals also provide outpatient services such as
outpatient surgery, laboratory, radiology, respiratory therapy,
cardiology and physical therapy. Each hospital has an organized
medical staff and a local board of trustees or governing board,
made up of members of the local community.
Our hospitals do not typically engage in extensive medical
research and education programs. However, some of our hospitals
are affiliated with medical schools and may participate in the
clinical rotation of medical interns and residents and other
education programs.
At December 31, 2008, we operated five psychiatric
hospitals with 490 licensed beds. Our psychiatric hospitals
provide therapeutic programs including child, adolescent and
adult psychiatric care, adult and adolescent alcohol and drug
abuse treatment and counseling.
We also operate outpatient health care facilities which include
freestanding surgery centers, diagnostic and imaging centers,
comprehensive outpatient rehabilitation and physical therapy
centers, outpatient radiation and oncology therapy centers and
various other facilities. These outpatient services are an
integral component of our strategy to develop comprehensive
health care networks in select communities. A majority of our
surgery centers are operated through partnerships or limited
liability companies, with majority ownership of each partnership
or limited liability company typically held by a general partner
or subsidiary that is an affiliate of HCA.
Certain of our affiliates provide a variety of management
services to our health care facilities, including patient safety
programs; ethics and compliance programs; national supply
contracts; equipment purchasing and leasing contracts;
accounting, financial and clinical systems; governmental
reimbursement assistance; construction planning and
coordination; information technology systems and solutions;
legal counsel; human resources services; and internal audit
services.
4
Sources
of Revenue
Hospital revenues depend upon inpatient occupancy levels, the
medical and ancillary services ordered by physicians and
provided to patients, the volume of outpatient procedures and
the charges or payment rates for such services. Charges and
reimbursement rates for inpatient services vary significantly
depending on the type of payer, the type of service (e.g.,
medical/surgical, intensive care or psychiatric) and the
geographic location of the hospital. Inpatient occupancy levels
fluctuate for various reasons, many of which are beyond our
control.
We receive payment for patient services from the federal
government under the Medicare program, state governments under
their respective Medicaid or similar programs, managed care
plans, private insurers and directly from patients. The
approximate percentages of our revenues from such sources were
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
December 31,
|
|
|
2008
|
|
2007
|
|
2006
|
|
Medicare
|
|
|
23
|
%
|
|
|
24
|
%
|
|
|
25
|
%
|
Managed Medicare
|
|
|
6
|
|
|
|
5
|
|
|
|
5
|
|
Medicaid
|
|
|
5
|
|
|
|
5
|
|
|
|
5
|
|
Managed Medicaid
|
|
|
3
|
|
|
|
3
|
|
|
|
3
|
|
Managed care and other insurers
|
|
|
53
|
|
|
|
54
|
|
|
|
54
|
|
Uninsured
|
|
|
10
|
|
|
|
9
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare is a federal program that provides certain hospital and
medical insurance benefits to persons age 65 and over, some
disabled persons, persons with end-stage renal disease and
persons with Lou Gehrigs Disease. Medicaid is a
federal-state program, administered by the states, which
provides hospital and medical benefits to qualifying individuals
who are unable to afford health care. All of our general, acute
care hospitals located in the United States are certified as
health care services providers for persons covered under
Medicare and Medicaid programs. Amounts received under Medicare
and Medicaid programs are generally significantly less than
established hospital gross charges for the services provided.
Our hospitals generally offer discounts from established charges
to certain group purchasers of health care services, including
private insurance companies, employers, HMOs, PPOs and other
managed care plans. These discount programs generally limit our
ability to increase revenues in response to increasing costs.
See Item 1, Business Competition.
Patients are generally not responsible for the total difference
between established hospital gross charges and amounts
reimbursed for such services under Medicare, Medicaid, HMOs or
PPOs and other managed care plans, but are responsible to the
extent of any exclusions, deductibles or coinsurance features of
their coverage. The amount of such exclusions, deductibles and
coinsurance continues to increase. Collection of amounts due
from individuals is typically more difficult than from
governmental or third-party payers. We provide discounts to
uninsured patients who do not qualify for Medicaid or charity
care under our charity care policy. These discounts are similar
to those provided to many local managed care plans. In
implementing the discount policy, we attempt to qualify
uninsured patients for Medicaid, other federal or state
assistance or charity care under our charity care policy. If an
uninsured patient does not qualify for these programs, the
uninsured discount is applied.
Medicare
Inpatient
Acute Care
Under the Medicare program, we receive reimbursement under a
prospective payment system (PPS) for general, acute
care hospital inpatient services. Under the hospital inpatient
PPS, fixed payment amounts per inpatient discharge are
established based on the patients assigned Medicare
severity-diagnosis related group (MS-DRG). Effective
October 1, 2007, the Centers for Medicare and Medicaid
Services (CMS) began a two-year transition to full
implementation of MS-DRGs to replace the previously used
Medicare diagnosis related groups (DRGs) in an
effort to better recognize severity of illness in Medicare
payment rates. This change represents a refinement to the
existing DRG system. MS-DRGs classify treatments for illnesses
according to the estimated
5
intensity of hospital resources necessary to furnish care for
each principal diagnosis. MS-DRG weights represent the average
resources for a given MS-DRG relative to the average resources
for all MS-DRGs. MS-DRG payments are adjusted for area wage
differentials. Hospitals, other than those defined as
new, receive PPS reimbursement for inpatient capital
costs based on MS-DRG weights multiplied by a geographically
adjusted federal rate. When the cost to treat certain patients
falls well outside the normal distribution, providers typically
receive additional outlier payments.
MS-DRG rates are updated and MS-DRG weights are recalibrated
each federal fiscal year (which begins October 1). The index
used to update the MS-DRG rates (the market basket)
gives consideration to the inflation experienced by hospitals
and entities outside the health care industry in purchasing
goods and services. In federal fiscal year 2008, the MS-DRG rate
was increased by the full market basket of 3.3%. For the federal
fiscal year 2009, CMS set the MS-DRG rate increase at full
market basket of 3.6%.
In August 2006, CMS changed the methodology used to recalibrate
the DRG weights from charge-based weights to cost relative
weights under a three-year transition period beginning in
federal fiscal year 2007. The adoption of the cost relative
weights is not anticipated to have a material financial impact
on us. Beginning October 1, 2008, MS-DRG weights are
calculated using 100% cost relative weights.
Effective October 1, 2007, CMS imposed a documentation and
coding adjustment to account for changes in payments under the
new MS-DRG system that are not related to changes in case mix.
Through legislative refinement, the documentation and coding
adjustments for federal fiscal years 2008 and 2009 are
reductions to the base payment rate of 0.6% and 0.9%,
respectively, for a cumulative reduction of 1.5%. However,
Congress has given CMS the ability to determine retrospectively
whether the documentation and coding adjustment levels for
federal fiscal years 2008 and 2009 were adequate to account for
changes in payments not related to changes in case mix. If the
levels are found to have been inadequate, CMS can impose an
adjustment to payments for federal fiscal years 2010, 2011 and
2012.
Further realignments in the MS-DRG system could also reduce the
payments we receive for certain specialties, including
cardiology and orthopedics. CMS has focused on payment levels
for such specialties in recent years in part because of the
proliferation of specialty hospitals. Changes in the payments
received for specialty services could have an adverse effect on
our revenues.
The Medicare Prescription Drug, Improvement, and Modernization
Act of 2003 (MMA) provided for DRG rate increases
for certain federal fiscal years at full market basket if data
for 10 patient care quality indicators were submitted to
the Secretary of the Department of Health and Human Services
(HHS). The Deficit Reduction Act of 2005 (DRA
2005) expanded and provided for the future expansion of
the number of quality measures that must be reported to receive
a full market basket update. CMS has published final rules that
expand to 44 the number of quality measures that hospitals are
required to report, beginning with discharges occurring in
calendar year 2009, in order to qualify for the full market
basket update to the inpatient prospective payment system in
federal fiscal year 2010. Failure to submit the required quality
indicators will result in a two percentage point reduction to
the market basket update. All of our hospitals paid under
Medicare inpatient MS-DRG PPS are participating in the quality
initiative by the Secretary of HHS by submitting the requested
quality data. While we will endeavor to comply with all data
submission requirements as additional requirements continue to
be added, our submissions may not be deemed timely or sufficient
to entitle us to the full market basket adjustment for all of
our hospitals.
As part of CMSs goal of transforming Medicare from a
passive payer to an active purchaser of quality goods and
services, beginning October 1, 2007, CMS requires hospitals
to submit information on general acute care inpatient Medicare
claims specifying whether diagnoses were present on admission
(POA). For discharges occurring after
October 1, 2008, Medicare no longer assigns an inpatient
hospital discharge to a higher paying MS-DRG if a selected
hospital-acquired condition (HAC) was not POA. In
this situation, the case would be paid as though the secondary
diagnosis was not present. Currently, there are ten categories
of conditions on the list of HACs. On January 15, 2009, CMS
announced three National Coverage Determinations
(NCDs) that prohibit Medicare reimbursement for
erroneous surgical procedures performed on an inpatient or
outpatient basis. These three erroneous surgical procedures are
in addition to the HACs designated in CMS regulations. These
changes are not expected to have a material effect on our
revenues or cash flows.
6
Historically, the Medicare program has set aside 5.10% of
Medicare inpatient payments to pay for outlier cases. CMS
estimates that outlier payments accounted for 4.64% and 4.65% of
total operating DRG payments for federal fiscal years 2007 and
2006, respectively. For federal fiscal year 2008, CMS
established an outlier threshold of $22,185, which resulted in
outlier payments estimated by CMS to be 4.70% of total operating
DRG payments. For federal fiscal year 2009, CMS has established
an outlier threshold of $20,045. We do not anticipate that the
change to the outlier threshold for federal fiscal year 2009
will have a material impact on our revenues.
Outpatient
CMS reimburses hospital outpatient services (and certain
Medicare Part B services furnished to hospital inpatients
who have no Part A coverage) on a PPS basis. CMS continues
to use fee schedules to pay for physical, occupational and
speech therapies, durable medical equipment, clinical diagnostic
laboratory services and nonimplantable orthotics and
prosthetics, freestanding surgery centers services and services
provided by independent diagnostic testing facilities.
Hospital outpatient services paid under PPS are classified into
groups called ambulatory payment classifications
(APCs). Services for each APC are similar clinically
and in terms of the resources they require. A payment rate is
established for each APC. Depending on the services provided, a
hospital may be paid for more than one APC for a patient visit.
The APC payment rates were updated for calendar years 2008 and
2007 by market baskets of 3.30% and 3.40%, respectively. On
November 18, 2008 CMS published a final rule that updated
payment rates for calendar year 2009 by the full market basket
of 3.60%. CMS continues to require that hospitals submit quality
data relating to outpatient care to receive the full market
basket increase under the outpatient PPS in calendar year 2010.
CMS requires that data on eleven quality measures be submitted
in calendar year 2009 for the payment determination in calendar
year 2010. Hospitals that fail to submit such data will receive
the market basket update minus two percentage points for the
outpatient PPS.
Rehabilitation
CMS reimburses inpatient rehabilitation facilities
(IRFs) on a PPS basis. Under IRF PPS, patients are
classified into case mix groups based upon impairment, age,
comorbidities (additional diseases or disorders from which the
patient suffers) and functional capability. IRFs are paid a
predetermined amount per discharge that reflects the
patients case mix group and is adjusted for area wage
levels, low-income patients, rural areas and high-cost outliers.
For federal fiscal years 2008 and 2007, CMS updated the PPS rate
for rehabilitation hospitals and units by market baskets of 3.2%
and 3.3%, respectively. However, CMS also applied a reduction to
the standard payment amount of 2.6% for federal fiscal year 2007
to account for coding changes that do not reflect real changes
in case mix. The Medicare, Medicaid and State Childrens
Health Insurance Program (SCHIP) Reauthorization Act
of 2007 eliminated the market basket update as of April 1,
2008 and continues the zero update through federal fiscal year
2009. As of December 31, 2008, we had one rehabilitation
hospital, which is operated through a joint venture, and 47
hospital rehabilitation units.
On May 7, 2004, CMS published a final rule to change the
criteria for being classified as an IRF, commonly known as the
75% rule. If a facility fails to meet the 75% rule
or other criteria to be classified as an IRF, it may be paid
under the acute care hospital inpatient or outpatient PPS, which
generally provide for lower payment amounts. Pursuant to the
final 75% rule, a specified percentage of a facilitys
inpatients over a given year must be treated for at least one of
13 conditions. The final rule provided for a transition period
during which the percentage threshold would increase, starting
at a 50% compliance threshold and culminating at a 75%
threshold, for cost reporting periods beginning on or after
July 1, 2007. Since then, several adjustments have been
made to the transition period. The passage of the Medicare,
Medicaid and SCHIP Reauthorization Act of 2007 set the
compliance threshold at 60% for cost reporting periods beginning
on or after July 1, 2006. Implementation of the 75% rule
has reduced our IRF admissions and can be expected to continue
to restrict the treatment of patients whose medical conditions
do not meet any of the 13 approved conditions.
7
Psychiatric
Inpatient hospital services furnished in psychiatric hospitals
and psychiatric units of general, acute care hospitals and
critical access hospitals are reimbursed under a prospective
payment system (IPF PPS), a per diem payment, with
adjustments to account for certain patient and facility
characteristics. IPF PPS contains an outlier policy
for extraordinarily costly cases and an adjustment to a
facilitys base payment if it maintains a full-service
emergency department. CMS has established the IPF PPS payment
rate in a manner intended to be budget neutral and has adopted a
July 1 update cycle. The rehabilitation, psychiatric and
long-term care (RPL) market basket update is used to
update the IPF PPS. The annual RPL market basket update for rate
year 2009 is 3.2%. As of December 31, 2008, we had five
psychiatric hospitals and 31 hospital psychiatric units.
Ambulatory
Surgery Centers
CMS reimburses ambulatory surgery centers (ASCs)
using a predetermined fee schedule. Effective January 1,
2007, as a result of DRA 2005, reimbursements for ASC overhead
costs were limited to no more than the overhead costs paid to
hospital outpatient departments under the Medicare hospital
outpatient PPS for the same procedure. On August 2, 2007,
CMS issued final regulations that changed payments for
procedures performed in an ASC. Effective January 1, 2008,
ASC payment groups increased from nine clinically disparate
payment groups to an extensive list of covered surgical
procedures among the APCs used under the outpatient PPS for
these surgical services. CMS estimates that the rates for
procedures performed in an ASC setting equal 65% of the
corresponding rates paid for the same procedures performed in an
outpatient hospital setting. Moreover, if CMS determines that a
procedure is commonly performed in a physicians office,
the ASC reimbursement for that procedure is limited to the
reimbursement allowable under the Medicare Part B Physician
Fee Schedule, with limited exceptions. In addition, all surgical
procedures, other than those that pose a significant safety risk
or generally require an overnight stay, are payable as ASC
procedures. This rule expands the number of procedures that
Medicare will pay for if performed in an ASC. Because the new
payment system has a significant impact on payments for certain
procedures, the final rule establishes a four-year transition
period for implementing the required payment rates. This change
may result in more Medicare procedures that are now performed in
hospitals being moved to ASCs, reducing surgical volume in our
hospitals. Also, more Medicare procedures that are now performed
in ASCs may be moved to physicians offices. Commercial
third-party payers may adopt similar policies.
Other
Under PPS, the payment rates are adjusted for the area
differences in wage levels by a factor (wage index)
reflecting the relative wage level in the geographic area
compared to the national average wage level. Beginning in
federal fiscal year 2007, CMS adjusted 100% of the wage index
factor for occupational mix. The redistributive impact of wage
index changes, while slightly negative in the aggregate, is not
anticipated to have a material financial impact for 2009.
The Medicare program reimburses 70% of bad debts related to
deductibles and coinsurance for patients with Medicare coverage,
after the provider has made a reasonable effort to collect these
amounts. On March 30, 2006, the United States District
Court for the Western District of Michigan entered a final order
in Battle Creek Health System v. Thompson, which
provided that reasonable collection efforts have not been
satisfied as long as the Medicare accounts remained with an
external collection agency. On appeal, the United States Court
of Appeals for the Sixth Circuit upheld the lower courts
decision. We incur substantial amounts of Medicare bad debts
every year that could be subject to the Battle Creek
decision. We utilize extensive in-house and external
collection efforts for our accounts receivable, including
deductible and coinsurance amounts owed by patients with
Medicare coverage. We utilize a secondary collection agency
after in-house and primary collection agency efforts have been
unsuccessful. During 2007, we modified our accounts receivable
collection processes to provide us with reasonable collection
results and comply with CMSs interpretation of reasonable
collection efforts. Possible future changes in judicial and
administrative interpretations of law and regulations governing
Medicare could disrupt our collections processes, increase our
costs or otherwise adversely affect our business and results of
operations.
8
As required by the MMA, CMS is implementing contractor reform
whereby CMS has competitively bid the Medicare fiscal
intermediary and Medicare carrier functions to 15 Medicare
Administrative Contractors (MACs). Hospital
companies have the option to work with the selected MAC in the
jurisdiction where a given hospital is located or, in the case
of chain providers, to use the MAC in the jurisdiction where the
hospital companys home office is located. For chain
providers, either all hospitals in the chain must choose to stay
with the MAC chosen for their locality or all hospitals must opt
to use the home office MAC. HCA has chosen to use the MACs
assigned to the localities in which our hospitals are located.
Recently, CMS has completed the process of awarding contracts on
all 15 MAC jurisdictions. Individual MAC jurisdictions are in
varying phases of transition. For the transition periods and for
a potentially unforeseen period thereafter, all of these changes
could impact claims processing functions and the resulting cash
flow; however, we are unable to predict the impact at this time.
The MMA established the Recovery Audit Contractor
(RAC) three-year demonstration program to conduct
post-payment reviews to detect and correct improper payments in
the
fee-for-service
Medicare program. Beginning in 2005, CMS contracted with three
different RACs to conduct these reviews in California, Florida
and New York. The program was expanded in August 2007 to include
Arizona, Massachusetts and South Carolina. Each RAC had
discretion over the types of reviews and record requests it
would conduct within the states for which it was responsible as
long as it followed the CMS-defined Statement of Work. HCA had
46 hospitals located in the demonstration areas, and 44 of these
hospitals had a review performed. The Tax Relief and Health Care
Act of 2006 made the RAC program permanent and mandated its
nationwide expansion by 2010. CMS has awarded contracts to four
RACs that will implement the permanent RAC program on a
nationwide basis. The final impact of the demonstration program
and the permanent, nationwide program cannot be quantified at
this time.
Managed
Medicare
Managed Medicare plans relate to situations where a private
company contracts with CMS to provide members with Medicare
Part A, Part B and Part D benefits. Managed
Medicare plans can be structured as HMOs, PPOs, or private
fee-for-service
plans. The Medicare program allows beneficiaries to choose
enrollment in certain managed Medicare plans. In 2003 changes to
federal law increased reimbursement to managed Medicare plans
and limited, to some extent, the financial risk to the companies
offering the plans. Following these changes, the number of
beneficiaries choosing to receive their Medicare benefits
through such plans has increased. However, the Medicare
Improvements for Patients and Providers Act of 2008 reduced
payments to managed Medicare plans, and CMS has recently
proposed additional cuts in payments to managed Medicare plans.
Future changes may result in reduced premium payments to managed
Medicare plans and may lead to decreased enrollment in such
plans.
Medicaid
Medicaid programs are funded jointly by the federal government
and the states and are administered by states under approved
plans. Most state Medicaid program payments are made under a PPS
or are based on negotiated payment levels with individual
hospitals. Medicaid reimbursement is often less than a
hospitals cost of services. The federal government and
many states are currently considering altering the level of
Medicaid funding (including upper payment limits) or program
eligibility that could adversely affect future levels of
Medicaid reimbursement received by our hospitals. As permitted
by law, certain states in which we operate have adopted
broad-based provider taxes to fund their Medicaid programs.
Since many states must operate with balanced budgets and since
the Medicaid program is often the states largest program,
states can be expected to adopt or consider adopting legislation
designed to reduce their Medicaid expenditures. DRA 2005
includes Medicaid cuts of approximately $4.8 billion over
five years. A congressional committee has estimated that
additional proposed legislative and regulatory changes, if
implemented, would reduce federal Medicaid funding by an
additional $49.7 billion over five years. The
implementation of many of these proposed changes is subject to a
statutorily mandated moratorium scheduled to expire in July
2009. States have also adopted, or are considering, legislation
designed to reduce coverage and program eligibility, enroll
Medicaid recipients in managed care programs
and/or
impose additional taxes on hospitals to help finance or expand
the states Medicaid systems. Future legislation or other
changes in the administration or interpretation of government
health programs could have a material, adverse effect on our
financial position and results of operations.
9
Managed
Medicaid
Managed Medicaid programs enable states to contract with one or
more entities for patient enrollment, care management and claims
adjudication. The states usually do not relinquish program
responsibilities for financing, eligibility criteria and core
benefit plan design. We generally contract directly with one of
the designated entities, usually a managed care organization.
The provisions of these programs are state-specific.
Enrollment in managed Medicaid plans has increased in recent
years, as state governments seek to control the cost of Medicaid
programs. However, general economic conditions in the states in
which we operate may require reductions in premium payments to
these plans and may reduce enrollment in these plans.
TRICARE
In December 2008, the Department of Defense implemented a
prospective payment system for hospital outpatient services
furnished to TRICARE beneficiaries similar to that utilized for
services furnished to Medicare beneficiaries. Because the
Medicare outpatient prospective payment system APC rates have
historically been below TRICARE rates, the adoption of this
payment methodology for TRICARE beneficiaries will reduce our
reimbursement. This change in TRICARE will have a material
impact on our revenues from this program; however, TRICARE
outpatient services do not represent a significant portion of
our patient volumes. The TRICARE outpatient payment rule has
been reopened for comment and the effective date delayed until
May 1, 2009. Further modification to the new outpatient
system may be made.
Annual
Cost Reports
All hospitals participating in the Medicare, Medicaid and
TRICARE programs, whether paid on a reasonable cost basis or
under a PPS, are required to meet certain financial reporting
requirements. Federal and, where applicable, state regulations
require the submission of annual cost reports covering the
revenues, costs and expenses associated with the services
provided by each hospital to Medicare beneficiaries and Medicaid
recipients.
Annual cost reports required under the Medicare and Medicaid
programs are subject to routine audits, which may result in
adjustments to the amounts ultimately determined to be due to us
under these reimbursement programs. These audits often require
several years to reach the final determination of amounts due to
or from us under these programs. Providers also have rights of
appeal, and it is common to contest issues raised in audits of
cost reports.
Managed
Care and Other Discounted Plans
Most of our hospitals offer discounts from established charges
to certain large group purchasers of health care services,
including managed care plans and private insurance companies.
Admissions reimbursed by commercial managed care and other
insurers were 35%, 37% and 36% of our total admissions for the
years ended December 31, 2008, 2007 and 2006, respectively.
Managed care contracts are typically negotiated for terms
between one and three years. While we generally received annual
average yield increases of 6% to 7% from managed care payers
during 2008, there can be no assurance that we will continue to
receive increases in the future.
Hospital
Utilization
We believe that the most important factors relating to the
overall utilization of a hospital are the quality and market
position of the hospital and the number and quality of
physicians and other health care professionals providing patient
care within the facility. Generally, we believe the ability of a
hospital to be a market leader is determined by its breadth of
services, level of technology, emphasis on quality of care and
convenience for patients and physicians. Other factors that
impact utilization include the growth in local population, local
economic conditions and market penetration of managed care
programs.
10
The following table sets forth certain operating statistics for
our health care facilities. Health care facility operations are
subject to certain seasonal fluctuations, including decreases in
patient utilization during holiday periods and increases in the
cold weather months. The data set forth in this table includes
only those facilities that are consolidated for financial
reporting purposes.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2008
|
|
2007
|
|
2006
|
|
2005
|
|
2004
|
|
Number of hospitals at end of period (a)
|
|
|
158
|
|
|
|
161
|
|
|
|
166
|
|
|
|
175
|
|
|
|
182
|
|
Number of freestanding outpatient surgery centers at end of
period (b)
|
|
|
97
|
|
|
|
99
|
|
|
|
98
|
|
|
|
87
|
|
|
|
84
|
|
Number of licensed beds at end of period (c)
|
|
|
38,504
|
|
|
|
38,405
|
|
|
|
39,354
|
|
|
|
41,265
|
|
|
|
41,852
|
|
Weighted average licensed beds (d)
|
|
|
38,422
|
|
|
|
39,065
|
|
|
|
40,653
|
|
|
|
41,902
|
|
|
|
41,997
|
|
Admissions (e)
|
|
|
1,541,800
|
|
|
|
1,552,700
|
|
|
|
1,610,100
|
|
|
|
1,647,800
|
|
|
|
1,659,200
|
|
Equivalent admissions (f)
|
|
|
2,363,600
|
|
|
|
2,352,400
|
|
|
|
2,416,700
|
|
|
|
2,476,600
|
|
|
|
2,454,000
|
|
Average length of stay (days) (g)
|
|
|
4.9
|
|
|
|
4.9
|
|
|
|
4.9
|
|
|
|
4.9
|
|
|
|
5.0
|
|
Average daily census (h)
|
|
|
20,795
|
|
|
|
21,049
|
|
|
|
21,688
|
|
|
|
22,225
|
|
|
|
22,493
|
|
Occupancy rate (i)
|
|
|
54
|
%
|
|
|
54
|
%
|
|
|
53
|
%
|
|
|
53
|
%
|
|
|
54
|
%
|
Emergency room visits (j)
|
|
|
5,246,400
|
|
|
|
5,116,100
|
|
|
|
5,213,500
|
|
|
|
5,415,200
|
|
|
|
5,219,500
|
|
Outpatient surgeries (k)
|
|
|
797,400
|
|
|
|
804,900
|
|
|
|
820,900
|
|
|
|
836,600
|
|
|
|
834,800
|
|
Inpatient surgeries (l)
|
|
|
493,100
|
|
|
|
516,500
|
|
|
|
533,100
|
|
|
|
541,400
|
|
|
|
541,000
|
|
|
|
|
(a) |
|
Excludes eight facilities in 2008 and 2007 and seven facilities
in 2006, 2005 and 2004 that are not consolidated (accounted for
using the equity method) for financial reporting purposes. |
|
(b) |
|
Excludes eight facilities in 2008, nine facilities in 2007 and
2006, seven facilities in 2005 and eight facilities in 2004 that
are not consolidated (accounted for using the equity method) for
financial reporting purposes. |
|
(c) |
|
Licensed beds are those beds for which a facility has been
granted approval to operate from the applicable state licensing
agency. |
|
(d) |
|
Weighted average licensed beds represents the average number of
licensed beds, weighted based on periods owned. |
|
(e) |
|
Represents the total number of patients admitted to our
hospitals and is used by management and certain investors as a
general measure of inpatient volume. |
|
(f) |
|
Equivalent admissions are used by management and certain
investors as a general measure of combined inpatient and
outpatient volume. Equivalent admissions are computed by
multiplying admissions (inpatient volume) by the sum of gross
inpatient revenue and gross outpatient revenue and then dividing
the resulting amount by gross inpatient revenue. The equivalent
admissions computation equates outpatient revenue to
the volume measure (admissions) used to measure inpatient
volume, resulting in a general measure of combined inpatient and
outpatient volume. |
|
(g) |
|
Represents the average number of days admitted patients stay in
our hospitals. |
|
(h) |
|
Represents the average number of patients in our hospital beds
each day. |
|
(i) |
|
Represents the percentage of hospital licensed beds occupied by
patients. Both average daily census and occupancy rate provide
measures of the utilization of inpatient rooms. |
|
(j) |
|
Represents the number of patients treated in our emergency rooms. |
|
(k) |
|
Represents the number of surgeries performed on patients who
were not admitted to our hospitals. Pain management and
endoscopy procedures are not included in outpatient surgeries. |
|
(l) |
|
Represents the number of surgeries performed on patients who
have been admitted to our hospitals. Pain management and
endoscopy procedures are not included in inpatient surgeries. |
11
Competition
Generally, other hospitals in the local communities served by
most of our hospitals provide services similar to those offered
by our hospitals. Additionally, in recent years the number of
freestanding surgery centers and diagnostic centers (including
facilities owned by physicians) in the geographic areas in which
we operate has increased significantly. As a result, most of our
hospitals operate in a highly competitive environment. In some
cases, competing hospitals are more established than our
hospitals. Some competing hospitals are owned by tax-supported
government agencies and many others are owned by
not-for-profit
entities that may be supported by endowments, charitable
contributions and/or tax revenues, and are exempt from sales,
property and income taxes. Such exemptions and support are not
available to our hospitals. In certain localities there are
large teaching hospitals that provide highly specialized
facilities, equipment and services which may not be available at
most of our hospitals. We are facing increasing competition from
physician-owned specialty hospitals and both our own and
unaffiliated freestanding surgery centers for market share in
high margin services.
Psychiatric hospitals frequently attract patients from areas
outside their immediate locale and, therefore, our psychiatric
hospitals compete with both local and regional hospitals,
including the psychiatric units of general, acute care hospitals.
Our strategies are designed to ensure our hospitals are
competitive. We believe our hospitals compete within local
communities on the basis of many factors, including the quality
of care; ability to attract and retain quality physicians,
skilled clinical personnel and other health care professionals;
location; breadth of services; technology offered and prices
charged. We have increased our focus on operating outpatient
services with improved accessibility and more convenient service
for patients, and increased predictability and efficiency for
physicians.
Two of the most significant factors to the competitive position
of a hospital are the number and quality of physicians
affiliated with the hospital. Although physicians may at any
time terminate their affiliation with a hospital we operate, our
hospitals seek to retain physicians with varied specialties on
the hospitals medical staffs and to attract other
qualified physicians. We believe that physicians refer patients
to a hospital on the basis of the quality and scope of services
it renders to patients and physicians, the quality of physicians
on the medical staff, the location of the hospital and the
quality of the hospitals facilities, equipment and
employees. Accordingly, we strive to maintain and provide
quality facilities, equipment, employees and services for
physicians and patients.
Another major factor in the competitive position of a hospital
is our ability to negotiate service contracts with purchasers of
group health care services. Managed care plans attempt to direct
and control the use of hospital services and obtain discounts
from hospitals established gross charges. In addition,
employers and traditional health insurers continue to attempt to
contain costs through negotiations with hospitals for managed
care programs and discounts from established gross charges.
Generally, hospitals compete for service contracts with group
health care services purchasers on the basis of price, market
reputation, geographic location, quality and range of services,
quality of the medical staff and convenience. Our future success
will depend, in part, on our ability to retain and renew our
managed care contracts and enter into new managed care contracts
on favorable terms. Other health care providers may impact our
ability to enter into managed care contracts or negotiate
increases in our reimbursement and other favorable terms and
conditions. For example, some of our competitors may negotiate
exclusivity provisions with managed care plans or otherwise
restrict the ability of managed care companies to contract with
us. The trend toward consolidation among non-government payers
tends to increase their bargaining power over fee structures.
The importance of obtaining contracts with managed care
organizations varies from community to community, depending on
the market strength of such organizations.
State certificate of need (CON) laws, which place
limitations on a hospitals ability to expand hospital
services and facilities, make capital expenditures and otherwise
make changes in operations, may also have the effect of
restricting competition. Before issuing a CON, these states
consider the need for additional or expanded health care
facilities or services. We currently operate health care
facilities in a number of states with CON laws. In those states
which have no CON laws or which set relatively high levels of
expenditures before they become reviewable by state authorities,
competition in the form of new services, facilities and capital
spending is more prevalent. See Item 1,
Business Regulation and Other Factors.
12
We and the health care industry as a whole face the challenge of
continuing to provide quality patient care while dealing with
rising costs and strong competition for patients. Changes in
medical technology, existing and future legislation, regulations
and interpretations, and managed care contracting for provider
services by private and government payers remain ongoing
challenges.
Admissions and average lengths of stay continue to be negatively
affected by payer-required preadmission authorization,
utilization review and payer pressure to maximize outpatient and
alternative health care delivery services for less acutely ill
patients. Increased competition, admission constraints and payer
pressures are expected to continue. To meet these challenges, we
intend to expand our facilities or acquire or construct new
facilities where appropriate, to better enable the provision of
a comprehensive array of outpatient services, offer discounts to
private payer groups, upgrade facilities and equipment, and
offer new or expanded programs and services.
Regulation
and Other Factors
Licensure,
Certification and Accreditation
Health care facility construction and operation are subject to
numerous federal, state and local regulations relating to the
adequacy of medical care, equipment, personnel, operating
policies and procedures, maintenance of adequate records, fire
prevention, rate-setting and compliance with building codes and
environmental protection laws. Facilities are subject to
periodic inspection by governmental and other authorities to
assure continued compliance with the various standards necessary
for licensing and accreditation. We believe that our health care
facilities are properly licensed under applicable state laws.
All of our general, acute care hospitals are certified for
participation in the Medicare and Medicaid programs and are
accredited by The Joint Commission. If any facility were to lose
its Joint Commission accreditation or otherwise lose its
certification under the Medicare and Medicaid programs, the
facility would be unable to receive reimbursement from the
Medicare and Medicaid programs. Management believes our
facilities are in substantial compliance with current applicable
federal, state, local and independent review body regulations
and standards. The requirements for licensure, certification and
accreditation are subject to change and, in order to remain
qualified, it may become necessary for us to make changes in our
facilities, equipment, personnel and services. The requirements
for licensure also may include notification or approval in the
event of the transfer or change of ownership. Failure to obtain
the necessary state approval in these circumstances can result
in the inability to complete an acquisition or change of
ownership.
Certificates
of Need
In some states where we operate hospitals and other health care
facilities, the construction or expansion of health care
facilities, the acquisition of existing facilities, the transfer
or change of ownership and the addition of new beds or services
may be subject to review by and prior approval of state
regulatory agencies under a CON program. Such laws generally
require the reviewing state agency to determine the public need
for additional or expanded health care facilities and services.
Failure to obtain necessary state approval can result in the
inability to expand facilities, complete an acquisition or
change ownership.
State
Rate Review
Some states have adopted legislation mandating rate or budget
review for hospitals or have adopted taxes on hospital revenues,
assessments or licensure fees to fund indigent health care
within the state. In the aggregate, indigent tax provisions have
not materially, adversely affected our results of operations.
Although we do not currently operate facilities in states that
mandate rate or budget reviews, we cannot predict whether we
will operate in such states in the future, or whether the states
in which we currently operate may adopt legislation mandating
such reviews.
Utilization
Review
Federal law contains numerous provisions designed to ensure that
services rendered by hospitals to Medicare and Medicaid patients
meet professionally recognized standards, are medically
necessary and that claims for reimbursement are properly filed.
These provisions include a requirement that a sampling of
admissions of
13
Medicare and Medicaid patients must be reviewed by quality
improvement organizations to assess the appropriateness of
Medicare and Medicaid patient admissions and discharges, the
quality of care provided, the validity of DRG classifications
and the appropriateness of cases of extraordinary length of stay
or cost. Quality improvement organizations may deny payment for
services provided, may assess fines and also have the authority
to recommend to HHS that a provider, which is in substantial
noncompliance with the appropriate standards, be excluded from
participating in the Medicare program. Most nongovernmental
managed care organizations also require utilization review.
Federal
Health Care Program Regulations
Participation in any federal health care program, including the
Medicare and Medicaid programs, is heavily regulated by statute
and regulation. If a hospital fails to substantially comply with
the numerous conditions of participation in the Medicare and
Medicaid programs or performs certain prohibited acts, the
hospitals participation in the federal health care
programs may be terminated, or civil or criminal penalties may
be imposed under certain provisions of the Social Security Act,
or both.
Anti-kickback
Statute
A section of the Social Security Act known as the
Anti-kickback Statute prohibits providers and others
from directly or indirectly soliciting, receiving, offering or
paying any remuneration with the intent of generating referrals
or orders for services or items covered by a federal health care
program. Courts have interpreted this statute broadly.
Violations of the Anti-kickback Statute may be punished by a
criminal fine of up to $25,000 for each violation or
imprisonment, civil money penalties of up to $50,000 per
violation and damages of up to three times the total amount of
the remuneration
and/or
exclusion from participation in federal health care programs,
including Medicare and Medicaid. Courts have held that there is
a violation of the Anti-kickback Statute if just one purpose of
the remuneration is to generate referrals, even if there are
other lawful purposes.
The Office of Inspector General at HHS (OIG), among
other regulatory agencies, is responsible for identifying and
eliminating fraud, abuse and waste. The OIG carries out this
mission through a nationwide program of audits, investigations
and inspections. As one means of providing guidance to health
care providers, the OIG issues Special Fraud Alerts.
These alerts do not have the force of law, but identify features
of arrangements or transactions that may indicate that the
arrangements or transactions violate the Anti-kickback Statute
or other federal health care laws. The OIG has identified
several incentive arrangements that constitute suspect
practices, including: (a) payment of any incentive by a
hospital each time a physician refers a patient to the hospital,
(b) the use of free or significantly discounted office
space or equipment in facilities usually located close to the
hospital, (c) provision of free or significantly discounted
billing, nursing or other staff services, (d) free training
for a physicians office staff in areas such as management
techniques and laboratory techniques, (e) guarantees which
provide that, if the physicians income fails to reach a
predetermined level, the hospital will pay any portion of the
remainder, (f) low-interest or interest-free loans, or
loans which may be forgiven if a physician refers patients to
the hospital, (g) payment of the costs of a
physicians travel and expenses for conferences,
(h) coverage on the hospitals group health insurance
plans at an inappropriately low cost to the physician,
(i) payment for services (which may include consultations
at the hospital) which require few, if any, substantive duties
by the physician, (j) purchasing goods or services from
physicians at prices in excess of their fair market value, and
(k) rental of space in physician offices, at other than
fair market value terms, by persons or entities to which
physicians refer. The OIG has encouraged persons having
information about hospitals who offer the above types of
incentives to physicians to report such information to the OIG.
The OIG also issues Special Advisory Bulletins as a means of
providing guidance to health care providers. These bulletins,
along with the Special Fraud Alerts, have focused on certain
arrangements that could be subject to heightened scrutiny by
government enforcement authorities, including:
(a) contractual joint venture arrangements and other joint
venture arrangements between those in a position to refer
business, such as physicians, and those providing items or
services for which Medicare or Medicaid pays, and
(b) certain gainsharing arrangements, i.e., the
practice of giving physicians a share of any reduction in a
hospitals costs for patient care attributable in part to
the physicians efforts.
14
In addition to issuing Special Fraud Alerts and Special Advisory
Bulletins, the OIG issues compliance program guidance for
certain types of health care providers. In January 2005, the OIG
published Supplemental Compliance Guidance for Hospitals,
supplementing its 1998 guidance for the hospital industry. In
the supplemental guidance, the OIG identifies a number of risk
areas under federal fraud and abuse statutes and regulations.
These areas of risk include compensation arrangements with
physicians, recruitment arrangements with physicians and joint
venture relationships with physicians.
As authorized by Congress, the OIG has published safe harbor
regulations that outline categories of activities that are
deemed protected from prosecution under the Anti-kickback
Statute. Currently, there are statutory exceptions and safe
harbors for various activities, including the following:
investment interests, space rental, equipment rental,
practitioner recruitment, personnel services and management
contracts, sale of practice, referral services, warranties,
discounts, employees, group purchasing organizations, waiver of
beneficiary coinsurance and deductible amounts, managed care
arrangements, obstetrical malpractice insurance subsidies,
investments in group practices, freestanding surgery centers,
ambulance replenishing, and referral agreements for specialty
services. The fact that conduct or a business arrangement does
not fall within a safe harbor, or that it is identified in a
fraud alert or advisory bulletin or as a risk area in the
Supplemental Compliance Guidelines for Hospitals, does not
automatically render the conduct or business arrangement illegal
under the Anti-kickback Statute. However, such conduct and
business arrangements may lead to increased scrutiny by
government enforcement authorities.
We have a variety of financial relationships with physicians and
others who either refer or influence the referral of patients to
our hospitals and other health care facilities, including
employment contracts, leases and professional service
agreements. We also have similar relationships with physicians
and facilities to which patients are referred from our
facilities. In addition, we provide financial incentives,
including minimum revenue guarantees, to recruit physicians into
the communities served by our hospitals. While we endeavor to
comply with the applicable safe harbors, certain of our current
arrangements, including joint ventures and financial
relationships with physicians and other referral sources and
persons and entities to which we refer patients, do not qualify
for safe harbor protection.
Although the Company believes that its arrangements with
physicians and other referral sources have been structured to
comply with current law and available interpretations, there can
be no assurance that regulatory authorities enforcing these laws
will determine these financial arrangements do not violate the
Anti-kickback Statute or other applicable laws. An adverse
determination could subject the Company to liabilities under the
Social Security Act, including criminal penalties, civil
monetary penalties and exclusion from participation in Medicare,
Medicaid or other federal health care programs.
Stark
Law
The Social Security Act also includes a provision commonly known
as the Stark Law. This law effectively prohibits
physicians from referring Medicare and Medicaid patients to
entities with which they or any of their immediate family
members have a financial relationship, if these entities provide
certain designated health services that are
reimbursable by Medicare, including inpatient and outpatient
hospital services, clinical laboratory services and radiology
services. The Stark Law also prevents the entity from billing a
federal health program for any items or services that result
from a prohibited referral and requires the entity to refund
amounts received for items or services provided pursuant to the
prohibited referral. Sanctions for violating the Stark Law
include denial of payment, civil monetary penalties of up to
$15,000 per prohibited service provided, and exclusion from the
Medicare and Medicaid programs. The statute also provides for a
penalty of up to $100,000 for a circumvention scheme. There are
exceptions to the self-referral prohibition for many of the
customary financial arrangements between physicians and
providers, including employment contracts, leases and
recruitment agreements. There is also an exception for a
physicians ownership interest in an entire hospital, as
opposed to an ownership interest in a hospital department.
Unlike safe harbors under the Anti-kickback Statute with which
compliance is voluntary, an arrangement must comply with every
requirement of a Stark Law exception or the arrangement is in
violation of the Stark Law.
CMS has issued three phases of final regulations implementing
the Stark Law, as well as final regulations in the 2009
Inpatient Prospective Payment System (IPPS) final
rule. Phases I, II and III became effective in
January
15
2002, July 2004 and December 2007, respectively. Some portions
of the 2009 IPPS Stark regulations became effective
October 1, 2008, and other portions become effective
October 1, 2009. While these regulations help clarify the
requirements of the exceptions to the Stark Law, it is unclear
how the government will interpret many of these exceptions for
enforcement purposes. The recent changes to the regulations
implementing the Stark Law further restrict the types of
arrangements that facilities and physicians may enter, including
additional restrictions on certain leases, percentage
compensation arrangements, and agreements under which a hospital
purchases services under arrangements. We may be
required to restructure or unwind some of our arrangements
because of these changes. Because many of these laws and their
implementing regulations are relatively new, we do not always
have the benefit of significant regulatory or judicial
interpretation of these laws and regulations. We attempt to
structure our relationships to meet an exception to the Stark
Law, but the regulations implementing the exceptions are
detailed and complex, and we cannot assure that every
relationship complies fully with the Stark Law.
In 2003, Congress passed legislation that modified the hospital
ownership exception to the Stark Law by creating an
18-month
moratorium on allowing physicians to own interests in new
specialty hospitals. The moratorium was extended by regulatory
and legislative action and expired on August 8, 2006. At
the conclusion of the moratorium, HHS announced that it will
require hospitals to disclose certain financial arrangements
with physicians. On September 14, 2007, CMS published an
information collection request called the Disclosure of
Financial Relationships Report (DFRR). HHS will
initially select 400 hospitals that will be required to report
the financial arrangements with physicians as required in the
DFRR. Those hospitals are comprised of 290 hospitals that failed
to respond to a previous voluntary CMS questionnaire about
investments and compensation relationships and 110 additional
hospitals. The DFRR and its supporting documentation are
currently under review by the Office of Management and Budget
and have not yet been released. CMS has indicated that
responding hospitals will have a limited amount of time to
compile a significant amount of information relating to their
financial relationships with physicians. A hospital may be
subject to substantial penalties if it is unable to assemble and
report this information within the required time frame or if any
applicable government agency determines that the submission is
inaccurate or incomplete. Depending on the final format of the
DFRR, responding hospitals may be subject to substantial
penalties as a result of enforcement actions brought by
government agencies and whistleblowers acting pursuant to the
FCA and similar state laws, based on such allegations as failure
to respond within required deadlines, that the response is
inaccurate or contains incomplete information, or that the
response indicates a potential violation of the Stark Law or
other requirements.
Similar
State Laws
Many states in which we operate also have laws similar to the
Anti-kickback Statute that prohibit payments to physicians for
patient referrals and laws similar to the Stark Law that
prohibit certain self-referrals. The scope of these state laws
is broad, since they can often apply regardless of the source of
payment for care, and little precedent exists for their
interpretation or enforcement. These statutes typically provide
for criminal and civil penalties, as well as loss of facility
licensure.
Other
Fraud and Abuse Provisions
The Health Insurance Portability and Accountability Act of 1996
(HIPAA) broadened the scope of certain fraud and
abuse laws by adding several criminal provisions for health care
fraud offenses that apply to all health benefit programs. The
Social Security Act also imposes criminal and civil penalties
for making false claims and statements to Medicare and Medicaid.
False claims include, but are not limited to, billing for
services not rendered or for misrepresenting actual services
rendered in order to obtain higher reimbursement, billing for
unnecessary goods and services, and cost report fraud. Federal
enforcement officials have the ability to exclude from Medicare
and Medicaid any investors, officers and managing employees
associated with business entities that have committed health
care fraud, even if the officer or managing employee had no
knowledge of the fraud. Criminal and civil penalties may be
imposed for a number of other prohibited activities, including
failure to return known overpayments, certain gainsharing
arrangements, billing Medicare amounts that are substantially in
excess of a providers usual charges, offering remuneration
to influence a Medicare or Medicaid beneficiarys selection
of a health care provider, contracting with an individual or
entity known to be excluded from a federal health care program,
making or accepting a payment to induce a physician to reduce or
limit services, and soliciting or
16
receiving any remuneration in return for referring an individual
for an item or service payable by a federal healthcare program.
Like the Anti-kickback Statute, these provisions are very broad.
To avoid liability, providers must, among other things,
carefully and accurately code claims for reimbursement, as well
as accurately prepare cost reports.
Some of these provisions, including the federal Civil Monetary
Penalty Law, require a lower burden of proof than other fraud
and abuse laws, including the Anti-kickback Statute. Civil
monetary penalties that may be imposed under the federal Civil
Monetary Penalty Law range from $10,000 to $50,000 per act, and
in some cases may result in penalties of up to three times the
remuneration offered, paid, solicited or received. In addition,
a violator may be subject to exclusion from federal and state
healthcare programs. Federal and state governments increasingly
use the federal Civil Monetary Penalty Law, especially where
they believe they cannot meet the higher burden of proof
requirements under the Anti-kickback Statute. Further,
individuals can receive up to $1,000 for providing information
on Medicare fraud and abuse that leads to the recovery of at
least $100 of Medicare funds under the Medicare Integrity
Program.
The
Federal False Claims Act and Similar State Laws
The qui tam, or whistleblower, provisions of the federal
False Claims Act (FCA) allow private individuals to
bring actions on behalf of the government alleging that the
defendant has defrauded the federal government. Further, the
government may use the FCA to prosecute Medicare and other
government program fraud in areas such as coding errors, billing
for services not provided and submitting false cost reports.
When a private party brings a qui tam action under the
FCA, the defendant often will not be made aware of the lawsuit
until the government commences its own investigation or makes a
determination whether it will intervene. When a defendant is
determined by a court of law to be liable under the FCA, the
defendant may be required to pay three times the actual damages
sustained by the government, plus mandatory civil penalties of
between $5,500 and $11,000 for each separate false claim. There
are many potential bases for liability under the FCA. Liability
often arises when an entity knowingly submits a false claim for
reimbursement to the federal government. The FCA defines the
term knowingly broadly. Though simple negligence
will not give rise to liability under the FCA, submitting a
claim with reckless disregard to its truth or falsity
constitutes a knowing submission under the FCA and,
therefore, will qualify for liability.
In some cases, whistleblowers and the federal government have
taken the position, and some courts have held, that providers
who allegedly have violated other statutes, such as the
Anti-kickback Statute and the Stark Law, have thereby submitted
false claims under the FCA. Every entity that receives at least
$5 million annually in Medicaid payments must have written
policies for all employees, contractors or agents, providing
detailed information about false claims, false statements and
whistleblower protections under certain federal laws, including
the FCA, and similar state laws. In addition, federal law
provides an incentive to states to enact false claims laws that
are comparable to the FCA. A number of states in which we
operate have adopted their own false claims provisions as well
as their own whistleblower provisions under which a private
party may file a civil lawsuit in state court.
HIPAA
Administrative Simplification and Privacy and Security
Requirements
The Administrative Simplification Provisions of HIPAA require
the use of uniform electronic data transmission standards for
certain health care claims and payment transactions submitted or
received electronically. These provisions are intended to
encourage electronic commerce in the health care industry. HHS
has issued regulations implementing the HIPAA Administrative
Simplification Provisions and compliance with these regulations
is mandatory for our facilities. In January 2009, CMS published
a final rule regarding updated standard code sets for certain
diagnoses and procedures known as ICD-10 code sets and related
changes to the formats used for certain electronic transactions.
While use of the ICD-10 code sets is not mandatory until
October 1, 2013, we will be modifying our payment systems
and processes to prepare for the implementation. In addition,
HIPAA requires that each provider use a National Provider
Identifier. While use of the ICD-10 code sets will require
significant administrative changes, we believe that the cost of
compliance with these regulations has not had and is not
expected to have a material, adverse effect on our business,
financial position or results of operations.
17
The privacy and security regulations promulgated pursuant to
HIPAA extensively regulate the use and disclosure of
individually identifiable health information and require covered
entities, including health plans, to implement administrative,
physical and technical safeguards to protect the security of
such information. Recently, the American Recovery and
Reinvestment Act of 2009 (ARRA) broadened the scope
of the HIPAA privacy and security regulations. Among other
things, the ARRA provides that HHS must issue regulations
requiring covered entities to report certain security breaches
to individuals affected by the breach and, in some cases, to HHS
or to the public via a website. This reporting obligation will
apply broadly to breaches involving unsecured protected health
information and will become effective 30 days from the date
HHS issues these regulations. In addition, the ARRA extends the
application of certain provisions of the security and privacy
regulations to business associates (entities that handle
identifiable health information on behalf of covered entities)
and subjects business associates to civil and criminal penalties
for violation of the regulations. We enforce a HIPAA compliance
plan, which we believe complies with HIPAA privacy and security
requirements and under which a HIPAA compliance group monitors
our compliance. The privacy regulations and security regulations
have and will continue to impose significant costs on our
facilities in order to comply with these standards.
Violations of the HIPAA privacy and security regulations may
result in civil and criminal penalties, and the ARRA has
strengthened the enforcement provisions of HIPAA, which may
result in increased enforcement activity. Under the ARRA, HHS is
required to conduct periodic compliance audits of covered
entities and their business associates. The ARRA broadens the
applicability of the criminal penalty provisions to employees of
covered entities and requires HHS to impose penalties for
violations resulting from willful neglect. The ARRA also
significantly increases the amount of the civil penalties, with
penalties of up to $50,000 per violation for a maximum civil
penalty of $1,500,000 in a calendar year for violations of the
same requirement. In addition, the ARRA authorizes state
attorneys general to bring civil actions seeking either
injunction or damages in response to violations of HIPAA privacy
and security regulations that threaten the privacy of state
residents.
We remain subject to any state laws that relate to privacy or
the reporting of security breaches that are more restrictive
than the regulations issued under HIPAA and the requirements of
the ARRA. For example, various state laws and regulations may
require us to notify affected individuals in the event of a data
breach involving certain individually identifiable health or
financial information. In addition, the Federal Trade Commission
issued a final rule in October 2007 requiring financial
institutions and creditors, which may include health providers
and health plans, to implement written identity theft prevention
programs to detect, prevent, and mitigate identity theft in
connection with certain accounts. The compliance date for this
rule has been postponed until May 1, 2009.
EMTALA
All of our hospitals are subject to the Emergency Medical
Treatment and Active Labor Act (EMTALA). This
federal law requires any hospital participating in the Medicare
program to conduct an appropriate medical screening examination
of every individual who presents to the hospitals
emergency room for treatment and, if the individual is suffering
from an emergency medical condition, to either stabilize the
condition or make an appropriate transfer of the individual to a
facility able to handle the condition. The obligation to screen
and stabilize emergency medical conditions exists regardless of
an individuals ability to pay for treatment. There are
severe penalties under EMTALA if a hospital fails to screen or
appropriately stabilize or transfer an individual or if the
hospital delays appropriate treatment in order to first inquire
about the individuals ability to pay. Penalties for
violations of EMTALA include civil monetary penalties and
exclusion from participation in the Medicare program. In
addition, an injured individual, the individuals family or
a medical facility that suffers a financial loss as a direct
result of a hospitals violation of the law can bring a
civil suit against the hospital.
The government broadly interprets EMTALA to cover situations in
which individuals do not actually present to a hospitals
emergency room, but present for emergency examination or
treatment to the hospitals campus, generally, or to a
hospital-based clinic that treats emergency medical conditions
or are transported in a hospital-owned ambulance, subject to
certain exceptions. EMTALA does not generally apply to
individuals admitted for inpatient services. The government also
has expressed its intent to investigate and enforce EMTALA
violations actively in the future. We believe our hospitals
operate in substantial compliance with EMTALA.
18
Corporate
Practice of Medicine/Fee Splitting
Some of the states in which we operate have laws prohibiting
corporations and other entities from employing physicians,
practicing medicine for a profit and making certain direct and
indirect payments or fee-splitting arrangements between health
care providers designed to induce or encourage the referral of
patients to, or the recommendation of, particular providers for
medical products and services. Possible sanctions for violation
of these restrictions include loss of license and civil and
criminal penalties. In addition, agreements between the
corporation and the physician may be considered void and
unenforceable. These statutes vary from state to state, are
often vague and have seldom been interpreted by the courts or
regulatory agencies.
Health
Care Industry Investigations
Significant media and public attention has focused in recent
years on the hospital industry. This media and public attention,
changes in government personnel or other factors may lead to
increased scrutiny of the health care industry. While we are
currently not aware of any material investigations of the
Company under federal or state health care laws or regulations,
it is possible that governmental entities could initiate
investigations or litigation in the future at facilities we
operate and that such matters could result in significant
penalties, as well as adverse publicity. It is also possible
that our executives and managers could be included in
governmental investigations or litigation or named as defendants
in private litigation.
Our substantial Medicare, Medicaid and other governmental
billings result in heightened scrutiny of our operations. We
continue to monitor all aspects of our business and have
developed a comprehensive ethics and compliance program that is
designed to meet or exceed applicable federal guidelines and
industry standards. Because the law in this area is complex and
constantly evolving, governmental investigations or litigation
may result in interpretations that are inconsistent with our or
industry practices.
In public statements surrounding current investigations,
governmental authorities have taken positions on a number of
issues, including some for which little official interpretation
previously has been available, that appear to be inconsistent
with practices that have been common within the industry and
that previously have not been challenged in this manner. In some
instances, government investigations that have in the past been
conducted under the civil provisions of federal law may now be
conducted as criminal investigations.
Both federal and state government agencies have increased their
focus on and coordination of civil and criminal enforcement
efforts in the health care area. The OIG and the Department of
Justice have, from time to time, established national
enforcement initiatives, targeting all hospital providers, that
focus on specific billing practices or other suspected areas of
abuse. In addition, governmental agencies and their agents, such
as the Medicare Administrative Contractors, fiscal
intermediaries and carriers, may conduct audits of our health
care operations. Private payers may conduct similar post-payment
audits, and we also perform internal audits and monitoring.
In addition to national enforcement initiatives, federal and
state investigations relate to a wide variety of routine health
care operations such as: cost reporting and billing practices,
including for Medicare outliers; financial arrangements with
referral sources; physician recruitment activities; physician
joint ventures; and hospital charges and collection practices
for self-pay patients. We engage in many of these routine health
care operations and other activities that could be the subject
of governmental investigations or inquiries. For example, we
have significant Medicare and Medicaid billings, numerous
financial arrangements with physicians who are referral sources
to our hospitals, and joint venture arrangements involving
physician investors. Certain of our individual facilities have
received, and other facilities may receive, government inquiries
from federal and state agencies. Any additional investigations
of the Company, our executives or managers could result in
significant liabilities or penalties to us, as well as adverse
publicity.
Commencing in 1997, we became aware we were the subject of
governmental investigations and litigation relating to our
business practices. As part of the investigations, the United
States intervened in a number of qui tam actions brought
by private parties. The investigations related to, among other
things, DRG coding, outpatient laboratory billing, home health
issues, physician relations, cost report and wound care issues.
The investigations were concluded through a series of agreements
executed in 2000 and 2003 with the Criminal Division of the
Department of Justice, the Civil Division of the Department of
Justice, various U.S. Attorneys offices, CMS, a
19
negotiating team representing states with claims against us, and
others. In January 2001, we entered into an eight year Corporate
Integrity Agreement (CIA) with the Office of
Inspector General of the Department of Health and Human
Services, which expired January 24, 2009. Violation or
breach of the CIA or other violation of federal or state laws
relating to Medicare, Medicaid or similar programs, could
subject us to substantial monetary fines, civil and criminal
penalties
and/or
exclusion from participation in the Medicare and Medicaid
programs and other federal and state health care programs.
Alleged violations may be pursued by the government or through
private qui tam actions. Sanctions imposed against us as a
result of such actions could have a material, adverse effect on
our results of operations and financial position.
Health
Care Reform
Health care is one of the largest industries in the United
States and continues to attract much legislative interest and
public attention. In recent years, various legislative proposals
regarding health care reform have been introduced or proposed in
Congress. We anticipate that national health care reform will be
a focus at the federal level in the near term. Several states
are also considering health care reform measures. This focus on
health care reform may increase the likelihood of significant
changes affecting the health care industry. Possible future
changes in the Medicare, Medicaid, and other state programs,
including Medicaid supplemental payments pursuant to upper
payment limit programs, may impact reimbursements to health care
providers and insurers. In addition, many states have enacted,
or are considering enacting, measures designed to reduce their
Medicaid expenditures and change private health care insurance.
States have also adopted, or are considering, legislation
designed to reduce coverage and program eligibility, enroll
Medicaid recipients in managed care programs
and/or
impose additional taxes on hospitals to help finance or expand
states Medicaid systems. Some states, including the states
in which we operate, have applied for and have been granted
federal waivers from current Medicaid regulations to allow them
to serve some or all of their Medicaid participants through
managed care providers. Hospital operating margins have been,
and may continue to be, under significant pressure because of
deterioration in pricing flexibility and payer mix, and growth
in operating expenses in excess of the increase in PPS payments
under the Medicare program.
General
Economic and Demographic Factors
Recently, the United States economy has weakened
significantly. Tightening credit markets, depressed consumer
spending and higher unemployment rates continue to pressure many
industries. During economic downturns, governmental entities
often experience budgetary constraints as a result of increased
costs and lower than expected tax collections. These budgetary
constraints may result in decreased spending for health and
human service programs, including Medicare, Medicaid and similar
programs, which represent significant payer sources for our
hospitals. Other risks we face from general economic weakness
include potential declines in the population covered under
managed care agreements, patient decisions to postpone or cancel
elective and non-emergent health care procedures, potential
increases in the uninsured and underinsured populations and
further difficulties in our collecting patient copayment and
deductible receivables.
The health care industry is impacted by the overall United
States financial pressures. The federal deficit, the
growing magnitude of Medicare expenditures and the aging of the
United States population will continue to place pressure on
federal health care programs.
Compliance
Program and Corporate Integrity Agreement
We maintain a comprehensive ethics and compliance program that
is designed to meet or exceed applicable federal guidelines and
industry standards. The program is intended to monitor and raise
awareness of various regulatory issues among employees and to
emphasize the importance of complying with governmental laws and
regulations. As part of the ethics and compliance program, we
provide annual ethics and compliance training to our employees
and encourage all employees to report any violations to their
supervisor, an ethics and compliance officer or a toll-free
telephone ethics line.
Until January 24, 2009, we operated under a CIA, which was
structured to assure the federal government of our overall
federal health care program compliance and specifically covered
DRG coding, outpatient PPS billing and physician relations. We
underwent major training efforts to ensure that our employees
learned and applied the
20
policies and procedures implemented under the CIA and our ethics
and compliance program. The CIA had the effect of increasing the
amount of information we provided to the federal government
regarding our health care practices and our compliance with
federal regulations. Under the CIA, we had numerous affirmative
obligations, including the requirement to report potential
violations of applicable federal health care laws and
regulations. Pursuant to this obligation, we reported a number
of potential violations of the Stark Law, the Anti-kickback
Statute, EMTALA, HIPAA and other laws, most of which we consider
to be nonviolations or technical violations. We will submit our
final report pursuant to the CIA by April 30, 2009. These
reports could result in greater scrutiny by regulatory
authorities. The government could determine that our reporting
and/or our
resolution of reported issues was inadequate. A determination
that we breached the CIA
and/or a
finding of violations of applicable health care laws or
regulations could subject us to repayment requirements,
substantial monetary penalties, civil penalties, exclusion from
participation in the Medicare and Medicaid and other federal and
state health care programs and, for violations of certain laws
and regulations, criminal penalties. Though the CIA expired on
January 24, 2009, we maintain our ethics and compliance
program in substantially the same form. However, the audit plans
in the CIA have been modified and the reportable events process
will be converted to an internal reporting process.
Antitrust
Laws
The federal government and most states have enacted antitrust
laws that prohibit certain types of conduct deemed to be
anti-competitive. These laws prohibit price fixing, concerted
refusal to deal, market monopolization, price discrimination,
tying arrangements, acquisitions of competitors and other
practices that have, or may have, an adverse effect on
competition. Violations of federal or state antitrust laws can
result in various sanctions, including criminal and civil
penalties. Antitrust enforcement in the health care industry is
currently a priority of the Federal Trade Commission. We believe
we are in compliance with such federal and state laws, but
future review of our practices by courts or regulatory
authorities could result in a determination that could adversely
affect our operations.
Environmental
Matters
We are subject to various federal, state and local statutes and
ordinances regulating the discharge of materials into the
environment. Management does not believe that we will be
required to expend any material amounts in order to comply with
these laws and regulations or that compliance will materially
affect our capital expenditures, results of operations or
financial condition.
Insurance
As typical in the health care industry, we are subject to claims
and legal actions by patients in the ordinary course of
business. Subject to a $5 million per occurrence
self-insured retention, our facilities are insured by our
wholly-owned insurance subsidiary for losses up to
$50 million per occurrence. The insurance subsidiary has
obtained reinsurance for professional liability risks generally
above a retention level of $15 million per occurrence. We
also maintain professional liability insurance with unrelated
commercial carriers for losses in excess of amounts insured by
our insurance subsidiary.
We purchase, from unrelated insurance companies, coverage for
directors and officers liability and property loss in amounts
that we believe are adequate. The directors and officers
liability coverage includes a $25 million corporate
deductible for the periods prior to the Merger and a
$1 million corporate deductible subsequent to the Merger.
In addition, we will continue to purchase coverage for our
directors and officers on an ongoing basis. The property
coverage includes varying deductibles depending on the cause of
the property damage. These deductibles range from $500,000 per
claim up to 5% of the affected property values for certain flood
and wind and earthquake related incidents.
Employees
and Medical Staffs
At December 31, 2008 we had approximately
191,000 employees, including approximately
51,000 part-time employees. References herein to
employees refer to employees of affiliates of HCA.
We are subject to various state and federal laws that regulate
wages, hours, benefits and other terms and conditions relating
to employment. Employees at 21 of our hospitals were represented
by various labor unions at December 31, 2008 and 2007. We
21
consider our employee relations to be satisfactory. Our
hospitals, as well as others, have experienced some recent union
organizational activity. We had elections at two hospitals in
California and one in Missouri during 2007 and no elections
during 2008. We expect to have one election in Missouri in 2009
as hospital employees have filed a decertification petition with
the National Labor Relations Board. We do not expect such
efforts to materially affect our future operations. Our
hospitals, like most hospitals, have experienced labor costs
rising faster than the general inflation rate. In some markets,
nurse and medical support personnel availability has become a
significant operating issue to health care providers. To address
this challenge, we have implemented several initiatives to
improve retention, recruiting, compensation programs and
productivity.
Our hospitals are staffed by licensed physicians, who generally
are not employees of our hospitals. However, some physicians
provide services in our hospitals under contracts which
generally describe a term of service, provide and establish the
duties and obligations of such physicians, require the
maintenance of certain performance criteria and fix compensation
for such services. Any licensed physician may apply to be
accepted to the medical staff of any of our hospitals, but the
hospitals medical staff and the appropriate governing
board of the hospital, in accordance with established
credentialing criteria, must approve acceptance to the staff.
Members of the medical staffs of our hospitals often also serve
on the medical staffs of other hospitals and may terminate their
affiliation with one of our hospitals at any time.
We may be required to continue to enhance wages and benefits to
recruit and retain nurses and other medical support personnel or
to hire more expensive temporary or contract personnel. We also
depend on the available labor pool of semi-skilled and unskilled
employees in each of the markets in which we operate. As the
competition increases to hire more people from labor pools that
are not growing at a rate sufficient to meet demand, our labor
costs could increase. Certain proposed changes in federal labor
laws, including the Employee Free Choice Act, may increase the
likelihood of employee unionization attempts. To the extent that
a significant portion of our employee base unionizes, our costs
could increase materially. In addition, union-mandated or
state-mandated nurse-staffing ratios could significantly affect
labor costs, and have an adverse impact on revenues if we are
unable to meet the required ratios and are required to limit
patient admissions as a result. The states in which we operate
could adopt mandatory nurse-staffing ratios or could reduce
mandatory nurse-staffing ratios already in place.
Risk
Factors
If any of the events discussed in the following risk factors
were to occur, our business, financial position, results of
operations, cash flows or prospects could be materially,
adversely affected. Additional risks and uncertainties not
presently known, or currently deemed immaterial, may also
constrain our business and operations.
Our Substantial Leverage Could Adversely Affect Our Ability
To Raise Additional Capital To Fund Our Operations, Limit
Our Ability To React To Changes In The Economy Or Our Industry,
Expose Us To Interest Rate Risk To The Extent Of Our Variable
Rate Debt And Prevent Us From Meeting Our Obligations.
Since completing the Recapitalization, we are highly leveraged.
As of December 31, 2008, our total indebtedness was
$26.989 billion. Our high degree of leverage could have
important consequences, including:
|
|
|
|
|
increasing our vulnerability to downturns or adverse changes in
general economic, industry or competitive conditions and adverse
changes in government regulations;
|
|
|
|
requiring a substantial portion of cash flow from operations to
be dedicated to the payment of principal and interest on our
indebtedness, therefore reducing our ability to use our cash
flow to fund our operations, capital expenditures and future
business opportunities;
|
|
|
|
exposing us to the risk of increased interest rates as certain
of our unhedged borrowings are at variable rates of interest;
|
|
|
|
limiting our ability to make strategic acquisitions or causing
us to make nonstrategic divestitures;
|
22
|
|
|
|
|
limiting our ability to obtain additional financing for working
capital, capital expenditures, product or service line
development, debt service requirements, acquisitions and general
corporate or other purposes; and
|
|
|
|
limiting our ability to adjust to changing market conditions and
placing us at a competitive disadvantage compared to our
competitors who are less highly leveraged.
|
We and our subsidiaries have the ability to incur additional
indebtedness in the future, subject to the restrictions
contained in our senior secured credit facilities and the
indentures governing our outstanding notes. If new indebtedness
is added to our current debt levels, the related risks that we
now face could intensify.
We May
Not Be Able To Generate Sufficient Cash To Service All Of Our
Indebtedness And May Not Be Able To Refinance Our Indebtedness
On Favorable Terms. If We Are Unable To Do So, We May Be Forced
To Take Other Actions To Satisfy Our Obligations Under Our
Indebtedness, Which May Not Be Successful.
Our ability to make scheduled payments on or to refinance our
debt obligations depends on our financial condition and
operating performance, which is subject to prevailing economic
and competitive conditions and to certain financial, business
and other factors beyond our control. We cannot assure you that
we will maintain a level of cash flows from operating activities
sufficient to permit us to pay the principal, premium, if any,
and interest on our indebtedness.
As of December 31, 2008, our substantial indebtedness
included $14.052 billion of indebtedness under our senior
secured credit facilities that matures in 2012 and 2013,
$5.700 billion of second lien notes maturing in 2014 and
2016 and $6.831 billion of unsecured senior notes and
debentures that mature on various dates from 2009 to 2095
(including $5.442 billion maturing through 2016). Because a
significant portion of our indebtedness matures in the next few
years, we may find it necessary or prudent to refinance that
indebtedness with longer-maturity debt at a higher interest
rate. In February 2009, for example, we issued $310 million
of
97/8% Senior
Secured Notes due in 2017. We used the net proceeds of that
offering to prepay term loans under our senior secured credit
facilities, which currently bear interest at a lower floating
rate. Our ability to refinance our indebtedness on favorable
terms, or at all, is directly affected by the current global
economic and financial crisis. In addition, our ability to incur
secured indebtedness (which may enable us to achieve better
pricing than the incurrence of unsecured indebtedness) depends
in part on the value of our assets, which depends, in turn, on
the strength of our cash flows and results of operations and on
economic and market conditions and other factors.
If our cash flows and capital resources are insufficient to fund
our debt service obligations or we are unable to refinance our
indebtedness, we may be forced to reduce or delay investments
and capital expenditures, or to sell assets, seek additional
capital or restructure our indebtedness. These alternative
measures may not be successful and may not permit us to meet our
scheduled debt service obligations. If our operating results and
available cash are insufficient to meet our debt service
obligations, we could face substantial liquidity problems and
might be required to dispose of material assets or operations to
meet our debt service and other obligations. We may not be able
to consummate those dispositions, or the proceeds from the
dispositions may not be adequate to meet any debt service
obligations then due.
Our Debt
Agreements Contain Restrictions That Limit Our Flexibility In
Operating Our Business.
Our senior secured credit facilities and the indentures
governing our outstanding notes contain various covenants that
limit our ability to engage in specified types of transactions.
These covenants limit our and certain of our subsidiaries
ability to, among other things:
|
|
|
|
|
incur additional indebtedness or issue certain preferred shares;
|
|
|
|
pay dividends on, repurchase or make distributions in respect of
our capital stock or make other restricted payments;
|
|
|
|
make certain investments;
|
|
|
|
sell or transfer assets;
|
23
|
|
|
|
|
create liens;
|
|
|
|
consolidate, merge, sell or otherwise dispose of all or
substantially all of our assets; and
|
|
|
|
enter into certain transactions with our affiliates.
|
Under our asset-based revolving credit facility, when (and for
as long as) the combined availability under our asset-based
revolving credit facility and our senior secured revolving
credit facility is less than a specified amount, for a certain
period of time, or if a payment or bankruptcy event of default
has occurred and is continuing, funds deposited into any of our
depository accounts will be transferred on a daily basis into a
blocked account with the administrative agent and applied to
prepay loans under the asset-based revolving credit facility and
to cash collateralize letters of credit issued thereunder.
Under our senior secured credit facilities we are required to
satisfy and maintain specified financial ratios. Our ability to
meet those financial ratios can be affected by events beyond our
control, and there can be no assurance that we will continue to
meet those ratios. A breach of any of these covenants could
result in a default under both of our senior secured credit
facilities. Upon the occurrence of an event of default under our
senior secured credit facilities, our lenders could elect to
declare all amounts outstanding under our senior secured credit
facilities to be immediately due and payable and terminate all
commitments to extend further credit. If we were unable to repay
those amounts, the lenders under our senior secured credit
facilities could proceed against the collateral granted to them
to secure each such indebtedness. We have pledged a significant
portion of our assets as collateral under our senior secured
credit facilities and our existing senior secured notes. If any
of the lenders under our senior secured credit facilities
accelerate the repayment of borrowings, there can be no
assurance that we will have sufficient assets to repay our
senior secured credit facilities and our outstanding notes.
Our
Hospitals Face Competition For Patients From Other Hospitals And
Health Care Providers.
The health care business is highly competitive, and competition
among hospitals and other health care providers for patients has
intensified in recent years. Generally, other hospitals in the
local communities served by most of our hospitals provide
services similar to those offered by our hospitals. In addition,
CMS publicizes on a website performance data related to quality
measures and data on patient satisfaction surveys that hospitals
submit in connection with their Medicare reimbursement. Federal
law provides for the future expansion of the number of quality
measures that must be reported. Additional quality measures and
future trends toward clinical transparency may have an
unanticipated impact on our competitive position and patient
volumes. If any of our hospitals achieve poor results (or
results that are lower than our competitors) on these quality
measures or on patient satisfaction surveys, patient volumes
could decline.
In addition, the number of freestanding specialty hospitals,
surgery centers and diagnostic and imaging centers in the
geographic areas in which we operate has increased
significantly. As a result, most of our hospitals operate in a
highly competitive environment. Some of the facilities that
compete with our hospitals are owned by governmental agencies or
not-for-profit corporations supported by endowments, charitable
contributions
and/or tax
revenues and can finance capital expenditures and operations on
a tax-exempt basis. Our hospitals are facing increasing
competition from physician-owned specialty hospitals and from
both our own and unaffiliated freestanding surgery centers for
market share in high margin services and for quality physicians
and personnel. If ambulatory surgery centers are better able to
compete in this environment than our hospitals, our hospitals
may experience a decline in patient volume, and we may
experience a decrease in margin, even if those patients use our
ambulatory surgery centers. In states that do not require prior
regulatory approval, known as a certificate of need
(CON), for the purchase, construction or expansion
of health care facilities or services, competing health care
providers face low barriers to entry and expansion. Further, if
our competitors are better able to attract patients, recruit
physicians, expand services or obtain favorable managed care
contracts at their facilities than our hospitals and ambulatory
surgery centers, we may experience an overall decline in patient
volume. See Item 1, Business
Competition.
24
The
Growth Of Uninsured And Patient Due Accounts And A Deterioration
In The Collectibility Of These Accounts Could Adversely Affect
Our Results Of Operations.
The primary collection risks of our accounts receivable relate
to the uninsured patient accounts and patient accounts for which
the primary insurance carrier has paid the amounts covered by
the applicable agreement, but patient responsibility amounts
(deductibles and copayments) remain outstanding. The provision
for doubtful accounts relates primarily to amounts due directly
from patients.
The amount of the provision for doubtful accounts is based upon
managements assessment of historical writeoffs and
expected net collections, business and economic conditions,
trends in federal and state governmental and private employer
health care coverage, the rate of growth in uninsured patient
admissions and other collection indicators. Due to a number of
factors, including the recent economic downturn and increase in
unemployment, we believe that our facilities may experience
growth in bad debts and charity care. At December 31, 2008,
our allowance for doubtful accounts represented approximately
93% of the $5.838 billion patient due accounts receivable
balance. For the year ended December 31, 2008, the
provision for doubtful accounts increased to 12.0% of revenues
compared to 11.7% of revenues in 2007.
A continuation of the trends that have resulted in an increasing
proportion of accounts receivable being comprised of uninsured
accounts and a deterioration in the collectibility of these
accounts will adversely affect our collection of accounts
receivable, cash flows and results of operations.
Changes
In Governmental And Judicial Interpretations May Negatively
Impact Our Ability To Obtain Reimbursement Of Medicare Bad
Debts
The Medicare program reimburses 70% of bad debts related to
deductibles and coinsurance for patients with Medicare coverage,
after the provider has made a reasonable effort to collect those
amounts. We utilize extensive in-house and external collection
efforts for our accounts receivable, including deductible and
coinsurance amounts owed by patients with Medicare coverage. We
use a secondary collection agency after in-house and primary
collection agency efforts have been unsuccessful. A recent court
case upheld CMSs interpretation that reasonable collection
efforts have not been satisfied as long as the Medicare accounts
remain with an external collection agency. We incur substantial
amounts of Medicare bad debts every year that could be subject
to this decision. During 2007, we modified our accounts
receivable collection processes to provide reasonable collection
results and comply with CMSs interpretation of reasonable
collection efforts. Possible future changes in judicial and
administrative interpretations of law and regulations governing
Medicare could disrupt our collections processes, increase our
costs or otherwise adversely affect our business and results of
operations.
Changes
In Governmental Programs May Reduce Our Revenues.
A significant portion of our patient volumes is derived from
government health care programs, principally Medicare and
Medicaid, which are highly regulated and subject to frequent and
substantial changes. We derived approximately 59% of our
admissions from the Medicare and Medicaid programs in 2008. In
recent years, legislative and regulatory changes have resulted
in limitations on and, in some cases, reductions in levels of
payments to health care providers for certain services under
these government programs. National health care reform is a
focus at the federal level, and we anticipate that it will
remain a focus in the near term. Several states are also
considering health care reform measures. This focus on health
care reform may increase the likelihood of significant changes
affecting government health care programs. Possible future
changes in the Medicare, Medicaid, and other state programs, may
reduce reimbursements to health care providers and insurers and
may also increase our operating costs, which could reduce our
profitability.
CMS issued final regulations effective January 1, 2008 that
increased ASC payment groups from nine clinically disparate
payment groups to an extensive list of covered surgical
procedures among the APCs used under the outpatient PPS for
these surgical services. CMS estimates that the payment rates
for procedures performed in an ASC setting equal 65% of the
corresponding rates paid for the same procedures performed in an
outpatient hospital setting. The final regulation establishes a
four-year transition period for implementing the revised payment
rates. This regulation significantly expands the number of
procedures that Medicare reimburses if performed in an ASC and
limits ASC reimbursement for procedures commonly performed in
physicians offices. More Medicare
25
procedures that are now performed in hospitals, such as ours,
may be moved to ASCs, reducing surgical volume in our hospitals.
Also, more Medicare procedures that are now performed in ASCs,
such as ours, may be moved to physicians offices.
Commercial third-party payers may adopt similar policies.
On August 22, 2007, CMS issued a final rule for federal
fiscal year 2008 for hospital inpatient PPS. This rule adopts a
two-year implementation of MS-DRGs, a Medicare severity-adjusted
diagnosis related group system. This change represents a
refinement to the existing Medicare DRG system. Realignments in
the DRG system could impact the margins we receive for certain
services. For federal fiscal year 2009, CMS has provided a 3.6%
market basket update for hospitals that submit certain quality
patient care indicators and a 1.6% update for hospitals that do
not submit this data. While we will endeavor to comply with all
quality data submission requirements, our submissions may not be
deemed timely or sufficient to entitle us to the full market
basket adjustment for all of our hospitals. Medicare payments to
hospitals in fiscal years 2009 and 2008 have been reduced to
eliminate what CMS estimates will be the effect of coding or
classifications changes as a result of hospitals implementing
the MS-DRG system. CMS may retrospectively determine if the
adjustment levels for federal fiscal years 2009 and 2008 were
adequate and may impose an adjustment in future years if CMS
finds that the adjustment was inadequate. Additionally, Medicare
payments to hospitals are subject to a number of other
adjustments, and the actual impact on payments to specific
hospitals may vary. In some cases, commercial third-party payers
and other payers such as some state Medicaid programs rely on
all or portions of the Medicare DRG system to determine payment
rates. The change from traditional Medicare DRGs to MS-DRGs
could adversely impact those payment rates if any other payers
adopt MS-DRGs.
Since most states must operate with balanced budgets and since
the Medicaid program is often the states largest program,
states can be expected to adopt or consider adopting legislation
designed to reduce their Medicaid expenditures. The current
economic downturn has increased the budgetary pressures on most
states, and these budgetary pressures have resulted and likely
will continue to result in decreased spending for Medicaid
programs in many states. Further, many states have also adopted,
or are considering, legislation designed to reduce coverage and
program eligibility, enroll Medicaid recipients in managed care
programs
and/or
impose additional taxes on hospitals to help finance or expand
the states Medicaid systems.
Recently, the Department of Defense implemented a prospective
payment system for hospital outpatient services furnished to
TRICARE beneficiaries similar to that utilized for services
furnished to Medicare beneficiaries. Because the Medicare
outpatient prospective payment system APC rates have
historically been below TRICARE rates, the adoption of this
payment methodology for TRICARE beneficiaries will reduce our
reimbursement. This change in TRICARE will have a material
impact on our revenues from this program; however, TRICARE
outpatient services do not represent a significant portion of
our patient volumes. The TRICARE outpatient payment rule has
been reopened for comment and the effective date delayed until
May 1, 2009. Further modification to the new outpatient
payment system may be made.
Changes in laws or regulations regarding government health
programs or other changes in the administration of government
health programs could have a material, adverse effect on our
financial position and results of operations.
If We Are
Unable To Retain And Negotiate Favorable Contracts With
Nongovernment Payers, Including Managed Care Plans, Our Revenues
May Be Reduced.
Our ability to obtain favorable contracts with nongovernment
payers, including health maintenance organizations, preferred
provider organizations and other managed care plans
significantly affects the revenues and operating results of our
facilities. Revenues derived from these entities and other
insurers accounted for 53% and 54% of our patient revenues for
the years ended December 31, 2008 and 2007, respectively.
Nongovernment payers, including managed care payers, continue to
demand discounted fee structures, and the trend toward
consolidation among nongovernment payers tends to increase their
bargaining power over fee structures. Our future success will
depend, in part, on our ability to retain and renew our managed
care contracts and enter into new managed care contracts on
terms favorable to us. Other health care providers may impact
our ability to enter into managed care contracts or negotiate
increases in our reimbursement and other favorable terms and
conditions. For example, some of our competitors may negotiate
exclusivity provisions with managed care plans or otherwise
restrict the ability of
26
managed care companies to contract with us. If we are unable to
retain and negotiate favorable contracts with managed care plans
or experience reductions in payment increases or amounts
received from nongovernment payers, our revenues may be reduced.
Our
Performance Depends On Our Ability To Recruit And Retain Quality
Physicians.
Physicians generally direct the majority of hospital admissions,
and the success of our hospitals depends, therefore, in part on
the number and quality of the physicians on the medical staffs
of our hospitals, the admitting practices of those physicians
and maintaining good relations with those physicians. Physicians
are often not employees of the hospitals at which they practice
and, in many of the markets that we serve, most physicians have
admitting privileges at other hospitals in addition to our
hospitals. Such physicians may terminate their affiliation with
our hospitals at any time. If we are unable to provide adequate
support personnel or technologically advanced equipment and
hospital facilities that meet the needs of those physicians,
they may be discouraged from referring patients to our
facilities, admissions may decrease and our operating
performance may decline.
Our
Hospitals Face Competition For Staffing, Which May Increase
Labor Costs And Reduce Profitability.
Our operations are dependent on the efforts, abilities and
experience of our management and medical support personnel, such
as nurses, pharmacists and lab technicians, as well as our
physicians. We compete with other health care providers in
recruiting and retaining qualified management and support
personnel responsible for the daily operations of each of our
hospitals, including nurses and other nonphysician health care
professionals. In some markets, the availability of nurses and
other medical support personnel has become a significant
operating issue to health care providers. We may be required to
continue to enhance wages and benefits to recruit and retain
nurses and other medical support personnel or to hire more
expensive temporary or contract personnel. We also depend on the
available labor pool of semi-skilled and unskilled employees in
each of the markets in which we operate. As the competition
increases to hire more people from labor pools that are not
growing at a rate sufficient to meet demand, our labor costs
could increase. Certain proposed changes in federal labor laws,
including the Employee Free Choice Act, may increase the
likelihood of employee unionization attempts. To the extent that
a significant portion of our employee base unionizes, our costs
could increase materially. In addition, union-mandated or
state-mandated nurse-staffing ratios could significantly affect
labor costs and have an adverse impact on revenue if we are
unable to meet the required ratios and are required to limit
admissions as a result. If our labor costs increase, we may not
be able to raise rates to offset these increased costs. Because
a significant percentage of our revenues consists of fixed,
prospective payments, our ability to pass along increased labor
costs is constrained. Our failure to recruit and retain
qualified management, nurses and other medical support
personnel, or to control labor costs, could have a material,
adverse effect on our results of operations.
If We
Fail To Comply With Extensive Laws And Government Regulations,
We Could Suffer Penalties Or Be Required To Make Significant
Changes To Our Operations.
The health care industry is required to comply with extensive
and complex laws and regulations at the federal, state and local
government levels relating to, among other things:
|
|
|
|
|
billing for services;
|
|
|
|
relationships with physicians and other referral sources;
|
|
|
|
adequacy of medical care;
|
|
|
|
quality of medical equipment and services;
|
|
|
|
qualifications of medical and support personnel;
|
|
|
|
confidentiality, maintenance and security issues associated with
health-related information and medical records;
|
|
|
|
the screening, stabilization and transfer of individuals who
have emergency medical conditions;
|
|
|
|
licensure and certification;
|
27
|
|
|
|
|
hospital rate or budget review;
|
|
|
|
operating policies and procedures; and
|
|
|
|
addition of facilities and services.
|
Among these laws are the federal Anti-kickback Statute, the
federal physician self-referral law (commonly called the Stark
Law) and the federal FCA and similar state laws. We have a
variety of financial relationships with physicians and others
who either refer or influence the referral of patients to our
hospitals and other health care facilities, and these laws
govern those relationships. The OIG has enacted safe harbor
regulations that outline practices that are deemed protected
from prosecution under the Anti-kickback Statute. While we
endeavor to comply with the applicable safe harbors, certain of
our current arrangements, including joint ventures and financial
relationships with physicians and other referral sources and
persons and entities to which we refer patients, do not qualify
for safe harbor protection. Failure to qualify for a safe harbor
does not mean that the arrangement necessarily violates the
Anti-kickback Statute but may subject the arrangement to greater
scrutiny; however, we cannot offer assurance that practices
outside of a safe harbor will not be found to violate the
Anti-kickback Statute. Allegations of violations of the
Anti-kickback Statute may be brought under the federal Civil
Monetary Penalty Law, which requires a lower burden of proof
than other fraud and abuse laws, including the Anti-kickback
Statute.
Our financial relationships with referring physicians and their
immediate family members must comply with the Stark Law by
meeting an exception. We attempt to structure our relationships
to meet an exception to the Stark Law, but the regulations
implementing the exceptions are detailed and complex, and we
cannot assure that every relationship complies fully with the
Stark Law. Unlike the Anti-kickback Statute, failure to meet an
exception under the Stark Law results in a violation of the
Stark Law, even if such violation is technical in nature.
Additionally, if we violate the Anti-kickback Statute or Stark
Law, or if we improperly bill for our services, we may be found
to violate the FCA, either under a suit brought by the
government or by a private person under a qui tam,
or whistleblower, suit.
If we fail to comply with the Anti-kickback Statute, the Stark
Law, the FCA or other applicable laws and regulations, we could
be subjected to liabilities, including civil penalties
(including the loss of our licenses to operate one or more
facilities), exclusion of one or more facilities from
participation in the Medicare, Medicaid and other federal and
state health care programs and, for violations of certain laws
and regulations, criminal penalties. See Regulation.
CMS is proceeding with a proposal to collect information from
400 hospitals regarding their ownership, investment and
compensation arrangements with physicians. Called the Disclosure
of Financial Relationships Report or DFRR, CMS
intends to use this data to monitor compliance with the Stark
Law, and CMS may share this information with other government
agencies. Many of these agencies have not previously analyzed
this information and have the authority to bring enforcement
actions against hospitals filing such reports.
Because many of these laws and their implementing regulations
are relatively new, we do not always have the benefit of
significant regulatory or judicial interpretation of these laws
and regulations. In the future, different interpretations or
enforcement of these laws and regulations could subject our
current or past practices to allegations of impropriety or
illegality or could require us to make changes in our
facilities, equipment, personnel, services, capital expenditure
programs and operating expenses. A determination that we have
violated these laws, or the public announcement that we are
being investigated for possible violations of these laws, could
have a material, adverse effect on our business, financial
condition, results of operations or prospects, and our business
reputation could suffer significantly. In addition, other
legislation or regulations at the federal or state level may be
adopted that adversely affect our business.
We
Have Been The Subject Of Governmental Investigations, Claims And
Litigation, And We Could Be The Subject Of Additional
Investigations In The Future.
Commencing in 1997, we became aware that we were the subject of
governmental investigations and litigation relating to our
business practices. The investigations were concluded through a
series of agreements executed in 2000 and 2003. In January 2001,
we entered into an eight-year CIA with the OIG, which expired
January 24, 2009.
28
Under the CIA, we had numerous affirmative obligations,
including the requirement to report potential violations of
applicable federal health care laws and regulations. Pursuant to
these obligations, we reported a number of potential violations
of the Stark Law, the Anti-kickback Statute, the EMTALA and
other laws, most of which we consider to be nonviolations or
technical violations. We will submit our final report pursuant
to the CIA by April 30, 2009. The government could
determine that our reporting
and/or our
resolution of reported issues was inadequate. If we are found to
have violated the CIA or any applicable health care laws or
regulations, we could be subject to repayment requirements,
substantial monetary fines, civil penalties, exclusion from
participation in the Medicare and Medicaid and other federal and
state health care programs, and, for violations of certain laws
and regulations, criminal penalties. Any such sanctions or
expenses could have a material, adverse effect on our financial
position, results of operations or liquidity.
Health care companies are subject to numerous investigations by
various governmental agencies. Further, under the federal FCA,
private parties have the right to bring qui tam, or
whistleblower, suits against companies that submit
false claims for payments to the government. Some states have
adopted similar state whistleblower and false claims provisions.
Certain of our individual facilities have received, and other
facilities may receive, government inquiries from federal and
state agencies. Depending on whether the underlying conduct in
these or future inquiries or investigations could be considered
systemic, their resolution could have a material, adverse effect
on our financial position, results of operations and liquidity.
Governmental agencies and their agents, such as the Medicare
Administrative Contractors, fiscal intermediaries and carriers,
as well as the OIG, conduct audits of our health care
operations. Private payers may conduct similar post-payment
audits, and we also perform internal audits and monitoring.
Depending on the nature of the conduct found in such audits and
whether the underlying conduct could be considered systemic, the
resolution of these audits could have a material, adverse effect
on our financial position, results of operations and liquidity.
The MMA established the RAC three-year demonstration program to
conduct post-payment reviews to detect and correct improper
payments in the fee-for-service Medicare program. Beginning in
2005, CMS contracted with three different RACs to conduct these
reviews in California, Florida and New York. The program was
expanded in August 2007 to include Arizona, Massachusetts and
South Carolina. We had 46 hospitals located in the demonstration
areas and 44 of these hospitals actually had a review performed.
The Tax Relief and Health Care Act of 2006 made the RAC program
permanent and mandated its nationwide expansion by 2010. Should
we be found out of compliance, depending on the nature of the
findings, our business, our financial position and our results
of operations could be negatively impacted.
Controls
Designed To Reduce Inpatient Services May Reduce Our
Revenues.
Controls imposed by Medicare, managed Medicare, Medicaid,
managed Medicaid and commercial third-party payers designed to
reduce admissions and lengths of stay, commonly referred to as
utilization review, have affected and are expected
to continue to affect our facilities. Utilization review entails
the review of the admission and course of treatment of a patient
by health plans. Inpatient utilization, average lengths of stay
and occupancy rates continue to be negatively affected by
payer-required preadmission authorization and utilization review
and by payer pressure to maximize outpatient and alternative
health care delivery services for less acutely ill patients.
Efforts to impose more stringent cost controls are expected to
continue. Although we are unable to predict the effect these
changes will have on our operations, significant limits on the
scope of services reimbursed and on reimbursement rates and fees
could have a material, adverse effect on our business, financial
position and results of operations.
Our
Overall Business Results May Suffer From The Recent Economic
Downturn.
Recently, the United States economy has weakened
significantly. Tightening credit markets, depressed consumer
spending and higher unemployment rates continue to pressure many
industries. During economic downturns, governmental entities
often experience budgetary constraints as a result of increased
costs and lower than expected tax collections. These budgetary
constraints may result in decreased spending for health and
human service programs, including Medicare, Medicaid and similar
programs, which represent significant payer sources for our
hospitals. Other risks we face from general economic weakness
include potential declines in the population
29
covered under managed care agreements, patient decisions to
postpone or cancel elective and non-emergent healthcare
procedures, potential increases in the uninsured and
underinsured populations and further difficulties in our
collecting patient copayment and deductible receivables.
The
Industry Trend Towards Value-Based Purchasing May Negatively
Impact Our Revenues.
There is a trend in the health care industry toward value-based
purchasing of health care services. These value-based purchasing
programs include both public reporting of quality data and
preventable adverse events tied to the quality and efficiency of
care provided by facilities. Governmental programs including
Medicare and Medicaid require hospitals to report certain
quality data to receive full reimbursement updates. In addition
Medicare does not reimburse for care related to certain
preventable adverse events (also called never
events). Many large commercial payers currently require
hospitals to report quality data, and several commercial payers
do not reimburse hospitals for certain preventable adverse
events. Further, we have implemented a policy pursuant to which
we do not bill patients or third-party payers for fees or
expenses incurred due to certain preventable adverse events. We
expect value-based purchasing programs, including programs that
condition reimbursement on patient outcome measures, to become
more common and to involve a higher percentage of reimbursement
amounts. We are unable at this time to predict how this trend
will affect our results of operations, but it could negatively
impact our revenues.
Our
Operations Could Be Impaired By A Failure Of Our Information
Systems.
Any system failure that causes an interruption in service or
availability of our systems could adversely affect operations or
delay the collection of revenues. Even though we have
implemented network security measures, our servers are
vulnerable to computer viruses, break-ins and similar
disruptions from unauthorized tampering. The occurrence of any
of these events could result in interruptions, delays, the loss
or corruption of data, or cessations in the availability of
systems, all of which could have a material, adverse effect on
our financial position and results of operations and harm our
business reputation.
The performance of our sophisticated information technology and
systems is critical to our business operations. In addition to
our shared services initiatives, our information systems are
essential to a number of critical areas of our operations,
including:
|
|
|
|
|
accounting and financial reporting;
|
|
|
|
billing and collecting accounts;
|
|
|
|
coding and compliance;
|
|
|
|
clinical systems;
|
|
|
|
medical records and document storage;
|
|
|
|
inventory management;
|
|
|
|
negotiating, pricing and administering managed care contracts
and supply contracts; and
|
|
|
|
monitoring quality of care and collecting data on quality
measures necessary for full Medicare payment updates.
|
State
Efforts To Regulate The Construction Or Expansion Of Health Care
Facilities Could Impair Our Ability To Operate And Expand Our
Operations.
Some states, particularly in the eastern part of the country,
require health care providers to obtain prior approval, known as
a CON, for the purchase, construction or expansion of health
care facilities, to make certain capital expenditures or to make
changes in services or bed capacity. In giving approval, these
states consider the need for additional or expanded health care
facilities or services. We currently operate health care
facilities in a number of states with CON laws. The failure to
obtain any requested CON could impair our ability to operate or
expand operations. Any such failure could, in turn, adversely
affect our ability to attract patients to our facilities and
grow our revenues, which would have an adverse effect on our
results of operations.
30
Our
Facilities Are Heavily Concentrated In Florida And Texas, Which
Makes Us Sensitive To Regulatory, Economic, Environmental And
Competitive Conditions And Changes In Those States.
We operated 166 hospitals at December 31, 2008, and 72 of
those hospitals are located in Florida and Texas. Our Florida
and Texas facilities combined revenues represented
approximately 51% of our consolidated revenues for the year
ended December 31, 2008. This concentration makes us
particularly sensitive to regulatory, economic, environmental
and competitive conditions and changes in those states. Any
material change in the current payment programs or regulatory,
economic, environmental or competitive conditions in those
states could have a disproportionate effect on our overall
business results.
In addition, our hospitals in Florida and Texas and other areas
across the Gulf Coast are located in hurricane-prone areas. In
the recent past, hurricanes have had a disruptive effect on the
operations of our hospitals in Florida, Texas and other coastal
states, and the patient populations in those states. Our
business activities could be harmed by a particularly active
hurricane season or even a single storm, and the property
insurance we obtain may not be adequate to cover losses from
future hurricanes or other natural disasters.
We May Be
Subject To Liabilities From Claims By The IRS.
We are currently contesting before the Appeals Division of the
Internal Revenue Service (the IRS) certain claimed
deficiencies and adjustments proposed by the IRS in connection
with its examination of the 2003 and 2004 federal income tax
returns for HCA and 17 affiliates that are treated as
partnerships for federal income tax purposes (affiliated
partnerships). The disputed items include the timing of
recognition of certain patient service revenues and our method
for calculating the tax allowance for doubtful accounts.
Eight taxable periods of HCA and its predecessors ended in 1995
through 2002 and the 2002 taxable year of 13 affiliated
partnerships, for which the primary remaining issue is the
computation of the tax allowance for doubtful accounts, are
pending before the IRS Examination Division or the United States
Tax Court as of December 31, 2008. The IRS began an audit
of the 2005 and 2006 federal income tax returns for HCA and
seven affiliated partnerships during 2008.
We May Be
Subject To Liabilities From Claims Brought Against Our
Facilities.
We are subject to litigation relating to our business practices,
including claims and legal actions by patients and others in the
ordinary course of business alleging malpractice, product
liability or other legal theories. See Item 3, Legal
Proceedings. Many of these actions involve large claims
and significant defense costs. We insure a portion of our
professional liability risks through a wholly-owned subsidiary.
Management believes our reserves for self-insured retentions and
insurance coverage are sufficient to cover insured claims
arising out of the operation of our facilities. Our wholly-owned
insurance subsidiary has entered into certain reinsurance
contracts, and the obligations covered by the reinsurance
contracts are included in its reserves for professional
liability risks, as the subsidiary remains liable to the extent
that the reinsurers do not meet their obligations under the
reinsurance contracts. If payments for claims exceed actuarially
determined estimates, are not covered by insurance or
reinsurers, if any, fail to meet their obligations, our results
of operations and financial position could be adversely affected.
We Are
Exposed To Market Risks Related To Changes In The Market Values
Of Securities And Interest Rate Changes.
We are exposed to market risk related to changes in market
values of securities. The investments in debt and equity
securities of our wholly-owned insurance subsidiary were
$1.614 billion and $8 million, respectively, at
December 31, 2008. These investments are carried at fair
value, with changes in unrealized gains and losses being
recorded as adjustments to other comprehensive income. At
December 31, 2008, we had a net unrealized loss of
$48 million on the insurance subsidiarys investment
securities.
We are exposed to market risk related to market illiquidity.
Liquidity of the investments in debt and equity securities of
our wholly-owned insurance subsidiary could be impaired by the
inability to access the capital markets. Should the wholly-owned
insurance subsidiary require significant amounts of cash in
excess of normal cash requirements to pay claims and other
expenses on short notice, we may have difficulty selling these
investments in a
31
timely manner or be forced to sell them at a price less than
what we might otherwise have been able to in a normal market
environment. At December 31, 2008, our wholly-owned
insurance subsidiary, had invested $536 million
($573 million par value) in municipal, tax-exempt student
loan auction rate securities which were classified as long-term
investments. The auction rate securities (ARS) are
publicly issued securities with long-term stated maturities for
which the interest rates are reset through a Dutch auction every
seven to 35 days. With the liquidity issues experienced in
global credit and capital markets, the ARS held by our
wholly-owned insurance subsidiary have experienced multiple
failed auctions, beginning on February 11, 2008, as the
amount of securities submitted for sale exceeded the amount of
purchase orders. There is a very limited market for the ARS at
this time. We do not currently intend to attempt to sell the ARS
as the liquidity needs of our insurance subsidiary are expected
to be met by other investments in its investment portfolio. If
uncertainties in the credit and capital markets continue or
there are ratings downgrades on the ARS held by our insurance
subsidiary, we may be required to recognize other-than-temporary
impairments on these long-term investments in future periods.
We are also exposed to market risk related to changes in
interest rates and periodically enter into interest rate swap
agreements to manage our exposure to these fluctuations. Our
interest rate swap agreements involve the exchange of fixed and
variable rate interest payments between two parties, based on
common notional principal amounts and maturity dates. The net
interest payments based on the notional amounts in these
agreements generally match the timing of the cash flows of the
related liabilities. The notional amounts of the swap agreements
represent balances used to calculate the exchange of cash flows
and are not assets or liabilities of HCA. See Item 7,
Managements Discussion and Analysis of Financial
Condition and Results of Operations Quantitative and
Qualitative Disclosures About Market Risk.
Since The
Recapitalization, The Investors Control Us And May Have
Conflicts Of Interest With Us In The Future.
As of December 31, 2008, the Investors and certain other
investors indirectly own 97.3% of our capital stock due to the
Recapitalization. As a result, the Investors have control over
our decisions to enter into any significant corporate
transaction and have the ability to prevent any transaction that
requires the approval of shareholders. For example, the
Investors could cause us to make acquisitions that increase the
amount of our indebtedness or sell assets.
Additionally, the Sponsors are in the business of making
investments in companies and may acquire and hold interests in
businesses that compete directly or indirectly with us. One or
more of the Sponsors may also pursue acquisition opportunities
that may be complementary to our business and, as a result,
those acquisition opportunities may not be available to us. So
long as investment funds associated with or designated by the
Sponsors continue to indirectly own a significant amount of the
outstanding shares of our common stock, even if such amount is
less than 50%, the Sponsors will continue to be able to strongly
influence or effectively control our decisions.
|
|
Item 1B.
|
Unresolved
Staff Comments
|
None.
32
The following table lists, by state, the number of hospitals
(general, acute care, psychiatric and rehabilitation) directly
or indirectly owned and operated by us as of December 31,
2008:
|
|
|
|
|
|
|
|
|
State
|
|
Hospitals
|
|
Beds
|
|
Alaska
|
|
|
1
|
|
|
|
250
|
|
California
|
|
|
5
|
|
|
|
1,511
|
|
Colorado
|
|
|
7
|
|
|
|
2,257
|
|
Florida
|
|
|
38
|
|
|
|
9,673
|
|
Georgia
|
|
|
11
|
|
|
|
1,925
|
|
Idaho
|
|
|
2
|
|
|
|
481
|
|
Indiana
|
|
|
1
|
|
|
|
278
|
|
Kansas
|
|
|
4
|
|
|
|
1,286
|
|
Kentucky
|
|
|
2
|
|
|
|
384
|
|
Louisiana
|
|
|
10
|
|
|
|
1,625
|
|
Mississippi
|
|
|
1
|
|
|
|
130
|
|
Missouri
|
|
|
6
|
|
|
|
1,055
|
|
Nevada
|
|
|
3
|
|
|
|
1,075
|
|
New Hampshire
|
|
|
2
|
|
|
|
295
|
|
Oklahoma
|
|
|
2
|
|
|
|
793
|
|
South Carolina
|
|
|
3
|
|
|
|
740
|
|
Tennessee
|
|
|
13
|
|
|
|
2,287
|
|
Texas
|
|
|
34
|
|
|
|
10,191
|
|
Utah
|
|
|
6
|
|
|
|
968
|
|
Virginia
|
|
|
9
|
|
|
|
2,963
|
|
International
|
|
|
|
|
|
|
|
|
England
|
|
|
6
|
|
|
|
704
|
|
|
|
|
|
|
|
|
|
|
|
|
|
166
|
|
|
|
40,871
|
|
|
|
|
|
|
|
|
|
|
In addition to the hospitals listed in the above table, we
directly or indirectly operate 105 freestanding surgery centers.
We also operate medical office buildings in conjunction with
some of our hospitals. These office buildings are primarily
occupied by physicians who practice at our hospitals. Under our
senior secured cash flow credit facility entered into in
connection with the Recapitalization, 14 of our general, acute
care hospitals were mortgaged as collateral.
We maintain our headquarters in approximately
1,209,000 square feet of space in the Nashville, Tennessee
area. In addition to the headquarters in Nashville, we maintain
regional service centers related to our shared services
initiatives. These service centers are located in markets in
which we operate hospitals.
We believe our headquarters, hospitals and other facilities are
suitable for their respective uses and are, in general, adequate
for our present needs. Our properties are subject to various
federal, state and local statutes and ordinances regulating
their operation. Management does not believe that compliance
with such statutes and ordinances will materially affect
our financial position or results of operations.
|
|
Item 3.
|
Legal
Proceedings
|
We operate in a highly regulated and litigious industry. As a
result, various lawsuits, claims and legal and regulatory
proceedings have been and can be expected to be instituted or
asserted against us. The resolution of any such lawsuits, claims
or legal and regulatory proceedings could have a material,
adverse effect on our results of operations or financial
position in a given period.
Government
Investigations, Claims and Litigation
In January 2001, we entered into an eight-year CIA with the OIG
which expired on January 24, 2009. Violation or breach of
the CIA, or violation of federal or state laws relating to
Medicare, Medicaid or similar programs, could subject us to
substantial monetary fines, civil and criminal penalties
and/or
exclusion from participation in the Medicare and Medicaid
programs. Alleged violations may be pursued by the government or
through private qui tam actions. Sanctions imposed
against us as a result of such actions could have a material,
adverse effect on our results of operations or financial
position.
33
ERISA
Litigation
On November 22, 2005, Brenda Thurman, a former employee of
an HCA affiliate, filed a complaint in the United States
District Court for the Middle District of Tennessee on behalf of
herself, the HCA Savings and Retirement Program (the
Plan), and a class of participants in the Plan who
held an interest in our common stock, against our Chairman and
Chief Executive Officer, President and Chief Operating Officer,
Executive Vice President and Chief Financial Officer, and other
unnamed individuals. The lawsuit, filed under
sections 502(a)(2) and 502(a)(3) of the Employee Retirement
Income Security Act (ERISA), 29 U.S.C.
§§ 1132(a)(2) and (3), alleges that defendants
breached their fiduciary duties owed to the Plan and to plan
participants and seeks monetary damages and injunctions and
other relief.
On January 13, 2006, the court signed an order staying all
proceedings and discovery in this matter, pending resolution of
a motion to dismiss the consolidated amended complaint in a
related federal securities class action against HCA. On
January 18, 2006, the magistrate judge signed an order
(1) consolidating Thurmans cause of action with all
other future actions making the same claims and arising out of
the same operative facts, (2) appointing Thurman as lead
plaintiff, and (3) appointing Thurmans attorneys as
lead counsel and liaison counsel in the case. We have reached an
agreement in principle to settle this suit, subject to final
court approval.
Merger
Litigation in State Court
On October 23, 2006, the Foundation for Seacoast Health
(the Foundation) filed a lawsuit against us and one
of our affiliates, HCA Health Services of New Hampshire, Inc.,
in the Superior Court of Rockingham County, New Hampshire.
Among other things, the complaint seeks to enforce certain
provisions of an asset purchase agreement between the parties,
including a purported right of first refusal to purchase a New
Hampshire hospital, that allegedly were triggered by the Merger
and other prior events. The Foundation initially sought to
enjoin the Merger. However, the parties reached an agreement
that allowed the Merger to proceed, while preserving the
plaintiffs opportunity to litigate whether the Merger
triggered the right of first refusal to purchase the hospital
and, if so, at what price the hospital could be repurchased. On
May 25, 2007, the court granted HCAs motion for
summary judgment disposing of the Foundations central
claims. The Foundation filed an appeal from the final judgment.
On July 15, 2008, the New Hampshire Supreme Court held that
the Merger did not trigger the right of first refusal. The Court
remanded to the lower court the claim that the right of first
refusal had been triggered by certain intra-corporate
transactions in 1999. The Court did not determine the merits of
that claim, and we will continue to defend the claim vigorously.
General
Liability and Other Claims
On April 10, 2006, a class action complaint was filed
against us in the District Court of Kansas alleging, among other
matters, nurse understaffing at all of our hospitals, certain
consumer protection act violations, negligence and unjust
enrichment. The complaint is seeking, among other relief,
declaratory relief and monetary damages, including disgorgement
of profits of $12.250 billion. A motion to dismiss this
action was granted on July 27, 2006, but the plaintiffs
appealed this dismissal. While the appeal was pending, the
Kansas Supreme Court for the first time construed the Kansas
Consumer Protection Act to apply to the provision of medical
services. Based on that new ruling, the 10th Circuit
reversed the district courts dismissal and remanded the
action for further consideration by the trial court. We will
continue to defend this claim vigorously.
We are a party to certain proceedings relating to claims for
income taxes and related interest in the United States Tax
Court. For a description of those proceedings, see Item 7,
Managements Discussion and Analysis of Financial
Condition and Results of Operations Pending IRS
Disputes and Note 6 to our consolidated financial
statements.
We are also subject to claims and suits arising in the ordinary
course of business, including claims for personal injuries or
for wrongful restriction of, or interference with,
physicians staff privileges. In certain of these actions
the claimants have asked for punitive damages against us, which
may not be covered by insurance. In the opinion of management,
the ultimate resolution of these pending claims and legal
proceedings will not have a material, adverse effect on our
results of operations or financial position.
|
|
Item 4.
|
Submission
of Matters to a Vote of Security Holders
|
No matters were submitted to a vote of security holders during
the fourth quarter of 2008.
34
PART II
|
|
Item 5.
|
Market
for Registrants Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities
|
Our outstanding common stock is privately held, and there is no
established public trading market for our common stock. As of
February 25, 2009, there were 631 holders of our common
stock. See Item 7, Managements Discussion and
Analysis of Financial condition and Results of
Operations Liquidity and Capital
Resources Financing Activities for a
description of the restrictions on our ability to pay dividends.
We did not pay any dividends in 2007 or 2008.
During the quarter ended December 31, 2008, HCA issued
431,216 shares of common stock in connection with the
cashless exercise of stock options for aggregate consideration
of $5,498,004 resulting in 217,732 net settled shares. The
shares were issued without registration in reliance on the
exemptions afforded by Section 4(2) of the Securities Act
of 1933, as amended, and Rule 701 promulgated thereunder.
On April 29, 2008, we registered our common stock pursuant
to Section 12(g) of the Securities Exchange Act of 1934, as
amended.
The following table provides certain information with respect to
our repurchase of common stock from October 1, 2008 through
December 31, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Approximate
|
|
|
|
|
|
|
|
|
|
Total Number
|
|
|
Dollar Value of
|
|
|
|
|
|
|
|
|
|
of Shares
|
|
|
Shares That
|
|
|
|
|
|
|
|
|
|
Purchased as
|
|
|
May Yet Be
|
|
|
|
|
|
|
|
|
|
Part of
|
|
|
Purchased
|
|
|
|
|
|
|
|
|
|
Publicly
|
|
|
Under Publicly
|
|
|
|
Total Number
|
|
|
|
|
|
Announced
|
|
|
Announced
|
|
|
|
of Shares
|
|
|
Average Price
|
|
|
Plans or
|
|
|
Plans or
|
|
Period
|
|
Purchased
|
|
|
Paid per Share
|
|
|
Programs
|
|
|
Programs
|
|
|
October 1, 2008 through October 31, 2008
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
$
|
|
|
November 1, 2008 through November 30, 2008
|
|
|
6,111
|
|
|
$
|
55.86
|
|
|
|
|
|
|
|
|
|
December 1, 2008 through December 31, 2008
|
|
|
26,121
|
|
|
$
|
55.86
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total for Fourth Quarter 2008
|
|
|
32,232
|
|
|
$
|
55.86
|
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During the fourth quarter of 2008, we purchased
32,232 shares pursuant to the terms of the Management
Stockholders Agreement and/or separation agreements and stock
purchase agreements between former employees and the Company.
35
|
|
Item 6.
|
Selected
Financial Data
|
HCA
INC.
SELECTED FINANCIAL DATA
AS OF AND FOR THE YEARS ENDED DECEMBER 31
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Summary of Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
28,374
|
|
|
$
|
26,858
|
|
|
$
|
25,477
|
|
|
$
|
24,455
|
|
|
$
|
23,502
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
11,440
|
|
|
|
10,714
|
|
|
|
10,409
|
|
|
|
9,928
|
|
|
|
9,419
|
|
Supplies
|
|
|
4,620
|
|
|
|
4,395
|
|
|
|
4,322
|
|
|
|
4,126
|
|
|
|
3,901
|
|
Other operating expenses
|
|
|
4,554
|
|
|
|
4,241
|
|
|
|
4,056
|
|
|
|
4,034
|
|
|
|
3,769
|
|
Provision for doubtful accounts
|
|
|
3,409
|
|
|
|
3,130
|
|
|
|
2,660
|
|
|
|
2,358
|
|
|
|
2,669
|
|
Equity in earnings of affiliates
|
|
|
(223
|
)
|
|
|
(206
|
)
|
|
|
(197
|
)
|
|
|
(221
|
)
|
|
|
(194
|
)
|
Gains on investments
|
|
|
|
|
|
|
(8
|
)
|
|
|
(243
|
)
|
|
|
(53
|
)
|
|
|
(56
|
)
|
Depreciation and amortization
|
|
|
1,416
|
|
|
|
1,426
|
|
|
|
1,391
|
|
|
|
1,374
|
|
|
|
1,250
|
|
Interest expense
|
|
|
2,021
|
|
|
|
2,215
|
|
|
|
955
|
|
|
|
655
|
|
|
|
563
|
|
Gains on sales of facilities
|
|
|
(97
|
)
|
|
|
(471
|
)
|
|
|
(205
|
)
|
|
|
(78
|
)
|
|
|
|
|
Impairment of long-lived assets
|
|
|
64
|
|
|
|
24
|
|
|
|
24
|
|
|
|
|
|
|
|
12
|
|
Transaction costs
|
|
|
|
|
|
|
|
|
|
|
442
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,204
|
|
|
|
25,460
|
|
|
|
23,614
|
|
|
|
22,123
|
|
|
|
21,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before minority interests and income taxes
|
|
|
1,170
|
|
|
|
1,398
|
|
|
|
1,863
|
|
|
|
2,332
|
|
|
|
2,169
|
|
Minority interests in earnings of consolidated entities
|
|
|
229
|
|
|
|
208
|
|
|
|
201
|
|
|
|
178
|
|
|
|
168
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
941
|
|
|
|
1,190
|
|
|
|
1,662
|
|
|
|
2,154
|
|
|
|
2,001
|
|
Provision for income taxes
|
|
|
268
|
|
|
|
316
|
|
|
|
626
|
|
|
|
730
|
|
|
|
755
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
673
|
|
|
$
|
874
|
|
|
$
|
1,036
|
|
|
$
|
1,424
|
|
|
$
|
1,246
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Position:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets
|
|
$
|
24,280
|
|
|
$
|
24,025
|
|
|
$
|
23,675
|
|
|
$
|
22,225
|
|
|
$
|
21,840
|
|
Working capital
|
|
|
2,391
|
|
|
|
2,356
|
|
|
|
2,502
|
|
|
|
1,320
|
|
|
|
1,509
|
|
Long-term debt, including amounts due within one year
|
|
|
26,989
|
|
|
|
27,308
|
|
|
|
28,408
|
|
|
|
10,475
|
|
|
|
10,530
|
|
Minority interests in equity of consolidated entities
|
|
|
995
|
|
|
|
938
|
|
|
|
907
|
|
|
|
828
|
|
|
|
809
|
|
Equity securities with contingent redemption rights
|
|
|
155
|
|
|
|
164
|
|
|
|
125
|
|
|
|
|
|
|
|
|
|
Stockholders (deficit) equity
|
|
|
(10,255
|
)
|
|
|
(10,538
|
)
|
|
|
(11,374
|
)
|
|
|
4,863
|
|
|
|
4,407
|
|
Cash Flow Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash provided by operating activities
|
|
$
|
1,797
|
|
|
$
|
1,396
|
|
|
$
|
1,845
|
|
|
$
|
2,971
|
|
|
$
|
2,954
|
|
Cash used in investing activities
|
|
|
(1,467
|
)
|
|
|
(479
|
)
|
|
|
(1,307
|
)
|
|
|
(1,681
|
)
|
|
|
(1,688
|
)
|
Cash used in financing activities
|
|
|
(258
|
)
|
|
|
(1,158
|
)
|
|
|
(240
|
)
|
|
|
(1,212
|
)
|
|
|
(1,347
|
)
|
36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Operating Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of hospitals at end of period(a)
|
|
|
158
|
|
|
|
161
|
|
|
|
166
|
|
|
|
175
|
|
|
|
182
|
|
Number of freestanding outpatient surgical centers at end of
period(b)
|
|
|
97
|
|
|
|
99
|
|
|
|
98
|
|
|
|
87
|
|
|
|
84
|
|
Number of licensed beds at end of period(c)
|
|
|
38,504
|
|
|
|
38,405
|
|
|
|
39,354
|
|
|
|
41,265
|
|
|
|
41,852
|
|
Weighted average licensed beds(d)
|
|
|
38,422
|
|
|
|
39,065
|
|
|
|
40,653
|
|
|
|
41,902
|
|
|
|
41,997
|
|
Admissions(e)
|
|
|
1,541,800
|
|
|
|
1,552,700
|
|
|
|
1,610,100
|
|
|
|
1,647,800
|
|
|
|
1,659,200
|
|
Equivalent admissions(f)
|
|
|
2,363,600
|
|
|
|
2,352,400
|
|
|
|
2,416,700
|
|
|
|
2,476,600
|
|
|
|
2,454,000
|
|
Average length of stay (days)(g)
|
|
|
4.9
|
|
|
|
4.9
|
|
|
|
4.9
|
|
|
|
4.9
|
|
|
|
5.0
|
|
Average daily census(h)
|
|
|
20,795
|
|
|
|
21,049
|
|
|
|
21,688
|
|
|
|
22,225
|
|
|
|
22,493
|
|
Occupancy(i)
|
|
|
54
|
%
|
|
|
54
|
%
|
|
|
53
|
%
|
|
|
53
|
%
|
|
|
54
|
%
|
Emergency room visits(j)
|
|
|
5,246,400
|
|
|
|
5,116,100
|
|
|
|
5,213,500
|
|
|
|
5,415,200
|
|
|
|
5,219,500
|
|
Outpatient surgeries(k)
|
|
|
797,400
|
|
|
|
804,900
|
|
|
|
820,900
|
|
|
|
836,600
|
|
|
|
834,800
|
|
Inpatient surgeries(l)
|
|
|
493,100
|
|
|
|
516,500
|
|
|
|
533,100
|
|
|
|
541,400
|
|
|
|
541,000
|
|
Days revenues in accounts receivable(m)
|
|
|
49
|
|
|
|
53
|
|
|
|
53
|
|
|
|
50
|
|
|
|
48
|
|
Gross patient revenues(n)
|
|
$
|
102,843
|
|
|
$
|
92,429
|
|
|
$
|
84,913
|
|
|
$
|
78,662
|
|
|
$
|
71,279
|
|
Outpatient revenues as a % of patient revenues(o)
|
|
|
37
|
%
|
|
|
37
|
%
|
|
|
36
|
%
|
|
|
36
|
%
|
|
|
37
|
%
|
|
|
|
(a)
|
|
Excludes eight facilities in 2008
and 2007 and seven facilities in 2006, 2005 and 2004 that are
not consolidated (accounted for using the equity method) for
financial reporting purposes.
|
|
|
|
(b)
|
|
Excludes eight facilities in 2008,
nine facilities in 2007 and 2006, seven facilities in 2005 and
eight facilities in 2004 that are not consolidated (accounted
for using the equity method) for financial reporting purposes.
|
|
(c)
|
|
Licensed beds are those beds for
which a facility has been granted approval to operate from the
applicable state licensing agency.
|
|
(d)
|
|
Weighted average licensed beds
represents the average number of licensed beds, weighted based
on periods owned.
|
|
(e)
|
|
Represents the total number of
patients admitted to our hospitals and is used by management and
certain investors as a general measure of inpatient volume.
|
|
(f)
|
|
Equivalent admissions are used by
management and certain investors as a general measure of
combined inpatient and outpatient volume. Equivalent admissions
are computed by multiplying admissions (inpatient volume) by the
sum of gross inpatient revenue and gross outpatient revenue and
then dividing the resulting amount by gross inpatient revenue.
The equivalent admissions computation equates
outpatient revenue to the volume measure (admissions) used to
measure inpatient volume, resulting in a general measure of
combined inpatient and outpatient volume.
|
|
(g)
|
|
Represents the average number of
days admitted patients stay in our hospitals.
|
|
(h)
|
|
Represents the average number of
patients in our hospital beds each day.
|
|
(i)
|
|
Represents the percentage of
hospital licensed beds occupied by patients. Both average daily
census and occupancy rate provide measures of the utilization of
inpatient rooms.
|
|
(j)
|
|
Represents the number of patients
treated in our emergency rooms.
|
|
(k)
|
|
Represents the number of surgeries
performed on patients who were not admitted to our hospitals.
Pain management and endoscopy procedures are not included in
outpatient surgeries.
|
|
(l)
|
|
Represents the number of surgeries
performed on patients who have been admitted to our hospitals.
Pain management and endoscopy procedures are not included in
inpatient surgeries.
|
|
(m)
|
|
Revenues per day is calculated by
dividing the revenues for the period by the days in the period.
Days revenues in accounts receivable is then calculated as
accounts receivable, net of the allowance for doubtful accounts,
at the end of the period divided by revenues per day.
|
|
(n)
|
|
Gross patient revenues are based
upon our standard charge listing. Gross charges/revenues
typically do not reflect what our hospital facilities are paid.
Gross charges/revenues are reduced by contractual adjustments,
discounts and charity care to determine reported revenues.
|
|
(o)
|
|
Represents the percentage of
patient revenues related to patients who are not admitted to our
hospitals.
|
37
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
The selected financial data and the accompanying consolidated
financial statements present certain information with respect to
the financial position, results of operations and cash flows of
HCA Inc. which should be read in conjunction with the following
discussion and analysis. The terms HCA,
Company, we, our, or
us, as used herein, refer to HCA Inc. and our
affiliates unless otherwise stated or indicated by context. The
term affiliates means direct and indirect
subsidiaries of HCA Inc. and partnerships and joint ventures in
which such subsidiaries are partners.
Forward-Looking
Statements
This annual report on
Form 10-K
includes certain disclosures which contain forward-looking
statements. Forward-looking statements include all
statements that do not relate solely to historical or current
facts, and can be identified by the use of words like
may, believe, will,
expect, project, estimate,
anticipate, plan, initiative
or continue. These forward-looking statements are
based on our current plans and expectations and are subject to a
number of known and unknown uncertainties and risks, many of
which are beyond our control, that could significantly affect
current plans and expectations and our future financial position
and results of operations. These factors include, but are not
limited to, (1) the ability to recognize the benefits of
the Recapitalization, (2) the impact of the substantial
indebtedness incurred to finance the Recapitalization and the
ability to refinance such indebtedness on acceptable terms,
(3) increases, particularly in the current economic
downturn, in the amount and risk of collectibility of uninsured
accounts and deductibles and copayment amounts for insured
accounts, (4) the ability to achieve operating and
financial targets, and attain expected levels of patient volumes
and control the costs of providing services, (5) possible
changes in the Medicare, Medicaid and other state programs,
including Medicaid supplemental payments pursuant to upper
payment limit (UPL) programs, that may impact
reimbursements to health care providers and insurers,
(6) the highly competitive nature of the health care
business, (7) changes in revenue mix, including potential
declines in the population covered under managed care agreements
due to the current economic downturn and the ability to enter
into and renew managed care provider agreements on acceptable
terms, (8) the efforts of insurers, health care providers
and others to contain health care costs, (9) the outcome of
our continuing efforts to monitor, maintain and comply with
appropriate laws, regulations, policies and procedures,
(10) changes in federal, state or local laws or regulations
affecting the health care industry, (11) increases in wages
and the ability to attract and retain qualified management and
personnel, including affiliated physicians, nurses and medical
and technical support personnel, (12) the possible
enactment of federal or state health care reform, (13) the
availability and terms of capital to fund the expansion of our
business and improvements to our existing facilities,
(14) changes in accounting practices, (15) changes in
general economic conditions nationally and regionally in our
markets, (16) future divestitures which may result in
charges, (17) changes in business strategy or development
plans, (18) delays in receiving payments for services
provided, (19) the outcome of pending and any future tax
audits, appeals and litigation associated with our tax
positions, (20) potential liabilities and other claims that
may be asserted against us, and (21) other risk factors
described in this annual report on
Form 10-K.
As a consequence, current plans, anticipated actions and future
financial position and results of operations may differ from
those expressed in any forward-looking statements made by or on
behalf of HCA. You are cautioned not to unduly rely on such
forward-looking statements when evaluating the information
presented in this report.
2008
Operations Summary
Net income totaled $673 million for the year ended
December 31, 2008 compared to $874 million for the
year ended December 31, 2007. The 2008 results include
gains on sales of facilities of $97 million and impairments
of long-lived assets of $64 million. The 2007 results
include gains on investments of $8 million, gains on sales
of facilities of $471 million and an impairment of
long-lived assets of $24 million.
38
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
2008
Operations Summary (Continued)
Revenues increased 5.6% on a consolidated basis and 7.0% on a
same facility basis for the year ended December 31, 2008
compared to the year ended December 31, 2007. The
consolidated revenues increase can be attributed to the combined
impact of a 5.2% increase in revenue per equivalent admission
and a 0.5% increase in equivalent admissions. The same facility
revenues increase resulted from a 5.1% increase in same facility
revenue per equivalent admission and a 1.9% increase in same
facility equivalent admissions.
During the year ended December 31, 2008, consolidated
admissions declined 0.7% and same facility admissions increased
0.9% compared to the year ended December 31, 2007.
Inpatient surgical volumes declined 4.5% on a consolidated basis
and declined 0.5% on a same facility basis during the year ended
December 31, 2008, compared to the year ended
December 31, 2007. Outpatient surgical volumes declined
0.9% on a consolidated basis and declined 0.2% on a same
facility basis during the year ended December 31, 2008,
compared to the year ended December 31, 2007.
For the year ended December 31, 2008, the provision for
doubtful accounts increased to 12.0% of revenues from 11.7% of
revenues for the year ended December 31, 2007. Same
facility uninsured admissions increased 1.7% and same facility
uninsured emergency room visits increased 4.5% for the year
ended December 31, 2008 compared to the year ended
December 31, 2007.
Interest expense totaled $2.021 billion for the year ended
December 31, 2008 compared to $2.215 billion for the
year ended December 31, 2007. The $194 million
decrease in interest expense for 2008 was due to reductions in
both the average debt balance and average interest rate during
2008.
Business
Strategy
We are committed to providing the communities we serve high
quality, cost-effective health care while complying fully with
our ethics policy, governmental regulations and guidelines and
industry standards. As a part of this strategy, management
focuses on the following principal elements:
Maintain Our Dedication to the Care and Improvement of Human
Life. Our business is built on putting patients
first and providing high quality health care services in the
communities we serve. Our dedicated professionals oversee our
Quality Review System, which measures clinical outcomes,
satisfaction and regulatory compliance to improve hospital
quality and performance. We are implementing hospitalist
programs in some facilities, evidence-based medicine programs
and infection reduction initiatives. In addition, we continue to
implement advanced health information technology to improve the
quality and convenience of services to our communities. We are
using our advanced electronic medication administration record,
which uses bar coding technology to ensure that each patient
receives the right medication, to build toward a fully
electronic health record that will provide convenient access,
electronic order entry and decision support for physicians.
These technologies improve patient safety, quality and
efficiency.
Maintain Our Commitment to Ethics and
Compliance. We are committed to a corporate
culture highlighted by the following values
compassion, honesty, integrity, fairness, loyalty, respect and
kindness. Our comprehensive ethics and compliance program
reinforces our dedication to these values.
Leverage Our Leading Local Market
Positions. We strive to maintain and enhance the
leading positions that we enjoy in the majority of our markets.
We believe that the broad geographic presence of our facilities
across a range of markets, in combination with the breadth and
quality of services provided by our facilities, increases our
attractiveness to patients and large employers and positions us
to negotiate more favorable terms from commercial payers and
increase the number of payers with whom we contract. We also
intend to strategically enhance our outpatient presence in our
communities to attract more patients to our facilities.
39
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Business
Strategy (Continued)
Expand Our Presence in Key Markets. We seek to
grow our business in key markets, focusing on large, high growth
urban and suburban communities, primarily in the southern and
western regions of the United States. We seek to strategically
invest in new and expanded services at our existing hospitals
and surgery centers to increase our revenues at those facilities
and provide the benefits of medical technology advances to our
communities. We intend to continue to expand high volume and
high margin specialty services, such as cardiology and
orthopedic services, and increase the capacity, scope and
convenience of our outpatient facilities. To complement this
intrinsic growth, we intend to continue to opportunistically
develop and acquire new hospitals and outpatient facilities.
Continue to Leverage Our Scale. We will
continue to obtain price efficiencies through our group
purchasing organization and build on the cost savings and
efficiencies in billing, collection and other processes we have
achieved through our regional service centers. We are
increasingly taking advantage of our national scale by
contracting for services on a multistate basis. We will expand
our successful shared services model for additional clinical and
support functions, such as physician credentialing, medical
transcription and electronic medical recordkeeping, across
multiple markets.
Continue to Develop Enduring Physician
Relationships. We depend on the quality and
dedication of the physicians who serve at our facilities, and we
recruit both primary care physicians and specialists to meet
community needs. We often assist recruited physicians with
establishing and building a practice or joining an existing
practice in compliance with regulatory standards. We intend to
improve both service levels and revenues in our markets by:
|
|
|
|
|
expanding the number of high quality specialty services, such as
cardiology, orthopedics, oncology and neonatology;
|
|
|
|
continuing to use joint ventures with physicians to further
develop our outpatient business, particularly through ambulatory
surgery centers and outpatient diagnostic centers;
|
|
|
|
developing medical office buildings to provide convenient
facilities for physicians to locate their practices and serve
their patients; and
|
|
|
|
continuing our focus on improving hospital quality and
performance and implementing advanced technologies in our
facilities to attract physicians to our facilities.
|
Become the Health Care Employer of Choice. We
will continue to use a number of industry-leading practices to
help ensure our hospitals are a health care employer of choice
in their respective communities. Our staffing initiatives for
both care providers and hospital management provide strategies
for recruitment, compensation and productivity to increase
employee retention and operating efficiency at our hospitals.
For example, we maintain an internal contract nursing agency to
supply our hospitals with high quality staffing at a lower cost
than external agencies. In addition, we have developed several
proprietary training and career development programs for our
physicians and hospital administrators, including an executive
development program designed to train the next generation of
hospital leadership. We believe our continued investment in the
training and retention of employees improves the quality of
care, enhances operational efficiency and fosters employee
loyalty.
Critical
Accounting Policies and Estimates
The preparation of our consolidated financial statements
requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities, the
disclosure of contingent liabilities and the reported amounts of
revenues and expenses. Our estimates are based on historical
experience and various other assumptions we believe are
reasonable under the circumstances. We evaluate our estimates on
an ongoing basis and make changes to the estimates and related
disclosures as experience develops or new information becomes
known. Actual results may differ from these estimates.
40
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Critical
Accounting Policies and Estimates (Continued)
We believe the following critical accounting policies affect our
more significant judgments and estimates used in the preparation
of our consolidated financial statements.
Revenues
Revenues are recorded during the period the health care services
are provided, based upon the estimated amounts due from payers.
Estimates of contractual allowances under managed care health
plans are based upon the payment terms specified in the related
contractual agreements. Laws and regulations governing the
Medicare and Medicaid programs are complex and subject to
interpretation. The estimated reimbursement amounts are made on
a payer-specific basis and are recorded based on the best
information available regarding managements interpretation
of the applicable laws, regulations and contract terms.
Management continually reviews the contractual estimation
process to consider and incorporate updates to laws and
regulations and the frequent changes in managed care contractual
terms resulting from contract renegotiations and renewals. We
have invested significant resources to refine and improve our
computerized billing systems and the information system data
used to make contractual allowance estimates. We have developed
standardized calculation processes and related training programs
to improve the utility of our patient accounting systems.
The Emergency Medical Treatment and Active Labor Act
(EMTALA) requires any hospital participating in the
Medicare program to conduct an appropriate medical screening
examination of every person who presents to the hospitals
emergency room for treatment and, if the individual is suffering
from an emergency medical condition, to either stabilize the
condition or make an appropriate transfer of the individual to a
facility able to handle the condition. The obligation to screen
and stabilize emergency medical conditions exists regardless of
an individuals ability to pay for treatment. Federal and
state laws and regulations, including but not limited to EMTALA,
require, and our commitment to providing quality patient care
encourages, the provision of services to patients who are
financially unable to pay for the health care services they
receive.
We do not pursue collection of amounts related to patients who
meet our guidelines to qualify as charity care; therefore, they
are not reported in revenues. Patients treated at our hospitals
for nonelective care, who have income at or below 200% of the
federal poverty level, are eligible for charity care. The
federal poverty level is established by the federal government
and is based on income and family size. We provide discounts
from our gross charges to uninsured patients who do not qualify
for Medicaid or charity care. These discounts are similar to
those provided to many local managed care plans.
Due to the complexities involved in the classification and
documentation of health care services authorized and provided,
the estimation of revenues earned and the related reimbursement
are often subject to interpretations that could result in
payments that are different from our estimates. A hypothetical
1% change in net receivables that are subject to contractual
discounts at December 31, 2008 would result in an impact on
pretax earnings of approximately $34 million.
Provision
for Doubtful Accounts and the Allowance for Doubtful
Accounts
The collection of outstanding receivables from Medicare, managed
care payers, other third-party payers and patients is our
primary source of cash and is critical to our operating
performance. The primary collection risks relate to uninsured
patient accounts, including patient accounts for which the
primary insurance carrier has paid the amounts covered by the
applicable agreement, but patient responsibility amounts
(deductibles and copayments) remain outstanding. The provision
for doubtful accounts and the allowance for doubtful accounts
relate primarily to amounts due directly from patients. An
estimated allowance for doubtful accounts is recorded for all
uninsured accounts, regardless of the aging of those accounts.
Accounts are written off when all reasonable internal and
external collection efforts have been performed. Prior to 2007,
we considered the return of an account from the
41
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Critical
Accounting Policies and Estimates (Continued)
Provision
for Doubtful Accounts and the Allowance for Doubtful Accounts
(Continued)
primary external collection agency to be the culmination of our
reasonable collection efforts and the timing basis for writing
off the account balance. During 2007, we modified our collection
policies to establish a review of all accounts against certain
standard collection criteria, upon completion of our internal
collection efforts. Accounts determined to possess positive
collectibility attributes are forwarded to a secondary external
collection agency and the other accounts are written off. The
accounts that are not collected by the secondary external
collection agency are written off when they are returned to us
by the collection agency (usually within 18 months). Our
collection policy change results in a delay in writing off the
accounts forwarded to the secondary external collection agency
compared to our previous policy, and during 2007 and 2008, we
incurred increases in both our gross accounts receivable and the
allowance for doubtful accounts due to this delay in recording
writeoffs. Writeoffs are based upon specific identification and
the writeoff process requires a writeoff adjustment entry to the
patient accounting system. We do not pursue collection of
amounts related to patients that meet our guidelines to qualify
as charity care. Charity care is not reported in revenues and
does not have an impact on the provision for doubtful accounts.
The amount of the provision for doubtful accounts is based upon
managements assessment of historical writeoffs and
expected net collections, business and economic conditions,
trends in federal, state, and private employer health care
coverage and other collection indicators. Management relies on
the results of detailed reviews of historical writeoffs and
recoveries at facilities that represent a majority of our
revenues and accounts receivable (the hindsight
analysis) as a primary source of information in estimating
the collectibility of our accounts receivable. We perform the
hindsight analysis quarterly, utilizing rolling twelve-months
accounts receivable collection and writeoff data. At
December 31, 2008, the allowance for doubtful accounts
represented approximately 93% of the $5.838 billion patient
due accounts receivable balance, including accounts, net of the
related estimated contractual discounts, related to patients for
which eligibility for Medicaid assistance or charity was being
evaluated (pending Medicaid accounts). At
December 31, 2007, the allowance for doubtful accounts
represented approximately 89% of the $4.825 billion patient
due accounts receivable balance, including pending Medicaid
accounts, net of the related estimated contractual discounts.
Days revenues in accounts receivable were 49 days,
53 days and 53 days at December 31, 2008, 2007
and 2006, respectively. Management expects a continuation of the
challenges related to the collection of the patient due
accounts. Adverse changes in the percentage of our patients
having adequate health care coverage, general economic
conditions, patient accounting service center operations, payer
mix, or trends in federal, state, and private employer health
care coverage could affect the collection of accounts
receivable, cash flows and results of operations.
42
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Critical
Accounting Policies and Estimates (Continued)
Provision
for Doubtful Accounts and the Allowance for Doubtful Accounts
(Continued)
The approximate breakdown of accounts receivable by payer
classification as of December 31, 2008 and 2007 is set
forth in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% of Accounts Receivable
|
|
|
Under 91 Days
|
|
91180 Days
|
|
Over 180 Days
|
|
Accounts receivable aging at December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare and Medicaid
|
|
|
10
|
%
|
|
|
1
|
%
|
|
|
2
|
%
|
Managed care and other insurers
|
|
|
17
|
|
|
|
4
|
|
|
|
3
|
|
Uninsured
|
|
|
21
|
|
|
|
9
|
|
|
|
33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
48
|
%
|
|
|
14
|
%
|
|
|
38
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable aging at December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare and Medicaid
|
|
|
11
|
%
|
|
|
1
|
%
|
|
|
2
|
%
|
Managed care and other insurers
|
|
|
19
|
|
|
|
4
|
|
|
|
4
|
|
Uninsured
|
|
|
20
|
|
|
|
11
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
50
|
%
|
|
|
16
|
%
|
|
|
34
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Professional
Liability Claims
We, along with virtually all health care providers, operate in
an environment with professional liability risks. Since
January 1, 2007, our facilities are insured by our
wholly-owned insurance subsidiary for losses up to
$50 million per occurrence, subject to a $5 million
per occurrence self-insured retention. Prior to 2007, our
facilities coverage with our insurance subsidiary was not
subject to the $5 million self-insured retention and a
substantial portion of our professional liability risks was
insured through our wholly-owned insurance subsidiary. Reserves
for professional liability risks were $1.387 billion and
$1.513 billion at December 31, 2008 and 2007,
respectively. The current portion of these reserves,
$279 million and $280 million at December 31,
2008 and 2007, respectively, is included in other accrued
expenses. Obligations covered by reinsurance contracts are
included in the reserves for professional liability risks, as
the insurance subsidiary remains liable to the extent reinsurers
do not meet their obligations. Reserves for professional
liability risks (net of $57 million and $44 million
receivable under reinsurance contracts at December 31, 2008
and 2007, respectively) were $1.330 billion and
$1.469 billion at December 31, 2008 and 2007,
respectively. Reserves and provisions for professional liability
risks are based upon actuarially determined estimates. The
estimated reserve ranges, net of amounts receivable under
reinsurance contracts, were $1.102 billion to
$1.332 billion at December 31, 2008 and
$1.224 billion to $1.471 billion at December 31,
2007. Reserves for professional liability risks represent the
estimated ultimate cost of all reported and unreported losses
incurred through the respective consolidated balance sheet
dates. The reserves are estimated using individual case-basis
valuations and actuarial analyses. Those estimates are subject
to the effects of trends in loss severity and frequency. The
estimates are continually reviewed and adjustments are recorded
as experience develops or new information becomes known. Changes
to the estimated reserve amounts are included in current
operating results. Provisions for losses related to professional
liability risks were $175 million, $163 million and
$217 million for the years ended December 31, 2008,
2007 and 2006, respectively.
The reserves for professional liability risks cover
approximately 2,800 and 2,600 individual claims at
December 31, 2008 and 2007, respectively, and estimates for
unreported potential claims. The time period required to resolve
these claims can vary depending upon the jurisdiction and
whether the claim is settled or litigated. The estimation of the
timing of payments beyond a year can vary significantly. Due to
the considerable variability that is
43
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Critical
Accounting Policies and Estimates (Continued)
inherent in such estimates, there can be no assurance that the
ultimate liability will not exceed managements estimates.
Income
Taxes
We calculate our provision for income taxes using the asset and
liability method, under which deferred tax assets and
liabilities are recognized by identifying the temporary
differences that arise from the recognition of items in
different periods for tax and accounting purposes. Deferred tax
assets generally represent the tax effects of amounts expensed
in our income statement for which tax deductions will be claimed
in future periods.
Although we believe that we have properly reported taxable
income and paid taxes in accordance with applicable laws,
federal, state or international taxing authorities may challenge
our tax positions upon audit. We account for uncertain tax
positions in accordance with Financial Accounting Standards
Board (FASB) Interpretation No. 48,
Accounting for Uncertainty in Income Taxes.
Accordingly, we report a liability for unrecognized tax benefits
from uncertain tax positions taken or expected to be taken in
our income tax return. Final audit results may vary from our
estimates.
Results
of Operations
Revenue/Volume
Trends
Our revenues depend upon inpatient occupancy levels, the
ancillary services and therapy programs ordered by physicians
and provided to patients, the volume of outpatient procedures
and the charge and negotiated payment rates for such services.
Gross charges typically do not reflect what our facilities are
actually paid. Our facilities have entered into agreements with
third-party payers, including government programs and managed
care health plans, under which the facilities are paid based
upon the cost of providing services, predetermined rates per
diagnosis, fixed per diem rates or discounts from gross charges.
We do not pursue collection of amounts related to patients who
meet our guidelines to qualify for charity care; therefore, they
are not reported in revenues. We provide discounts to uninsured
patients who do not qualify for Medicaid or charity care that
are similar to the discounts provided to many local managed care
plans.
Revenues increased 5.6% to $28.374 billion for the year
ended December 31, 2008 from $26.858 billion for the
year ended December 31, 2007 and increased 5.4% for the
year ended December 31, 2007 from $25.477 billion for
the year ended December 31, 2006. The increase in revenues
in 2008 can be primarily attributed to the combined impact of a
5.2% increase in revenue per equivalent admission and a 0.5%
increase in equivalent admissions compared to the prior year.
The increase in revenues in 2007 can be primarily attributed to
an 8.3% increase in revenue per equivalent admission, offsetting
a 2.7% decline in equivalent admissions compared to 2006.
Admissions declined 0.7% in 2008 compared to 2007 and declined
3.6% in 2007 compared to 2006. Inpatient surgeries declined 4.5%
and outpatient surgeries declined 0.9% during 2008 compared to
2007. Inpatient surgeries declined 3.1% and outpatient surgeries
declined 2.0% during 2007 compared to 2006. Emergency room
visits increased 2.5% during 2008 compared to 2007 and declined
1.9% during 2007 compared to 2006.
Same facility revenues increased 7.0% for the year ended
December 31, 2008 compared to the year ended
December 31, 2007 and increased 7.4% for the year ended
December 31, 2007 compared to the year ended
December 31, 2006. The 7.0% increase for 2008 can be
primarily attributed to the combined impact of a 5.1% increase
in same facility revenue per equivalent admission and a 1.9%
increase in same facility equivalent admissions. The 7.4%
increase for 2007 can be primarily attributed to an 8.1%
increase in same facility revenue per equivalent admission,
offsetting a 0.7% decline in equivalent admissions.
Same facility admissions increased 0.9% in 2008 compared to 2007
and declined 1.3% in 2007 compared to 2006. Same facility
inpatient surgeries declined 0.5% and same facility outpatient
surgeries declined 0.2% during
44
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Results
of Operations (Continued)
Revenue/Volume
Trends (Continued)
2008 compared to 2007. Same facility inpatient surgeries
declined 1.0% and same facility outpatient surgeries declined
1.1% during 2007 compared to 2006. Same facility emergency room
visits increased 3.6% during 2008 compared to 2007 and increased
0.7% during 2007 compared to 2006.
Same facility uninsured emergency room visits increased 4.5% and
same facility uninsured admissions increased 1.7% during 2008
compared to 2007. Same facility uninsured emergency room visits
increased 7.3% and same facility uninsured admissions increased
9.4% during 2007 compared to 2006. Management believes same
facility uninsured emergency room visits and same facility
uninsured admissions could continue to increase during 2009 if
the adverse general economic and unemployment trends continue.
Admissions related to Medicare, managed Medicare, Medicaid,
managed Medicaid, managed care and other insurers and the
uninsured for the years ended December 31, 2008, 2007 and
2006 are set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2008
|
|
2007
|
|
2006
|
|
Medicare
|
|
|
35
|
%
|
|
|
35
|
%
|
|
|
37
|
%
|
Managed Medicare
|
|
|
9
|
|
|
|
7
|
|
|
|
6
|
|
Medicaid
|
|
|
8
|
|
|
|
8
|
|
|
|
9
|
|
Managed Medicaid
|
|
|
7
|
|
|
|
7
|
|
|
|
6
|
|
Managed care and other insurers
|
|
|
35
|
|
|
|
37
|
|
|
|
36
|
|
Uninsured
|
|
|
6
|
|
|
|
6
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Several factors negatively affected patient volumes in 2008 and
2007. More stringent enforcement of case management guidelines
led to certain patient services being classified as outpatient
observation visits instead of
one-day
admissions. Unit closures and changes in Medicare admission
guidelines led to reductions in rehabilitation and skilled
nursing admissions. Cardiac admissions have been affected by
competition from physician-owned heart hospitals.
The approximate percentages of our inpatient revenues related to
Medicare, managed Medicare, Medicaid, managed Medicaid, managed
care plans and other insurers and the uninsured for the years
ended December 31, 2008, 2007 and 2006 are set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2008
|
|
2007
|
|
2006
|
|
Medicare
|
|
|
31
|
%
|
|
|
32
|
%
|
|
|
34
|
%
|
Managed Medicare
|
|
|
8
|
|
|
|
7
|
|
|
|
6
|
|
Medicaid
|
|
|
7
|
|
|
|
7
|
|
|
|
6
|
|
Managed Medicaid
|
|
|
4
|
|
|
|
4
|
|
|
|
3
|
|
Managed care and other insurers
|
|
|
44
|
|
|
|
44
|
|
|
|
46
|
|
Uninsured
|
|
|
6
|
|
|
|
6
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2008, we owned and operated 38 hospitals
and 33 surgery centers in the state of Florida. Our Florida
facilities revenues totaled $7.099 billion and
$6.732 billion for the years ended December 31, 2008
and 2007, respectively. At December 31, 2008, we owned and
operated 34 hospitals and 23 surgery centers in the state of
45
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Results
of Operations (Continued)
Revenue/Volume
Trends (Continued)
Texas. Our Texas facilities revenues totaled
$7.351 billion and $6.911 billion for the years ended
December 31, 2008 and 2007, respectively. During 2008 and
2007, 55% of our admissions and 51% of our revenues were
generated by our Florida and Texas facilities. Uninsured
admissions in Florida and Texas represented 63% and 62% of our
uninsured admissions during 2008 and 2007, respectively.
We provided $1.747 billion, $1.530 billion and
$1.296 billion of charity care (amounts are based upon our
gross charges) during the years ended December 31, 2008,
2007 and 2006, respectively. We provide discounts to uninsured
patients who do not qualify for Medicaid or charity care. These
discounts are similar to those provided to many local managed
care plans and totaled $1.853 billion, $1.474 billion
and $1.095 billion for the years ended December 31,
2008, 2007 and 2006, respectively.
We receive a significant portion of our revenues from government
health programs, principally Medicare and Medicaid, which are
highly regulated and subject to frequent and substantial
changes. We have increased the indigent care services we provide
in several communities in the state of Texas, in affiliation
with other hospitals. The state of Texas has been involved in
the effort to increase the indigent care provided by private
hospitals. As a result of this additional indigent care provided
by private hospitals, public hospital districts or counties in
Texas have available funds that were previously devoted to
indigent care. The public hospital districts or counties are
under no contractual or legal obligation to provide such
indigent care. The public hospital districts or counties have
elected to transfer some portion of these newly available funds
to the states Medicaid program. Such action is at the sole
discretion of the public hospital districts or counties. It is
anticipated that these contributions to the state will be
matched with federal Medicaid funds. The state then may make
supplemental payments to hospitals in the state for Medicaid
services rendered. Hospitals receiving Medicaid supplemental
payments may include those that are providing additional
indigent care services. Such payments must be within the federal
UPL established by federal regulation.
During 2007, based upon a review of certain expenditures claimed
for federal Medicaid matching funds by the state of Texas, the
Centers for Medicare and Medicaid Services (CMS)
deferred a portion of claimed amounts. CMS completed its review
of the claimed expenditures and released the previously deferred
amounts during 2008. Our Texas Medicaid revenues included
$262 million and $232 million during 2008 and 2007,
respectively, of Medicaid supplemental payments pursuant to UPL
programs. We expect to continue to recognize net benefits
related to the Texas Medicaid supplemental payment program based
upon the routine incurrence of indigent care expenditures and
expected processing of Medicaid supplemental payments.
46
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Results
of Operations (Continued)
Operating
Results Summary
The following are comparative summaries of operating results for
the years ended December 31, 2008, 2007 and 2006 (dollars
in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
Amount
|
|
|
Ratio
|
|
|
Amount
|
|
|
Ratio
|
|
|
Amount
|
|
|
Ratio
|
|
|
Revenues
|
|
$
|
28,374
|
|
|
|
100.0
|
|
|
$
|
26,858
|
|
|
|
100.0
|
|
|
$
|
25,477
|
|
|
|
100.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
11,440
|
|
|
|
40.3
|
|
|
|
10,714
|
|
|
|
39.9
|
|
|
|
10,409
|
|
|
|
40.9
|
|
Supplies
|
|
|
4,620
|
|
|
|
16.3
|
|
|
|
4,395
|
|
|
|
16.4
|
|
|
|
4,322
|
|
|
|
17.0
|
|
Other operating expenses
|
|
|
4,554
|
|
|
|
16.1
|
|
|
|
4,241
|
|
|
|
15.7
|
|
|
|
4,056
|
|
|
|
16.0
|
|
Provision for doubtful accounts
|
|
|
3,409
|
|
|
|
12.0
|
|
|
|
3,130
|
|
|
|
11.7
|
|
|
|
2,660
|
|
|
|
10.4
|
|
Equity in earnings of affiliates
|
|
|
(223
|
)
|
|
|
(0.8
|
)
|
|
|
(206
|
)
|
|
|
(0.8
|
)
|
|
|
(197
|
)
|
|
|
(0.8
|
)
|
Gains on investments
|
|
|
|
|
|
|
|
|
|
|
(8
|
)
|
|
|
|
|
|
|
(243
|
)
|
|
|
(1.0
|
)
|
Depreciation and amortization
|
|
|
1,416
|
|
|
|
5.0
|
|
|
|
1,426
|
|
|
|
5.4
|
|
|
|
1,391
|
|
|
|
5.5
|
|
Interest expense
|
|
|
2,021
|
|
|
|
7.1
|
|
|
|
2,215
|
|
|
|
8.2
|
|
|
|
955
|
|
|
|
3.7
|
|
Gains on sales of facilities
|
|
|
(97
|
)
|
|
|
(0.3
|
)
|
|
|
(471
|
)
|
|
|
(1.8
|
)
|
|
|
(205
|
)
|
|
|
(0.8
|
)
|
Impairment of long-lived assets
|
|
|
64
|
|
|
|
0.2
|
|
|
|
24
|
|
|
|
0.1
|
|
|
|
24
|
|
|
|
0.1
|
|
Transaction costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
442
|
|
|
|
1.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,204
|
|
|
|
95.9
|
|
|
|
25,460
|
|
|
|
94.8
|
|
|
|
23,614
|
|
|
|
92.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before minority interests and income taxes
|
|
|
1,170
|
|
|
|
4.1
|
|
|
|
1,398
|
|
|
|
5.2
|
|
|
|
1,863
|
|
|
|
7.3
|
|
Minority interests in earnings of consolidated entities
|
|
|
229
|
|
|
|
0.8
|
|
|
|
208
|
|
|
|
0.8
|
|
|
|
201
|
|
|
|
0.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
941
|
|
|
|
3.3
|
|
|
|
1,190
|
|
|
|
4.4
|
|
|
|
1,662
|
|
|
|
6.5
|
|
Provision for income taxes
|
|
|
268
|
|
|
|
0.9
|
|
|
|
316
|
|
|
|
1.1
|
|
|
|
626
|
|
|
|
2.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
673
|
|
|
|
2.4
|
|
|
$
|
874
|
|
|
|
3.3
|
|
|
$
|
1,036
|
|
|
|
4.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% changes from prior year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
5.6
|
%
|
|
|
|
|
|
|
5.4
|
%
|
|
|
|
|
|
|
4.2
|
%
|
|
|
|
|
Income before income taxes
|
|
|
(20.9
|
)
|
|
|
|
|
|
|
(28.4
|
)
|
|
|
|
|
|
|
(22.9
|
)
|
|
|
|
|
Net income
|
|
|
(23.0
|
)
|
|
|
|
|
|
|
(15.7
|
)
|
|
|
|
|
|
|
(27.2
|
)
|
|
|
|
|
Admissions(a)
|
|
|
(0.7
|
)
|
|
|
|
|
|
|
(3.6
|
)
|
|
|
|
|
|
|
(2.3
|
)
|
|
|
|
|
Equivalent admissions(b)
|
|
|
0.5
|
|
|
|
|
|
|
|
(2.7
|
)
|
|
|
|
|
|
|
(2.4
|
)
|
|
|
|
|
Revenue per equivalent admission
|
|
|
5.2
|
|
|
|
|
|
|
|
8.3
|
|
|
|
|
|
|
|
6.8
|
|
|
|
|
|
Same facility % changes from prior year(c):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
7.0
|
|
|
|
|
|
|
|
7.4
|
|
|
|
|
|
|
|
6.2
|
|
|
|
|
|
Admissions(a)
|
|
|
0.9
|
|
|
|
|
|
|
|
(1.3
|
)
|
|
|
|
|
|
|
0.2
|
|
|
|
|
|
Equivalent admissions(b)
|
|
|
1.9
|
|
|
|
|
|
|
|
(0.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue per equivalent admission
|
|
|
5.1
|
|
|
|
|
|
|
|
8.1
|
|
|
|
|
|
|
|
6.2
|
|
|
|
|
|
|
|
|
(a) |
|
Represents the total number of patients admitted to our
hospitals and is used by management and certain investors as a
general measure of inpatient volume. |
|
(b) |
|
Equivalent admissions are used by management and certain
investors as a general measure of combined inpatient and
outpatient volume. Equivalent admissions are computed by
multiplying admissions (inpatient volume) by the sum of gross
inpatient revenue and gross outpatient revenue and then dividing
the resulting amount by gross inpatient revenue. The equivalent
admissions computation equates outpatient revenue to
the volume measure (admissions) used to measure inpatient
volume, resulting in a general measure of combined inpatient and
outpatient volume. |
|
(c) |
|
Same facility information excludes the operations of hospitals
and their related facilities that were either acquired, divested
or removed from service during the current and prior year. |
47
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Results
of Operations (Continued)
Years
Ended December 31, 2008 and 2007
Net income totaled $673 million for the year ended
December 31, 2008 compared to $874 million for the
year ended December 31, 2007. Financial results for 2008
include gains on sales of facilities of $97 million and
asset impairment charges of $64 million. Financial results
for 2007 include gains on sales of facilities of
$471 million and an asset impairment charge of
$24 million.
Revenues increased 5.6% to $28.374 billion for 2008 from
$26.858 billion for 2007. The increase in revenues was due
primarily to the combined impact of a 5.2% increase in revenue
per equivalent admission and a 0.5% increase in equivalent
admissions compared to 2007. Same facility revenues increased
7.0% due primarily to the combined impact of a 5.1% increase in
same facility revenue per equivalent admission and a 1.9%
increase in same facility equivalent admissions compared to 2007.
During 2008, same facility admissions increased 0.9%, compared
to 2007. Inpatient surgical volumes declined 4.5% on a
consolidated basis and same facility inpatient surgeries
declined 0.5% during 2008 compared to 2007. Outpatient surgical
volumes declined 0.9% on a consolidated basis and same facility
outpatient surgeries declined 0.2% during 2008 compared to 2007.
Salaries and benefits, as a percentage of revenues, were 40.3%
in 2008 and 39.9% in 2007. Salaries and benefits per equivalent
admission increased 6.3% in 2008 compared to 2007. Same facility
labor rate increases averaged 5.1% for 2008 compared to 2007.
Supplies, as a percentage of revenues, were 16.3% in 2008 and
16.4% in 2007. Supply costs per equivalent admission increased
4.5% in 2008 compared to 2007. Same facility supply costs
increased 8.0% for medical devices, 2.8% for pharmacy supplies,
18.7% for blood products and 6.6% for general medical and
surgical items in 2008 compared to 2007.
Other operating expenses, as a percentage of revenues, increased
to 16.1% in 2008 from 15.7% in 2007. Other operating expenses
are primarily comprised of contract services, professional fees,
repairs and maintenance, rents and leases, utilities, insurance
(including professional liability insurance) and nonincome
taxes. Increases in professional fees paid to hospitalists,
emergency room physicians and anesthesiologists represented
20 basis points of the 2008 increase in other operating
expenses. Other operating expenses include $143 million and
$187 million of indigent care costs in certain Texas
markets during 2008 and 2007, respectively. Provisions for
losses related to professional liability risks were
$175 million and $163 million for 2008 and 2007,
respectively.
Provision for doubtful accounts, as a percentage of revenues,
increased to 12.0% for 2008 from 11.7% in 2007. The provision
for doubtful accounts and the allowance for doubtful accounts
relate primarily to uninsured amounts due directly from
patients. The increase in the provision for doubtful accounts,
as a percentage of revenues, can be attributed to an increasing
amount of patient financial responsibility under certain managed
care plans and same facility increases in uninsured emergency
room visits of 4.5% and uninsured admissions of 1.7% in 2008
compared to 2007. At December 31, 2008, our allowance for
doubtful accounts represented approximately 93% of the $5.838
billion total patient due accounts receivable balance, including
accounts, net of estimated contractual discounts, related to
patients for which eligibility for Medicaid coverage was being
evaluated.
Equity in earnings of affiliates increased from
$206 million for 2007 to $223 million for 2008. Equity
in earnings of affiliates relates primarily to our Denver,
Colorado market joint venture.
No net gains on investments were recognized during 2008 and net
gains on investments for 2007 of $8 million relate to sales
of investment securities by our wholly-owned insurance
subsidiary. Net unrealized losses on investment securities were
$48 million at December 31, 2008, representing a
$69 million decline from a net unrealized gain position of
$21 million at December 31, 2007.
48
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Results
of Operations (Continued)
Years
Ended December 31, 2008 and 2007 (Continued)
Depreciation and amortization decreased, as a percentage of
revenue, to 5.0% in 2008 from 5.4% in 2007. Depreciation expense
was $1.412 billion for 2008 and $1.421 billion for
2007.
Interest expense decreased to $2.021 billion for 2008 from
$2.215 billion for 2007. The decrease in interest expense
was due to reductions in both the average debt balance and the
average effective interest rate on long-term debt. Our average
debt balance was $27.211 billion for 2008 compared to
$27.732 billion for 2007. The average interest rate for our
long-term debt decreased from 7.6% at December 31, 2007 to
6.9% at December 31, 2008.
Gains on sales of facilities were $97 million for 2008 and
included $81 million of net gains on the sales of two
hospital facilities and $16 million of net gains on sales
of real estate and other health care entity investments. Gains
on sales of facilities were $471 million for 2007 and
included a $312 million gain on the sale of our two
Switzerland hospitals, a $131 million gain on the sale of a
facility in Florida and $28 million of net gains on sales
of real estate and other health care entity investments.
Minority interests in earnings of consolidated entities
increased from $208 million for 2007 to $229 million
for 2008. The increase relates primarily to our Austin, Texas
market partnership and our group purchasing organization.
The effective tax rate was 28.5% for 2008 and 26.6% for 2007.
Primarily as a result of reaching a settlement with the IRS
Appeals Division and the revision of the amount of a proposed
IRS adjustment related to prior taxable periods, we reduced our
provision for income taxes by $69 million in 2008. Our 2007
provision for income taxes was reduced by $85 million,
principally based on receiving new information related to tax
positions taken in a prior taxable year, and by an additional
$39 million to adjust 2006 state tax accruals to the
amounts reported on completed tax returns and based upon an
analysis of the Recapitalization costs. Excluding the effect of
these adjustments, the effective tax rates for 2008 and 2007
would have been 35.8% and 37.0%, respectively.
Years
Ended December 31, 2007 and 2006
Net income totaled $874 million for the year ended
December 31, 2007 compared to $1.036 billion for the
year ended December 31, 2006. Financial results for 2007
include gains on sales of facilities of $471 million, gains
on investments of $8 million and an asset impairment charge
of $24 million. Financial results for 2006 include gains on
sales of facilities of $205 million, gains on investments
of $243 million, expenses related to the Recapitalization
of $442 million and an asset impairment charge of
$24 million.
Revenues increased 5.4% to $26.858 billion for 2007 from
$25.477 billion for 2006. The increase in revenues was due
primarily to an 8.3% increase in revenue per equivalent
admission, offsetting a 2.7% decline in equivalent admissions
compared to the prior year. Same facility revenues increased
7.4% due to an 8.1% increase in same facility revenue per
equivalent admission, offsetting a 0.7% decline in same facility
equivalent admissions compared to the prior year.
During 2007, same facility admissions declined 1.3% compared to
2006. Inpatient surgical volumes declined 3.1% on a consolidated
basis and same facility inpatient surgeries declined 1.0% during
2007 compared to 2006. Outpatient surgical volumes declined 2.0%
on a consolidated basis and same facility outpatient surgeries
declined 1.1% during 2007 compared to 2006.
Salaries and benefits, as a percentage of revenues, were 39.9%
in 2007 and 40.9% in 2006. Salaries and benefits per equivalent
admission increased 5.8% in 2007 compared to 2006. Labor rate
increases averaged 5.0% for 2007 compared to 2006.
Supplies, as a percentage of revenues, were 16.4% in 2007 and
17.0% in 2006. Supply costs per equivalent admission increased
4.5% in 2007 compared to 2006. Same facility supply costs
increased 6.4% for medical
49
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Results
of Operations (Continued)
Years
Ended December 31, 2007 and 2006 (Continued)
devices, primarily for orthopedic supplies, 13.1% for blood
products, and 5.6% for general medical and surgical items.
Other operating expenses, as a percentage of revenues, decreased
to 15.7% in 2007 from 16.0% in 2006. Other operating expenses
are primarily comprised of contract services, professional fees,
repairs and maintenance, rents and leases, utilities, insurance
(including professional liability insurance) and nonincome
taxes. Other operating expenses include $187 million and
$11 million of indigent care costs in certain Texas markets
during 2007 and 2006, respectively. Provisions for losses
related to professional liability risks were $163 million
and $217 million for 2007 and 2006, respectively. The
reduction in the provision for professional liability risks
reflects the recognition by our actuaries of improving frequency
and severity claim trends at our facilities.
Provision for doubtful accounts, as a percentage of revenues,
increased to 11.7% for 2007 from 10.4% in 2006. The provision
for doubtful accounts and the allowance for doubtful accounts
relate primarily to uninsured amounts due directly from
patients. The increase in the provision for doubtful accounts,
as a percentage of revenues, can be attributed to an increasing
amount of patient financial responsibility under certain managed
care plans and same facility increases in uninsured emergency
room visits of 7.3% and uninsured admissions of 9.4% in 2007
compared to 2006. At December 31, 2007, our allowance for
doubtful accounts represented approximately 89% of the
$4.825 billion total patient due accounts receivable
balance, including accounts, net of estimated contractual
discounts, related to patients for which eligibility for
Medicaid coverage was being evaluated.
Equity in earnings of affiliates increased from
$197 million for 2006 to $206 million for 2007. Equity
in earnings of affiliates relates primarily to our Denver,
Colorado market joint venture.
Gains on investments for 2007 and 2006 of $8 million and
$243 million, respectively, relate to sales of investment
securities by our wholly-owned insurance subsidiary. The
decrease in realized gains for 2007 was primarily due to the
decision to liquidate our equity investment portfolio and
reinvest in debt and interest-bearing investments during the
fourth quarter of 2006. Net unrealized gains on investment
securities declined from $25 million at December 31,
2006 to $21 million at December 31, 2007.
Depreciation and amortization decreased, as a percentage of
revenues, to 5.4% in 2007 from 5.5% in 2006. Purchases of
property and equipment of $1.444 billion during 2007 were
generally equivalent to depreciation expense for 2007 of
$1.421 billion.
Interest expense increased to $2.215 billion for 2007 from
$955 million for 2006. The increase in interest expense is
primarily due to the increased debt related to the
Recapitalization. Our average debt balance was
$27.732 billion for 2007 compared to $13.811 billion
for 2006. The average interest rate for our long-term debt
decreased from 7.9% at December 31, 2006 to 7.6% at
December 31, 2007.
Gains on sales of facilities were $471 million for 2007 and
included a $312 million gain on the sale of our two
Switzerland hospitals and a $131 million gain on the sale
of a facility in Florida. Gains on sales of facilities were
$205 million for 2006 and included a $92 million gain
on the sale of four hospitals in West Virginia and Virginia and
a $93 million gain on the sale of two hospitals in Florida.
Minority interests in earnings of consolidated entities
increased from $201 million for 2006 to $208 million
for 2007. The increase relates primarily to the operations of
surgery centers and other outpatient services entities.
The effective tax rate was 26.6% for 2007 and 37.6% for 2006.
Based on new information received in 2007 related primarily to
tax positions taken in prior taxable periods, we reduced our
provision for income taxes by $85 million, and by an
additional $39 million to adjust 2006 state tax
accruals to the amounts reported on completed
50
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Results
of Operations (Continued)
Years
Ended December 31, 2007 and 2006 (Continued)
tax returns and based upon an analysis of the Recapitalization
costs. Excluding the effect of these adjustments, the effective
tax rate for 2007 would have been 37.0%.
Liquidity
and Capital Resources
Our primary cash requirements are paying our operating expenses,
servicing of our debt, capital expenditures on our existing
properties and acquisitions of hospitals and other health care
entities. Our primary cash sources are cash flow from operating
activities, issuances of debt and equity securities and
dispositions of hospitals and other health care entities.
Cash provided by operating activities totaled
$1.797 billion in 2008 compared to $1.396 billion in
2007 and $1.845 billion in 2006. Working capital totaled
$2.391 billion at December 31, 2008 and
$2.356 billion at December 31, 2007. The
$401 million increase in cash provided by operating
activities for 2008, compared to 2007, relates primarily to
changes in working capital items. The changes in accounts
receivable (net of the provision for doubtful accounts),
inventories and other assets, and accounts payable and accrued
expenses contributed $42 million to cash provided by
operating activities for 2008 while changes in these items
decreased cash provided by operating activities by
$485 million for 2007. The $449 million decrease in
cash provided by operating activities for 2007, compared to
2006, relates primarily to the combined impact of a
$604 million increase in net cash payments for interest and
income taxes and a $205 million increase from changes in
working capital items. The net impact of the cash payments for
interest and income taxes was an increase in cash payments of
$111 million for 2008 compared to 2007 and an increase of
$604 million for 2007 compared to 2006.
Cash used in investing activities was $1.467 billion,
$479 million and $1.307 billion in 2008, 2007 and
2006, respectively. Excluding acquisitions, capital expenditures
were $1.600 billion in 2008, $1.444 billion in 2007
and $1.865 billion in 2006. We expended $85 million,
$32 million and $112 million for acquisitions of
hospitals and health care entities during 2008, 2007 and 2006,
respectively. Expenditures for acquisitions in all three years
were generally comprised of outpatient and ancillary services
entities and were funded by a combination of cash flows from
operations and the issuance or incurrence of debt. Planned
capital expenditures are expected to approximate
$1.5 billion in 2009. At December 31, 2008, there were
projects under construction which had an estimated additional
cost to complete and equip over the next five years of
$1.450 billion. We expect to finance capital expenditures
with internally generated and borrowed funds.
During 2008, we received cash proceeds of $143 million from
dispositions of two hospitals, and $50 million from sales
of other health care entities and real estate investments.
During 2007, we sold three hospitals for cash proceeds of
$661 million, and we also received cash proceeds of
$106 million related primarily to the sales of real estate
investments. The sales of nine hospitals were completed during
2006 for cash proceeds of $560 million, and we also
received cash proceeds of $91 million on the sales of real
estate investments and our equity investment in a hospital joint
venture.
Cash used in financing activities totaled $258 million in
2008, $1.158 billion in 2007 and $240 million in 2006.
During 2008 and 2007, we used cash proceeds from sales of
facilities and available cash provided by operations to make net
debt repayments of $260 million and $1.270 billion,
respectively. The Recapitalization included the issuance of
$19.964 billion of long-term debt, the receipt of
$3.782 billion of equity contributions, the repurchase of
$20.364 billion of common stock, the payment of
$745 million for Recapitalization related fees and
expenses, and the retirement of $3.182 billion of existing
long-term debt. We may in the future repurchase portions of our
debt securities, subject to certain limitations, from time to
time in either the open market or through privately negotiated
transactions, in accordance with applicable SEC and other legal
requirements. The timing, prices, and sizes of purchases depend
upon prevailing trading prices, general economic and market
conditions, and other factors,
51
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Liquidity
and Capital Resources (Continued)
including applicable securities laws. Funds for the repurchase
of debt securities have, and are expected to, come primarily
from cash generated from operations and borrowed funds.
In addition to cash flows from operations, available sources of
capital include amounts available under our senior secured
credit facilities ($1.858 billion as of December 31,
2008 and $2.038 billion as of February 28,
2009) and anticipated access to public and private debt
markets.
Investments of our professional liability insurance subsidiary,
to maintain statutory equity and pay claims incurred prior to
2007, totaled $1.622 billion and $1.899 billion at
December 31, 2008 and 2007, respectively. The insurance
subsidiary maintained reserves for professional liability risk
of $816 million and $1.165 billion at December 31, 2008 and
2007, respectively. Our facilities are insured by our
wholly-owned insurance subsidiary for losses up to
$50 million per occurrence; however, since January 2007,
this coverage is subject to a $5 million per occurrence
self-insured retention. Claims payments, net of reinsurance
recoveries, during the next twelve months are expected to
approximate $250 million. We estimate that approximately
$50 million of the expected net claim payments during the
next twelve months will relate to claims incurred subsequent to
2006.
Financing
Activities
Due to the Recapitalization, we are a highly leveraged company
with significant debt service requirements. Our debt totaled
$26.989 billion and $27.308 billion at
December 31, 2008 and 2007, respectively. Our interest
expense was $2.021 billion for 2008 and $2.215 billion
for 2007.
In connection with the Recapitalization, we entered into
(i) a $2.000 billion senior secured asset-based
revolving credit facility with a borrowing base of 85% of
eligible accounts receivable, subject to customary reserves and
eligibility criteria (fully utilized at December 31, 2008)
(the ABL credit facility) and (ii) a senior
secured credit agreement (the cash flow credit
facility and, together with the ABL credit facility, the
senior secured credit facilities), consisting of a
$2.000 billion revolving credit facility
($1.858 billion available at December 31, 2008 after
giving effect to certain outstanding letters of credit), a
$2.750 billion term loan A ($2.525 billion outstanding
at December 31, 2008), a $8.800 billion term loan B
($8.624 billion outstanding at December 31,
2008) and a 1.000 billion European term loan
(611 million, or $853 million, outstanding at
December 31, 2008).
Also in connection with the Recapitalization, we issued
$4.200 billion of senior secured notes (comprised of
$1.000 billion of
91/8% notes
due 2014 and $3.200 billion of
91/4% notes
due 2016) and $1.500 billion of
95/8%
cash/103/8%
in-kind senior secured toggle notes (which allow us, at our
option, to pay interest
in-kind
during the first five years) due 2016, which are subject to
certain standard covenants. In November 2008, we elected to make
an interest payment for the interest period ending in May 2009
by paying in-kind instead of paying interest in cash.
The senior secured credit facilities and senior secured notes
are fully and unconditionally guaranteed by substantially all
existing and future, direct and indirect, wholly-owned material
domestic subsidiaries that are Unrestricted
Subsidiaries under our Indenture dated as of
December 16, 1993 (except for certain special purpose
subsidiaries that only guarantee and pledge their assets under
our ABL credit facility). In addition, borrowings under the
European term loan are guaranteed by all material, wholly-owned
European subsidiaries.
Management believes that cash flows from operations, amounts
available under our senior secured credit facilities and our
anticipated access to public and private debt markets will be
sufficient to meet expected liquidity needs during the next
twelve months.
52
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Contractual
Obligations and Off-Balance Sheet Arrangements
As of December 31, 2008, maturities of contractual
obligations and other commercial commitments are presented in
the table below (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period
|
|
Contractual Obligations(a)
|
|
Total
|
|
|
Current
|
|
|
2-3 Years
|
|
|
4-5 Years
|
|
|
After 5 Years
|
|
|
Long-term debt including interest, excluding the senior secured
credit facilities(b)
|
|
$
|
22,500
|
|
|
$
|
1,175
|
|
|
$
|
3,291
|
|
|
$
|
3,842
|
|
|
$
|
14,192
|
|
Loans outstanding under the senior secured credit facilities,
including interest(b)
|
|
|
17,337
|
|
|
|
1,157
|
|
|
|
2,492
|
|
|
|
13,688
|
|
|
|
|
|
Operating leases(c)
|
|
|
1,255
|
|
|
|
225
|
|
|
|
352
|
|
|
|
224
|
|
|
|
454
|
|
Purchase and other obligations(c)
|
|
|
36
|
|
|
|
30
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total contractual obligations
|
|
$
|
41,128
|
|
|
$
|
2,587
|
|
|
$
|
6,141
|
|
|
$
|
17,754
|
|
|
$
|
14,646
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Commercial Commitments Not Recorded on the
|
|
Commitment Expiration by Period
|
|
Consolidated Balance Sheet
|
|
Total
|
|
|
Current
|
|
|
2-3 Years
|
|
|
4-5 Years
|
|
|
After 5 Years
|
|
|
Surety bonds(d)
|
|
$
|
141
|
|
|
$
|
134
|
|
|
$
|
7
|
|
|
$
|
|
|
|
$
|
|
|
Letters of credit(e)
|
|
|
92
|
|
|
|
12
|
|
|
|
|
|
|
|
50
|
|
|
|
30
|
|
Physician commitments(f)
|
|
|
39
|
|
|
|
16
|
|
|
|
23
|
|
|
|
|
|
|
|
|
|
Guarantees(g)
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total commercial commitments
|
|
$
|
274
|
|
|
$
|
162
|
|
|
$
|
30
|
|
|
$
|
50
|
|
|
$
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
We have not included obligations to pay estimated professional
liability claims ($1.387 billion at December 31,
2008) in this table. The estimated professional liability
claims, which have occurred prior to 2007, are expected to be
funded by the designated investment securities that are
restricted for this purpose ($1.622 billion at
December 31, 2008). We also have not included obligations
related to unrecognized tax benefits of $625 million at
December 31, 2008, as we cannot reasonably estimate the
timing or amounts of additional cash payments, if any, at this
time. |
|
(b) |
|
Estimates of interest payments assumes that interest rates,
borrowing spreads and foreign currency exchange rates at
December 31, 2008, remain constant during the period
presented. |
|
(c) |
|
Future operating lease obligations and purchase obligations are
not recorded in our consolidated balance sheet. |
|
(d) |
|
Amounts relate primarily to instances in which we have agreed to
indemnify various commercial insurers who have provided surety
bonds to cover damages for malpractice cases which were awarded
to plaintiffs by the courts. These cases are currently under
appeal and the bonds will not be released by the courts until
the cases are closed. |
|
(e) |
|
Amounts relate primarily to instances in which we have letters
of credit outstanding with insurance companies that issued
workers compensation insurance policies to us in prior years.
The letters of credit serve as security to the insurance
companies for payment obligations we retained. |
|
(f) |
|
In consideration for physicians relocating to the communities in
which our hospitals are located and agreeing to engage in
private practice for the benefit of the respective communities,
we make advances to physicians, normally over a period of one
year, to assist in establishing the physicians practices.
The actual amount of these commitments to be advanced often
depends upon the financial results of the physicians
private practices during the recruitment agreement payment
period. The physician commitments reflected were based on our
maximum exposure on effective agreements at December 31,
2008. |
|
(g) |
|
We have entered into guarantee agreements related to certain
leases. |
53
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Market
Risk
We are exposed to market risk related to changes in market
values of securities. The investments in debt and equity
securities of our wholly-owned insurance subsidiary were
$1.614 billion and $8 million, respectively, at
December 31, 2008. These investments are carried at fair
value, with changes in unrealized gains and losses being
recorded as adjustments to other comprehensive income. At
December 31, 2008, we had a net unrealized loss of
$48 million on the insurance subsidiarys investment
securities.
We are exposed to market risk related to market illiquidity.
Liquidity of the investments in debt and equity securities of
our wholly-owned insurance subsidiary could be impaired by the
inability to access the capital markets. Should the wholly-owned
insurance subsidiary require significant amounts of cash in
excess of normal cash requirements to pay claims and other
expenses on short notice, we may have difficulty selling these
investments in a timely manner or be forced to sell them at a
price less than what we might otherwise have been able to in a
normal market environment. At December 31, 2008, our
wholly-owned insurance subsidiary had invested $536 million
($573 million par value) in municipal, tax-exempt student
loan auction rate securities which were classified as long-term
investments. The auction rate securities (ARS) are
publicly issued securities with long-term stated maturities for
which the interest rates are reset through a Dutch auction every
seven to 35 days. With the liquidity issues experienced in
global credit and capital markets, the ARS held by our
wholly-owned insurance subsidiary have experienced multiple
failed auctions, beginning on February 11, 2008, as the
amount of securities submitted for sale exceeded the amount of
purchase orders. There is a very limited market for the ARS at
this time. We do not currently intend to attempt to sell the ARS
as the liquidity needs of our insurance subsidiary are expected
to be met by other investments in its investment portfolio.
These securities continue to accrue and pay interest
semi-annually based on the failed auction maximum rate formulas
stated in their respective Official Statements. During the
failed auction period beginning February 11, 2008 and
ending December 31, 2008, certain issuers of our ARS have
redeemed $93 million of our securities at par value. If
uncertainties in the credit and capital markets continue or
there are ratings downgrades on the ARS held by our insurance
subsidiary, we may be required to recognize other-than-temporary
impairments on these long-term investments in future periods.
We are also exposed to market risk related to changes in
interest rates and we periodically enter into interest rate swap
agreements to manage our exposure to these fluctuations. Our
interest rate swap agreements involve the exchange of fixed and
variable rate interest payments between two parties, based on
common notional principal amounts and maturity dates. The
notional amounts of the swap agreements represent balances used
to calculate the exchange of cash flows and are not our assets
or liabilities. Our credit risk related to these agreements is
considered low because the swap agreements are with creditworthy
financial institutions. The interest payments under these
agreements are settled on a net basis. These derivatives have
been recognized in the financial statements at their respective
fair values. Changes in the fair value of these derivatives are
included in other comprehensive income.
With respect to our interest-bearing liabilities, approximately
$5.055 billion of long-term debt at December 31, 2008
is subject to variable rates of interest, while the remaining
balance in long-term debt of $21.934 billion at
December 31, 2008 is subject to fixed rates of interest.
Both the general level of interest rates and, for the senior
secured credit facilities, our leverage affect our variable
interest rates. Our variable rate debt is comprised primarily of
amounts outstanding under the senior secured credit facilities.
Borrowings under the senior secured credit facilities bear
interest at a rate equal to an applicable margin plus, at our
option, either (a) a base rate determined by reference to
the higher of (1) the federal funds rate plus
1/2
of 1% and (2) the prime rate of Bank of America or
(b) a LIBOR rate for the currency of such borrowing for the
relevant interest period. The applicable margin for borrowings
under the senior secured credit facilities, with the exception
of term loan B where the margin is static, may be reduced
subject to attaining certain leverage ratios. The average rate
for our long-term debt decreased from 7.6% at December 31,
2007 to 6.9% at December 31, 2008. On February 16,
2007, we amended the cash flow credit facility to reduce the
applicable margins with respect to the term borrowings
thereunder. On June 20, 2007, we amended the ABL credit
facility to reduce the applicable margin with respect to
borrowings thereunder.
54
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
Market
Risk (Continued)
The estimated fair value of our total long-term debt was
$20.225 billion at December 31, 2008. The estimates of
fair value are based upon the quoted market prices for the same
or similar issues of long-term debt with the same maturities.
Based on a hypothetical 1% increase in interest rates, the
potential annualized reduction to future pretax earnings would
be approximately $51 million. To mitigate the impact of
fluctuations in interest rates, we generally target a portion of
our debt portfolio to be maintained at fixed rates.
Our international operations and the European term loan expose
us to market risks associated with foreign currencies. In order
to mitigate the currency exposure related to debt service
obligations through December 31, 2011 under the European
term loan, we have entered into cross currency swap agreements.
A cross currency swap is an agreement between two parties to
exchange a stream of principal and interest payments in one
currency for a stream of principal and interest payments in
another currency over a specified period.
Financial
Instruments
Derivative financial instruments are employed to manage risks,
including foreign currency and interest rate exposures, and are
not used for trading or speculative purposes. We recognize
derivative instruments, such as interest rate swap agreements
and foreign exchange contracts, in the consolidated balance
sheets at fair value. Changes in the fair value of derivatives
are recognized periodically either in earnings or in
stockholders equity, as a component of other comprehensive
income, depending on whether the derivative financial instrument
qualifies for hedge accounting, and if so, whether it qualifies
as a fair value hedge or a cash flow hedge. Gains and losses on
derivatives designated as cash flow hedges, to the extent they
are effective, are recorded in other comprehensive income, and
subsequently reclassified to earnings to offset the impact of
the hedged items when they occur. Changes in the fair value of
derivatives not qualifying as hedges, and for any portion of a
hedge that is ineffective, are reported in earnings.
The net interest paid or received on interest rate swaps is
recognized as interest expense. Gains and losses resulting from
the early termination of interest rate swap agreements are
deferred and amortized as adjustments to expense over the
remaining period of the debt originally covered by the
terminated swap.
Effects
of Inflation and Changing Prices
Various federal, state and local laws have been enacted that, in
certain cases, limit our ability to increase prices. Revenues
for general, acute care hospital services rendered to Medicare
patients are established under the federal governments
prospective payment system. Total fee-for-service Medicare
revenues approximated 23% in 2008, 24% in 2007 and 25% in 2006
of our total patient revenues.
Management believes that hospital industry operating margins
have been, and may continue to be, under significant pressure
because of changes in payer mix and growth in operating expenses
in excess of the increase in prospective payments under the
Medicare program. In addition, as a result of increasing
regulatory and competitive pressures, our ability to maintain
operating margins through price increases to non-Medicare
patients is limited.
IRS
Disputes
We are currently contesting before the Appeals Division of the
Internal Revenue Service (the IRS) certain claimed
deficiencies and adjustments proposed by the IRS in connection
with its examinations of the 2003 and 2004 federal income
returns for HCA and 17 affiliates that are treated as
partnerships for federal income tax purposes (affiliated
partnerships). The disputed items include the timing of
recognition of certain patient service revenues and our method
for calculating the tax allowance for doubtful accounts.
55
HCA
INC.
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS (Continued)
IRS
Disputes (Continued)
Eight taxable periods of HCA and its predecessors ended in 1995
through 2002 and the 2002 taxable year of 13 affiliated
partnerships, for which the primary remaining issue is the
computation of the tax allowance for doubtful accounts, are
pending before the IRS Examination Division or the United States
Tax Court as of December 31, 2008. The IRS began an audit
of the 2005 and 2006 federal income tax returns for HCA and
seven affiliated partnerships during 2008.
Management believes that HCA, its predecessors and affiliates
properly reported taxable income and paid taxes in accordance
with applicable laws and agreements established with the IRS and
that final resolution of these disputes will not have a
material, adverse effect on our results of operations or
financial position. However, if payments due upon final
resolution of these issues exceed our recorded estimates, such
resolutions could have a material, adverse effect on our results
of operations or financial position.
56
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
The information called for by this item is provided under the
caption Market Risk under Item 7,
Managements Discussion and Analysis of Financial
Condition and Results of Operations.
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
Information with respect to this Item is contained in our
consolidated financial statements indicated in the Index to
Consolidated Financial Statements on
Page F-1
of this annual report on
Form 10-K.
|
|
Item 9.
|
Changes
in and Disagreements with Accountants on Accounting and
Financial Disclosure
|
None.
|
|
Item 9A.
|
Controls
and Procedures
|
|
|
1.
|
Conclusion
Regarding the Effectiveness of Disclosure Controls and
Procedures
|
Under the supervision and with the participation of our
management, including our principal executive officer and
principal financial officer, we conducted an evaluation of our
disclosure controls and procedures, as such term is defined
under
Rule 13a-15(e)
promulgated under the Securities Exchange Act of 1934, as
amended (the Exchange Act). Based on this
evaluation, our principal executive officer and our principal
financial officer concluded that our disclosure controls and
procedures were effective as of the end of the period covered by
this annual report.
|
|
2.
|
Internal
Control Over Financial Reporting
|
(a) Managements Report on Internal Control Over
Financial Reporting
Our management is responsible for establishing and maintaining
effective internal control over financial reporting, as such
term is defined in Exchange Act
Rule 13a-15(f).
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Therefore, even those systems determined to be effective can
provide only reasonable assurance with respect to financial
statement preparation and presentation.
Under the supervision and with the participation of our
management, including our principal executive officer and
principal financial officer, we conducted an assessment of the
effectiveness of our internal control over financial reporting
based on the framework in Internal Control
Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission. Based on our
assessment under the framework in Internal Control
Integrated Framework, our management concluded that our internal
control over financial reporting was effective as of
December 31, 2008.
Ernst & Young, LLP, the independent registered public
accounting firm that audited our consolidated financial
statements included in this
Form 10-K,
has issued a report on our internal control over financial
reporting, which is included herein.
57
(b) Attestation Report of the Independent Registered Public
Accounting Firm
Report of
Independent Registered Public Accounting Firm
The Board of Directors and Stockholders
HCA Inc.
We have audited HCA Inc.s internal control over financial
reporting as of December 31, 2008, based on criteria
established in Internal Control Integrated Framework
issued by the Committee of Sponsoring Organizations of the
Treadway Commission (the COSO criteria). HCA Inc.s
management is responsible for maintaining effective internal
control over financial reporting, and for its assessment of the
effectiveness of internal control over financial reporting
included in the accompanying Managements Report on
Internal Control Over Financial Reporting. Our responsibility is
to express an opinion on the Companys internal control
over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the
design and operating effectiveness of internal control based on
the assessed risk, and performing such other procedures as we
considered necessary in the circumstances. We believe that our
audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
In our opinion, HCA Inc. maintained, in all material respects,
effective internal control over financial reporting as of
December 31, 2008, based on the COSO criteria.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated balance sheets of HCA Inc. as of December 31,
2008 and 2007, and the related consolidated statements of
income, stockholders (deficit) equity and cash flows for
each of the three years in the period ended December 31,
2008, and our report dated March 3, 2009 expressed an
unqualified opinion thereon.
/s/ Ernst & Young LLP
Nashville, Tennessee
March 3, 2009
58
|
|
Item 9B.
|
Other
Information
|
On March 2, 2009, we amended our $13.550 billion and
1.000 billion senior secured cash flow credit
facility, dated as of November 17, 2006, as amended
February 16, 2007 (the cash flow credit
facility), to allow for one or more future issuances of
additional secured notes, which may include notes that are
secured on a pari passu basis or on a junior basis with
the obligations under the cash flow credit facility, so long as
(1) such notes do not require any scheduled payment or
redemption prior to the scheduled term loan B final maturity
date as currently in effect and (2) the proceeds from any
such issuance are used within three business days of receipt to
prepay term loans under the cash flow credit facility in
accordance with the terms of the cash flow credit facility. The
U.S. security documents related to the cash flow credit
facility were also amended and restated, or in the case of the
U.S. mortgages, will be amended and restated, in connection
with the amendment in order to give effect to the security
interests granted to holders of such additional secured notes.
On March 2, 2009, we amended our $2.000 billion senior
secured asset-based revolving credit facility, dated as of
November 17, 2006, as amended and restated as of
June 20, 2007 (the ABL credit facility), to
allow for one or more future issuances of additional secured
notes or loans, which may include notes or loans that are
secured on a pari passu basis or on a junior basis with the
obligations under the cash flow credit facility, so long as the
proceeds from any such issuance are used to prepay term loans
under the cash flow credit facility within three business days
of the receipt thereof. The amendment to the ABL credit facility
also altered the excess facility availability requirement to
include a separate minimum facility availability requirement
applicable to the ABL credit facility, and increased the
applicable LIBOR and ABR margins for all borrowings under the
ABL credit facility by 0.25% each.
On February 19, 2009, we issued $310 million of
97/8%
Senior Secured Notes due in 2017, which are subject to certain
standard covenants.
See also Item 13, Certain Relationships and Related
Transactions for a description of certain relationships
between the Administrative Agent under the cash flow credit
facility and the ABL credit facility, and our company.
59
PART III
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance
|
As of February 25, 2009, our directors were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
|
Name
|
|
Age
|
|
Since
|
|
Position(s)
|
|
Jack O. Bovender, Jr.
|
|
|
63
|
|
|
|
1999
|
|
|
Chairman of the Board
|
Christopher J. Birosak
|
|
|
54
|
|
|
|
2006
|
|
|
Director
|
George A. Bitar
|
|
|
44
|
|
|
|
2006
|
|
|
Director
|
Richard M. Bracken
|
|
|
56
|
|
|
|
2002
|
|
|
President, Chief Executive Officer and Director
|
John P. Connaughton
|
|
|
43
|
|
|
|
2006
|
|
|
Director
|
Kenneth W. Freeman
|
|
|
58
|
|
|
|
2009
|
|
|
Director
|
Thomas F. Frist III
|
|
|
41
|
|
|
|
2006
|
|
|
Director
|
William R. Frist
|
|
|
39
|
|
|
|
2009
|
|
|
Director
|
Christopher R. Gordon
|
|
|
36
|
|
|
|
2006
|
|
|
Director
|
Michael W. Michelson
|
|
|
57
|
|
|
|
2006
|
|
|
Director
|
James C. Momtazee
|
|
|
37
|
|
|
|
2006
|
|
|
Director
|
Stephen G. Pagliuca
|
|
|
54
|
|
|
|
2006
|
|
|
Director
|
Nathan C. Thorne
|
|
|
55
|
|
|
|
2006
|
|
|
Director
|
As of February 25, 2009, our executive officers (other than
Messrs. Bovender and Bracken who are listed above) were as
follows:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position(s)
|
|
R. Milton Johnson
|
|
|
52
|
|
|
Executive Vice President and Chief Financial Officer
|
David G. Anderson
|
|
|
61
|
|
|
Senior Vice President Finance and Treasurer
|
Victor L. Campbell
|
|
|
62
|
|
|
Senior Vice President
|
V. Carl George
|
|
|
64
|
|
|
Senior Vice President Development
|
Charles J. Hall
|
|
|
55
|
|
|
President Eastern Group
|
Samuel N. Hazen
|
|
|
48
|
|
|
President Western Group
|
A. Bruce Moore, Jr.
|
|
|
49
|
|
|
President Outpatient Services Group
|
Jonathan B. Perlin, M.D.
|
|
|
48
|
|
|
President Clinical Services Group and Chief
Medical Officer
|
W. Paul Rutledge
|
|
|
54
|
|
|
President Central Group
|
Joseph N. Steakley
|
|
|
54
|
|
|
Senior Vice President Internal Audit Services
|
John M. Steele
|
|
|
53
|
|
|
Senior Vice President Human Resources
|
Donald W. Stinnett
|
|
|
52
|
|
|
Senior Vice President and Controller
|
Beverly B. Wallace
|
|
|
58
|
|
|
President Shared Services Group
|
Robert A. Waterman
|
|
|
55
|
|
|
Senior Vice President and General Counsel
|
Noel Brown Williams
|
|
|
53
|
|
|
Senior Vice President and Chief Information Officer
|
Alan R. Yuspeh
|
|
|
59
|
|
|
Senior Vice President and Chief Ethics and Compliance Officer
|
Our Board of Directors consists of thirteen directors, who are
each managers of Hercules Holding. The Amended and Restated
Limited Liability Company Agreement of Hercules Holding requires
that the members of Hercules Holding take all necessary action
to ensure that the persons who serve as managers of Hercules
Holding also serve on the Board of Directors of HCA. See
Item 13, Certain Relationships and Related
Transactions. In addition, Messrs. Bovenders
and Brackens employment agreements provide that they will
continue to serve as
60
members of our Board of Directors so long as they remain
officers of HCA, with Mr. Bovender to serve as the Chairman
through December 15, 2009. Because of these requirements,
together with Hercules Holdings ownership of 97.3% of our
outstanding common stock, we do not currently have a policy or
procedures with respect to shareholder recommendations for
nominees to the Board of Directors.
Jack O. Bovender, Jr. has served as our Chairman
since January 2002. Mr. Bovender served as Chairman and
Chief Executive Officer of the Company from January 2002 to
January 2009 and President and Chief Executive Officer of the
Company from January 2001 to December 2001. From August 1997 to
January 2001, Mr. Bovender served as President and Chief
Operating Officer of the Company. From April 1994 to August
1997, he was retired. Prior to his retirement, Mr. Bovender
served as Chief Operating Officer of HCA-Hospital Corporation of
America from 1992 until 1994. Prior to 1992, Mr. Bovender
held several senior level positions with HCA-Hospital
Corporation of America.
Christopher J. Birosak is a Managing Director in the
Merrill Lynch Global Private Equity Division which he joined in
2004. Prior to joining the Global Private Equity Division,
Mr. Birosak worked in various capacities in the Merrill
Lynch Leveraged Finance Group with particular emphasis on
leveraged buyouts and mergers and acquisitions related
financings. Mr. Birosak also serves on the board of
directors of the Atrium Companies, Inc. and NPC International.
Mr. Birosak joined Merrill Lynch in 1994.
George A. Bitar has been a Managing Director in the
Merrill Lynch Global Private Equity Division where he serves as
Co-Head of the North America Region, and a Managing Director in
Merrill Lynch Global Private Equity, Inc., the Manager of ML
Global Private Equity Fund, L.P., a proprietary private equity
fund since 1999. Mr. Bitar serves on the Board of Hertz
Global Holdings, Inc., The Hertz Corporation, Advantage Sales
and Marketing, Inc. and Aeolus Re Ltd.
Richard M. Bracken was appointed as our President and
Chief Executive Officer in January 2009 and has served as a
Director of the Company since 2002. Mr. Bracken was
appointed Chief Operating Officer in July 2001 and served as
President and Chief Operating Officer from January 2002 to
January 2009. Mr. Bracken served as President
Western Group of the Company from August 1997 until July 2001.
From January 1995 to August 1997, Mr. Bracken served as
President of the Pacific Division of the Company. Prior to 1995,
Mr. Bracken served in various hospital Chief Executive
Officer and Administrator positions with HCA-Hospital
Corporation of America.
John P. Connaughton has been a Managing Director of Bain
Capital Partners, LLC since 1997 and a member of the firm since
1989. Prior to joining Bain Capital, Mr. Connaughton was a
consultant at Bain & Company, Inc., where he worked in
the health care, consumer products and business services
industries. Mr. Connaughton currently serves as a director
of Clear Channel Communications, Inc., M/C Communications
(PriMed), CRC Health Group, Warner Chilcott, Ltd., Sungard Data
Systems, Warner Music Group, AMC Theatres, Quintiles
Transnational Corp. and The Boston Celtics.
Kenneth W. Freeman has been a member of the general
partner of Kohlberg Kravis & Co. L.P. since 2007 and
joined the firm as Managing Director in May 2005. From May 2004
to December 2004, Mr. Freeman was Chairman of Quest
Diagnostics Incorporated, and from January 1996 to May 2004, he
served as Chairman and Chief Executive Officer of Quest
Diagnostics Incorporated. From May 1995 to December 1996,
Mr. Freeman was President and Chief Executive Officer of
Corning Clinical Laboratories, the predecessor company to Quest
Diagnostics. Prior to that, he served in various general
management and financial roles with Corning Incorporated.
Mr. Freeman currently serves as a director of Accellent,
Inc. and Masonite Corporation.
Thomas F. Frist III is a principal of Frist Capital
LLC, a private investment vehicle for Mr. Frist and certain
related persons and has held such position since 1998.
Mr. Frist is also a general partner at Frisco Partners,
another Frist family investment vehicle. Mr. Frist is the
brother of William R. Frist, who also serves as a director.
William R. Frist is a principal of Frist Capital LLC, a
private investment vehicle for Mr. Frist and certain
related persons and has held such position since 2003.
Mr. Frist is also a general partner at Frisco Partners,
another Frist family investment vehicle. Mr. Frist is the
brother of Thomas F. Frist, III, who also serves as a
director.
61
Christopher R. Gordon is a Managing Director of Bain
Capital Partners, LLC and joined the firm in 1997. Prior to
joining Bain Capital, Mr. Gordon was a consultant at
Bain & Company. Mr. Gordon currently serves as a
director of Accellent, Inc. and CRC Health Corporation.
Michael W. Michelson has been a member of the limited
liability company which serves as the general partner of
Kohlberg Kravis Roberts & Co. L.P. since 1996. Prior
to that, he was a general partner of Kohlberg Kravis
Roberts & Co. L.P. Mr. Michelson is also a
director of Biomet, Inc. and Jazz Pharmaceuticals, Inc.
James C. Momtazee has been a member of the limited
liability company which serves as the general partner of
Kohlberg Kravis Roberts & Co. L.P. since 2009. From
1996 to 2009, he was an executive of Kohlberg Kravis
Roberts & Co. L.P. From 1994 to 1996,
Mr. Momtazee was with Donaldson, Lufkin &
Jenrette in its investment banking department. Mr. Momtazee
is also a director of Accellent, Inc. and Jazz Pharmaceuticals,
Inc.
Stephen G. Pagliuca is a Managing Director of Bain
Capital Partners, LLC. Mr. Pagliuca is also a Managing
Partner and an Owner of the Boston Celtics Basketball franchise.
Mr. Pagliuca joined Bain & Company in 1982 and
founded the Information Partners private equity fund for Bain
Capital in 1989. He also worked as a senior accountant and
international tax specialist for Peat Marwick
Mitchell & Company in the Netherlands.
Mr. Pagliuca currently serves as a director of Burger King
Holdings Inc., Gartner, Inc., Warner Chilcott, Ltd., Quintiles
Transnational Corp. and M/C Communications.
Nathan C. Thorne has been a Senior Vice President of
Merrill Lynch & Co., Inc., a subsidiary of Bank of
America Corporation since February 2006, and President of
Merrill Lynch Global Private Equity since 2002. Mr. Thorne
joined Merrill Lynch in 1984.
R. Milton Johnson has served as Executive Vice
President and Chief Financial Officer of the Company since July
2004. Mr. Johnson served as Senior Vice President and
Controller of the Company from July 1999 until July 2004.
Mr. Johnson served as Vice President and Controller of the
Company from November 1998 to July 1999. Prior to that time,
Mr. Johnson served as Vice President Tax of the
Company from April 1995 to October 1998. Prior to that time,
Mr. Johnson served as Director of Tax for Healthtrust from
September 1987 to April 1995.
David G. Anderson has served as Senior Vice
President Finance and Treasurer of the Company since
July 1999. Mr. Anderson served as Vice President
Finance of the Company from September 1993 to July
1999 and was elected to the additional position of Treasurer in
November 1996. From March 1993 until September 1993,
Mr. Anderson served as Vice President Finance
and Treasurer of Galen Health Care, Inc. From July 1988 to March
1993, Mr. Anderson served as Vice President
Finance and Treasurer of Humana Inc.
Victor L. Campbell has served as Senior Vice President of
the Company since February 1994. Prior to that time,
Mr. Campbell served as HCA-Hospital Corporation of
Americas Vice President for Investor, Corporate and
Government Relations. Mr. Campbell joined HCA-Hospital
Corporation of America in 1972. Mr. Campbell serves on the
Board of the Nashville Health Care Council, as a member of the
American Hospital Associations Presidents Forum, and
on the Board and Executive Committee of the Federation of
American Hospitals.
V. Carl George has served as Senior Vice
President Development of the Company since July
1999. Mr. George served as Vice President
Development of the Company from April 1995 to July 1999. From
September 1987 to April 1995, Mr. George served as Director
of Development for Healthtrust. Prior to working for
Healthtrust, Mr. George served with HCA-Hospital
Corporation of America in various positions.
Charles J. Hall was appointed President
Eastern Group of the Company in October 2006. Prior to that
time, Mr. Hall had served as President North
Florida Division since April 2003. Mr. Hall had previously
served the Company as President of the East Florida Division
from January 1999 until April 2003, as a Market President in the
East Florida Division from January 1998 until December 1998, as
President of the South Florida Division from February 1996 until
December 1997, and as President of the Southwest Florida
Division from October 1994 until February 1996, and in various
other capacities since 1987.
Samuel N. Hazen was appointed President
Western Group of the Company in July 2001. Mr. Hazen served
as Chief Financial Officer Western Group of the
Company from August 1995 to July 2001. Mr. Hazen served as
Chief Financial Officer North Texas Division of the
Company from February 1994 to July 1995. Prior to that
62
time, Mr. Hazen served in various hospital and regional
Chief Financial Officer positions with Humana Inc. and Galen
Health Care, Inc.
A. Bruce Moore, Jr. was appointed
President Outpatient Services Group in January 2006.
Mr. Moore had served as Senior Vice President and as Chief
Operating Officer Outpatient Services Group since
July 2004 and as Senior Vice President Operations
Administration from July 1999 until July 2004. Mr. Moore
served as Vice President Operations Administration
of the Company from September 1997 to July 1999, as Vice
President Benefits from October 1996 to September
1997, and as Vice President Compensation from March
1995 until October 1996.
Dr. Jonathan B. Perlin was appointed
President Clinical Services Group and Chief Medical
Officer in November 2007. Dr. Perlin had served as Chief
Medical Officer and Senior Vice President Quality of
the Company from August 2006 to November 2007. Prior to joining
the Company, Dr. Perlin served as Under Secretary for
Health in the U.S. Department of Veterans Affairs since
April 2004. Dr. Perlin joined the Veterans Health
Administration in November 1999 where he served in various
capacities, including as Deputy Under Secretary for Health from
July 2002 to April 2004, and as Chief Quality and Performance
Officer from November 1999 to September 2002.
W. Paul Rutledge was appointed as
President Central Group in October 2005.
Mr. Rutledge had served as President of the MidAmerica
Division since January 2001. He served as President of TriStar
Health System from June 1996 to January 2001 and served as
President of Centennial Medical Center from May 1993 to June
1996. He has served in leadership capacities with HCA for more
than 25 years, working with hospitals in the Southeast.
Joseph N. Steakley has served as Senior Vice
President Internal Audit Services of the Company
since July 1999. Mr. Steakley served as Vice President
Internal Audit Services from November 1997 to July
1999. From October 1989 until October 1997, Mr. Steakley
was a partner with Ernst & Young LLP.
Mr. Steakley is a member of the board of directors of J.
Alexanders Corporation, where he serves on the
compensation committee and as chairman of the audit committee.
John M. Steele has served as Senior Vice
President Human Resources of the Company since
November 2003. Mr. Steele served as Vice
President Compensation and Recruitment of the
Company from November 1997 to October 2003. From March 1995 to
November 1997, Mr. Steele served as Assistant Vice
President Recruitment.
Donald W. Stinnett was appointed Senior Vice President
and Controller in December 2008. Mr. Stinnett served as
Chief Financial Officer Eastern Group from October
2005 to December 2008 and Chief Financial Officer of the Far
West Division from July 1999 to October 2005. Mr. Stinnett
served as Chief Financial Officer and Vice President of Finance
of Franciscan Health System of the Ohio Valley from 1995 until
1999, and served in various capacities with Franciscan Health
System of Cincinnati and Providence Hospital in Cincinnati prior
to that time.
Beverly B. Wallace was appointed President
Shared Services Group in March 2006. From January 2003 until
March 2006, Ms. Wallace served as President
Financial Services Group. Ms. Wallace served as
Senior Vice President Revenue Cycle Operations
Management of the Company from July 1999 to January 2003.
Ms. Wallace served as Vice President Managed
Care of the Company from July 1998 to July 1999. From 1997 to
1998, Ms. Wallace served as President Homecare
Division of the Company. From 1996 to 1997, Ms. Wallace
served as Chief Financial Officer Nashville Division
of the Company. From 1994 to 1996, Ms. Wallace served as
Chief Financial Officer
Mid-America
Division of the Company.
Robert A. Waterman has served as Senior Vice President
and General Counsel of the Company since November 1997.
Mr. Waterman served as a partner in the law firm of
Latham & Watkins from September 1993 to October 1997;
he was also Chair of the firms healthcare group during
1997.
Noel Brown Williams has served as Senior Vice President
and Chief Information Officer of the Company since October 1997.
From October 1996 to September 1997, Ms. Williams served as
Chief Information Officer for American Service Group/Prison
Health Services, Inc. From September 1995 to September 1996,
Ms. Williams worked as an independent consultant. From June
1993 to June 1995, Ms. Williams served as Vice President,
63
Information Services for HCA Information Services. From February
1979 to June 1993, she held various positions with HCA-Hospital
Corporation of America Information Services.
Alan R. Yuspeh has served as Senior Vice President and
Chief Ethics and Compliance Officer of the Company since May
2007. From October 1997 to May 2007, Mr. Yuspeh served as
Senior Vice President Ethics, Compliance and
Corporate Responsibility of the Company. From September 1991
until October 1997, Mr. Yuspeh was a partner with the law
firm of Howrey & Simon. As a part of his law practice,
Mr. Yuspeh served from 1987 to 1997 as Coordinator of the
Defense Industry Initiative on Business Ethics and Conduct.
Audit
Committee Financial Expert
Our Audit and Compliance Committee is composed of Christopher J.
Birosak, Thomas F. Frist III, Christopher R. Gordon and James C.
Momtazee. In light of our status as a closely held company and
the absence of a public listing or trading market for our common
stock, our Board has not designated any member of the Audit and
Compliance Committee as an audit committee financial
expert. Though not formally considered by our Board given
that our securities are not traded on any national securities
exchange, based upon the listing standards of the New York Stock
Exchange (the NYSE), the national securities
exchange upon which our common stock was listed prior to the
Merger, we do not believe that any of Messrs. Birosak,
Frist, Gordon or Momtazee would be considered independent
because of their relationships with certain affiliates of the
funds and other entities which hold significant interests in
Hercules Holding, which owns 97.3% of our outstanding common
stock, and other relationships with us. See Item 13,
Certain Relationships and Related Transactions.
Code of
Ethics
We have a Code of Conduct which is applicable to all our
directors, officers and employees (the Code of
Conduct). The Code of Conduct is available on the Ethics
and Compliance and Corporate Governance pages of our website at
www.hcahealthcare.com. To the extent required pursuant to
applicable SEC regulations, we intend to post amendments to or
waivers from our Code of Conduct (to the extent applicable to
our chief executive officer, principal financial officer or
principal accounting officer) at this location on our website or
report the same on a Current Report on
Form 8-K.
Our Code of Conduct is available free of charge upon request to
our Corporate Secretary, HCA Inc., One Park Plaza, Nashville, TN
37203.
Section 16(a)
Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934
requires our directors, executive officers and greater than
ten-percent shareholders to file initial reports of ownership
and reports of changes in ownership of any of our securities
with the SEC and us. We believe that during the 2008 fiscal
year, all of our directors, executive officers and greater than
ten-percent shareholders complied with the requirements of
Section 16(a). This belief is based on our review of forms
filed or written notice that no reports were required.
|
|
Item 11.
|
Executive
Compensation
|
Compensation
Discussion and Analysis
The Compensation Committee (the Committee) of the
Board of Directors is generally charged with the oversight of
our executive compensation and rewards programs. The Committee
is currently composed of John P. Connaughton, Michael W.
Michelson and George A. Bitar. In 2008, the Committee also
included Thomas F. Frist, Jr., M.D., and
determinations with respect to 2008 compensation were made by
such Committee. Responsibilities of the Committee include the
review and approval of the following items:
|
|
|
|
|
Executive compensation strategy and philosophy;
|
|
|
|
Compensation arrangements for executive management;
|
|
|
|
Design and administration of the annual cash-based Senior
Officer Performance Excellence Program (PEP);
|
|
|
|
Design and administration of our equity incentive plans;
|
64
|
|
|
|
|
Executive benefits and perquisites (including the HCA
Restoration Plan and the Supplemental Executive Retirement
Plan); and
|
|
|
|
Any other executive compensation or benefits related items
deemed appropriate by the Committee.
|
In addition, the Committee considers the proper alignment of
executive pay policies with Company values and strategy by
overseeing employee compensation policies, corporate performance
measurement and assessment, and Chief Executive Officer
performance assessment. The Committee may retain the services of
independent outside consultants, as it deems appropriate, to
assist in the strategic review of programs and arrangements
relating to executive compensation and performance.
The following executive compensation discussion and analysis
describes the principles underlying our executive compensation
policies and decisions as well as the material elements of
compensation for our named executive officers. Our named
executive officers for 2008 were:
|
|
|
|
|
Jack O. Bovender, Jr., Chairman of the Board and Chief
Executive Officer;
|
|
|
|
Richard M. Bracken, President and Chief Operating Officer;
|
|
|
|
R. Milton Johnson, Executive Vice President and Chief
Financial Officer;
|
|
|
|
Samuel N. Hazen, President Western Group; and
|
|
|
|
Beverly B. Wallace, President Shared Services Group.
|
Effective December 31, 2008, Mr. Bovender retired as
Chief Executive Officer but retained the role of Chairman of the
Board, and effective January 1, 2009, Mr. Bracken was
appointed to serve as Chief Executive Officer and President of
the Company.
As discussed in more detail below, the material elements and
structure of the named executive officers compensation
program for 2008 was negotiated and determined in connection
with the Merger.
Compensation
Philosophy and Objectives
The core philosophy of our executive compensation program is to
support the Companys primary objective of providing the
highest quality health care to our patients while enhancing the
long term value of the Company to our shareholders.
Specifically, the Committee believes the most effective
executive compensation program (for all executives, including
named executive officers):
|
|
|
|
|
Reinforces HCAs strategic initiatives;
|
|
|
|
Aligns the economic interests of our executives with those of
our shareholders; and
|
|
|
|
Encourages attraction and long term retention of key
contributors.
|
The Committee is committed to a strong, positive link between
our objectives and our compensation and benefits practices.
Our compensation philosophy also allows for flexibility in
establishing executive compensation based on an evaluation of
information prepared by management or other advisors and other
subjective and objective considerations deemed appropriate by
the Committee. The Committee will also consider the
recommendations of our Chief Executive Officer. This flexibility
is important to ensure our compensation programs are competitive
and that our compensation decisions appropriately reflect the
unique contributions and characteristics of our executives.
65
Compensation
Structure and Benchmarking
Our compensation program is heavily weighted towards
performance-based compensation, reflecting our philosophy of
increasing the long-term value of the Company and supporting
strategic imperatives. Total direct compensation and other
benefits consist of the following elements:
|
|
|
Total Direct Compensation
|
|
Base Salary
|
|
|
Annual Cash-Based Incentives (offered
through our PEP)
|
|
|
Long-Term Equity Incentives (in the form
of Stock Options)
|
|
|
|
Other Benefits
|
|
Retirement Plans
|
|
|
Limited Perquisites and Other Personal
Benefits
|
|
|
Severance Benefits
|
The Committee does not support rigid adherence to benchmarks or
compensatory formulas and strives to make compensation decisions
which effectively support our compensation objectives and
reflect the unique attributes of the Company and each executive.
Our general practice, however, with respect to pay positioning,
is that executive base salaries and annual incentive (PEP)
target values should generally position total annual cash
compensation between the median and 75th percentile of
similarly-sized general industry companies. We utilize the
general industry as our primary source for competitive pay
levels because HCA is significantly larger than its industry
peers. See the discussion of benchmarking below for further
information. The named executive officers pay fell within
the range noted above for jobs with equivalent market
comparisons.
The cash compensation mix between salary and PEP is currently
more weighted towards salary rather than PEP than competitive
practice among our general industry peers would suggest. Over
time, we intend to continue moving towards a mix of cash
compensation that will place a greater emphasis on annual
performance-based compensation.
Although we look at competitive long-term equity incentive award
values in similarly-sized general industry companies when
assessing the competitiveness of our compensation programs, we
did not base our 2007 stock option grants on these levels since
equity is structured differently in closely held companies than
in publicly-traded companies. As is typical in similar
situations, the Investors wanted to share a certain percentage
of the equity with executives shortly after the consummation of
the Merger and establish performance objectives and incentives
up front in lieu of annual grants to ensure our executives
long-term economic interests would be aligned with those of the
Investors. This pool of equity was then further allocated based
on the executives anticipated impact on, and potential
for, driving Company strategy and performance. The resulting
total direct pay mix is heavily weighted towards
performance-based pay (PEP plus stock options) rather than fixed
pay, which the Committee believes reflects the compensation
philosophy and objectives discussed above. No additional long
term equity incentives were granted to the named executive
officers in 2008.
Compensation
Process
While our 2008 named executive officer compensation was largely
determined at the time of the Merger, the Committee ensures that
executives pay levels are generally consistent with the
compensation strategy described above, in part, by conducting
annual assessments of competitive executive compensation.
Management (but no named executive officer), in collaboration
with the Committees independent consultant, Semler Brossy
Consulting Group, LLC, collects and presents compensation data
from similarly-sized general industry companies, based to the
extent possible on comparable position matches and compensation
components. The following nationally recognized survey sources
were utilized in anticipation of establishing 2008 executive
compensation:
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
Companies in
|
Survey
|
|
Revenue Scope (Median Revenue)
|
|
Sample
|
|
Towers Perrin Executive Compensation Database
|
|
|
Greater than $20B ($35.0B
|
)
|
|
|
58
|
|
Hewitt Total Compensation Measurement
|
|
|
$10B - $25B ($15.0B
|
)
|
|
|
68
|
|
Hewitt Total Compensation Measurement
|
|
|
Greater than $25B ($46.5B
|
)
|
|
|
36
|
|
66
These particular revenue scopes were selected because they were
the closest approximations to HCAs revenue size. Each
survey that provided an appropriate position match and
sufficient sample size to be used in the compensation review was
weighted equally. For this purpose, the two Hewitt survey cuts
were considered as one survey, and we used a weighted average of
the two surveys (65% for the $10B $25B cut and 35%
for the Greater than $25B).
Data was also collected from health care providers within our
industry including Community Health Systems, Inc., Health
Management Associates, Inc., Kindred Healthcare, Inc., LifePoint
Hospitals, Inc., Tenet Healthcare Corporation and Universal
Health Services, Inc. These health care providers are used only
as a secondary point of reference for industry practices since
we are significantly larger than these companies. The data from
this analysis did not affect named executive officer pay level
decisions in 2008. Semler Brossy also performed a competitive
pay analysis specific for the Chairman of the Board, the
President and Chief Executive Officer and the Executive Vice
President and Chief Financial Officer to be utilized in setting
2009 compensation for Mr. Bovender, Mr. Bracken and
Mr. Johnson. A custom proxy analysis was utilized, covering 150
selected companies in the S&P 500 (excluding the financial
services sector). The following cuts of this database were used
for market comparisons: (i) companies with $15 billion
to $35 billion in revenues (52 companies) and
(ii) companies in the broader health care sector
(21 companies).
Consistent with our flexible compensation philosophy, the
Committee is not required to approve compensation precisely
reflecting the results of these surveys, and may also consider,
among other factors (typically not reflected in these surveys):
the requirements of the applicable employment agreements, the
executives individual performance during the year, his or
her projected role and responsibilities for the coming year, his
or her actual and potential impact on the successful execution
of Company strategy, recommendations from our chief executive
officer and compensation consultants, an officers prior
compensation, experience, and professional status, internal pay
equity considerations, and employment market conditions and
compensation practices within our peer group. The weighting of
these and other relevant factors is determined on a
case-by-case
basis for each executive upon consideration of the relevant
facts and circumstances.
Employment
Agreements
In connection with the Merger, we entered into employment
agreements with each of our named executive officers and certain
other members of senior management to help ensure the retention
of those executives critical to the future success of the
Company. Among other things, these agreements set the
executives compensation terms, their rights upon a
termination of employment, and restrictive covenants around
non-competition, non-solicitation, and confidentiality. These
terms and conditions are further explained in the remaining
portion of this Compensation Discussion and Analysis and under
Narrative Disclosure to Summary Compensation Table and
Grants of Plan-Based Awards Table Employment
Agreements.
In light of Mr. Bovenders retirement from the
position of Chief Executive Officer, effective December 31,
2008, and continuing service to the Company as executive
Chairman until December 15, 2009, the Company entered into
an Amended and Restated Employment Agreement with
Mr. Bovender, effective December 31, 2008. The
material amendments to Mr. Bovenders prior employment
agreement as set forth in the Amended and Restated Employment
Agreement are described below under
Mr. Bovenders Severance Benefits and
under Narrative Disclosure to Summary Compensation Table
and Grants of Plan-Based Awards Table Employment
Agreements.
The Company also amended Mr. Brackens employment
agreement, effective January 1, 2009, to reflect his
appointment to the position of Chief Executive Officer and
President.
Elements
of Compensation
Base
Salary
Base salaries are intended to provide reasonable and competitive
fixed compensation for regular job duties. The threshold base
salaries for our executives are set forth in their employment
agreements. We did not increase named executive officer base
salaries in 2008, other than an approximate 5.3% increase in
Mr. Johnsons base salary
67
in order to better align his salary with market for his position
as Chief Financial Officer based on general industry surveys. In
light of Mr. Bovenders retirement from the position
of Chief Executive Officer and continuing role as Chairman and
Mr. Brackens assumption of the responsibilities of
Chief Executive Officer and President, Mr. Bovenders
base salary for 2009 was reduced to approximately
$1.144 million for his Employment Term (as described
further in Narrative Disclosure to Summary Compensation
Table and Grants of Plan-Based Awards Table
Employment Agreements.), and Mr. Brackens 2009
base salary was increased to $1.325 million. Similarly,
taking into consideration the additional responsibilities being
assumed by the position of Executive Vice President and Chief
Financial Officer and relevant market comparables,
Mr. Johnsons 2009 salary was set at $850,000,
reflecting an increase of approximately 7.6%. In light of our
goal of reducing the emphasis of base salary in our cash
compensation mix, we do not intend to provide salary increases
to any of our named executive officers in 2009, other than those
described above.
Annual
Incentive Compensation: PEP
The PEP is intended to reward named executive officers for
annual financial performance, with the goals of providing high
quality health care for our patients and increasing shareholder
value. Each named executive officer in the Companys
2008-2009
Senior Officer Performance Excellence Program
(2008-2009
PEP) was assigned a 2008 annual award target expressed as
a percentage of salary ranging from 66% to 126% (see individual
targets in table below). In light of our goal to further
emphasize performance-based pay, we increased the named
executive officers PEP target opportunities by
approximately 6% for 2008 in lieu of salary increases (with the
exception of Mr. Johnsons 2008 salary increase).
These targets are intended to provide a meaningful incentive for
executives to achieve or exceed performance goals.
The
2008-2009
PEP was designed to provide 100% of the target award for target
performance, 50% of the target award for a minimum acceptable
(threshold) level of performance, and a maximum of 200% of the
target award for maximum performance, while no payments are made
for performance below threshold levels. The Committee believes
this payout curve is consistent with competitive practice. More
importantly, it promotes and rewards continuous growth as
performance goals have consistently been set at increasingly
higher levels each year. Actual awards under the PEP are
generally determined using the following two steps:
1. The executives conduct must reflect our Mission
and Values by upholding our Code of Conduct and following our
compliance policies and procedures. This step is critical to
reinforcing our commitment to integrity and the delivery of high
quality health care. In the event the Committee determines the
participants conduct during the fiscal year is not in
compliance with the first step, he or she will not be eligible
for an incentive award.
2. The actual award amount is determined based upon Company
performance. In 2008, the PEP for all named executive officers,
other than Mr. Hazen, incorporated one Company financial
performance measure, EBITDA, defined in the 2008-2009 PEP as
earnings before interest, taxes, depreciation, amortization,
minority interest expense, gains or losses on sales of
facilities, gains or losses on extinguishment of debt, asset or
investment impairment charges, restructuring charges, and any
other significant nonrecurring non-cash gains or charges (but
excluding any expenses for share-based compensation under
Statement of Financial Accounting Standards No. 123(R),
Share-Based
Payment (SFAS 123(R)) with respect to any
awards granted under the 2008-2009 PEP) (EBITDA).
The Company EBITDA target for 2008 was $4.720 billion
($4.714 billion after adjustment) for the named executive
officers. Mr. Hazens 2008 PEP, as the Western Group
President, was based 50% on Company EBITDA and 50% on Western
Group EBITDA (with a Western Group EBITDA target for 2008 of
$2.328 billion) to ensure his accountability for his
groups results. The Committee chose to base annual
incentives on EBITDA for a number of reasons:
|
|
|
|
|
It effectively measures overall Company performance;
|
|
|
|
It is an important surrogate for cash flow, a critical metric
related to paying down the Companys significant debt
obligation;
|
|
|
|
It is the key metric driving the valuation in the internal
Company model, consistent with the valuation approach used by
industry analysts; and
|
|
|
|
It is consistent with the metric used for the vesting of the
financial performance portion of our option grants.
|
68
These EBITDA targets should not be understood as
managements predictions of future performance or other
guidance and investors should not apply these in any other
context. Our 2008 threshold and maximum goals were set at
approximately +/- 3.6% of the target goal to reflect likely
performance volatility. EBITDA targets were linked to the
Companys short-term and long-term business objectives to
ensure incentives are provided for appropriate annual growth and
stretch performance.
Pursuant to the terms of the
2008-2009
PEP and the named executive officer employment agreements, the
Committee exercised its ability to make adjustments to the
Companys 2008 EBITDA performance target for dispositions
of facilities occurring during the 2008 fiscal year. The
adjustments to the target resulted in a decrease of
approximately $6 million.
The Committee intends to set the named executive officers
2009 target performance goals based on aggressive, yet
realistic, expectations of Company performance ensuring
successful execution of our plans in order to realize the most
value from these awards. While we do not intend to disclose our
2009 PEP EBITDA target as an understanding of that target is not
necessary for a fair understanding of the named executive
officers compensation for 2008 and could result in
competitive harm and market confusion, we consistently set
targets that require an increase in EBITDA year over year to
promote continuous growth consistent with our business plan.
Upon review of the Companys 2008 financial performance,
the Committee determined that Company EBITDA performance for the
fiscal year ended December 31, 2008 fell below the target
performance, but above threshold performance as set by the
Compensation Committee; likewise, the EBITDA performance of the
Western Group also exceeded threshold performance but was less
than target performance. Accordingly, the 2008 PEP will be paid
out as follows to the named executive officers (the actual 2008
PEP payout amounts are included in the Non-Equity
Incentive Plan Compensation column of the Summary
Compensation Table):
|
|
|
|
|
|
|
|
|
|
|
2008 Target PEP
|
|
2008 Actual PEP Award
|
Named Executive Officer
|
|
(% of Salary)
|
|
(% of Salary)
|
|
Jack O. Bovender, Jr. (Chairman and CEO)
|
|
|
126
|
%
|
|
|
85.9
|
%
|
Richard M. Bracken (President and COO)
|
|
|
96
|
%
|
|
|
65.5
|
%
|
R. Milton Johnson (Executive Vice President and CFO)
|
|
|
66
|
%
|
|
|
45.0
|
%
|
Samuel N. Hazen (President, Western Group)
|
|
|
66
|
%
|
|
|
44.5
|
%
|
Beverly B. Wallace (President, Shared Services Group)
|
|
|
66
|
%
|
|
|
45.0
|
%
|
In 2008, the
2008-2009
PEP was approved by the Committee. Therefore, the 2009 PEP
program will work under the same plan as in 2008. Each named
executive officer in the Companys
2008-2009
PEP was assigned a maximum 2009 annual award target expressed as
a percentage of salary ranging from 72% to 132% which under the
terms of the
2008-2009
PEP applies to the lesser of (a) the Named Executive
Officers 2009 base salary, or (b) 125% of the Named
Executive Officers 2008 base salary. The Committee has the
discretion to reduce, but not increase, the 2009 Threshold,
Target and Maximum percentages as set forth in the
2008-2009
PEP. Mr. Bovenders 2009 PEP target or Annual Bonus is
set forth in his Amended and Restated Employment Agreement,
effective December 31, 2008, as described in
Narrative Disclosure to Summary Compensation Table and
Grants of Plan-Based Awards Table
Mr. Bovenders Employment Agreement. The
Committee set Mr. Brackens 2009 target percentage at
130% of his 2009 base salary in connection with his appointment
as Chief Executive Officer and President and amended the
2008-2009
PEP to set Mr. Johnsons 2009 target percentage at 80%
of his 2009 base salary in light of the additional
responsibilities assumed by the position of Executive Vice
President and Chief Financial Officer. The Committee anticipates
that the 2009 PEP target percentage will remain at 66% of base
salary for Mr. Hazen and Ms. Wallace, respectively.
The Committee also has the ability to supplement the financial
metrics and weightings with additional measures other than
EBITDA including: (a) operating income, profit or
efficiencies; (b) return on equity, assets, capital,
capital employed or investment; (c) after-tax operating
income; (d) net income; (e) earnings or book value per
share; (f) cash flow(s); (g) stock price or total
shareholder return; (h) debt reduction; (i) strategic
business objectives, consisting of one or more objectives based
on meeting specified cost targets, business expansion goals and
goals relating to acquisitions or divestitures; or (j) any
combination thereof.
69
Long-Term
Equity Incentive Awards: Options
In connection with the Merger, the Board of Directors approved
and adopted the 2006 Stock Incentive Plan for Key Employees of
HCA Inc. and its Affiliates (the 2006 Plan). The
purpose of the 2006 Plan is to:
|
|
|
|
|
Promote our long term financial interests and growth by
attracting and retaining management and other personnel and key
service providers with the training, experience and abilities to
enable them to make substantial contributions to the success of
our business;
|
|
|
|
Motivate management personnel by means of growth-related
incentives to achieve long range goals; and
|
|
|
|
Further the alignment of interests of participants with those of
our shareholders through opportunities for increased stock or
stock-based ownership in the Company.
|
In January 2007, pursuant to the terms of the named executive
officers respective employment agreements, the Committee
approved long-term stock option grants to our named executive
officers under the 2006 Plan consisting solely of a one-time,
multi-year stock option grant in lieu of annual long-term equity
incentive award grants (New Options). In addition to
the New Options granted in 2007, the Company committed to grant
the named executive officers 2x Time Options in their respective
employment agreements, as described in more detail below under
Narrative Disclosure to Summary Compensation Table and
Grants of Plan-Based Awards Table Employment
Agreements. The Committee believes that stock options are
the most effective long-term vehicle to directly align the
interests of executives with those of our shareholders by
motivating performance that results in the long-term
appreciation of the Companys value, since they only
provide value to the executive if the value of the Company
increases. As is typical in leveraged buyout situations, the
Committee determined that granting all of the stock options
(except the 2x Time Options) up front rather than annually was
appropriate to aid in retaining key leaders critical to the
Companys success over the next several years and, coupled
with the executives significant personal investments in
connection with the Merger, provide an equity incentive and
stake in the Company that directly aligns the long-term economic
interests of the executives with those of the Investors.
The New Options have a ten year term and are divided so that
1/3
are time vested options,
1/3
are EBITDA-based performance vested options and
1/3
are performance options that vest based on investment return to
the Sponsors, each as described below. The combination of time,
performance and investor return based vesting of these awards is
designed to compensate executives for long term commitment to
the Company, while motivating sustained increases in our
financial performance and helping ensure the Sponsors have
received an appropriate return on their invested capital before
executives receive significant value from these grants.
The time vested options are granted to aid in retention.
Consistent with this goal, the time vested options granted in
2007 vest and become exercisable in equal increments of 20% on
each of the first five anniversaries of the grant date. The time
vested options have an exercise price equivalent to fair market
value on the date of grant. Since our common stock is not
currently traded on a national securities exchange, fair market
value was determined reasonably and in good faith by the Board
of Directors after consultation with the Chief Executive Officer
and other advisors.
The EBITDA-based performance vested options are intended to
motivate sustained improvement in long-term performance.
Consistent with this goal, the EBITDA-based performance vested
options granted in 2007 are eligible to vest and become
exercisable in equal increments of 20% at the end of fiscal
years 2007, 2008, 2009, 2010 and 2011 if certain annual EBITDA
performance targets are achieved. These EBITDA performance
targets were established at the time of the Merger and can be
adjusted by the Board of Directors in consultation with the
Chief Executive Officer as described below. We chose EBITDA
(defined in the award agreements as earnings before interest,
taxes, depreciation, amortization, minority interest expense,
gains or losses on sales of facilities, gains or losses on
extinguishment of debt, asset or investment impairment charges,
restructuring charges, and any other significant nonrecurring
non-cash gains or charges (but excluding any expenses for
share-based compensation under SFAS 123(R) with respect to
any awards granted under the 2006 Plan) as the performance
metric since it is a key driver of our valuation and for other
reasons as described above in the Annual Incentive
Compensation: PEP section of this Compensation Discussion
and Analysis. Due to the number of events that can occur within
our industry in any given year that are beyond the control of
management but may significantly impact our financial
performance (e.g., health care regulations, industry-wide
significant fluctuations in volume, etc.), we have
70
incorporated
catch-up
vesting provisions. The EBITDA-based performance vested options
may vest and become exercisable on a catch up basis,
such that, options that were eligible to vest but failed to vest
due to our failure to achieve prior EBITDA targets will vest if
at the end of any subsequent year or at the end of fiscal year
2012, the cumulative total EBITDA earned in all prior years
exceeds the cumulative EBITDA target at the end of such fiscal
year.
As discussed above, we do not intend to disclose the
2009-2011
EBITDA performance targets as they reflect competitive,
sensitive information regarding our budget. However, we
deliberately set our targets at increasingly higher levels.
Thus, while designed to be attainable, target performance levels
for these years require strong, improving performance and
execution, which in our view, provides an incentive firmly
aligned with shareholder interests.
As with the EBITDA targets under our
2008-2009
PEP, pursuant to the terms of the 2006 Plan and the Stock Option
Agreements governing the 2007 grants, the Board of Directors, in
consultation with our Chief Executive Officer, has the ability
to adjust the established EBITDA targets for significant events,
changes in accounting rules and other customary adjustment
events. We believe these adjustments may be necessary in order
to effectuate the intents and purposes of our compensation plans
and to avoid unintended consequences that are inconsistent with
these intents and purposes. The Board of Directors exercised its
ability to make adjustments to the Companys
2008-2011
EBITDA performance targets (including cumulative EBITDA targets)
for facility dispositions and acquisitions and accounting
changes occurring during the 2008 fiscal year.
The options that vest based on investment return to the Sponsors
are intended to align the interests of executives with those of
our principal shareholders to ensure shareholders receive their
expected return on their investment before the executives can
receive their gains on this portion of the option grant. These
options vest and become exercisable with respect to 10% of the
common stock subject to such options at the end of fiscal years
2007, 2008, 2009, 2010 and 2011 if the Investor Return (as
defined below) is at least equal to two times the price paid to
shareholders in the Merger (or $102.00), and with respect to an
additional 10% at the end of fiscal years 2007, 2008, 2009, 2010
and 2011 if the Investor Return is at least equal to
two-and-a-half
times the price paid to shareholders in the Merger (or $127.50).
Investor Return means, on any of the first five
anniversaries of the closing date of the Merger, or any date
thereafter, all cash proceeds actually received by affiliates of
the Sponsors after the closing date in respect of their common
stock, including the receipt of any cash dividends or other cash
distributions (including the fair market value of any
distribution of common stock by the Sponsors to their limited
partners), determined on a fully diluted, per share basis. The
Sponsor investment return options also may become vested and
exercisable on a catch up basis if the relevant
Investor Return is achieved at any time occurring prior to the
expiration of such options.
Upon review of the Companys 2008 financial performance,
the Committee determined that the Company achieved the 2008
EBITDA performance target of $4.603 billion
($4.592 billion after adjustment) under the New Option
awards; therefore, pursuant to the terms of the 2007 Stock
Option Agreements, 20% of each named executive officers
EBITDA-based performance vested options vested as of
December 31, 2008. Further, 20% of each named executive
officers time vested options vested on the second
anniversary of their grant date, January 30, 2009. No
portion of the options that vest based on Investor Return vested
as of the end of the 2008 fiscal year; however, such options
remain subject to the catch up vesting provisions
described above.
For additional information concerning the options awarded in
2007, see the Grants of Plan-Based Awards Table.
As discussed above, except in the cases of promotions or new
hires, the Committee does not intend to award additional stock
options to our named executive officers (other than the 2x Time
Options the Company committed to grant the named executive
officers in their respective employment agreements, as described
in more detail below under Narrative Disclosure to Summary
Compensation Table and Grants of Plan-Based Awards
Table Employment Agreements). Grants made in
connection with promotions and new hires will be formally
approved by the Committee. The exercise price of grants made in
connection with promotions and new hires will be based on the
quarterly fair market value as determined reasonably and in good
faith by the Board of Directors after consultation with the
Chief Executive Officer and other advisors. We anticipate that
any option grants approved under the 2006 Plan in 2009 (other
than the 2x Time Options) will be structured identical to those
granted in 2007
71
except that the options will vest over a three year period
rather than a five year period, with the time vested options
vesting and becoming exercisable in equal increments of
approximately 33% on each of the first three anniversaries of
the grant date, the EBITDA-based performance vested options
being eligible to vest and become exercisable in equal
increments of approximately 33% at the end of fiscal years 2009,
2010 and 2011 if the applicable EBITDA performance targets are
achieved (with the same catch up provision as
described above), and the options that vest based on investment
return to the Sponsors vesting and becoming exercisable with
respect to approximately 16.67% of the common stock subject to
such options at the end of fiscal years 2009, 2010 and 2011 if
the Investor Return (as defined above) is at least equal to two
times the price paid to shareholders in the Merger (or $102.00),
and with respect to an additional approximately 16.67% at the
end of fiscal years 2009, 2010 and 2011 if the Investor Return
is at least equal to
two-and-a-half
times the price paid to shareholders in the Merger (or $127.50)
(provided that the investor return options granted in
2009 may also become vested and exercisable on a
catch up basis if the relevant Investor Return is
achieved prior to the eighth anniversary of the grant date).
Ownership
Guidelines
While we have maintained stock ownership guidelines in the past,
as a non-listed company, we no longer have a policy regarding
stock ownership guidelines. However, we do believe equity
ownership aligns our executive officers interests with
those of the Investors. Accordingly, all of our named executive
officers were required to rollover at least half their
pre-Merger equity and, therefore, maintain significant stock
ownership in the Company. See Item 12, Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters.
Retirement
Plans
At the beginning of 2008, we maintained two qualified retirement
plans, the HCA 401(k) Plan and the HCA Retirement Plan, to aid
in retention and to assist employees in providing for their
retirement. As of April 1, 2008, the HCA Retirement Plan
merged into the HCA 401(k) Plan resulting in one qualified
retirement plan. Generally all employees who have completed the
required service are eligible to participate in the HCA 401(k)
Plan. Each of our named executive officers participates in the
plan. For additional information on these plans, including
amounts contributed by HCA in 2008 to the named executive
officers, see the Summary Compensation Table and related
footnotes and narratives and Pension Benefits.
Our key executives, including the named executive officers, also
participate in two supplemental retirement programs. The
Committee and the Board initially approved these supplemental
programs to:
|
|
|
|
|
Recognize significant long-term contributions and commitments by
executives to the Company and to performance over an extended
period of time;
|
|
|
|
Induce our executives to continue in our employ through a
specified normal retirement age (initially 62 through 65, but
reduced to 60 upon the change in control at the time of the
Merger in 2006); and
|
|
|
|
Provide a competitive benefit to aid in attracting and retaining
key executive talent.
|
The Restoration Plan provides a benefit to replace a portion of
the contributions lost in the HCA 401(k) Plan due to
certain IRS limitations. Effective January 1, 2008,
participants in the SERP (described below) are no longer
eligible for Restoration Plan contributions; however, the
hypothetical accounts maintained for each named executive
officer as of January 1, 2008 will continue to be
maintained and will be increased or decreased with investment
earnings based on the actual investment return. For additional
information concerning the Restoration Plan, see
Nonqualified Deferred Compensation.
Key executives also participate in the Supplemental Executive
Retirement Plan, or the SERP, adopted in 2001. The
SERP benefit brings the total value of annual retirement income
to a specific income replacement level. For named executive
officers with 25 years or more of service, this income
replacement level is 60% of final average pay (base salary and
PEP payouts) at normal retirement, a competitive level of
benefit at the time the plan was implemented. Due to the Merger,
all participants are fully vested in their SERP benefits and the
plan is now frozen to new entrants. For additional information
concerning the SERP, see Pension Benefits.
72
In the event a participant renders service to another health
care organization within five years following retirement or
termination of employment, he or she forfeits the rights to any
further payment, and must repay any payments already made. This
non-competition provision is subject to waiver by the Committee
with respect to the named executive officers.
Personal
Benefits
Our executive officers receive limited, if any, benefits outside
of those offered to our other employees. Generally, we provide
these benefits to increase travel and work efficiencies and
allow for more productive use of the executives time.
Mr. Bovender and Mr. Bracken are permitted to use the
Company aircraft for personal trips, subject to the
aircrafts availability. Other named executive officers may
have their spouses accompany them on business trips taken on the
Company aircraft, subject to seat availability. In addition,
there are times when it is appropriate for an executives
spouse to attend events related to our business. On those
occasions, we will pay for the travel expenses of the
executives spouse. We will, on an as needed basis, provide
mobile telephones and personal digital assistants to our
employees and certain of our executive officers have obtained
such devices through us. The value of these personal benefits,
if any, is included in the executive officers income for
tax purposes and, in certain limited circumstances, the
additional income attributed to an executive officer as a result
of one or more of these benefits will be grossed up to cover the
taxes due on that income. Except as otherwise discussed herein,
other welfare and employee-benefit programs are the same for all
of our eligible employees, including our executive officers. For
additional information, see footnote (6) to the Summary
Compensation Table.
Severance
and Change in Control Benefits
As noted above, all of our named executive officers have entered
into employment agreements, which provide, among other things,
each executives rights upon a termination of employment in
exchange for non-competition, non-solicitation, and
confidentiality covenants. We believe that reasonable severance
benefits are appropriate in order to be competitive in our
executive retention efforts. These benefits should reflect the
fact that it may be difficult for such executives to find
comparable employment within a short period of time. We also
believe that these types of agreements are appropriate and
customary in situations such as the Merger wherein the
executives have made significant personal investments in the
Company and that investment is generally illiquid for a
significant period of time. Finally, we believe formalized
severance arrangements are common benefits offered by employers
competing for similar senior executive talent.
Severance
Benefits for Named Executive Officers (other than
Chairman)
If employment is terminated by the Company without
cause or by the executive for good
reason (whether or not the termination was in connection
with a
change-in-control),
the executive would be entitled to accrued rights
(Cause, good reason and accrued rights are as defined in
Narrative Disclosure to Summary Compensation Table and
Grants of Plan-Based Awards Table Employment
Agreements) plus:
|
|
|
|
|
Subject to restrictive covenants and the signing of a general
release of claims, an amount equal to two times for
Mr. Hazen and Ms. Wallace and three times in the case
of Messrs. Bracken and Johnson the sum of base salary plus
PEP paid or payable in respect of the fiscal year immediately
preceding the fiscal year in which termination occurs, payable
over a two year period;
|
|
|
|
Pro-rata bonus; and
|
|
|
|
Continued coverage under our group health plans during the
period over which the cash severance is paid.
|
Additionally, unvested options will be forfeited; however,
vested New Options will remain exercisable until the first
anniversary of the termination of the executives
employment.
Because we believe that a termination by the executive for good
reason (a constructive termination) is conceptually the same as
an actual termination by the Company without cause, we believe
it is appropriate to provide severance benefits following such a
constructive termination of the named executive officers
employment. All of our severance provisions are believed to be
within the realm of competitive practice and are intended to
provide fair and reasonable compensation to the executive upon a
termination event.
73
Mr. Bovenders
Severance Benefits
In light of his long-term service to the Company and his
retirement from the position of Chief Executive Officer, the
Company entered into an Amended and Restated Employment
Agreement with Mr. Bovender, effective December 31,
2008 (the Amended Employment Agreement).
Mr. Bovenders Amended Employment Agreement provides,
effective as of the expiration of the Employment Term (as
defined in Narrative Disclosure to Summary Compensation
Table and Grants of Plan-Based Awards Table
Employment Agreements) or Mr. Bovenders sooner
voluntary termination for any reason (including by reason of
death or disability, but other than for good
reason), that Mr. Bovender would be entitled to
receive the accrued rights as described above for
the other named executive officers. Mr. Bovender would also
be entitled to receive a pro rata portion of his bonus under the
2008-2009
PEP based on the Companys actual results for 2009
(Mr. Bovenders Prorated Bonus).
Additionally, in the event Mr. Bovenders Additional
Bonus (as defined in Narrative Disclosure to Summary
Compensation Table and Grants of Plan-Based Awards
Table Employment Agreements) has not been
earned as of the termination date, the Committee will consider
in good faith whether or not all or a portion of
Mr. Bovenders Additional Bonus will be included as
part of Mr. Bovenders Prorated Bonus. The same
severance applies regardless of whether the termination was in
connection with a change in control of the Company.
Mr. Bovender would also be entitled to continued coverage
under the Companys group health plans for
Mr. Bovender and his wife until age 65, reimbursement
of any unreimbursed business expenses properly incurred and such
employee benefits, if any, as to which Mr. Bovender would
be entitled under the Companys employee benefit plans.
The Amended Employment Agreement also provides that, effective
as of the expiration of the Employment Term or
Mr. Bovenders sooner voluntary termination for any
reason (including by reason of death or disability, but other
than for good reason), (i) neither
Mr. Bovender nor the Company shall have any put or call
rights with respect to Mr. Bovenders New Options or
stock acquired upon the exercise of any such options;
(ii) Mr. Bovenders rollover stock
options will remain exercisable as if Mr. Bovenders
employment terminated by reason of retirement in
accordance with the terms of the applicable equity plans and
award agreements; (iii) the unvested New Options (including
any issued 2x Time Options) held by Mr. Bovender that vest
solely based on the passage of time will vest as if
Mr. Bovenders employment had continued through the
next three anniversaries of their date of grant (it being
understood that any 2x Time Options issued after
Mr. Bovenders termination or retirement shall also
continue to vest through the remainder of the extended vesting
period); (iv) the unvested New Options held by
Mr. Bovender that are EBITDA performance options will
remain outstanding and will vest, if at all, on the next four
dates that they would have otherwise vested had
Mr. Bovenders employment continued, based upon the
extent to which performance goals are met; (v) the unvested
New Options held by Mr. Bovender that are Investor
Return performance options will remain outstanding and
will vest, if at all, on the dates that they would have
otherwise vested had Mr. Bovenders employment
continued through the expiration of such options, based upon the
extent to which performance goals are met; and
(vi) Mr. Bovenders New Options will remain
exercisable until the second anniversary of the last date on
which his EBITDA performance options are eligible to vest (which
is December 31, 2014), except that
(a) Mr. Bovenders 2x Time Options will remain
exercisable until the fifth anniversary of the last date on
which his EBITDA performance options are eligible to vest (which
is December 31, 2017), and
(b) Mr. Bovenders Investor Return
performance options will remain exercisable until the expiration
of such options.
If Mr. Bovenders employment is terminated by the
Company without cause or by Mr. Bovender for
good reason (whether or not the termination was in
connection with a
change-in-control),
Mr. Bovender would be entitled to receive the benefits
described above and, subject to the delivery of a customary
release and continued compliance with the noncompetition,
nonsolicitation and confidentiality restrictions in the Amended
Employment Agreement, an amount (if any) equal to
Mr. Bovenders base salary that would have been
otherwise payable through the end of the Employment Term.
If Mr. Bovenders employment is terminated by the
Company for cause, Mr. Bovender shall be
entitled to receive the amounts and benefits described in the
first paragraph of this section, except that Mr. Bovender
shall not be entitled to receive Mr. Bovenders
Prorated Bonus and shall not be entitled to any other benefits
described above. Mr. Bovenders vested New Options
will, upon such event, remain exercisable until the first
anniversary of the termination of Mr. Bovenders
employment.
74
Change
in Control Benefits
Pursuant to the Stock Option Agreements governing the New
Options granted in 2007 under the 2006 Plan, upon a Change in
Control of the Company (as defined below), all unvested time
vesting New Options (that have not otherwise terminated or
become exercisable) shall become immediately exercisable.
Performance options that vest subject to the achievement of
EBITDA targets will become exercisable upon a Change in Control
of the Company if: (i) prior to the date of the occurrence
of such event, all EBITDA targets have been achieved for years
ending prior to such date; (ii) on the date of the
occurrence of such event, the Companys actual cumulative
total EBITDA earned in all years occurring after the performance
option grant date, and ending on the date of the Change in
Control, exceeds the cumulative total of all EBITDA targets in
effect for those same years; or (iii) the Investor Return
is at least
two-and-a-half
times the price paid to the shareholders in the Merger (or
$127.50). For purposes of the vesting provision set forth in
clause (ii) above, the EBITDA target for the year in which
the Change in Control occurs shall be equitably adjusted by the
Board of Directors in good faith in consultation with the chief
executive officer (which adjustment shall take into account the
time during such year at which the Change in Control occurs).
Performance vesting options that vest based on the investment
return to the Sponsors will only vest upon the occurrence of a
Change in Control if, as a result of such event, the applicable
Investor Return (i.e., at least two times the price paid to the
shareholders in the Merger for half of these options and at
least
two-and-one-half
times the price paid to the shareholders in the Merger for the
other half of these options) is also achieved in such
transaction (if not previously achieved). Change in
Control means in one or more of a series of transactions
(i) the transfer or sale of all or substantially all of the
assets of the Company (or any direct or indirect parent of the
Company) to an Unaffiliated Person (as defined below);
(ii) a merger, consolidation, recapitalization or
reorganization of the Company (or any direct or indirect parent
of the Company) with or into another Unaffiliated Person, or a
transfer or sale of the voting stock of the Company (or any
direct or indirect parent of the Company), an Investor, or any
affiliate of any of the Investors to an Unaffiliated Person, in
any such event that results in more than 50% of the common stock
of the Company (or any direct or indirect parent of the Company)
or the resulting company being held by an Unaffiliated Person;
or (iii) a merger, consolidation, recapitalization or
reorganization of the Company (or any direct or indirect parent
of the Company) with or into another Unaffiliated Person, or a
transfer or sale by the Company (or any direct or indirect
parent of the Company), an Investor or any affiliate of any of
the Investors, in any such event after which the Investors and
their affiliates (x) collectively own less than 15% of the
Common Stock of and (y) collectively have the ability to
appoint less than 50% of the directors to the Board (or any
resulting company after a merger). For purposes of this
definition, the term Unaffiliated Person means a
person or group who is not an Investor, an affiliate of any of
the Investors or an entity in which any Investor holds, directly
or indirectly, a majority of the economic interest in such
entity.
Additional information regarding applicable payments under such
agreements for the named executive officers is provided under
Narrative Disclosure to Summary Compensation Table and
Grants of Plan-Based Awards Table Employment
Agreements and Potential Payments Upon Termination
or Change in Control.
Recoupment
of Compensation
While we do not presently have any formal policies or practices
that provide for the recovery or adjustment of amounts
previously paid to a named executive officer in the event the
operating results on which the payment was based were restated
or otherwise adjusted, in such event we would reserve the right
to seek all appropriate remedies available under the law.
Tax and
Accounting Implications
On April 29, 2008, we registered our common stock pursuant
to Section 12(g) of the Securities Exchange Act of 1934, as
amended; and the Company became subject to Section 162(m)
of the Internal Revenue Code, as amended (the Code)
for fiscal year 2008 and beyond, so long as the Companys
stock remains registered with the SEC. The Committee considers
the impact of Section 162(m) in the design of its
compensation strategies. Under Section 162(m), compensation
paid to executive officers in excess of $1,000,000 cannot be
taken by us as a tax deduction unless the compensation qualifies
as performance-based compensation. We have determined, however,
that we will not necessarily seek to limit executive
compensation to amounts deductible under Section 162(m) if
such limitation is not in the best interests of our
stockholders. While considering the tax implications of its
75
compensation decisions, the Committee believes its primary focus
should be to attract, retain and motivate executives and to
align the executives interests with those of our
stakeholders.
The Committee operates its compensation programs with the good
faith intention of complying with Section 409A of the
Internal Revenue Code. We account for stock based payments with
respect to our long term equity incentive award programs in
accordance with the requirements of SFAS 123(R).
Compensation
Committee Report
The Compensation Committee has reviewed and discussed the
foregoing Compensation Discussion and Analysis with management.
Based on our review and discussion with management, we have
recommended to the Board of Directors that the Compensation
Discussion and Analysis be included in this annual report on
Form 10-K.
John P. Connaughton, Chairperson
Michael W. Michelson
George A. Bitar
Summary
Compensation Table
The following table sets forth information regarding the
compensation earned by the Chief Executive Officer, the Chief
Financial Officer and our other three most highly compensated
executive officers during 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
Value and
|
|
|
|
|
|
|
|
|
|
|
Restricted
|
|
|
|
Incentive
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
Option
|
|
Plan
|
|
Deferred
|
|
All Other
|
|
|
|
|
|
|
Salary
|
|
Awards
|
|
Awards
|
|
Compensation
|
|
Compensation
|
|
Compensation
|
|
|
Name and Principal Positions
|
|
Year
|
|
($)(1)
|
|
($)(2)
|
|
($)(3)
|
|
($)(4)
|
|
Earnings ($)(5)
|
|
($)(6)
|
|
Total ($)
|
|
Jack O. Bovender, Jr.
|
|
|
2008
|
|
|
$
|
1,620,228
|
|
|
|
|
|
|
$
|
5,189,950
|
|
|
$
|
1,391,886
|
|
|
$
|
3,926,217
|
|
|
$
|
45,321
|
|
|
$
|
12,173,602
|
|
Chairman and
|
|
|
2007
|
|
|
$
|
1,620,228
|
|
|
|
|
|
|
$
|
1,165,087
|
|
|
$
|
3,888,547
|
|
|
|
|
|
|
$
|
197,092
|
|
|
$
|
6,870,954
|
|
Chief Executive Officer
|
|
|
2006
|
|
|
$
|
1,535,137
|
|
|
$
|
6,393,996
|
|
|
$
|
6,714,520
|
|
|
$
|
1,944,274
|
|
|
$
|
10,715,751
|
|
|
$
|
1,013,576
|
|
|
$
|
28,317,254
|
|
Richard M. Bracken
|
|
|
2008
|
|
|
$
|
1,060,872
|
|
|
|
|
|
|
$
|
1,112,136
|
|
|
$
|
694,370
|
|
|
$
|
1,740,620
|
|
|
$
|
31,781
|
|
|
$
|
4,639,779
|
|
President, Chief
|
|
|
2007
|
|
|
$
|
1,060,872
|
|
|
|
|
|
|
$
|
1,019,458
|
|
|
$
|
1,909,570
|
|
|
$
|
590,370
|
|
|
$
|
142,932
|
|
|
$
|
4,723,202
|
|
Operating Officer, Director
|
|
|
2006
|
|
|
$
|
952,420
|
|
|
$
|
2,937,283
|
|
|
$
|
2,966,787
|
|
|
$
|
954,785
|
|
|
$
|
4,912,088
|
|
|
$
|
514,772
|
|
|
$
|
13,238,135
|
|
R. Milton Johnson
|
|
|
2008
|
|
|
$
|
786,698
|
|
|
|
|
|
|
$
|
794,388
|
|
|
$
|
355,491
|
|
|
$
|
1,871,790
|
|
|
$
|
38,769
|
|
|
$
|
3,847,136
|
|
Executive Vice President
|
|
|
2007
|
|
|
$
|
750,379
|
|
|
|
|
|
|
$
|
728,189
|
|
|
$
|
900,455
|
|
|
$
|
509,442
|
|
|
$
|
82,462
|
|
|
$
|
2,970,927
|
|
and Chief Financial Officer
|
|
|
2006
|
|
|
$
|
655,016
|
|
|
$
|
1,820,053
|
|
|
$
|
1,787,629
|
|
|
$
|
450,227
|
|
|
$
|
1,848,700
|
|
|
$
|
295,160
|
|
|
$
|
6,856,785
|
|
Samuel N. Hazen
|
|
|
2008
|
|
|
$
|
788,672
|
|
|
|
|
|
|
$
|
508,404
|
|
|
$
|
350,807
|
|
|
$
|
810,462
|
|
|
$
|
15,651
|
|
|
$
|
2,473,996
|
|
President
|
|
|
2007
|
|
|
$
|
788,672
|
|
|
|
|
|
|
$
|
466,037
|
|
|
$
|
830,779
|
|
|
$
|
258,787
|
|
|
$
|
84,767
|
|
|
$
|
2,429,042
|
|
Western Group
|
|
|
2006
|
|
|
$
|
688,438
|
|
|
$
|
1,812,299
|
|
|
$
|
1,787,629
|
|
|
$
|
473,203
|
|
|
$
|
1,828,748
|
|
|
$
|
329,324
|
|
|
$
|
6,919,641
|
|
Beverly B. Wallace
|
|
|
2008
|
|
|
$
|
700,000
|
|
|
|
|
|
|
$
|
444,852
|
|
|
$
|
314,992
|
|
|
$
|
2,080,836
|
|
|
$
|
15,651
|
|
|
$
|
3,556,331
|
|
President Shared Services Group
|
|
|
2007
|
|
|
$
|
700,000
|
|
|
|
|
|
|
$
|
407,781
|
|
|
$
|
840,000
|
|
|
$
|
676,111
|
|
|
$
|
75,013
|
|
|
$
|
2,698,905
|
|
|
|
|
(1) |
|
Salary amounts for 2006 do not include the value of restricted
stock awards granted pursuant to the HCA Inc. Amended and
Restated Management Stock Purchase Plan, which was terminated
upon consummation of the Merger, (the MSPP) in lieu
of a portion of annual salary. Such awards are included in the
Restricted Stock Awards column. The 2006 base salary
for each of Messrs. Bovender, Bracken, Johnson and Hazen,
were $1,615,662, $1,057,882, $748,265 and $786,450, respectively. |
|
(2) |
|
Restricted Stock Awards for 2006 include all compensation
expense recognized in our financial statements in 2006 in
accordance with SFAS 123(R) with respect to restricted
shares awarded to the named executive officers, including
restricted shares awarded pursuant to the HCA 2005 Equity
Incentive Plan (the 2005 Plan) and predecessor
plans, and restricted shares awarded pursuant to the MSPP. As a
result of the Merger, all outstanding restricted shares vested
and therefore all compensation expense with respect to
restricted shares was recognized in 2006 in accordance with
SFAS 123(R). See Note 3 to our consolidated financial
statements. |
|
(3) |
|
Option Awards for 2007 and 2008 include the compensation expense
recognized in our financial statements for fiscal years 2007 and
2008, respectively, in accordance with SFAS 123(R) with
respect to New Options to purchase shares of our common stock
awarded to the named executive officers in fiscal year 2007
under the |
76
|
|
|
|
|
2006 Plan. Pursuant to the terms of his Amended and Restated
Employment Agreement with the Company, all remaining
compensation expense with respect to the options granted to
Mr. Bovender in fiscal year 2007 under the 2006 Plan was
recognized in 2008 in accordance with SFAS 123(R). See
Note 3 to our consolidated financial statements. |
|
|
|
Option Awards for 2006 include all compensation expense
recognized in our financial statements for fiscal year 2006 in
accordance with SFAS 123(R) with respect to options to
purchase shares of our common stock awarded to the named
executive officers, including options awarded pursuant to the
2005 Plan and predecessor plans. As a result of the Merger, all
options outstanding at the time of the Merger vested and
therefore all compensation expense with respect to such options
was recognized in 2006 in accordance with SFAS 123(R). See
Note 3 to our consolidated financial statements. |
|
(4) |
|
Non-Equity Incentive Plan Compensation for 2008 reflects amounts
earned for the year ended December 31, 2008 under the
2008-2009
PEP, which amounts will be paid in the first quarter of 2009
pursuant to the terms of the
2008-2009
PEP. For 2008, the Company did not achieve its target
performance level, but exceeded its threshold performance level,
as adjusted, with respect to the Companys EBITDA;
therefore, pursuant to the terms of the
2008-2009
PEP, 2008 awards under the
2008-2009
PEP will be paid out to the named executive officers at
approximately 68.2% of each such officers respective
target amount, with the exception of Mr. Hazen, whose award
will be paid out at approximately 67.4% of his target amount,
due to the 50% of his PEP based on the Western Group EBITDA,
which also exceeded the threshold performance level but did not
reach the target performance level. |
|
|
|
Non-Equity Incentive Plan Compensation for 2007 reflects amounts
earned for the year ended December 31, 2007 under the 2007
PEP, which amounts will be paid in the first quarter of 2008
pursuant to the terms of the 2007 PEP. For 2007, the Company
exceeded its maximum performance level, as adjusted, with
respect to the Companys EBITDA; therefore, pursuant to the
terms of the 2007 PEP, awards under the 2007 PEP were paid out
to the named executive officers, at the maximum level of 200% of
their respective target amounts, with the exception of
Mr. Hazen, whose award was paid out at 175.6% of the target
amount, due to the 50% of his PEP based on the Western Group
EBITDA, which exceeded the target but did not reach the maximum
performance level. |
|
|
|
Non-Equity Incentive Plan Compensation for 2006 reflects amounts
paid under the 2006 PEP in November 2006, which amounts became
due and payable to certain of our executive officers, including
the named executive officers, as a result of the change in
control of the Company upon consummation of the Merger. |
|
(5) |
|
All amounts for 2008 are attributable to changes in value of the
SERP benefits. Assumptions used to calculate these figures are
provided under the table titled Pension Benefits.
The changes in the SERP benefit value during 2008 were impacted
mainly by: (i) the passage of time which reflects another
year of pay and service plus actual investment return,
(ii) the discount rate changing from 6.00% to 6.25%, which
resulted in a decrease in the value and (iii) the
opportunity for participants to change their benefit election
before 2009 for terminations and retirements occurring after
2008. Mr. Bovender elected to change his benefit payment
from an annuity to a lump sum. The impact of these events on the
SERP benefit values was: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bovender
|
|
Bracken
|
|
Johnson
|
|
Hazen
|
|
Wallace
|
|
Passage of Time
|
|
$
|
1,432,831
|
|
|
$
|
2,142,217
|
|
|
$
|
2,100,290
|
|
|
$
|
1,037,631
|
|
|
$
|
2,301,107
|
|
Discount Rate Change
|
|
$
|
(467,374
|
)
|
|
$
|
(401,597
|
)
|
|
$
|
(228,500
|
)
|
|
$
|
(227,169
|
)
|
|
$
|
(220,271
|
)
|
Change in Election
|
|
$
|
2,960,760
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All amounts for 2007 are attributable to changes in value of the
SERP benefits. Assumptions used to calculate these figures are
provided under the table titled Pension Benefits.
The changes in the SERP benefit value during 2007 were impacted
mainly by: (i) the passage of time which reflects another
year of pay and service, (ii) the discount rate changing
from 5.75% to 6.00%, which resulted in a decrease in the value
and (iii) the use of the named executive officers
actual elections compared to 2006 when benefits were valued
assuming a 50% probability of electing a lump sum and a 50%
probability of electing an annuity. All named executive officers
77
elected a lump sum payment at retirement, with the exception of
Mr. Bovender, who elected an annuity. The impact of these
events on the SERP benefit values was:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bovender
|
|
Bracken
|
|
Johnson
|
|
Hazen
|
|
Wallace
|
|
Passage of Time
|
|
$
|
(966,974
|
)
|
|
$
|
399,630
|
|
|
$
|
510,118
|
|
|
$
|
266,066
|
|
|
$
|
549,404
|
|
Discount Rate Change
|
|
$
|
(542,195
|
)
|
|
$
|
(351,603
|
)
|
|
$
|
(145,992
|
)
|
|
$
|
(186,325
|
)
|
|
$
|
(165,945
|
)
|
Actual Election
|
|
$
|
(1,322,788
|
)
|
|
$
|
542,343
|
|
|
$
|
145,315
|
|
|
$
|
179,046
|
|
|
$
|
292,652
|
|
All amounts for 2006 are attributable to increases in value to
the SERP benefits. In addition to the assumptions set forth
under the table titled Pension Benefits, for the
purposes of calculating the 2006 figures, benefits are valued
assuming a 50% probability of electing a lump sum and a 50%
probability of electing an annuity.
Messrs. Bovenders, Brackens Johnsons and
Hazens SERP benefit value increased in 2006 by $4,185,617,
$1,272,074, $299,972, and $287,717, respectively, as a result of
the passage of time. In 2006, their SERP benefit value further
increased due to three special, one-time events: (i) the
payments made under the 2006 Senior Officer PEP in November 2006
described in footnote (4) to the Summary Compensation
Table, which had the effect of increasing the named executive
officers current final average earnings; (ii) the
Merger constituted a change in control under the terms of the
SERP, which triggered a decrease in the normal retirement age
under the SERP from age 65 (or 62 with 10 years of
service) to age 60; and (iii) the Committee approved
the amendment of the SERP to include a lump sum payment
provision and to revise certain actuarial factors. The impact of
these events on the SERP benefit values was:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bovender
|
|
Bracken
|
|
Johnson
|
|
Hazen
|
|
Timing of PEP payment
|
|
$
|
2,593,533
|
|
|
$
|
732,167
|
|
|
$
|
293,215
|
|
|
$
|
263,193
|
|
Change to retirement age
|
|
$
|
1,250,090
|
|
|
$
|
1,535,685
|
|
|
$
|
576,907
|
|
|
$
|
620,300
|
|
Lump sum provision and actuarial factors
|
|
$
|
2,686,511
|
|
|
$
|
1,372,162
|
|
|
$
|
678,606
|
|
|
$
|
657,538
|
|
|
|
|
(6) |
|
2008 Amounts consist of: |
|
|
|
|
|
Company contributions to our Retirement Plan and matching
Company contributions to our 401(k) Plan as set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bovender
|
|
Bracken
|
|
Johnson
|
|
Hazen
|
|
Wallace
|
|
HCA Retirement Plan
|
|
$
|
3,163
|
|
|
$
|
3,163
|
|
|
$
|
3,163
|
|
|
$
|
3,163
|
|
|
$
|
3,163
|
|
HCA 401(k) matching contribution
|
|
$
|
12,488
|
|
|
$
|
12,488
|
|
|
$
|
12,488
|
|
|
$
|
12,488
|
|
|
$
|
12,488
|
|
HCA Restoration Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective January 1, 2008, participants in the SERP are no
longer eligible for Restoration Plan contributions.
|
|
|
|
|
Personal use of corporate aircraft. In 2008,
Messrs. Bovender, Bracken and Johnson were allowed personal
use of Company aircraft with an estimated incremental cost of
$28,913, $15,233 and $4,546, respectively, to the Company.
Mr. Hazen and Ms. Wallace did not have any personal
travel on Company aircraft in 2008. We calculate the aggregate
incremental cost of the personal use of Company aircraft based
on a methodology that includes the average aggregate cost, on a
per nautical mile basis, of variable expenses incurred in
connection with personal plane usage, including trip-related
maintenance, landing fees, fuel, crew hotels and meals, on-board
catering, trip-related hangar and parking costs and other
variable costs. Because our aircraft are used primarily for
business travel, our incremental cost methodology does not
include fixed costs of owning and operating aircraft that do not
change based on usage. We grossed up the income attributed to
Messrs. Bovender and Bracken with respect to certain trips
on Company aircraft. The additional income attributed to them as
a result of gross ups was $588 and $599, respectively. In
addition, we will pay the expenses of our executives
spouses associated with travel to
and/or
attendance at business related events at which spouse attendance
is appropriate. We paid approximately $107, $189 and $13,660 for
travel
and/or other
expenses incurred by Messrs. Bovenders,
Brackens and Johnsons wives, respectively, for such
business related events, and additional income of $62, $109 and
$4,912 was attributed to Messrs. Bovender, Bracken and
Johnson, respectively, as a result of the gross up on such
amounts.
|
78
2007 Amounts consist of:
|
|
|
|
|
Company contributions to our Retirement Plan, matching Company
contributions to our 401(k) Plan and Company accruals for our
Restoration Plan as set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bovender
|
|
Bracken
|
|
Johnson
|
|
Hazen
|
|
Wallace
|
|
HCA Retirement Plan
|
|
$
|
19,388
|
|
|
$
|
19,388
|
|
|
$
|
19,388
|
|
|
$
|
19,388
|
|
|
$
|
19,388
|
|
HCA 401(k) matching contribution
|
|
$
|
2,250
|
|
|
$
|
3,375
|
|
|
$
|
3,375
|
|
|
$
|
3,375
|
|
|
$
|
3,375
|
|
HCA Restoration Plan
|
|
$
|
153,475
|
|
|
$
|
91,946
|
|
|
$
|
57,792
|
|
|
$
|
62,004
|
|
|
$
|
52,250
|
|
|
|
|
|
|
Personal use of corporate aircraft. In 2007,
Messrs. Bovender and Bracken were allowed personal use of
Company aircraft with an estimated incremental cost of $21,350
and $26,895, respectively, to the Company, calculated as
described above. Mr. Hazen and Ms. Wallace did not
have any personal travel on Companys aircraft in 2007. We
grossed up the income attributed to Messrs. Bovender and
Bracken with respect to certain trips on Company aircraft. The
additional income attributed to them as a result of gross ups
was $629 and $863, respectively. In addition, we will pay the
travel expenses of our executives spouses associated with
travel to business related events at which spouse attendance is
appropriate. We paid approximately $342 for travel by
Mr. Brackens wife on a commercial airline and related
expenses for such an event, and additional income of $123 was
attributed to Mr. Bracken as a result of the gross up on
such amount.
|
2006 Amounts consist of:
|
|
|
|
|
The cash payment received as a result of the deemed purchase
under the MSPP. Salary amounts withheld on behalf of the
participants in the MSPP through the closing date of the Merger
were deemed to have been used to purchase shares of our common
stock under the terms of the MSPP, using the closing date of the
Merger as the last date of the applicable offering period, and
then converted into the right to receive a cash payment equal to
the number of shares deemed purchased under the MSPP multiplied
by $51.00. Salary amounts were refunded to the participants, and
they also received a cash payment equal to the difference
between $51.00 and the deemed purchase price, multiplied by the
number of shares the participant was deemed to have purchased.
Messrs. Bovender, Bracken, Johnson and Hazen received cash
payments of $20,860, $27,326, $24,157 and $25,379, respectively.
|
|
|
|
Company contributions to our Retirement Plan, matching Company
contributions to our 401(k) Plan and Company accruals for our
Restoration Plan in 2006 as set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bovender
|
|
Bracken
|
|
Johnson
|
|
Hazen
|
|
HCA Retirement Plan
|
|
$
|
19,019
|
|
|
$
|
19,019
|
|
|
$
|
19,019
|
|
|
$
|
19,019
|
|
HCA 401(k) matching contribution
|
|
$
|
3,125
|
|
|
$
|
3,300
|
|
|
$
|
3,300
|
|
|
$
|
3,300
|
|
HCA Restoration Plan
|
|
$
|
856,424
|
|
|
$
|
409,933
|
|
|
$
|
212,109
|
|
|
$
|
247,060
|
|
|
|
|
|
|
Dividends on restricted shares. On March 1, 2006,
June 1, 2006 and September 1, 2006, we paid dividends
of $0.15 per share, $0.17 per share and $0.17 per share,
respectively, for each issued and outstanding share of common
stock of HCA, including restricted shares.
Messrs. Bovender, Bracken, Johnson and Hazen received
aggregate dividends of $82,525, $42,030, $25,267 and $27,754,
respectively, in 2006 in respect of restricted shares held by
them.
|
|
|
|
Personal use of corporate aircraft. In 2006, each of
Messrs. Bovender, Bracken, Johnson and Hazen were allowed
personal use of Company aircraft with estimated incremental cost
of approximately $30,336, $12,173, $11,308 and $6,812,
respectively, to the Company, calculated as described above. We
grossed up the income attributed to Messrs. Bovender and
Bracken with respect to certain trips on Company aircraft. The
additional income attributed to them as a result of gross ups
was $1,287 and $522, respectively. In addition, we will pay the
travel expenses of our executives spouses associated with
travel to business related events at which spouse attendance is
appropriate. We paid approximately $469 for travel by
Mr. Brackens wife on a commercial airline for such an
event.
|
79
Grants of
Plan-Based Awards
The following table provides information with respect to awards
made under our
2008-2009
PEP during the 2008 fiscal year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
|
|
|
|
|
|
|
Estimated Possible Payouts
|
|
Estimated Possible Payouts
|
|
Awards:
|
|
Exercise or
|
|
|
|
|
|
|
Under Non-Equity Incentive
|
|
Under Equity Incentive
|
|
Number of
|
|
Base Price
|
|
Grant Date
|
|
|
|
|
Plan Awards ($)(1)
|
|
Plan Awards (#)
|
|
Securities
|
|
of Option
|
|
Fair Value
|
|
|
Grant
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Underlying
|
|
Awards
|
|
of Option
|
Name
|
|
Date
|
|
($)
|
|
($)
|
|
($)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
Options
|
|
($/sh)
|
|
Awards
|
|
Jack O. Bovender, Jr.
|
|
|
N/A
|
|
|
$
|
1,020,744
|
|
|
$
|
2,041,487
|
|
|
$
|
4,082,975
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richard M. Bracken
|
|
|
N/A
|
|
|
$
|
509,219
|
|
|
$
|
1,018,437
|
|
|
$
|
2,036,874
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R. Milton Johnson
|
|
|
N/A
|
|
|
$
|
260,705
|
|
|
$
|
521,410
|
|
|
$
|
1,042,820
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel N. Hazen
|
|
|
N/A
|
|
|
$
|
260,262
|
|
|
$
|
520,524
|
|
|
$
|
1,041,047
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beverly B. Wallace
|
|
|
N/A
|
|
|
$
|
231,000
|
|
|
$
|
462,000
|
|
|
$
|
924,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Non-equity incentive awards granted to each of the named
executive officers pursuant to our
2008-2009
PEP for the 2008 fiscal year, as described in more detail under
Compensation Discussion and Analysis Annual
Incentive Compensation: PEP. The amounts shown in the
Threshold column reflect the threshold payment,
which is 50% of the amount shown in the Target
column. The amount shown in the Maximum column is
200% of the target amount. These amounts are based on the
individuals salary and position as of the date the
2008-2009
Senior Officer PEP was approved by the Compensation Committee.
Pursuant to the terms of the
2008-2009
PEP, awards have already been determined and will be paid out to
the named executive officers at approximately 68.2% of each such
officers respective target amount, with the exception of
Mr. Hazen, whose award vested and will be paid out at
approximately 67.4% of the target amount. Messrs. Bovender,
Bracken, Johnson and Hazen and Ms. Wallace will receive
$1,391,886, $694,370, $355,491, $350,807 and $314,992,
respectively, under the
2008-2009
Senior Officer PEP for the 2008 fiscal year; such amounts are
reflected in the Non-Equity Incentive Plan
Compensation column of the Summary Compensation Table. |
Narrative
Disclosure to Summary Compensation Table and Grants of
Plan-Based Awards Table
Total
Compensation
In 2008 and 2007, total direct compensation, as described in the
Summary Compensation Table, consisted primarily of base salary,
annual PEP awards payable in cash, and, in 2007, long term stock
option grants designed to be one-time grants to cover at least
five years of service. This mix was intended to reflect our
philosophy that a significant portion of an executives
compensation should be equity-linked
and/or tied
to our operating performance. In addition, we provided an
opportunity for executives to participate in two supplemental
retirement plans; however, effective January 1, 2008,
participants in the SERP are no longer eligible for Restoration
Plan contributions, although Restoration Plan accounts will
continue to be maintained for such participants (for additional
information concerning the Restoration Plan, see
Nonqualified Deferred Compensation). In 2006, by
contrast, total compensation, as described in the Summary
Compensation Table, was significantly impacted by the Merger and
related one time events.
Options
In January 2007, New Options to purchase common stock of the
Company were granted under the 2006 Plan to members of
management and key employees, including the named executive
officers. The New Options were designed to be long term equity
incentive awards, constituting a one-time stock option grant in
lieu of annual equity grants. The New Options granted in 2007
have a ten year term and are structured so that
1/3
are time vested options (vesting in five equal installments on
the first five anniversaries of the grant date),
1/3
are EBITDA-based performance vested options and
1/3
are performance options that vest based on investment return to
the Sponsors. The terms of the New Options granted in 2007 are
described in greater detail under Compensation Discussion
and Analysis Long Term Equity Incentive Awards:
Options. Compensation expense associated with the New
Option awards was recognized in 2008 and 2007 in accordance with
SFAS 123(R) and is included under the Option
Awards column of the Summary Compensation Table.
80
As a result of the Merger, all unvested awards under the 2005
Plan (and all predecessor equity incentive plans) vested in
November 2006. Generally, all outstanding options under the 2005
Plan (and any predecessor plans) were cancelled and converted
into the right to receive a cash payment equal to the number of
shares of common stock underlying the option multiplied by the
amount by which the Merger consideration of $51.00 per share
exceeded the exercise price for the options (without interest
and less any applicable withholding taxes). However, certain
members of management, including the named executive officers,
were given the opportunity to convert options held by them prior
to consummation of the Merger into options to purchase shares of
common stock of the surviving corporation (Rollover
Options). Immediately after the consummation of the
Merger, all Rollover Options (other than those with an exercise
price below $12.75) were adjusted so that they retained the same
spread value (as defined below) as immediately prior
to the Merger, but the new per share exercise price for all
Rollover Options would be $12.75. The term spread
value means the difference between (x) the aggregate
fair market value of the common stock (determined using the
Merger consideration of $51.00 per share) subject to the
outstanding options held by the participant immediately prior to
the Merger that became Rollover Options, and (y) the
aggregate exercise price of those options. All previously
unrecognized compensation expense associated with the Rollover
Options was recognized in 2006; therefore, we did not record any
compensation expense related to the Rollover Options in 2008 or
2007. New Options and Rollover Options held by the named
executive officers are described in the Outstanding Equity
Awards at Fiscal Year-End Table.
Employment
Agreements
In connection with the Merger, on November 16, 2006,
Hercules Holding entered into substantially similar employment
agreements with each of the named executive officers and certain
other executives, which agreements were shortly thereafter
assumed by the Company and which agreements govern the terms of
each executives employment. However, in light of
Mr. Bovenders retirement from the position of Chief
Executive Officer, effective December 31, 2008, and
continuing service to the Company as Chairman until
December 15, 2009, the Company entered into an Amended and
Restated Employment Agreement with Mr. Bovender, effective
December 31, 2008, the terms of which are described below.
The Company also entered into an amendment to
Mr. Brackens employment agreement, effective
January 1, 2009, to reflect his appointment to the position
of Chief Executive Officer and President.
Executive
Employment Agreements (Other than the
Chairmans)
The term of employment under each of these agreements is
indefinite, and they are terminable by either party at any time;
provided that an executive must give no less than 90 days
notice prior to a resignation.
Each employment agreement sets forth the executives annual
base salary, which will be subject to discretionary annual
increases upon review by the Board of Directors, and states that
the executive will be eligible to earn an annual bonus as a
percentage of salary with respect to each fiscal year, based
upon the extent to which annual performance targets established
by the Board of Directors are achieved. The employment
agreements committed us to provide each executive with annual
bonus opportunities in 2008 that were consistent with those
applicable to the 2007 fiscal year, unless doing so would be
adverse to our interests or the interests of our shareholders,
and for later fiscal years, the agreements provide that the
Board of Directors will set bonus opportunities in consultation
with our Chief Executive Officer. With respect to the 2008 and
2007 fiscal years, each executive was eligible to earn under the
2008-2009
PEP and the
2008-2007
PEP, respectively, (i) a target bonus, if performance
targets were met; (ii) a specified percentage of the target
bonus, if threshold levels of performance were
achieved but performance targets were not met; or (iii) a
multiple of the target bonus if maximum performance
goals were achieved, with the annual bonus amount being
interpolated, in the sole discretion of the Board of Directors,
for performance results that exceeded threshold
levels but do not meet or exceed maximum levels. The
annual bonus opportunities for 2008 were set forth in the
2008-2009
PEP, as described in more detail under Compensation
Discussion and Analysis Annual Incentive
Compensation: PEP. As described above, awards under the
2008 PEP have already been determined and will be paid out to
the named executive officers, at approximately 68.2% of each
such officers respective target amount, with the exception
of Mr. Hazen, whose award vested and will be paid out at
approximately 67.4% of the target amount. As described above,
awards under the 2007 PEP were paid out to the named executive
officers, at the maximum level of 200% of their respective
target amounts, with the exception
81
of Mr. Hazen, whose award was paid out at 175.6% of his
target amount. Each employment agreement also sets forth the
number of options that the executive received pursuant to the
2006 Plan as a percentage of the total equity initially made
available for grants pursuant to the 2006 Plan. Such option
awards, the New Options, were made January 30, 2007 and are
described above.
Pursuant to each employment agreement, if an executives
employment terminates due to death or disability, the executive
would be entitled to receive (i) any base salary and any
bonus that is earned and unpaid through the date of termination;
(ii) reimbursement of any unreimbursed business expenses
properly incurred by the executive; (iii) such employee
benefits, if any, as to which the executive may be entitled
under our employee benefit plans (the payments and benefits
described in (i) through (iii) being accrued
rights); and (iv) a pro rata portion of any annual
bonus that the executive would have been entitled to receive
pursuant to the employment agreement based upon our actual
results for the year of termination (with such proration based
on the percentage of the fiscal year that shall have elapsed
through the date of termination of employment, payable to the
executive when the annual bonus would have been otherwise
payable (the pro rata bonus)).
If an executives employment is terminated by us without
cause (as defined below) or by the executive for
good reason (as defined below) (each a
qualifying termination), the executive would be
(i) entitled to the accrued rights; (ii) subject to
compliance with certain confidentiality, non-competition and
non-solicitation covenants contained in his or her employment
agreement and execution of a general release of claims on behalf
of the Company, an amount equal to the product of (x) two
(three in the case of Richard M. Bracken and R. Milton Johnson)
and (y) the sum of (A) the executives base
salary and (B) annual bonus paid or payable in respect of
the fiscal year immediately preceding the fiscal year in which
termination occurs, payable over a two-year period;
(iii) entitled to the pro rata bonus; and
(iv) entitled to continued coverage under our group health
plans during the period over which the cash severance described
in clause (ii) is paid. The executives vested New
Options would also remain exercisable until the first
anniversary of the termination of the executives
employment. However, in lieu of receiving the payments and
benefits described in (ii), (iii) and (iv) immediately
above, the executive may instead elect to have his or her
covenants not to compete waived by us. The same severance
applies regardless of whether the termination was in connection
with a change in control of the Company.
Cause is defined as an executives
(i) willful and continued failure to perform his material
duties to the Company which continues beyond 10 business days
after a written demand for substantial performance is delivered;
(ii) willful or intentional engagement in material
misconduct that causes material and demonstrable injury,
monetarily or otherwise, to the Company or the Sponsors;
(iii) conviction of, or a plea of nolo contendere
to, a crime constituting a felony, or a misdemeanor for
which a sentence of more than six months imprisonment is
imposed; or (iv) willful and material breach of his
covenants under the employment agreement which continues beyond
the designated cure period or of the agreements relating to the
new equity. Good Reason is defined as (i) a
reduction in the executives base salary (other than a
general reduction that affects all similarly situated employees
in substantially the same proportions which is implemented by
the Board in good faith after consultation with the chief
executive officer and chief operating officer, a reduction in
the executives annual incentive compensation opportunity,
or the reduction of benefits payable to the executive under the
SERP; (ii) a substantial diminution in the executives
title, duties and responsibilities; or (iii) a transfer of
the executives primary workplace to a location that is
more than 20 miles from his or her current workplace (other
than, in the case of (i) and (ii), any isolated,
insubstantial and inadvertent failure that is not in bad faith
and is cured within 10 business days after the executives
written notice to the Company).
In the event of an executives termination of employment
that is not a qualifying termination or a termination due to
death or disability, he or she will only be entitled to the
accrued rights (as defined above).
In each of the employment agreements with the named executive
officers, we also commit to grant, among the named executive
officers and certain other executives, 10% of the options
initially authorized for grant under the 2006 Plan at some time
before November 17, 2011 (but with a good faith commitment
to do so before a change in control (as defined in
the 2006 Plan and set forth above) or a public
offering (as defined in the 2006 Plan) and before the time
when our Board of Directors reasonably believes that the fair
market value of our common stock is likely to exceed the
equivalent of $102.00 per share) at an exercise price per share
that is the equivalent of $102.00 per share (2x Time
Options). A percentage of these options will be vested at
the time of the grant, such percentage
82
corresponding to the elapsed percentage of the period measured
between November 17, 2006 and November 17, 2011. When
granted, these options will be allocated among the recipients by
our Board of Directors in consultation with our chief executive
officer based upon the perceived contributions of each recipient
since November 17, 2006. The terms of the 2x Time Options
will otherwise be consistent with other time vesting options
granted under the 2006 Plan. Additionally, pursuant to the
employment agreements, we agree to indemnify each executive
against any adverse tax consequences (including, without
limitation, under Section 409A and 4999 of the Internal
Revenue Code), if any, that result from the adjustment by us of
stock options held by the executive in connection with Merger or
the future payment of any extraordinary cash dividends.
Additional information with respect to potential payments to the
named executive officers pursuant to their employment agreements
and the 2006 Plan is contained in Potential Payments Upon
Termination or Change in Control.
Mr. Bovenders
Employment Agreement
The Company entered into the Amended Employment Agreement with
Jack O. Bovender, Jr. on October 27, 2008, which
became effective on December 31, 2008. Pursuant to the
terms of the Amended Employment Agreement, Mr. Bovender
will continue to be employed by HCA Management Services, L.P.,
an affiliate of the Company, and shall serve as executive
Chairman of the Company for a period commencing
December 31, 2008 and ending December 15, 2009 (the
Employment Term).
The Amended Employment Agreement provides that Mr. Bovender
shall receive a base salary (i) at the monthly rate of
$135,000 for the first three months of the Employment Term and
(ii) at the monthly rate of $86,957 for the next eight and
one-half months of the Employment Term
(Mr. Bovenders Base Salary).
Mr. Bovender is entitled to the full amount of any annual
bonus earned, but unpaid, as of the effective date of the
Amended Employment Agreement for the year ended
December 31, 2008 under the Companys
2008-2009
PEP. For calendar year 2009, Mr. Bovender is eligible to
earn a bonus under the
2008-2009
PEP with a target bonus of $500,000.
Mr. Bovender has an additional 2009 bonus opportunity of up
to $250,000 based upon the achievement of other objectives, to
be determined by the compensation committee of the Company
(Mr. Bovenders Additional Bonus). The
Amended Employment Agreement generally provides for the
provision of or reimbursement of expenses associated with office
space, shared clerical support and office equipment until
Mr. Bovender reaches age 70.
The terms of Mr. Bovenders employment agreement with
respect to termination of his employment are described in detail
under Compensation Discussion and Analysis
Severance and Change in Control Agreements
Mr. Bovenders Severance Benefits.
Additional information with respect to potential payments to
Mr. Bovender pursuant to his Amended Employment Agreement
and the 2006 Plan is contained in Potential Payments Upon
Termination or Change in Control.
Outstanding
Equity Awards at Fiscal Year-End
The following table includes certain information with respect to
options held by the named executive officers as of
December 31, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Incentive
|
|
|
|
|
|
|
Number of
|
|
Number of
|
|
Plan Awards: Number
|
|
|
|
|
|
|
Securities
|
|
Securities
|
|
of Securities
|
|
|
|
|
|
|
Underlying
|
|
Underlying
|
|
Underlying
|
|
Option
|
|
|
|
|
Unexercised
|
|
Unexercised
|
|
Unexercised
|
|
Exercise
|
|
Option
|
|
|
Options
|
|
Options
|
|
Unearned
|
|
Price
|
|
Expiration
|
Name
|
|
Exercisable(#)(1)(2)
|
|
Unexercisable(#)(2)
|
|
Options(#)(2)
|
|
($)(3)(4)
|
|
Date
|
|
Jack O. Bovender, Jr.
|
|
|
143,058
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/25/2011
|
|
Jack O. Bovender, Jr.
|
|
|
53,882
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/24/2012
|
|
Jack O. Bovender, Jr.
|
|
|
69,411
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2013
|
|
Jack O. Bovender, Jr.
|
|
|
53,751
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2014
|
|
Jack O. Bovender, Jr.
|
|
|
24,549
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/27/2015
|
|
83
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Incentive
|
|
|
|
|
|
|
Number of
|
|
Number of
|
|
Plan Awards: Number
|
|
|
|
|
|
|
Securities
|
|
Securities
|
|
of Securities
|
|
|
|
|
|
|
Underlying
|
|
Underlying
|
|
Underlying
|
|
Option
|
|
|
|
|
Unexercised
|
|
Unexercised
|
|
Unexercised
|
|
Exercise
|
|
Option
|
|
|
Options
|
|
Options
|
|
Unearned
|
|
Price
|
|
Expiration
|
Name
|
|
Exercisable(#)(1)(2)
|
|
Unexercisable(#)(2)
|
|
Options(#)(2)
|
|
($)(3)(4)
|
|
Date
|
|
Jack O. Bovender, Jr.
|
|
|
15,843
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/26/2016
|
|
Jack O. Bovender, Jr.
|
|
|
79,920
|
|
|
|
106,562
|
|
|
|
213,122
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
Richard M. Bracken
|
|
|
8,052
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
3/22/2011
|
|
Richard M. Bracken
|
|
|
26,248
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
7/26/2011
|
|
Richard M. Bracken
|
|
|
29,934
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/24/2012
|
|
Richard M. Bracken
|
|
|
40,490
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2013
|
|
Richard M. Bracken
|
|
|
30,235
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2014
|
|
Richard M. Bracken
|
|
|
10,739
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/27/2015
|
|
Richard M. Bracken
|
|
|
7,095
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/26/2016
|
|
Richard M. Bracken
|
|
|
69,930
|
|
|
|
93,242
|
|
|
|
186,482
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
R. Milton Johnson
|
|
|
6,039
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
3/22/2011
|
|
R. Milton Johnson
|
|
|
9,579
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/24/2012
|
|
R. Milton Johnson
|
|
|
9,254
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2013
|
|
R. Milton Johnson
|
|
|
8,062
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2014
|
|
R. Milton Johnson
|
|
|
26,013
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
7/22/2014
|
|
R. Milton Johnson
|
|
|
6,441
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/27/2015
|
|
R. Milton Johnson
|
|
|
4,301
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/26/2016
|
|
R. Milton Johnson
|
|
|
49,950
|
|
|
|
66,601
|
|
|
|
133,202
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
Samuel N. Hazen
|
|
|
6,039
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
3/22/2011
|
|
Samuel N. Hazen
|
|
|
13,124
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
7/26/2011
|
|
Samuel N. Hazen
|
|
|
19,158
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/24/2012
|
|
Samuel N. Hazen
|
|
|
23,137
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2013
|
|
Samuel N. Hazen
|
|
|
16,797
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2014
|
|
Samuel N. Hazen
|
|
|
6,441
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/27/2015
|
|
Samuel N. Hazen
|
|
|
4,301
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/26/2016
|
|
Samuel N. Hazen
|
|
|
31,968
|
|
|
|
42,625
|
|
|
|
85,248
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
Beverly B. Wallace
|
|
|
6,039
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
3/22/2011
|
|
Beverly B. Wallace
|
|
|
9,579
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/24/2012
|
|
Beverly B. Wallace
|
|
|
13,882
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2013
|
|
Beverly B. Wallace
|
|
|
11,422
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/29/2014
|
|
Beverly B. Wallace
|
|
|
4,601
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/27/2015
|
|
Beverly B. Wallace
|
|
|
3,559
|
|
|
|
|
|
|
|
|
|
|
$
|
12.75
|
|
|
|
1/26/2016
|
|
Beverly B. Wallace
|
|
|
27,972
|
|
|
|
37,297
|
|
|
|
74,592
|
|
|
$
|
51.00
|
|
|
|
1/30/2017
|
|
|
|
|
(1) |
|
Reflects Rollover Options, as further described under
Narrative Disclosure to Summary Compensation Table and
Grants of Plan-Based Awards Table Options, the
20% of the named executive officers time vested New
Options that vested as of January 30, 2008 and 40% of the
named executive officers EBITDA-based performance vested
New Options, comprised of the 20% that vested as of
December 31, 2007 and the 20% that vested as of
December 31, 2008 (upon the Committees determination
that the Company achieved the 2007 and 2008 EBITDA performance
targets under the option awards, as adjusted, as described in
more detail under Compensation Discussion and
Analysis Long Term Equity Incentive Awards:
Options). |
84
|
|
|
(2) |
|
Reflects New Options awarded in January 2007 under the 2006 Plan
by the Compensation Committee as part of the named executive
officers long term equity incentive award. The New Options
granted in 2007 are structured so that 1/3 are time vested
options (vesting in five equal installments on the first five
anniversaries of the January 30, 2007 grant date), 1/3 are
EBITDA-based performance vested options (vesting in equal
increments of 20% at the end of fiscal years 2007, 2008, 2009,
2010 and 2011 if certain annual EBITDA performance targets are
achieved, subject to catch up vesting, such that,
options that were eligible to vest but failed to vest due to our
failure to achieve prior EBITDA targets will vest if at the end
of any subsequent year or at the end of fiscal year 2012, the
cumulative total EBITDA earned in all prior years exceeds the
cumulative EBITDA target at the end of such fiscal year) and 1/3
are performance options that vest based on investment return to
the Sponsors (vesting with respect to 10% of the common stock
subject to such options at the end of fiscal years 2007, 2008,
2009, 2010 and 2011 if the Investor Return is at least $102.00
and with respect to an additional 10% at the end of fiscal years
2007, 2008, 2009, 2010 and 2011 if the Investor Return is at
least $127.50, subject to catch up vesting if the
relevant Investor Return is achieved at any time occurring prior
to January 30, 2017, so long as the named executive officer
remains employed by the Company). The time vested options are
reflected in the Number of Securities Underlying
Unexercised Options Unexercisable column (with the
exception of the 20% of the time vested options that vested as
of January 30, 2008, which are reflected in the
Number of Securities Underlying Unexercised Options
Exercisable column), and the EBITDA-based performance
vested options and investment return performance vested options
are both reflected in the Equity Incentive Plan Awards:
Number of Securities Underlying Unexercised Unearned
Options column (with the exception of the 40% of the
EBITDA-based performance vested options that vested as of
December 31, 2007 and December 31, 2008, which are
reflected in the Number of Securities Underlying
Unexercised Options Exercisable column). The terms of
these option awards are described in more detail under
Narrative Disclosure to Summary Compensation Table and
Grants of Plan-Based Awards Table Options. |
|
(3) |
|
Immediately after the consummation of the Merger, all Rollover
Options (other than those with an exercise price below $12.75)
were adjusted such that they retained the same spread
value (as defined below) as immediately prior to the
Merger, but the new per share exercise price for all Rollover
Options would be $12.75. The term spread value means
the difference between (x) the aggregate fair market value
of the common stock (determined using the Merger consideration
of $51.00 per share) subject to the outstanding options held by
the participant immediately prior to the Merger that became
Rollover Options, and (y) the aggregate exercise price of
those options. |
|
(4) |
|
The exercise price for the New Options granted under the 2006
Plan to the named executive officers on January 30, 2007
was equal to the fair value of our common stock on the date of
the grant, as determined by our Board of Directors in
consultation with our Chief Executive Officer and other
advisors, pursuant to the terms of the 2006 Plan. |
Option
Exercises and Stock Vested
The following table includes certain information with respect to
options exercised by the named executive officers during the
fiscal year ended December 31, 2008.
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Number of Shares
|
|
|
|
|
Acquired on
|
|
Value Realized on
|
Name
|
|
Exercise(1)
|
|
Exercise ($)(2)
|
|
R. Milton Johnson
|
|
|
87,180
|
|
|
$
|
3,758,330
|
|
Samuel N. Hazen
|
|
|
28,123
|
|
|
$
|
1,212,383
|
|
|
|
|
(1) |
|
Messrs. Johnson and Hazen elected a cashless exercise of
87,180 and 28,123 stock options, respectively, resulting in net
shares realized of 42,773 and 13,972, respectively. |
|
(2) |
|
Represents the difference between the exercise price of the
options and the fair market value of the common stock on the
date of exercise, as determined by our Board of Directors in
consultation with our Chief Executive Officer and other advisors. |
85
Pension
Benefits
Our SERP is intended to qualify as a top-hat plan
designed to benefit a select group of management or highly
compensated employees. There are no other defined benefit plans
that provide for payments or benefits to any of the named
executive officers. Information about benefits provided by the
SERP is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Years
|
|
Present Value of
|
|
Payments During
|
Name
|
|
Plan Name
|
|
Credited Service
|
|
Accumulated Benefit
|
|
Last Fiscal Year
|
|
Jack O. Bovender, Jr
|
|
|
SERP
|
|
|
|
29
|
|
|
$
|
22,172,777
|
|
|
$
|
0
|
|
Richard M. Bracken
|
|
|
SERP
|
|
|
|
27
|
|
|
$
|
10,207,328
|
|
|
$
|
0
|
|
R. Milton Johnson
|
|
|
SERP
|
|
|
|
26
|
|
|
$
|
4,321,235
|
|
|
$
|
0
|
|
Samuel N. Hazen
|
|
|
SERP
|
|
|
|
26
|
|
|
$
|
3,605,578
|
|
|
$
|
0
|
|
Beverly B. Wallace
|
|
|
SERP
|
|
|
|
25
|
|
|
$
|
6,649,507
|
|
|
$
|
0
|
|
Mr. Bovender is eligible for normal retirement.
Mr. Bracken and Ms. Wallace are eligible for early
retirement. The remaining named executive officers have not
satisfied the eligibility requirements for normal or early
retirement. All of the named executive officers are 100% vested
in their accrued SERP benefit.
Plan
Provisions
In the event the employees accrued benefits under
the Companys Plans (computed using actuarial
factors) are insufficient to provide the life
annuity amount, the SERP will provide a benefit equal to
the amount of the shortfall. Benefits can be paid in the form of
an annuity or a lump sum. The lump sum is calculated by
converting the annuity benefit using the actuarial
factors. All benefits with a present value not exceeding
one million dollars are paid as a lump sum regardless of the
election made.
Normal retirement eligibility requires attainment of age 60
for employees who were participants at the time of the change in
control which occurred as a result of the Merger, including all
of the named executive officers. Early retirement eligibility
requires age 55 with 20 or more years of service. The
service requirement for early retirement is waived for employees
participating in the SERP at the time of its inception in 2001,
including all of the named executive officers. The life
annuity amount payable to a participant who takes early
retirement is reduced by three percent for each full year or
portion thereof that the participant retires prior to normal
retirement age.
The life annuity amount is the annual benefit
payable as a life annuity to a participant upon normal
retirement. It is equal to the participants accrual
rate multiplied by the product of the participants
years of service times the participants
pay average. The SERP benefit for each year equals
the life annuity amount less the annual life annuity amount
produced by the employees accrued benefit under the
Companys Plans.
The accrual rate is a percentage assigned to each
participant, and is either 2.2% or 2.4%. All of the named
executive officers are assigned a percentage of 2.4%.
A participant is credited with a year of service for
each calendar year that the participant performs
1,000 hours of service for HCA or one of our subsidiaries,
or for each year the participant is otherwise credited by us,
subject to a maximum credit of 25 years of service.
A participants pay average is an amount equal
to one-fifth of the sum of the compensation during the period of
60 consecutive months for which total compensation is greatest
within the 120 consecutive month period immediately preceding
the participants retirement. For purposes of this
calculation, the participants compensation includes base
compensation, payments under the PEP, and bonuses paid prior to
the establishment of the PEP.
The accrued benefits under the Companys Plans
for an employee equals the sum of the employer-funded benefits
accrued under the HCA Retirement Plan, the HCA 401(k) Plan and
any other tax-qualified plan maintained by us or one of our
subsidiaries, the income/loss adjusted amount distributed to the
participant under any of these plans, the account credit and the
income/loss adjusted amount distributed to the participant under
the Restoration Plan and any other nonqualified retirement plans
sponsored by us or one of our subsidiaries.
The actuarial factors include (a) interest at
the long term Applicable Federal Rate under Section 1274(d)
of the Code or any successor thereto as of the first day of
November preceding the plan year in or for which a benefit
86
amount is calculated, and (b) mortality based on the
prevailing commissioners standard table (as described in
Code section 807(d)(5)(A)) used in determining reserves for
group annuity contracts.
Credited service does not include any amount other than service
with us or one of our subsidiaries.
Assumptions
The Present Value of Accumulated Benefit is based on a
measurement date of December 31, 2008.
The assumption is made that there is no probability of
pre-retirement death or termination. Retirement age is assumed
to be the Normal Retirement Age as defined in the SERP for all
named executive officers, as adjusted by the provisions relating
to change in control, or age 60. Age 60 also
represents the earliest date the named executive officers are
eligible to receive an unreduced benefit.
All other assumptions used in the calculations are the same as
those used for the valuation of the plan liabilities in this
annual report.
Supplemental
Information
In the event a participant renders service to another health
care organization within five years following retirement or
termination of employment, he or she forfeits his rights to any
further payment, and must repay any benefits already paid. This
non-competition provision is subject to waiver by the Committee
with respect to the named executive officers.
Nonqualified
Deferred Compensation
Amounts shown in the table are attributable to the HCA
Restoration Plan, an unfunded, nonqualified defined contribution
plan designed to restore benefits under the HCA Retirement Plan
based on compensation in excess of the Code
Section 401(a)(17) compensation limit ($230,000 in 2008).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive
|
|
Registrant
|
|
Aggregate
|
|
|
|
Aggregate
|
|
|
Contributions
|
|
Contributions
|
|
Earnings
|
|
Aggregate
|
|
Balance
|
|
|
in Last
|
|
in Last
|
|
in Last
|
|
Withdrawals/
|
|
at Last
|
Name
|
|
Fiscal Year
|
|
Fiscal Year
|
|
Fiscal Year
|
|
Distributions
|
|
Fiscal Year
|
|
Jack O. Bovender, Jr
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
(849,699
|
)
|
|
$
|
0
|
|
|
$
|
2,193,745
|
|
Richard M. Bracken
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
(445,541
|
)
|
|
$
|
0
|
|
|
$
|
1,151,250
|
|
R. Milton Johnson
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
(182,049
|
)
|
|
$
|
0
|
|
|
$
|
472,090
|
|
Samuel N. Hazen
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
(243,513
|
)
|
|
$
|
0
|
|
|
$
|
630,201
|
|
Beverly B. Wallace
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
(149,832
|
)
|
|
$
|
0
|
|
|
$
|
388,934
|
|
The following amounts from the column titled Aggregate
Balance at Last Fiscal Year have been reported in the
Summary Compensation Tables in prior years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restoration Contribution
|
Name
|
|
2002
|
|
2003
|
|
2004
|
|
2005
|
|
2006
|
|
2007
|
|
Jack O. Bovender, Jr
|
|
$
|
268,523
|
|
|
$
|
289,899
|
|
|
$
|
363,481
|
|
|
$
|
295,062
|
|
|
$
|
856,424
|
|
|
$
|
153,475
|
|
Richard M. Bracken
|
|
$
|
146,549
|
|
|
$
|
162,344
|
|
|
$
|
192,858
|
|
|
$
|
172,571
|
|
|
$
|
409,933
|
|
|
$
|
91,946
|
|
R. Milton Johnson
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
71,441
|
|
|
$
|
212,109
|
|
|
$
|
57,792
|
|
Samuel N. Hazen
|
|
|
|
|
|
$
|
79,510
|
|
|
$
|
101,488
|
|
|
$
|
97,331
|
|
|
$
|
247,060
|
|
|
$
|
62,004
|
|
Beverly B. Wallace
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
52,250
|
|
Plan
Provisions
Until 2008, hypothetical accounts for each participant were
credited each year with a contribution designed to restore the
HCA Retirement Plan based on compensation in excess of the Code
Section 401(a)(17) compensation limit ($230,000 in 2008),
based on years of service. Effective January 1, 2008,
participants in the SERP are no longer eligible for Restoration
Plan contributions. However, the hypothetical accounts as of
January 1, 2008 will
87
continue to be maintained and will be increased or decreased
with investment earnings based on the actual investment return.
No employee deferrals are allowed under this or any other
nonqualified deferred compensation plan.
Eligible employees make a one time election prior to
participation (or prior to December 31, 2006, if earlier)
regarding the form of distribution of the benefit. Participants
choose between a lump sum and five or ten installments.
Distributions are paid (or begin) during the July following the
year of termination of employment or retirement. All balances
not exceeding $500,000 are automatically paid as a lump sum. If
no election is made, the benefit is paid in a lump sum.
Supplemental
Information
In the event a participant renders service to another health
care organization within five years following retirement or
termination of employment, he or she forfeits the rights to any
further payment, and must repay any payments already made. This
non-competition provision is subject to waiver by the Committee
with respect to the named executive officers.
Potential
Payments Upon Termination or Change in Control
The following tables show the estimated amount of potential cash
severance payable to each of the named executive officers, as
well as the estimated value of continuing benefits, based on
compensation and benefit levels in effect on December 31,
2008, assuming the executives employment terminates or the
Company undergoes a Change in Control (as defined in the 2006
Plan and set forth above under Narrative to Summary
Compensation Table and Grants of Plan-Based Awards
Table Options) effective December 31,
2008. Due to the numerous factors involved in estimating these
amounts, the actual value of benefits and amounts to be paid can
only be determined upon an executives termination of
employment.
Jack O.
Bovender, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
Voluntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
Voluntary
|
|
Early
|
|
Normal
|
|
Without
|
|
Termination
|
|
for Good
|
|
|
|
|
|
Change in
|
|
|
Termination
|
|
Retirement
|
|
Retirement
|
|
Cause
|
|
for Cause
|
|
Reason
|
|
Disability
|
|
Death
|
|
Control
|
|
Cash Severance(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,144,134
|
|
|
|
|
|
|
$
|
1,144,134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(2)
|
|
$
|
1,391,886
|
|
|
$
|
1,391,886
|
|
|
$
|
1,391,886
|
|
|
$
|
1,391,886
|
|
|
$
|
1,391,886
|
|
|
$
|
1,391,886
|
|
|
$
|
1,391,886
|
|
|
$
|
1,391,886
|
|
|
$
|
1,391,886
|
|
Unvested Stock Options(3)
|
|
$
|
1,424,184
|
|
|
$
|
1,424,184
|
|
|
$
|
1,424,184
|
|
|
$
|
1,424,184
|
|
|
|
|
|
|
$
|
1,424,184
|
|
|
$
|
1,424,184
|
|
|
$
|
1,424,184
|
|
|
$
|
1,553,664
|
|
SERP(4)
|
|
$
|
22,431,999
|
|
|
$
|
22,431,999
|
|
|
$
|
22,431,999
|
|
|
$
|
22,431,999
|
|
|
$
|
22,431,999
|
|
|
$
|
22,431,999
|
|
|
$
|
22,431,999
|
|
|
$
|
18,736,776
|
|
|
|
|
|
Retirement Plans(5)
|
|
$
|
2,398,833
|
|
|
$
|
2,398,833
|
|
|
$
|
2,398,833
|
|
|
$
|
2,398,833
|
|
|
$
|
2,398,833
|
|
|
$
|
2,398,833
|
|
|
$
|
2,398,833
|
|
|
$
|
2,398,833
|
|
|
|
|
|
Health and Welfare Benefits(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
15,505
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability Income(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,275,926
|
|
|
|
|
|
|
|
|
|
Life Insurance Benefits(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,021,000
|
|
|
|
|
|
Accrued Vacation Pay
|
|
$
|
224,339
|
|
|
$
|
224,339
|
|
|
$
|
224,339
|
|
|
$
|
224,339
|
|
|
$
|
224,339
|
|
|
$
|
224,339
|
|
|
$
|
224,339
|
|
|
$
|
224,339
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
27,871,241
|
|
|
$
|
27,871,241
|
|
|
$
|
27,871,241
|
|
|
$
|
29,030,880
|
|
|
$
|
26,447,057
|
|
|
$
|
29,015,375
|
|
|
$
|
29,147,167
|
|
|
$
|
26,197,018
|
|
|
$
|
2,945,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents the amounts Mr. Bovender would be entitled to
receive pursuant to Mr. Bovenders Amended Employment
Agreement in effect on December 31, 2008. Under his prior
employment agreement, Mr. Bovender would have been entitled
to receive $16,526,325 in cash severance if his employment had
been involuntarily terminated without cause or voluntarily
terminated for good reason on December 31, 2008 prior to
his resignation from the position of Chief Executive Officer.
See Narrative to Summary Compensation Table and Grants of
Plan-Based Awards Table Employment Agreements. |
|
(2) |
|
Represents the amount Mr. Bovender would be entitled to
receive for the 2008 fiscal year pursuant to the
2008-2009
PEP and his Amended Employment Agreement, which amount is also
included in the Non-Equity Incentive Plan
Compensation column of the Summary Compensation Table.
Under his prior employment agreement, Mr. Bovender would
have been entitled to receive $0 in non-equity incentive plan
compensation if his employment had been terminated for cause on
December 31, 2008 prior to his resignation from the
position |
88
|
|
|
|
|
of Chief Executive Officer. See Narrative to Summary
Compensation Table and Grants of Plan-Based Awards
Table
2008-2009
PEP and Employment Agreements. |
|
(3) |
|
The amounts set forth in the Voluntary Termination,
Early Retirement, Normal Retirement,
Involuntary Termination Without Cause,
Voluntary Termination for Good Reason,
Disability and Death columns represent
the intrinsic value of all unvested stock options, which,
pursuant to Mr. Bovenders Amended Employment
Agreement, will continue to vest after the termination of his
employment (other than a termination for cause), calculated as
the difference between the exercise price of
Mr. Bovenders unvested New Options subject to such
continued vesting provision and the fair value price of our
common stock on December 31, 2008 as determined by our
Board of Directors in consultation with our Chief Executive
Officer and other advisors for internal purposes ($55.86 per
share). For the purposes of this calculation, it is assumed that
the 2009, 2010 and 2011 EBITDA performance targets under the
option awards are achieved by the Company and that the Company
achieves an Investor Return of at least 2.5 times the Base Price
of $51.00 at the end of each of the 2009, 2010 and 2011 fiscal
years, respectively. See Compensation Discussion and
Analysis Severance and Change in Control
Agreements. |
|
|
|
The amount set forth in the Change in Control column
represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Mr. Bovenders unvested New Options and the fair value
price of our common stock on December 31, 2008 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($55.86 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of at least
2.5 times the Base Price of $51.00 at the end of the 2008 fiscal
year. |
|
(4) |
|
Reflects the actual lump sum value of the SERP based on the 2008
interest rate of 4.89%. |
|
(5) |
|
Reflects the estimated lump sum present value of qualified and
nonqualified retirement plans to which Mr. Bovender would
be entitled. The value includes $169,452 from the HCA Retirement
Plan, $35,636 from the HCA 401(k) Plan (which represents the
value of the Companys matching contributions), and
$2,193,745 from the HCA Restoration Plan. |
|
(6) |
|
Reflects the present value of the medical premiums for
Mr. Bovender and his spouse from termination to age 65
as required pursuant to Mr. Bovenders Amended
Employment Agreement. See Narrative Disclosure to Summary
Compensation Table and Grants of Plan-Based Awards
Table Employment Agreements. |
|
(7) |
|
Reflects the estimated lump sum present value of all future
payments which Mr. Bovender would be entitled to receive
under our disability program, including five months of salary
continuation, monthly long term disability benefits of $10,000
per month payable after the five-month elimination period for
42 months, and monthly benefits of $10,000 per month from
our Supplemental Insurance Program payable after the six-month
elimination period for 36 months. |
|
(8) |
|
No post-retirement or post-termination life insurance or death
benefits are provided to Mr. Bovender.
Mr. Bovenders payment upon death while actively
employed includes $1,621,000 of Company-paid life insurance and
$400,000 from the Executive Death Benefit Plan. |
89
Richard
M. Bracken
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
Voluntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
Voluntary
|
|
Early
|
|
Normal
|
|
Without
|
|
Termination
|
|
for Good
|
|
|
|
|
|
Change in
|
|
|
Termination
|
|
Retirement
|
|
Retirement
|
|
Cause
|
|
for Cause
|
|
Reason
|
|
Disability
|
|
Death
|
|
Control
|
|
Cash Severance(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
8,911,326
|
|
|
|
|
|
|
$
|
8,911,326
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(2)
|
|
$
|
694,370
|
|
|
$
|
694,370
|
|
|
$
|
694,370
|
|
|
$
|
694,370
|
|
|
|
|
|
|
$
|
694,370
|
|
|
$
|
694,370
|
|
|
$
|
694,370
|
|
|
$
|
694,370
|
|
Unvested Stock Options(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,359,459
|
|
SERP(4)
|
|
$
|
12,950,117
|
|
|
$
|
12,950,117
|
|
|
|
|
|
|
$
|
12,950,117
|
|
|
$
|
12,950,117
|
|
|
$
|
12,950,117
|
|
|
$
|
12,950,117
|
|
|
$
|
11,608,638
|
|
|
|
|
|
Retirement Plans(5)
|
|
$
|
2,016,285
|
|
|
$
|
2,016,285
|
|
|
$
|
2,016,285
|
|
|
$
|
2,016,285
|
|
|
$
|
2,016,285
|
|
|
$
|
2,016,285
|
|
|
$
|
2,016,285
|
|
|
$
|
2,016,285
|
|
|
|
|
|
Health and Welfare Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability Income(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,710,666
|
|
|
|
|
|
|
|
|
|
Life Insurance Benefits(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,136,000
|
|
|
|
|
|
Accrued Vacation Pay
|
|
$
|
146,890
|
|
|
$
|
146,890
|
|
|
$
|
146,890
|
|
|
$
|
146,890
|
|
|
$
|
146,890
|
|
|
$
|
146,890
|
|
|
$
|
146,890
|
|
|
$
|
146,890
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
15,807,662
|
|
|
$
|
15,807,662
|
|
|
$
|
2,857,545
|
|
|
$
|
24,718,988
|
|
|
$
|
15,113,292
|
|
|
$
|
24,718,988
|
|
|
$
|
17,518,328
|
|
|
$
|
15,602,183
|
|
|
$
|
2,053,829
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents amounts Mr. Bracken would be entitled to receive
pursuant to his employment agreement. See Narrative
Disclosure to Summary Compensation Table and Grants of
Plan-Based Awards Table Employment Agreements. |
|
(2) |
|
Represents the amount Mr. Bracken would be entitled to
receive for the 2008 fiscal year pursuant to the
2008-2009
PEP and his employment agreement, which amount is also included
in the Non-Equity Incentive Plan Compensation column
of the Summary Compensation Table. See Narrative to
Summary Compensation Table and Grants of Plan-Based Awards
Table
2008-2009
PEP and Employment Agreements. |
|
(3) |
|
Represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Mr. Brackens unvested New Options and the fair value
price of our common stock on December 31, 2008 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($55.86 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of at least
2.5 times the Base Price of $51.00 at the end of the 2008 fiscal
year. |
|
(4) |
|
Reflects the actual lump sum value of the SERP based on the 2008
interest rate of 4.89%. |
|
(5) |
|
Reflects the estimated lump sum present value of qualified and
nonqualified retirement plans to which Mr. Bracken would be
entitled. The value includes $607,368 from the HCA Retirement
Plan, $257,667 from the HCA 401(k) Plan (which represents the
value of the Companys matching contributions), and
$1,151,250 from the HCA Restoration Plan. |
|
(6) |
|
Reflects the estimated lump sum present value of all future
payments which Mr. Bracken would be entitled to receive
under our disability program, including five months of salary
continuation, monthly long term disability benefits of $10,000
per month payable after the five-month elimination period until
age 65, and monthly benefits of $10,000 per month from our
Supplemental Insurance Program payable after the six-month
elimination period to age 65. |
|
(7) |
|
No post-retirement or post-termination life insurance or death
benefits are provided to Mr. Bracken.
Mr. Brackens payment upon death while actively
employed includes $1,061,000 of Company-paid life insurance and
$75,000 from the Executive Death Benefit Plan. |
90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
Voluntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
Voluntary
|
|
Early
|
|
Normal
|
|
Without
|
|
Termination
|
|
for Good
|
|
|
|
|
|
Change in
|
|
|
Termination
|
|
Retirement
|
|
Retirement
|
|
Cause
|
|
for Cause
|
|
Reason
|
|
Disability
|
|
Death
|
|
Control
|
|
Cash Severance(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,071,410
|
|
|
|
|
|
|
$
|
5,071,410
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(2)
|
|
$
|
355,491
|
|
|
$
|
355,491
|
|
|
$
|
355,491
|
|
|
$
|
355,491
|
|
|
|
|
|
|
$
|
355,491
|
|
|
$
|
355,491
|
|
|
$
|
355,491
|
|
|
$
|
355,491
|
|
Unvested Stock Options(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
971,043
|
|
SERP(4)
|
|
$
|
6,030,535
|
|
|
|
|
|
|
|
|
|
|
$
|
6,030,535
|
|
|
$
|
6,030,535
|
|
|
$
|
6,030,535
|
|
|
$
|
6,030,535
|
|
|
$
|
5,725,084
|
|
|
|
|
|
Retirement Plans(5)
|
|
$
|
1,182,513
|
|
|
$
|
1,182,513
|
|
|
$
|
1,182,513
|
|
|
$
|
1,182,513
|
|
|
$
|
1,182,513
|
|
|
$
|
1,182,513
|
|
|
$
|
1,182,513
|
|
|
$
|
1,182,513
|
|
|
|
|
|
Health and Welfare Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability Income(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,980,591
|
|
|
|
|
|
|
|
|
|
Life Insurance Benefits(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
790,000
|
|
|
|
|
|
Accrued Vacation Pay
|
|
$
|
109,387
|
|
|
$
|
109,387
|
|
|
$
|
109,387
|
|
|
$
|
109,387
|
|
|
$
|
109,387
|
|
|
$
|
109,387
|
|
|
$
|
109,387
|
|
|
$
|
109,387
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
7,677,926
|
|
|
$
|
1,647,391
|
|
|
$
|
1,647,391
|
|
|
$
|
12,749,336
|
|
|
$
|
7,322,435
|
|
|
$
|
12,749,336
|
|
|
$
|
9,658,517
|
|
|
$
|
8,162,475
|
|
|
$
|
1,326,534
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents amounts Mr. Johnson would be entitled to receive
pursuant to his employment agreement. See Narrative to
Summary Compensation Table and Grants of Plan-Based Awards
Table Employment Agreements. |
|
(2) |
|
Represents the amount Mr. Johnson would be entitled to
receive for the 2008 fiscal year pursuant to the
2008-2009
PEP and his employment agreement, which amount is also included
in the Non-Equity Incentive Plan Compensation column
of the Summary Compensation Table. See Narrative to
Summary Compensation Table and Grants of Plan-Based Awards
Table
2008-2009
PEP and Employment Agreements. |
|
(3) |
|
Represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Mr. Johnsons unvested New Options and the fair value
price of our common stock on December 31, 2008 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($55.86 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of at least
2.5 times the Base Price of $51.00 at the end of the 2008 fiscal
year. |
|
(4) |
|
Reflects the actual lump sum value of the SERP based on the 2008
interest rate of 4.89%. |
|
(5) |
|
Reflects the estimated lump sum present value of qualified and
nonqualified retirement plans to which Mr. Johnson would be
entitled. The value includes $209,470 from the HCA Retirement
Plan, $500,953 from the HCA 401(k) Plan (which represents the
value of the Companys matching contributions), and
$472,090 from the HCA Restoration Plan. |
|
(6) |
|
Reflects the estimated lump sum present value of all future
payments which Mr. Johnson would be entitled to receive
under our disability program, including five months of salary
continuation, monthly long term disability benefits of $10,000
per month payable after the five-month elimination period until
age 65, and monthly benefits of $10,000 per month from our
Supplemental Insurance Program payable after the six-month
elimination period to age 65. |
|
(7) |
|
No post-retirement or post-termination life insurance or death
benefits are provided to Mr. Johnson.
Mr. Johnsons payment upon death while actively
employed includes $790,000 of Company-paid life insurance. |
91
Samuel N.
Hazen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
Voluntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
Voluntary
|
|
Early
|
|
Normal
|
|
Without
|
|
Termination
|
|
for Good
|
|
|
|
|
|
Change in
|
|
|
Termination
|
|
Retirement
|
|
Retirement
|
|
Cause
|
|
for Cause
|
|
Reason
|
|
Disability
|
|
Death
|
|
Control
|
|
Cash Severance(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,238,902
|
|
|
|
|
|
|
$
|
3,238,902
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(2)
|
|
$
|
350,807
|
|
|
$
|
350,807
|
|
|
$
|
350,807
|
|
|
$
|
350,807
|
|
|
|
|
|
|
$
|
350,807
|
|
|
$
|
350,807
|
|
|
$
|
350,807
|
|
|
$
|
350,807
|
|
Unvested Stock Options(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
621,463
|
|
SERP(4)
|
|
$
|
5,166,117
|
|
|
|
|
|
|
|
|
|
|
$
|
5,166,117
|
|
|
$
|
5,166,117
|
|
|
$
|
5,166,117
|
|
|
$
|
5,166,117
|
|
|
$
|
5,102,711
|
|
|
|
|
|
Retirement Plans(5)
|
|
$
|
1,044,566
|
|
|
$
|
1,044,566
|
|
|
$
|
1,044,566
|
|
|
$
|
1,044,566
|
|
|
$
|
1,044,566
|
|
|
$
|
1,044,566
|
|
|
$
|
1,044,566
|
|
|
$
|
1,044,566
|
|
|
|
|
|
Health and Welfare Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability Income(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,227,535
|
|
|
|
|
|
|
|
|
|
Life Insurance Benefits(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
789,000
|
|
|
|
|
|
Accrued Vacation Pay
|
|
$
|
109,201
|
|
|
$
|
109,201
|
|
|
$
|
109,201
|
|
|
$
|
109,201
|
|
|
$
|
109,201
|
|
|
$
|
109,201
|
|
|
$
|
109,201
|
|
|
$
|
109,201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
6,670,691
|
|
|
$
|
1,504,574
|
|
|
$
|
1,504,574
|
|
|
$
|
9,909,593
|
|
|
$
|
6,319,884
|
|
|
$
|
9,909,593
|
|
|
$
|
8,898,226
|
|
|
$
|
7,396,285
|
|
|
$
|
972,270
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents amounts Mr. Hazen would be entitled to receive
pursuant to his employment agreement. See Narrative to
Summary Compensation Table and Grants of Plan-Based Awards
Table Employment Agreements. |
|
(2) |
|
Represents the amount Mr. Hazen would be entitled to
receive for the 2008 fiscal year pursuant to the
2008-2009
PEP and his employment agreement, which amount is also included
in the Non-Equity Incentive Plan Compensation column
of the Summary Compensation Table. See Narrative to
Summary Compensation Table and Grants of Plan-Based Awards
Table
2008-2009
PEP and Employment Agreements. |
|
(3) |
|
Represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Mr. Hazens unvested New Options and the fair value
price of our common stock on December 31, 2008 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($55.86 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of at least
2.5 times the Base Price of $51.00 at the end of the 2008 fiscal
year. |
|
(4) |
|
Reflects the actual lump sum value of the SERP based on the 2008
interest rate of 4.89%. |
|
(5) |
|
Reflects the estimated lump sum present value of qualified and
nonqualified retirement plans to which Mr. Hazen would be
entitled. The value includes $230,172 from the HCA Retirement
Plan, $184,193 from the HCA 401(k) Plan (which represents the
value of the Companys matching contributions), and
$630,201 from the HCA Restoration Plan. |
|
(6) |
|
Reflects the estimated lump sum present value of all future
payments which Mr. Hazen would be entitled to receive under
our disability program, including five months of salary
continuation, monthly long term disability benefits of $10,000
per month payable after the five-month elimination period until
age 65, and monthly benefits of $10,000 per month from our
Supplemental Insurance Program payable after the six-month
elimination period to age 65. |
|
(7) |
|
No post-retirement or post-termination life insurance or death
benefits are provided to Mr. Hazen. Mr. Hazens
payment upon death while actively employed with the Company
includes $789,000 of the Company-paid life insurance. |
92
Beverly
B. Wallace
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
Voluntary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
Voluntary
|
|
Early
|
|
Normal
|
|
Without
|
|
Termination
|
|
for Good
|
|
|
|
|
|
Change in
|
|
|
Termination
|
|
Retirement
|
|
Retirement
|
|
Cause
|
|
for Cause
|
|
Reason
|
|
Disability
|
|
Death
|
|
Control
|
|
Cash Severance(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,080,000
|
|
|
|
|
|
|
$
|
3,080,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Bonus(2)
|
|
$
|
314,992
|
|
|
$
|
314,992
|
|
|
$
|
314,992
|
|
|
$
|
314,992
|
|
|
|
|
|
|
$
|
314,992
|
|
|
$
|
314,992
|
|
|
$
|
314,992
|
|
|
$
|
314,992
|
|
Unvested Stock Options(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
543,781
|
|
SERP(4)
|
|
$
|
7,579,094
|
|
|
$
|
7,579,094
|
|
|
|
|
|
|
$
|
7,579,094
|
|
|
$
|
7,579,094
|
|
|
$
|
7,579,094
|
|
|
$
|
7,579,094
|
|
|
$
|
6,890,049
|
|
|
|
|
|
Retirement Plans(5)
|
|
$
|
751,634
|
|
|
$
|
751,634
|
|
|
$
|
751,634
|
|
|
$
|
751,634
|
|
|
$
|
751,634
|
|
|
$
|
751,634
|
|
|
$
|
751,634
|
|
|
$
|
751,634
|
|
|
|
|
|
Health and Welfare Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disability Income(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,378,922
|
|
|
|
|
|
|
|
|
|
Life Insurance Benefits(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
700,000
|
|
|
|
|
|
Accrued Vacation Pay
|
|
$
|
96,923
|
|
|
$
|
96,923
|
|
|
$
|
96,923
|
|
|
$
|
96,923
|
|
|
$
|
96,923
|
|
|
$
|
96,923
|
|
|
$
|
96,923
|
|
|
$
|
96,923
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
8,742,643
|
|
|
$
|
8,742,643
|
|
|
$
|
1,163,549
|
|
|
$
|
11,822,643
|
|
|
$
|
8,427,651
|
|
|
$
|
11,822,643
|
|
|
$
|
10,121,565
|
|
|
$
|
8,753,598
|
|
|
$
|
858,773
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents amounts Ms. Wallace would be entitled to receive
pursuant to her employment agreement. See Narrative to
Summary Compensation Table and Grants of Plan-Based Awards
Table Employment Agreements. |
|
(2) |
|
Represents the amount Ms. Wallace would be entitled to
receive for the 2008 fiscal year pursuant to the
2008-2009
PEP and her employment agreement, which amount is also included
in the Non-Equity Incentive Plan Compensation column
of the Summary Compensation Table. See Narrative to
Summary Compensation Table and Grants of Plan-Based Awards
Table
2008-2009
PEP and Employment Agreements. |
|
(3) |
|
Represents the intrinsic value of all unvested stock options,
which will become vested upon the Change in Control, calculated
as the difference between the exercise price of
Ms. Wallaces unvested New Options and the fair value
price of our common stock on December 31, 2008 as
determined by our Board of Directors in consultation with our
Chief Executive Officer and other advisors for internal purposes
($55.86 per share). For the purposes of this calculation, it is
assumed that the Company achieved an Investor Return of at least
2.5 times the Base Price of $51.00 at the end of the 2008 fiscal
year. |
|
(4) |
|
Reflects the actual lump sum value of the SERP based on the 2008
interest rate of 4.89%. |
|
(5) |
|
Reflects the estimated lump sum present value of qualified and
nonqualified retirement plans to which Ms. Wallace would be
entitled. The value includes $212,350 from the HCA Retirement
Plan, $150,350 from the HCA 401(k) Plan (which represents the
value of the Companys matching contributions), and
$388,934 from the HCA Restoration Plan. |
|
(6) |
|
Reflects the estimated lump sum present value of all future
payments which Ms. Wallace would be entitled to receive
under our disability program, including five months of salary
continuation, monthly long term disability benefits of $10,000
per month payable after the five-month elimination period until
age 65, and monthly benefits of $10,000 per month from our
Supplemental Insurance Program payable after the six-month
elimination period to age 65. |
|
(7) |
|
No post-retirement or post-termination life insurance or death
benefits are provided to Ms. Wallace.
Ms. Wallaces payment upon death while actively
employed includes $700,000 of Company-paid life insurance. |
Director
Compensation
During the year ended December 31, 2008, none of our
directors received compensation for their service as a member of
our Board. Our directors are reimbursed for any expenses
incurred in connection with their service.
Compensation
Committee Interlocks and Insider Participation
During 2008, the Compensation Committee of the Board of
Directors was composed of Michael W. Michelson, George A. Bitar,
John P. Connaughton and Thomas F. Frist, Jr., M.D.
Dr. Frist served as an executive officer and Chairman of
our Board of Directors from January 2001 to January 2002. From
July 1997 to January 2001, Dr. Frist served as our Chairman
and Chief Executive Officer. Dr. Frist served as Vice
Chairman of the Board of Directors from April 1995 to July 1997
and as Chairman from February 1994 to April 1995. He was
Chairman,
93
Chief Executive Officer and President of HCA-Hospital
Corporation of America from 1988 to February 1994.
Dr. Frist, who retired from our Board of Directors
effective January 1, 2009, is the father of Thomas F.
Frist, III and William R. Frist, who currently serve as
directors. (Thomas F. Frist, III has been a director since
November 2006, and William R. Frist has been a director since
January 2009.) None of the other members of the Compensation
Committee have at any time been an officer or employee of HCA or
any of its subsidiaries. Each member of the Compensation
Committee is also a manager of Hercules Holding, and the Amended
and Restated Limited Liability Company Agreement of Hercules
Holding requires that the members of Hercules Holding take all
necessary action to ensure that the persons who serves as
managers of Hercules Holding also serve on our Board of
Directors. Messrs. Michelson, Bitar and Connaughton are
affiliated with KKR, MLGPE (an affiliate of Bank of America
Corporation), and Bain, respectively, each of which is a party
to the sponsor management agreement with us. Dr. Frist and
certain other members of the Frist family, are also party to the
sponsor management agreement with us. The Amended and Restated
Limited Liability Company Agreement of Hercules Holding, the
sponsor management agreement and certain transactions with
affiliates of MLGPE and KKR are described in greater detail in
Item 13, Certain Relationships and Related
Transactions.
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
The following table sets forth information regarding the
beneficial ownership of our common stock as of February 25,
2009 for:
|
|
|
|
|
each person who is known by us to own beneficially more than 5%
of the outstanding shares of our common stock;
|
|
|
|
each of our directors;
|
|
|
|
each of our executive officers named in the Summary Compensation
Table; and
|
|
|
|
all of our directors and executive officers as a group.
|
94
The percentages of shares outstanding provided in the tables are
based on 94,371,407 shares of our common stock, par value
$0.01 per share, outstanding as of February 25, 2009.
Beneficial ownership is determined in accordance with the rules
of the SEC and generally includes voting or investment power
with respect to securities. Shares issuable upon the exercise of
options that are exercisable within 60 days of
February 25, 2009 are considered outstanding for the
purpose of calculating the percentage of outstanding shares of
our common stock held by the individual, but not for the purpose
of calculating the percentage of outstanding shares held by any
other individual. The address of each of our directors and
executive officers listed below is
c/o HCA
Inc., One Park Plaza, Nashville, Tennessee 37203.
|
|
|
|
|
|
|
|
|
Name of Beneficial Owner
|
|
Number of Shares
|
|
Percent
|
|
Hercules Holding II, LLC
|
|
|
91,845,692
|
(1)
|
|
|
97.3
|
%
|
Christopher J. Birosak
|
|
|
|
(1)
|
|
|
|
|
George A. Bitar
|
|
|
|
(1)
|
|
|
|
|
Jack O. Bovender, Jr.
|
|
|
588,836
|
(2)
|
|
|
|
*
|
Richard M. Bracken
|
|
|
327,516
|
(3)
|
|
|
|
*
|
John P. Connaughton
|
|
|
|
(1)
|
|
|
|
|
Kenneth W. Freeman
|
|
|
|
(1)
|
|
|
|
|
Thomas F. Frist III
|
|
|
|
(1)
|
|
|
|
|
William R. Frist
|
|
|
|
(1)
|
|
|
|
|
Christopher R. Gordon
|
|
|
|
(1)
|
|
|
|
|
Samuel N. Hazen
|
|
|
165,593
|
(4)
|
|
|
|
*
|
R. Milton Johnson
|
|
|
179,062
|
(5)
|
|
|
|
*
|
Michael W. Michelson
|
|
|
|
(1)
|
|
|
|
|
James C. Momtazee
|
|
|
|
(1)
|
|
|
|
|
Stephen G. Pagliuca
|
|
|
|
(1)
|
|
|
|
|
Nathan C. Thorne
|
|
|
|
(1)
|
|
|
|
|
Beverly B. Wallace
|
|
|
88,778
|
(6)
|
|
|
|
*
|
All directors and executive officers as a group (29 persons)
|
|
|
2,257,973
|
(7)
|
|
|
2.4
|
%
|
|
|
|
* |
|
Less than one percent. |
|
(1) |
|
Hercules Holding holds 91,845,692 shares, or 97.3%, of our
outstanding common stock. Hercules Holding is held by a private
investor group, including affiliates of Bain Capital Partners
(Bain), Kohlberg Kravis Roberts & Co. L.P.
(KKR) and Merrill Lynch Global Private Equity
(MLGPE, previously the private equity arm of Merrill
Lynch & Co., Inc. which is a wholly-owned subsidiary of
Bank of America Corporation), and affiliates of HCA founder
Dr. Thomas F. Frist, Jr., including Mr. Thomas F.
Frist III and Mr. William R. Frist, who serve as
directors. Messrs. Connaughton, Gordon and Pagliuca are
affiliated with Bain, whose affiliated funds may be deemed to
have indirect beneficial ownership of 23,373,333 shares, or
24.8%, of our outstanding common stock through their interests
in Hercules Holding. Messrs. Freeman, Michelson and
Momtazee are affiliated with KKR, which indirectly holds
23,373,332 shares, or 24.8%, of our outstanding common
stock through the interests of certain of its affiliated funds
in Hercules Holding. Messrs. Birosak, Bitar and Thorne are
affiliated with Bank of America Corporation, which indirectly
holds 23,373,333 shares, or 24.8%, of our outstanding
common stock through the interests of certain of its affiliated
funds in Hercules Holding and 980,393, or 1.0%, of our
outstanding common stock through Banc of America Securities LLC.
Thomas F. Frist, III and William R. Frist may each be
deemed to indirectly beneficially hold 17,804,125 shares,
or 18.9%, of our outstanding common stock through their
interests in Hercules Holding. Each of such persons, other than
Hercules Holdings disclaims membership in any such group and
disclaims beneficial ownership of these securities, except to
the extent of its pecuniary interest therein. The principal
office addresses of Hercules Holding are
c/o Bain
Capital Partners, LLC, 111 Huntington Avenue, Boston, MA 02199,
c/o Kohlberg
Kravis Roberts & Co. L.P., 2800 Sand Hill Road,
Suite 200, Menlo Park, CA 94025,
c/o Merrill
Lynch Global Private |
95
|
|
|
|
|
Equity, Four World Financial Center, Floor 23, New York, NY
10080 and
c/o Dr. Thomas
F. Frist, Jr., 3100 West End Ave., Suite 500,
Nashville, TN 37203. |
|
(2) |
|
Includes 467,054 shares issuable upon exercise of options. |
|
(3) |
|
Includes 246,033 shares issuable upon exercise of options. |
|
(4) |
|
Includes 131,621 shares issuable upon exercise of options. |
|
(5) |
|
Includes 136,289 shares issuable upon exercise of options. |
|
(6) |
|
Includes 86,378 shares issuable upon exercise of options. |
|
(7) |
|
Includes 1,708,580 shares issuable upon exercise of options. |
This table provides certain information as of December 31,
2008 with respect to our equity compensation plans (shares in
thousands):
EQUITY
COMPENSATION PLAN INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
|
Number of securities
|
|
|
Weighted-average
|
|
|
Number of securities remaining
|
|
|
|
to be issued
|
|
|
exercise price of
|
|
|
available for future issuance
|
|
|
|
upon exercise of
|
|
|
outstanding
|
|
|
under equity compensation
|
|
|
|
outstanding options,
|
|
|
options,
|
|
|
plans (excluding securities
|
|
|
|
warrants and rights
|
|
|
warrants and rights
|
|
|
reflected in column(a) )
|
|
|
Equity compensation plans approved by security holders
|
|
|
10,636,700
|
|
|
$
|
45.02
|
|
|
|
1,788,300
|
|
Equity compensation plans not approved by security holders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
10,636,700
|
|
|
$
|
45.02
|
|
|
|
1,788,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
For additional information concerning our equity compensation
plans, see the discussion in Note 3 Share-Based
Compensation in the notes to the consolidated financial
statements. |
|
|
Item 13.
|
Certain
Relationships and Related Transactions
|
In accordance with its charter, our Audit and Compliance
Committee reviews and approves all material related party
transactions. Prior to its approval of any material related
party transaction, the Audit and Compliance Committee will
discuss the proposed transaction with management and our
independent auditor. In addition, our Code of Conduct requires
that all of our employees, including our executive officers,
remain free of conflicts of interest in the performance of their
responsibilities to the Company. An executive officer who wishes
to enter into a transaction in which their interests might
conflict with ours must first receive the approval of the Audit
and Compliance Committee. The Amended and Restated Limited
Liability Company Agreement of Hercules Holding II, LLC
generally requires that an Investor must obtain the prior
written consent of each other Investor before it or any of its
affiliates (including our directors) enter into any transaction
with us.
Stockholder
Agreements
On January 30, 2007, our Board of Directors awarded to
members of management and certain key employees New Options to
purchase shares of our common stock (New Options together with
the Rollover Options, Options) pursuant to the 2006
Plan. Our Compensation Committee approved additional option
awards periodically throughout the years ended December 31,
2008 and 2007 to members of management and certain key employees
in cases of promotions, significant contributions to the Company
and new hires. In connection with their option awards, the
participants under the 2006 Plan were required to enter into a
Management Stockholders Agreement, a Sale Participation
Agreement, and an Option Agreement with respect to the New
Options. Below are brief summaries of the principal terms of the
Management Stockholders Agreement and the Sale
Participation Agreement each of which are qualified in their
entirety by reference to the agreements themselves, forms of
which were filed as Exhibits 10.12 and 10.13, respectively,
to our annual report on
Form 10-K
for the fiscal year ended December 31, 2006. The terms of
the Option Agreement with respect to New Options and the 2006
Plan are
96
described in more detail in Item 11, Executive
Compensation Compensation Discussion and
Analysis Long Term Equity Incentive Awards.
Management Stockholders Agreement. The
Management Stockholders Agreement imposes significant
restrictions on transfers of shares of our common stock.
Generally, shares will be nontransferable by any means at any
time prior to the earlier of a Change in Control (as
defined in the Management Stockholders Agreement) or the
fifth anniversary of the closing date of the Merger, except
(i) sales pursuant to an effective registration statement
under the Securities Act of 1933, as amended (the
Securities Act) filed by the Company in accordance
with the Management Stockholders Agreement, (ii) a
sale pursuant to the Sale Participation Agreement (described
below), (iii) a sale to certain Permitted
Transferees (as defined in the Management
Stockholders Agreement), or (iv) as otherwise
permitted by our Board of Directors or pursuant to a waiver of
the restrictions on transfers given by unanimous agreement of
the Sponsors. On and after such fifth anniversary through the
earlier of a Change in Control or the eighth anniversary of the
closing date of the Merger, a management stockholder will be
able to transfer shares of our common stock, but only to the
extent that, on a cumulative basis, the management stockholders
in the aggregate do not transfer a greater percentage of their
equity than the percentage of equity sold or otherwise disposed
of by the Sponsors.
In the event that a management stockholder wishes to sell their
stock at any time following the fifth anniversary of the closing
date of the Merger but prior to an initial public offering of
our common stock, the Management Stockholders Agreement
provides the Company with a right of first offer on those shares
upon the same terms and conditions pursuant to which the
management stockholder would sell them to a third party. In the
event that a registration statement is filed with respect to our
common stock in the future, the Management Stockholders
Agreement prohibits management stockholders from selling shares
not included in the registration statement from the time of
receipt of notice until 180 days (in the case of an initial
public offering) or 90 days (in the case of any other
public offering) of the date of the registration statement. The
Management Stockholders Agreement also provides for the
management stockholders ability to cause us to repurchase
their outstanding stock and options in the event of the
management stockholders death or disability, and for our
ability to cause the management stockholder to sell their stock
or options back to the Company upon certain termination events.
The Management Stockholders Agreement provides that, in
the event we propose to sell shares to the Sponsors, certain
members of senior management, including the executive officers
(the Senior Management Stockholders) have a
preemptive right to purchase shares in the offering. The maximum
shares a Senior Management Stockholder may purchase is a
proportionate number of the shares offered to the percentage of
shares owned by the Senior Management Stockholder prior to the
offering. Additionally, following the initial public offering of
our common stock, the Senior Management Stockholders will have
limited piggyback registration rights with respect
to their shares of common stock. The maximum number of shares of
Common Stock which a Senior Management Stockholder may register
is generally proportionate with the percentage of common stock
being sold by the Sponsors (relative to their holdings thereof).
Sale Participation Agreement. The Sale
Participation Agreement grants the Senior Management
Stockholders the right to participate in any private direct or
indirect sale of shares of common stock by the Sponsors (such
right being referred to herein as the Tag-Along
Right), and requires all management stockholders to
participate in any such private sale if so elected by the
Sponsors in the event that the Sponsors are proposing to sell at
least 50% of the outstanding common stock held by the Sponsors,
whether directly or through their interests in Hercules Holding
(such right being referred to herein as the Drag-Along
Right). The number of shares of common stock which would
be required to be sold by a management stockholder pursuant to
the exercise of the Drag-Along Right will be the sum of the
number of shares of common stock then owned by the management
stockholder and his affiliates plus all shares of common stock
the management stockholder is entitled to acquire under any
unexercised Options (to the extent such Options are exercisable
or would become exercisable as a result of the consummation of
the proposed sale), multiplied by a fraction (x) the
numerator of which shall be the aggregate number of shares of
common stock proposed to be transferred by the Sponsors in the
proposed sale and (y) the denominator of which shall be the
total number of shares of common stock owned by the sponsors
entitled to participate in the proposed sale. Management
stockholders will bear their pro rata share of any fees,
commissions, adjustments to purchase price, expenses or
indemnities in connection with any sale under the Sale
Participation Agreement.
97
Amended
and Restated Limited Liability Company Agreement of Hercules
Holding II, LLC
The Investors and certain other investment funds who agreed to
co-invest with them through a vehicle jointly controlled by the
Investors to provide equity financing for the Recapitalization
entered into a limited liability company operating agreement in
respect of Hercules Holding (the LLC Agreement). The
LLC Agreement contains agreements among the parties with respect
to the election of our directors, restrictions on the issuance
or transfer of interests in us, including a right of first
offer, tag-along rights and drag-along rights, and other
corporate governance provisions (including the right to approve
various corporate actions).
Pursuant to the LLC Agreement, Hercules Holding and its members
are required to take necessary action to ensure that each
manager on the board of Hercules Holding also serves on our
Board of Directors. Each of the Sponsors has the right to
appoint three managers to Hercules Holdings board, the
Frist family has the right to appoint two managers to the board,
and the remaining two managers on the board are to come from our
management team (currently Messrs. Bovender and Bracken).
The rights of the Sponsors and the Frist family to designate
managers are subject to their ownership percentages in Hercules
Holding remaining above a specified percentage of the
outstanding ownership interests in Hercules Holding.
The LLC Agreement also requires that, in addition to a majority
of the total number of managers being present to constitute a
quorum for the transaction of business at any board or committee
meeting, at least one manager designated by each of the
Investors must be present, unless waived by that Investor. The
LLC Agreement further provides that, for so long as at least two
Sponsors are entitled to designate managers to Hercules
Holdings board, at least one manager from each of two
Sponsors must consent to any board or committee action in order
for it to be valid. The LLC Agreement requires that our
organizational and governing documents contain provisions
similar to those described in this paragraph.
Registration
Rights Agreement
Hercules Holding and the Investors entered into a registration
rights agreement with us upon completion of the
Recapitalization. Pursuant to this agreement, the Investors can
cause us to register shares of our common stock held by Hercules
Holding under the Securities Act and, if requested, to maintain
a shelf registration statement effective with respect to such
shares. The Investors are also entitled to participate on a pro
rata basis in any registration of our common stock under the
Securities Act that we may undertake.
Sponsor
Management Agreement
In connection with the Merger, we entered into a management
agreement with affiliates of each of the Sponsors and certain
members of the Frist family, including Thomas F.
Frist, Jr., M.D., Thomas F. Frist, III and
William R. Frist, pursuant to which such entities or their
affiliates will provide management services to us. Pursuant to
the agreement, in 2008, we paid management fees of
$15 million and reimbursed out-of-pocket expenses incurred
in connection with the provision of services pursuant to the
agreement. The agreement provides that the aggregate annual
management fee, initially set at $15 million, increases
annually beginning in 2008 at a rate equal to the percentage
increase of Adjusted EBITDA (as defined in the Management
Agreement) in the applicable year compared to the preceding
year. The agreement also provides that we will pay a 1% fee in
connection with certain subsequent financing, acquisition,
disposition and change of control transactions, as well as a
termination fee based on the net present value of future payment
obligations under the management agreement, in the event of an
initial public offering or under certain other circumstances. No
fees were paid under either of these provisions in 2008. The
agreement includes customary exculpation and indemnification
provisions in favor of the Sponsors and their affiliates and the
Frists.
Other
Relationships
In 2008, we paid approximately $25.5 million to HCP, Inc.
(NYSE: HCP), representing the aggregate annual lease payments
for certain medical office buildings leased by the Company.
Charles A. Elcan was an executive officer of HCP, Inc. until
April 30, 2008 and is the
son-in-law
of Dr. Thomas F. Frist, Jr. (who was a member of our
Board of Directors in 2008) and
brother-in-law
of Thomas F. Frist, III, and William R. Frist, who are
members of our Board of Directors.
98
Christopher S. George serves as the chief executive officer of
an HCA-affiliated hospital, and in 2008, Mr. George earned
total compensation in respect of base salary and bonus of
approximately $440,000 for his services. Mr. George also
received certain other benefits, including awards of equity,
customary to similar positions within the Company.
Mr. Georges father, V. Carl George, is an executive
officer of HCA.
Dustin A. Greene serves as the chief operating officer of an
HCA-affiliated hospital, and in 2008, Mr. Greene earned
total compensation in respect of base salary and bonus of
approximately $143,000 for his services. Mr. Greene also
received certain other benefits, including awards of equity,
customary to similar positions within the Company.
Mr. Greenes
father-in-law,
W. Paul Rutledge, is an executive officer of HCA.
Bank of America, N.A. (Bank of America) acts as
administrative agent and is a lender under each of our senior
secured cash flow credit facility and our asset-based revolving
credit facility. Affiliates of Bank of America indirectly own
approximately 25.8% of the shares of our company. We have
engaged Banc of America Securities LLC, an affiliate of Bank of
America, as arranger and documentation agent in connection with
certain amendments to our senior secured cash flow credit
facility and our senior secured asset-based revolving credit
facility. Under that engagement, upon such amendments becoming
effective, we paid Banc of America Securities LLC aggregate fees
of $6 million relating to the amendments to our senior
secured credit facilities.
In addition, Banc of America Securities LLC acted as joint
book-running manager and a representative of the initial
purchasers of the
97/8% Senior
Secured Notes due 2017 (the 2009 Second Lien Notes)
that we issued on February 19, 2009. The proceeds of the
issuance of the notes were used to repay indebtedness under the
senior secured credit facilities, and Bank of America received
its pro rata portion of such repayment. In addition, Banc of
America Securities LLC received placement fees of $1,401,034 in
connection with the issuance of the 2009 Second Lien Notes.
KKR Capital Markets LLC, one of the other initial purchasers of
the 2009 Second Lien Notes, is an affiliate of KKR, whose
affiliates own approximately 24.8% of the shares of our company,
and received placement fees of $191,050 in connection with the
issuance of the 2009 Second Lien Notes.
Director
Independence
Our Board of Directors is composed of Jack O.
Bovender, Jr., Chairman, Christopher J. Birosak, George A.
Bitar, Richard M. Bracken, John P. Connaughton, Kenneth W.
Freeman, William R. Frist, Thomas F. Frist III, Christopher R.
Gordon, Michael W. Michelson, James C. Momtazee, Stephen G.
Pagliuca, and Nathan C. Thorne. Our Board of Directors currently
has four standing committees: the Audit and Compliance
Committee, the Compensation Committee, the Executive Committee
and the Patient Safety and Quality of Care Committee. Each of
the Investors has the right to have at least one director serve
on all standing committees.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient
|
|
|
|
|
|
|
|
|
Safety and
|
|
|
Audit and
|
|
|
|
|
|
Quality of
|
Name of Director
|
|
Compliance
|
|
Compensation
|
|
Executive
|
|
Care
|
|
Christopher J. Birosak
|
|
X
|
|
|
|
|
|
|
George A. Bitar
|
|
|
|
X
|
|
|
|
|
Jack O. Bovender, Jr.*
|
|
|
|
|
|
Chair
|
|
|
Richard M. Bracken*
|
|
|
|
|
|
|
|
|
John P. Connaughton
|
|
|
|
Chair
|
|
|
|
|
Kenneth W. Freeman
|
|
|
|
|
|
|
|
X
|
Thomas F. Frist III
|
|
X
|
|
|
|
X
|
|
|
William R. Frist
|
|
|
|
|
|
|
|
X
|
Christopher R. Gordon
|
|
X
|
|
|
|
|
|
|
Michael W. Michelson
|
|
|
|
X
|
|
X
|
|
|
James C. Momtazee
|
|
Chair
|
|
|
|
|
|
|
Stephen G. Pagliuca
|
|
|
|
|
|
X
|
|
X
|
Nathan C. Thorne
|
|
|
|
|
|
X
|
|
Chair
|
|
|
|
* |
|
Indicates management director. |
99
Though not formally considered by our Board because our common
stock is not currently listed or traded on any national
securities exchange, based upon the listing standards of the
NYSE, the national securities exchange upon which our common
stock was traded prior to the Merger, we do not believe that any
of our directors would be considered independent
because of their relationships with certain affiliates of the
funds and other entities which hold significant interests in
Hercules Holding, which, as of December 31, 2008, owned
97.3% of our outstanding common stock, and other relationships
with us. See Item 13, Certain Relationships and
Related Transactions. Accordingly, we do not believe that
any of Messrs. Birosak, Frist, Gordon or Momtazee, the
members of our Audit and Compliance committee, would meet the
independence requirements or
Rule 10A-1
of the Exchange Act or the NYSEs audit committee
independence requirements, or that Messrs. Bitar,
Connaughton or Michelson, the members of our Compensation
Committee, would meet the NYSEs independence requirements.
We do not have a nominating/corporate governance committee, or a
committee that serves a similar purpose.
|
|
Item 14.
|
Principal
Accountant Fees and Services
|
The Audit and Compliance Committee has appointed
Ernst & Young LLP as our independent registered public
accounting firm. The independent registered public accounting
firm will audit our consolidated financial statements for 2009
and the effectiveness of our internal controls over financial
reporting as of December 31, 2009.
Audit Fees. The aggregate audit fees billed by
Ernst & Young LLP for professional services rendered
for the audit of our annual consolidated financial statements,
for the reviews of the condensed consolidated financial
statements included in our quarterly reports on
Form 10-Q,
for the audit of the effectiveness of the Companys
internal control over financial reporting, under the
Sarbanes-Oxley Act of 2002, and services that are normally
provided by the independent registered public accounting firm in
connection with statutory and regulatory filings totaled
$8.5 million for 2008 and $8.9 million for 2007.
Audit-Related Fees. The aggregate fees billed
by Ernst & Young LLP for assurance and related
services not described above under Audit Fees were
$1.4 million for 2008 and $1.3 million for 2007.
Audit-related services principally include audits of certain of
our subsidiaries and benefit plans.
Tax Fees. The aggregate fees billed by
Ernst & Young LLP for professional services rendered
for tax compliance, tax advice and tax planning were
$1.9 million for 2008 and $2.2 million for 2007.
All Other Fees. The aggregate fees billed by
Ernst & Young LLP for products or services other than
those described above were $92,000 for 2008 and $749,000 for
2007.
The Board of Directors has adopted an Audit and Compliance
Committee Charter which, among other things, requires the Audit
and Compliance Committee to preapprove all audit and permitted
nonaudit services (including the fees and terms thereof) to be
performed for us by our independent registered public accounting
firm, subject to the ability to delegate authority to a
subcommittee for certain preapprovals.
All services performed for us by Ernst & Young LLP in
2008 were preapproved by the Audit and Compliance Committee. The
Audit and Compliance Committee concluded that the provision of
audit-related services, tax services and other services by
Ernst & Young LLP was compatible with the maintenance
of the firms independence in the conduct of its auditing
functions.
100
PART IV
|
|
Item 15.
|
Exhibits
and Financial Statement Schedules
|
(a) Documents filed as part of the report:
1. Financial Statements. The accompanying Index to
Consolidated Financial Statements on
page F-1
of this annual report on
Form 10-K
is provided in response to this item.
2. List of Financial Statement Schedules. All
schedules are omitted because the required information is either
not present, not present in material amounts or presented within
the consolidated financial statements.
3. List of Exhibits
|
|
|
|
|
|
|
|
2
|
.1
|
|
|
|
Agreement and Plan of Merger, dated July 24, 2006, by and
among HCA Inc., Hercules Holding II, LLC and Hercules
Acquisition Corporation (filed as Exhibit 2.1 to the
Companys Current Report on
Form 8-K
filed July 25, 2006, and incorporated herein by reference).
|
|
3
|
.1
|
|
|
|
Amended and Restated Certificate of Incorporation of the Company
(filed as Exhibit 3.1 to the Companys Annual Report
on
Form 10-K
for the fiscal year ended December 31, 2007, and
incorporated herein by reference).
|
|
3
|
.2
|
|
|
|
Amended and Restated Bylaws of the Company (filed as
Exhibit 3.2 to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
incorporated herein by reference).
|
|
4
|
.1
|
|
|
|
Specimen Certificate for shares of Common Stock, par value $0.01
per share, of the Company (filed as Exhibit 3 to the
Companys
Form 8-A/A,
Amendment No. 2, dated March 11, 2004, and
incorporated herein by reference).
|
|
4
|
.2
|
|
|
|
Indenture, dated November 17, 2006, among HCA Inc., the
guarantors party thereto and The Bank of New York, as trustee
(filed as Exhibit 4.1 to the Companys Current Report
on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
|
4
|
.3
|
|
|
|
Security Agreement, dated as of November 17, 2006, among
HCA Inc., the subsidiary grantors party thereto and The Bank of
New York, as collateral agent (filed as Exhibit 4.2 to the
Companys Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
|
4
|
.4
|
|
|
|
Pledge Agreement, dated as of November 17, 2006, among HCA
Inc., the subsidiary pledgors party thereto and The Bank of New
York, as collateral agent (filed as Exhibit 4.3 to the
Companys Current Report of
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
|
4
|
.5(a)
|
|
|
|
Form of
91/8% Senior
Secured Notes due 2014 (included in Exhibit 4.2).
|
|
4
|
.5(b)
|
|
|
|
Form of
91/4% Senior
Secured Notes due 2016 (included in Exhibit 4.2).
|
|
4
|
.5(c)
|
|
|
|
Form of
95/8%/103/8% Senior
Secured Toggle Notes due 1016 (included in Exhibit 4.2).
|
|
4
|
.6
|
|
|
|
Indenture, dated February 19, 2009, among HCA Inc, the
guarantors party thereto, The Bank of New York Mellon, as
collateral agent and The Bank of New York Mellon
Trust Company, N.A., as trustee. (filed as Exhibit 4.1
to the Companys Current Report on
Form 8-K
filed February 25, 2009, and incorporated herein by
reference).
|
|
4
|
.7
|
|
|
|
Form of
97/8% Senior
Secured Notes due 2017 (included in Exhibit 4.6).
|
|
4
|
.8(a)
|
|
|
|
$13,550,000,000 1,000,000,000 Credit
Agreement, dated as of November 17, 2006, among HCA Inc.,
HCA UK Capital Limited, the lending institutions from time to
time parties thereto, Banc of America Securities LLC,
J.P. Morgan Securities Inc., Citigroup Global Markets Inc.
and Merrill Lynch, Pierce, Fenner & Smith
Incorporated, as joint lead arrangers and joint bookrunners,
Bank of America, N.A., as administrative agent, JPMorgan Chase
Bank, N.A. and Citicorp North America, Inc., as
co-syndication
agents and Merrill Lynch Capital Corporation, as documentation
agent (filed as Exhibit 4.8 to the Companys Current
Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
101
|
|
|
|
|
|
|
|
4
|
.8(b)
|
|
|
|
Amendment No. 1 to the Credit Agreement, dated as of
February 16, 2007, among HCA Inc., HCA UK Capital Limited,
the lending institutions from time to time parties thereto, Bank
of America, N.A., as administrative agent, JPMorgan Chase Bank,
N.A., and Citicorp North America, Inc., as Co-Syndication
Agents, Banc of America Securities, LLC, J.P. Morgan
Securities Inc., Citigroup Global Markets Inc. and Merrill
Lynch, Pierce, Fenner & Smith Incorporated, as joint
lead arrangers and bookrunners, Deutsche Bank Securities and
Wachovia Capital Markets LLC, as joint bookrunners and Merrill
Lynch Capital Corporation, as documentation agent (filed as
Exhibit 4.7(b) to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
4
|
.8(c)
|
|
|
|
Amendment No. 2 to the Credit Agreement, dated as of
March 2, 2009, among HCA Inc., HCA UK Capital Limited, the
lending institutions from time to time parties thereto, Bank of
America, N.A., as administrative agent, JPMorgan Chase Bank,
N.A., and Citicorp North America, Inc., as Co-Syndication
Agents, Banc of America Securities, LLC, J.P. Morgan
Securities Inc., Citigroup Global Markets Inc. and Merrill
Lynch, Pierce, Fenner & Smith Incorporated, as joint
lead arrangers and bookrunners, Deutsche Bank Securities and
Wachovia Capital Markets LLC, as joint bookrunners and Merrill
Lynch Capital Corporation, as documentation agent.
|
|
4
|
.9
|
|
|
|
U.S. Guarantee, dated November 17, 2006, among HCA Inc.,
the subsidiary guarantors party thereto and Bank of America,
N.A., as administrative agent (filed as Exhibit 4.9 to the
Companys Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
|
4
|
.10
|
|
|
|
Amended and Restated Security Agreement, dated as of
March 2, 2009, among the Company, the Subsidiary Grantors
named therein and Bank of America, N.A., as collateral agent.
|
|
4
|
.11
|
|
|
|
Amended and Restated Pledge Agreement, dated as of March 2,
2009, among the Company, the Subsidiary Pledgors named therein
and Bank of America, N.A., as Collateral Agent.
|
|
4
|
.12(a)
|
|
|
|
$2,000,000,000 Amended and Restated Credit Agreement, dated as
of June 20, 2007, among HCA Inc., the subsidiary borrowers
parties thereto, the lending institutions from time to time
parties thereto, Banc of America Securities LLC,
J.P. Morgan Securities Inc., Citigroup Global Markets Inc.
and Merrill Lynch, Pierce, Fenner & Smith
Incorporated, as joint lead arrangers and joint bookrunners,
Bank of America, N.A., as administrative agent, JPMorgan Chase
Bank, N.A. and Citicorp North America, Inc., as co-syndication
agents, and Merrill Lynch Capital Corporation, as documentation
agent (filed as Exhibit 4.1 to the Companys Current
Report on
Form 8-K
filed June 26, 2007, and incorporated herein by reference).
|
|
4
|
.12(b)
|
|
|
|
Amendment No. 1 to the $2,000,000,000 Amended and Restated
Credit Agreement, dated as of March 2, 2009, among HCA
Inc., the subsidiary borrowers parties thereto, the lending
institutions from time to time parties thereto, Banc of America
Securities LLC, J.P. Morgan Securities Inc., Citigroup
Global Markets Inc. and Merrill Lynch, Pierce,
Fenner & Smith Incorporated, as joint lead arrangers
and joint bookrunners, Bank of America, N.A., as administrative
agent, JPMorgan Chase Bank, N.A. and Citicorp North America,
Inc., as co-syndication agents, and Merrill Lynch Capital
Corporation, as documentation agent.
|
|
4
|
.13
|
|
|
|
Security Agreement, dated as of November 17, 2006, among
HCA Inc., the subsidiary borrowers party thereto and Bank of
America, N.A., as collateral agent (filed as Exhibit 4.13
to the Companys Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
|
4
|
.14(a)
|
|
|
|
General Intercreditor Agreement, dated as of November 17,
2006, between Bank of America, N.A., as First Lien Collateral
Agent, and The Bank of New York, as Junior Lien Collateral Agent
(filed as Exhibit 4.13(a) to the Companys
Registration Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.14(b)
|
|
|
|
Receivables Intercreditor Agreement, dated as of
November 17, 2006, among Bank of America, N.A., as ABL
Collateral Agent, Bank of America, N.A., as CF Collateral Agent
and The Bank of New York, as Bonds Collateral Agent (filed as
Exhibit 4.13(b) to the Companys Registration
Statement on
Form S-4
(File
No. 333-145054),
and incorporated herein by reference).
|
|
4
|
.15
|
|
|
|
Registration Rights Agreement, dated as of November 17,
2006, among HCA Inc., Hercules Holding II, LLC and certain other
parties thereto (filed as Exhibit 4.4 to the Companys
Current Report on
Form 8-K
filed November 24, 2006, and incorporated herein by
reference).
|
102
|
|
|
|
|
|
|
|
4
|
.16
|
|
|
|
Registration Rights Agreement, dated as of March 16, 1989,
by and among HCA-Hospital Corporation of America and the persons
listed on the signature pages thereto (filed as Exhibit(g)(24)
to Amendment No. 3 to the
Schedule 13E-3
filed by HCA-Hospital Corporation of America, Hospital
Corporation of America and The HCA Profit Sharing Plan on
March 22, 1989, and incorporated herein by reference).
|
|
4
|
.17
|
|
|
|
Assignment and Assumption Agreement, dated as of
February 10, 1994, between HCA-Hospital Corporation of
America and the Company relating to the Registration Rights
Agreement, as amended (filed as Exhibit 4.7 to the
Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 1993, and
incorporated herein by reference).
|
|
4
|
.18(a)
|
|
|
|
Indenture, dated as of December 16, 1993 between the
Company and The First National Bank of Chicago, as Trustee
(filed as Exhibit 4.11 to the Companys Annual Report
on
Form 10-K
for the fiscal year ended December 31, 1993, and
incorporated herein by reference).
|
|
4
|
.18(b)
|
|
|
|
First Supplemental Indenture, dated as of May 25, 2000
between the Company and Bank One Trust Company, N.A., as
Trustee (filed as Exhibit 4.4 to the Companys
Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2000, and incorporated
herein by reference).
|
|
4
|
.18(c)
|
|
|
|
Second Supplemental Indenture, dated as of July 1, 2001
between the Company and Bank One Trust Company, N.A., as
Trustee (filed as Exhibit 4.1 to the Companys
Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2001, and incorporated
herein by reference).
|
|
4
|
.18(d)
|
|
|
|
Third Supplemental Indenture, dated as of December 5, 2001
between the Company and The Bank of New York, as Trustee (filed
as Exhibit 4.5(d) to the Companys Annual Report of
Form 10-K
for the fiscal year ended December 31, 2001, and
incorporated herein by reference).
|
|
4
|
.18(e)
|
|
|
|
Fourth Supplemental Indenture, dated as of November 14,
2006, between the Company and The Bank of New York, as Trustee
(filed as Exhibit 4.1 to the Companys Current Report
on
Form 8-K
filed November 16, 2006, and incorporated herein by
reference).
|
|
4
|
.19
|
|
|
|
Form of 7.5% Debentures due 2023 (filed as Exhibit 4.2
to the Companys Current Report on
Form 8-K
dated December 15, 1993, and incorporated herein by
reference).
|
|
4
|
.20
|
|
|
|
Form of 8.36% Debenture due 2024 (filed as Exhibit 4.1
to the Companys Current Report on
Form 8-K
dated April 20, 1994, and incorporated herein by reference).
|
|
4
|
.21
|
|
|
|
Form of Fixed Rate Global Medium Term Note (filed as
Exhibit 4.1 to the Companys Current Report on
Form 8-K
dated July 11, 1994, and incorporated herein by reference).
|
|
4
|
.22
|
|
|
|
Form of Floating Rate Global Medium Term Note (filed as
Exhibit 4.2 to the Companys Current Report on
Form 8-K
dated July 11, 1994, and incorporated herein by reference).
|
|
4
|
.23
|
|
|
|
Form of 7.69% Note due 2025 (filed as Exhibit 4.10 to
the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2004, and
incorporated herein by reference).
|
|
4
|
.24
|
|
|
|
Form of 7.19% Debenture due 2015 (filed as Exhibit 4.1
to the Companys Current Report on
Form 8-K
dated November 20, 1995, and incorporated herein by
reference).
|
|
4
|
.25
|
|
|
|
Form of 7.50% Debenture due 2095 (filed as Exhibit 4.2
to the Companys Current Report on
Form 8-K
dated November 20, 1995, and incorporated herein by
reference).
|
|
4
|
.26
|
|
|
|
Form of 7.05% Debenture due 2027 (filed as Exhibit 4.1
to the Companys Current Report on
Form 8-K
dated December 5, 1995, and incorporated herein by
reference).
|
|
4
|
.27
|
|
|
|
Form of Fixed Rate Global Medium Term Note (filed as
Exhibit 4.1 to the Companys Current Report on
Form 8-K
dated July 2, 1996, and incorporated herein by reference).
|
|
4
|
.28(a)
|
|
|
|
8.750% Note in the principal amount of $400,000,000 due
2010 (filed as Exhibit 4.1 to the Companys Current
Report on
Form 8-K
dated August 23, 2000, and incorporated herein by
reference).
|
|
4
|
.28(b)
|
|
|
|
8.750% Note in the principal amount of $350,000,000 due
2010 (filed as Exhibit 4.2 to the Companys Current
Report on
Form 8-K
dated August 23, 2000, and incorporated herein by
reference).
|
|
4
|
.29
|
|
|
|
8.75% Note due 2010 in the principal amount of
£150,000,000 (filed as Exhibit 4.1 to the
Companys Current Report on
Form 8-K
dated October 25, 2000, and incorporated herein by
reference).
|
|
4
|
.30(a)
|
|
|
|
77/8% Note
in the principal amount of $100,000,000 due 2011 (filed as
Exhibit 4.1 to the Companys Current Report on
Form 8-K
dated January 23, 2001, and incorporated herein by
reference).
|
|
4
|
.30(b)
|
|
|
|
77/8% Note
in the principal amount of $400,000,000 due 2011 (filed as
Exhibit 4.2 to the Companys Current Report on
Form 8-K
dated January 23, 2001, and incorporated herein by
reference).
|
103
|
|
|
|
|
|
|
|
4
|
.31(a)
|
|
|
|
6.95% Note due 2012 in the principal amount of
$400,000,000. (filed as Exhibit 4.5 to the Companys
Current Report on
Form 8-K
dated April 23, 2002, and incorporated herein by reference).
|
|
4
|
.31(b)
|
|
|
|
6.95% Note due 2012 in the principal amount of
$100,000,000. (filed as Exhibit 4.6 to the Companys
Current Report on
Form 8-K
dated April 23, 2002, and incorporated herein by reference).
|
|
4
|
.32(a)
|
|
|
|
6.30% Note due 2012 in the principal amount of
$400,000,000. (filed as Exhibit 4.1 to the Companys
Current Report on
Form 8-K
dated September 18, 2002, and incorporated herein by
reference).
|
|
4
|
.32(b)
|
|
|
|
6.30% Note due 2012 in the principal amount of
$100,000,000. (filed as Exhibit 4.2 to the Companys
Current Report on
Form 8-K
dated September 18, 2002, and incorporated herein by
reference).
|
|
4
|
.33(a)
|
|
|
|
6.25% Note due 2013 in the principal amount of $400,000,000
(filed as Exhibit 4.1 to the Companys Current Report
on
Form 8-K
dated February 5, 2003, and incorporated herein by
reference).
|
|
4
|
.33(b)
|
|
|
|
6.25% Note due 2013 in the principal amount of $100,000,000
(filed as Exhibit 4.2 to the Companys Current Report
on
Form 8-K
dated February 5, 2003, and incorporated herein by
reference).
|
|
4
|
.34(a)
|
|
|
|
6
3/4% Note
due 2013 in the principal amount of $400,000,000 (filed as
Exhibit 4.1 to the Companys Current Report on
Form 8-K
dated July 23, 2003, and incorporated herein by reference).
|
|
4
|
.34(b)
|
|
|
|
6
3/4% Note
due 2013 in the principal amount of $100,000,000 (filed as
Exhibit 4.2 to the Companys Current Report on
Form 8-K
dated July 23, 2003, and incorporated herein by reference).
|
|
4
|
.35
|
|
|
|
7.50% Note due 2033 in the principal amount of $250,000,000
(filed as Exhibit 4.2 to the Companys Current Report
on
Form 8-K
dated November 6, 2003, and incorporated herein by
reference).
|
|
4
|
.36
|
|
|
|
5.75% Note due 2014 in the principal amount of $500,000,000
(filed as Exhibit 4.1 to the Companys Current Report
on
Form 8-K
dated March 8, 2004, and incorporated herein by reference).
|
|
4
|
.37
|
|
|
|
5.500% Note due 2009 in the principal amount of
$500,000,000 (filed as Exhibit 4.1 to the Companys
Current Report on
Form 8-K
dated November 16, 2004, and incorporated herein by
reference).
|
|
4
|
.38(a)
|
|
|
|
6.375% Note due 2015 in the principal amount of
$500,000,000 (filed as Exhibit 4.2 to the Companys
Current Report on
Form 8-K
dated November 16, 2004, and incorporated herein by
reference).
|
|
4
|
.38(b)
|
|
|
|
6.375% Note due 2015 in the principal amount of
$250,000,000 (filed as Exhibit 4.3 to the Companys
Current Report on
Form 8-K
dated November 16, 2004, and incorporated herein by
reference).
|
|
4
|
.39(a)
|
|
|
|
6.500% Note due 2016 in the principal amount of
$500,000,000 (filed as Exhibit 4.1 to the Companys
Current Report on
Form 8-K
filed on February 8, 2006, and incorporated herein by
reference).
|
|
4
|
.39(b)
|
|
|
|
6.500% Note due 2016 in the principal amount of
$500,000,000 (filed as Exhibit 4.2 to the Companys
Current Report on
Form 8-K
filed on February 8, 2006, and incorporated herein by
reference).
|
|
10
|
.1(a)
|
|
|
|
Amended and Restated Columbia/HCA Healthcare Corporation 1992
Stock and Incentive Plan (filed as Exhibit 10.7(b) to the
Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 1998, and
incorporated herein by reference).*
|
|
10
|
.1(b)
|
|
|
|
First Amendment to Amended and Restated Columbia/HCA Healthcare
Corporation 1992 Stock and Incentive Plan (filed as
Exhibit 10.2 to the Companys Quarterly Report on
Form 10-Q
for the quarter ended September 30, 1999, and incorporated
herein by reference).*
|
|
10
|
.2
|
|
|
|
HCA-Hospital Corporation of America Nonqualified Initial Option
Plan (filed as Exhibit 4.6 to the Companys
Registration Statement on
Form S-3
(File
No. 33-52379),
and incorporated herein by reference).*
|
|
10
|
.3
|
|
|
|
Form of Indemnity Agreement with certain officers and directors
(filed as Exhibit 10(kk) to Galen Health Care, Inc.s
Registration Statement on Form 10, as amended, and
incorporated herein by reference).
|
|
10
|
.4
|
|
|
|
Form of Galen Health Care, Inc. 1993 Adjustment Plan (filed as
Exhibit 4.15 to the Companys Registration Statement
on
Form S-8
(File
No. 33-50147),
and incorporated herein by reference).*
|
|
10
|
.5
|
|
|
|
HCA-Hospital
Corporation of America 1992 Stock Compensation Plan (filed as
Exhibit 10(t) to
HCA-Hospital
Corporation of Americas Registration Statement on
Form S-1
(File
No. 33-44906),
and incorporated herein by reference).*
|
|
10
|
.6
|
|
|
|
Columbia/HCA Healthcare Corporation 2000 Equity Incentive Plan
(filed as Exhibit A to the Companys Proxy Statement
for the Annual Meeting of Stockholders on May 25, 2000, and
incorporated herein by reference).*
|
104
|
|
|
|
|
|
|
|
10
|
.7
|
|
|
|
Form of Non-Qualified Stock Option Award Agreement (Officers)
(filed as Exhibit 99.2 to the Companys Current Report
on
Form 8-K
dated February 2, 2005, and incorporated herein by
reference).*
|
|
10
|
.8
|
|
|
|
HCA 2005 Equity Incentive Plan (filed as Exhibit B to the
Companys Proxy Statement for the Annual Meeting of
Shareholders on May 26, 2005, and incorporated herein by
reference);.*
|
|
10
|
.9
|
|
|
|
Form of 2005 Non-Qualified Stock Option Agreement (Officers)
(filed as Exhibit 99.2 to the Companys Current Report
on
Form 8-K
dated October 6, 2005, and incorporated herein by
reference).*
|
|
10
|
.10
|
|
|
|
Form of 2006 Non-Qualified Stock Option Award Agreement
(Officers) (filed as Exhibit 10.2 to the Companys
Current Report on
Form 8-K
dated February 1, 2006, and incorporated herein by
reference).*
|
|
10
|
.11
|
|
|
|
2006 Stock Incentive Plan for Key Employees of HCA Inc. and its
Affiliates (filed as Exhibit 10.11 to the Companys
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).*
|
|
10
|
.12
|
|
|
|
Management Stockholders Agreement dated November 17,
2006 (filed as Exhibit 10.12 to the Companys Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.13
|
|
|
|
Sale Participation Agreement dated November 17, 2006 (filed
as Exhibit 10.13 to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.14
|
|
|
|
Form of Option Rollover Agreement (filed as Exhibit 10.14
to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).*
|
|
10
|
.15
|
|
|
|
Form of Option Agreement (2007) (filed as Exhibit 10.15 to
the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).*
|
|
10
|
.16
|
|
|
|
Form of Option Agreement (2008) (filed as Exhibit 10.16 to
the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
incorporated herein by reference).*
|
|
10
|
.17
|
|
|
|
Form of Option Agreement (2009).*
|
|
10
|
.18
|
|
|
|
Exchange and Purchase Agreement (filed as Exhibit 10.16 to
the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.19
|
|
|
|
Civil and Administrative Settlement Agreement, dated
December 14, 2000 between the Company, the United States
Department of Justice and others (filed as Exhibit 99.2 to
the Companys Current Report on
Form 8-K
dated December 20, 2000, and incorporated herein by
reference).
|
|
10
|
.20
|
|
|
|
Plea Agreement, dated December 14, 2000 between the
Company, Columbia Homecare Group, Inc., Columbia Management
Companies, Inc. and the United States Department of Justice
(filed as Exhibit 99.3 to the Companys Current Report
on
Form 8-K
dated December 20, 2000, and incorporated herein by
reference).
|
|
10
|
.21
|
|
|
|
Corporate Integrity Agreement, dated December 14, 2000
between the Company and the Office of Inspector General of the
United States Department of Health and Human Services (filed as
Exhibit 99.4 to the Companys Current Report on
Form 8-K
dated December 20, 2000, and incorporated herein by
reference).
|
|
10
|
.22
|
|
|
|
Management Agreement, dated November 17, 2006, among HCA
Inc., Bain Capital Partners, LLC, Kohlberg Kravis
Roberts & Co. L.P., Dr. Thomas F. Frist Jr.,
Patricia F. Elcan, William R. Frist and Thomas F.
Frist, III, and Merrill Lynch Global Partners, Inc. (filed
as Exhibit 10.20 to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).
|
|
10
|
.23
|
|
|
|
Retirement Agreement between the Company and Thomas F. Frist,
Jr., M.D. dated as of January 1, 2002 (filed as
Exhibit 10.30 to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2001, and
incorporated herein by reference).*
|
|
10
|
.24
|
|
|
|
Amended and Restated HCA Supplemental Executive Retirement Plan,
effective January 1, 2007, except as provided therein.*
|
|
10
|
.25
|
|
|
|
Amended and Restated HCA Restoration Plan, effective
January 1, 2008.*
|
105
|
|
|
|
|
|
|
|
10
|
.26
|
|
|
|
HCA Inc. 2006 Senior Officer Performance Excellence Program
(filed as Exhibit 10.3 to the Companys Current Report
on 8-K filed
February 1, 2006, and incorporated herein by reference).*
|
|
10
|
.27
|
|
|
|
HCA Inc. 2007 Senior Officer Performance Excellence Program
(filed as Exhibit 10.26 to the Companys Annual Report
on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).*
|
|
10
|
.28(a)
|
|
|
|
HCA Inc.
2008-2009
Senior Officer Performance Excellence Program (filed as
Exhibit 10.27 to the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
incorporated herein by reference).*
|
|
10
|
.28(b)
|
|
|
|
HCA Inc. Amendment No. 1 to the
2008-2009
Senior Officer Performance Excellence Program.*
|
|
10
|
.29(a)
|
|
|
|
Employment Agreement dated November 16, 2006 (Jack O.
Bovender Jr.) (filed as Exhibit 10.27(a) to the
Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).*
|
|
10
|
.29(b)
|
|
|
|
Employment Agreement dated November 16, 2006 (Richard M.
Bracken) (filed as Exhibit 10.27(b) to the Companys
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).*
|
|
10
|
.29(c)
|
|
|
|
Employment Agreement dated November 16, 2006 (R. Milton
Johnson) (filed as Exhibit 10.27(c) to the Companys
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).*
|
|
10
|
.29(d)
|
|
|
|
Employment Agreement dated November 16, 2006 (Samuel N.
Hazen) (filed as Exhibit 10.27(d) to the Companys
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2006, and
incorporated herein by reference).*
|
|
10
|
.29(e)
|
|
|
|
Employment Agreement dated November 16, 2006 (Beverly B.
Wallace) (filed as Exhibit 10.28(e) to the Companys
Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, and
incorporated herein by reference).*
|
|
10
|
.29(f)
|
|
|
|
Amended and Restated Employment Agreement dated October 27,
2008 (Jack O. Bovender, Jr.).*
|
|
10
|
.29(g)
|
|
|
|
Amendment to Employment Agreement effective January 1, 2009
(Richard M. Bracken).*
|
|
10
|
.30
|
|
|
|
Administrative Settlement Agreement dated June 25, 2003 by
and between the United States Department of Health and Human
Services, acting through the Centers for Medicare and Medicaid
Services, and the Company (filed as Exhibit 10.1 to the
Companys Quarterly Report of
Form 10-Q
for the quarter ended June 30, 2003, and incorporated
herein by reference).
|
|
10
|
.31
|
|
|
|
Civil Settlement Agreement by and among the United States of
America, acting through the United States Department of Justice
and on behalf of the Office of Inspector General of the
Department of Health and Human Services, the TRICARE Management
Activity (filed as Exhibit 10.2 to the Companys
Quarterly Report of
Form 10-Q
for the quarter ended June 30, 2003, and incorporated
herein by reference).
|
|
10
|
.32
|
|
|
|
Form of Amended and Restated Limited Liability Company Agreement
of Hercules Holding II, LLC dated as of November 17, 2006,
among Hercules Holding II, LLC and certain other parties thereto
(filed as Exhibit 10.3 to the Companys Registration
Statement on Form 8-A (File No. 000-18406) and
incorporated herein by reference).
|
|
21
|
|
|
|
|
List of Subsidiaries.
|
|
23
|
|
|
|
|
Consent of Ernst & Young LLP.
|
|
31
|
.1
|
|
|
|
Certification of Chief Executive Officer Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31
|
.2
|
|
|
|
Certification of Chief Financial Officer Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32
|
|
|
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002.
|
|
|
|
* |
|
Management compensatory plan or arrangement. |
106
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
HCA INC.
|
|
|
|
By:
|
/s/ Richard
M. Bracken
|
Richard M. Bracken
President and Chief
Executive Officer
Dated: March 4, 2009
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Jack
O. Bovender, Jr.
Jack
O. Bovender, Jr.
|
|
Chairman of the Board
|
|
March 3, 2009
|
|
|
|
|
|
/s/ Richard
M. Bracken
Richard
M. Bracken
|
|
President, Chief Executive Officer and Director (Principal
Executive Officer)
|
|
March 3, 2009
|
|
|
|
|
|
/s/ R.
Milton Johnson
R.
Milton Johnson
|
|
Executive Vice President and Chief Financial Officer (Principal
Financial Officer and Principal Accounting Officer)
|
|
March 3, 2009
|
|
|
|
|
|
/s/ Christopher
J. Birosak
Christopher
J. Birosak
|
|
Director
|
|
March 3, 2009
|
|
|
|
|
|
/s/ George
A. Bitar
George
A. Bitar
|
|
Director
|
|
March 3, 2009
|
|
|
|
|
|
/s/ John
P. Connaughton
John
P. Connaughton
|
|
Director
|
|
March 3, 2009
|
|
|
|
|
|
/s/ Kenneth
W. Freeman
Kenneth
W. Freeman
|
|
Director
|
|
March 3, 2009
|
|
|
|
|
|
/s/ Thomas
F. Frist, III
Thomas
F. Frist, III
|
|
Director
|
|
March 3, 2009
|
|
|
|
|
|
/s/ William
R. Frist
William
R. Frist
|
|
Director
|
|
March 3, 2009
|
|
|
|
|
|
/s/ Christopher
R. Gordon
Christopher
R. Gordon
|
|
Director
|
|
March 3, 2009
|
|
|
|
|
|
/s/ Michael
W. Michelson
Michael
W. Michelson
|
|
Director
|
|
March 3, 2009
|
|
|
|
|
|
/s/ James
C. Momtazee
James
C. Momtazee
|
|
Director
|
|
March 3, 2009
|
|
|
|
|
|
/s/ Stephen
G. Pagliuca
Stephen
G. Pagliuca
|
|
Director
|
|
March 3, 2009
|
|
|
|
|
|
/s/ Nathan
C. Thorne
Nathan
C. Thorne
|
|
Director
|
|
March 3, 2009
|
107
HCA
INC.
INDEX TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
Page
|
|
|
|
|
F-2
|
|
Consolidated Financial Statements:
|
|
|
|
|
|
|
|
F-3
|
|
|
|
|
F-4
|
|
|
|
|
F-5
|
|
|
|
|
F-6
|
|
|
|
|
F-7
|
|
|
|
|
F-42
|
|
F-1
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
HCA Inc.
We have audited the accompanying consolidated balance sheets of
HCA Inc. as of December 31, 2008 and 2007, and the related
consolidated statements of income, stockholders (deficit)
equity, and cash flows for each of the three years in the period
ended December 31, 2008. These financial statements are the
responsibility of the Companys management. Our
responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above
present fairly, in all material respects, the consolidated
financial position of HCA Inc. at December 31, 2008 and
2007, and the consolidated results of its operations and its
cash flows for each of the three years in the period ended
December 31, 2008, in conformity with U.S. generally
accepted accounting principles.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), HCA
Inc.s internal control over financial reporting as of
December 31, 2008, based on criteria established in
Internal Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway
Commission, and our report dated March 3, 2009 expressed an
unqualified opinion thereon.
/s/ Ernst & Young LLP
Nashville, Tennessee
March 3, 2009
F-2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Revenues
|
|
$
|
28,374
|
|
|
$
|
26,858
|
|
|
$
|
25,477
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
11,440
|
|
|
|
10,714
|
|
|
|
10,409
|
|
Supplies
|
|
|
4,620
|
|
|
|
4,395
|
|
|
|
4,322
|
|
Other operating expenses
|
|
|
4,554
|
|
|
|
4,241
|
|
|
|
4,056
|
|
Provision for doubtful accounts
|
|
|
3,409
|
|
|
|
3,130
|
|
|
|
2,660
|
|
Equity in earnings of affiliates
|
|
|
(223
|
)
|
|
|
(206
|
)
|
|
|
(197
|
)
|
Gains on investments
|
|
|
|
|
|
|
(8
|
)
|
|
|
(243
|
)
|
Depreciation and amortization
|
|
|
1,416
|
|
|
|
1,426
|
|
|
|
1,391
|
|
Interest expense
|
|
|
2,021
|
|
|
|
2,215
|
|
|
|
955
|
|
Gains on sales of facilities
|
|
|
(97
|
)
|
|
|
(471
|
)
|
|
|
(205
|
)
|
Impairment of long-lived assets
|
|
|
64
|
|
|
|
24
|
|
|
|
24
|
|
Transaction costs
|
|
|
|
|
|
|
|
|
|
|
442
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,204
|
|
|
|
25,460
|
|
|
|
23,614
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before minority interests and income taxes
|
|
|
1,170
|
|
|
|
1,398
|
|
|
|
1,863
|
|
Minority interests in earnings of consolidated entities
|
|
|
229
|
|
|
|
208
|
|
|
|
201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
941
|
|
|
|
1,190
|
|
|
|
1,662
|
|
Provision for income taxes
|
|
|
268
|
|
|
|
316
|
|
|
|
626
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
673
|
|
|
$
|
874
|
|
|
$
|
1,036
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
F-3
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
465
|
|
|
$
|
393
|
|
Accounts receivable, less allowance for doubtful accounts of
$5,435 and $4,289
|
|
|
3,780
|
|
|
|
3,895
|
|
Inventories
|
|
|
737
|
|
|
|
710
|
|
Deferred income taxes
|
|
|
914
|
|
|
|
592
|
|
Other
|
|
|
405
|
|
|
|
615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,301
|
|
|
|
6,205
|
|
Property and equipment, at cost:
|
|
|
|
|
|
|
|
|
Land
|
|
|
1,189
|
|
|
|
1,240
|
|
Buildings
|
|
|
8,670
|
|
|
|
8,518
|
|
Equipment
|
|
|
12,833
|
|
|
|
12,088
|
|
Construction in progress
|
|
|
1,022
|
|
|
|
733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,714
|
|
|
|
22,579
|
|
Accumulated depreciation
|
|
|
(12,185
|
)
|
|
|
(11,137
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
11,529
|
|
|
|
11,442
|
|
|
|
|
|
|
|
|
|
|
Investments of insurance subsidiary
|
|
|
1,422
|
|
|
|
1,669
|
|
Investments in and advances to affiliates
|
|
|
842
|
|
|
|
688
|
|
Goodwill
|
|
|
2,580
|
|
|
|
2,629
|
|
Deferred loan costs
|
|
|
458
|
|
|
|
539
|
|
Other
|
|
|
1,148
|
|
|
|
853
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
24,280
|
|
|
$
|
24,025
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS DEFICIT
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
1,370
|
|
|
$
|
1,370
|
|
Accrued salaries
|
|
|
854
|
|
|
|
780
|
|
Other accrued expenses
|
|
|
1,282
|
|
|
|
1,391
|
|
Long-term debt due within one year
|
|
|
404
|
|
|
|
308
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,910
|
|
|
|
3,849
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
26,585
|
|
|
|
27,000
|
|
Professional liability risks
|
|
|
1,108
|
|
|
|
1,233
|
|
Income taxes and other liabilities
|
|
|
1,782
|
|
|
|
1,379
|
|
Minority interests in equity of consolidated entities
|
|
|
995
|
|
|
|
938
|
|
|
|
|
|
|
|
|
|
|
Equity securities with contingent redemption rights
|
|
|
155
|
|
|
|
164
|
|
|
|
|
|
|
|
|
|
|
Stockholders deficit:
|
|
|
|
|
|
|
|
|
Common stock $0.01 par; authorized
125,000,000 shares 2008 and 2007; outstanding
94,367,500 shares 2008 and
94,182,400 shares 2007
|
|
|
1
|
|
|
|
1
|
|
Capital in excess of par value
|
|
|
165
|
|
|
|
112
|
|
Accumulated other comprehensive loss
|
|
|
(604
|
)
|
|
|
(172
|
)
|
Retained deficit
|
|
|
(9,817
|
)
|
|
|
(10,479
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,255
|
)
|
|
|
(10,538
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
24,280
|
|
|
$
|
24,025
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
F-4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital in
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Excess of
|
|
|
Other
|
|
|
Retained
|
|
|
|
|
|
|
Shares
|
|
|
Par
|
|
|
Par
|
|
|
Comprehensive
|
|
|
Earnings
|
|
|
|
|
|
|
(000)
|
|
|
Value
|
|
|
Value
|
|
|
Income (Loss)
|
|
|
(Deficit)
|
|
|
Total
|
|
|
Balances, December 31, 2005
|
|
|
417,513
|
|
|
$
|
4
|
|
|
$
|
|
|
|
$
|
130
|
|
|
$
|
4,729
|
|
|
$
|
4,863
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,036
|
|
|
|
1,036
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in net unrealized gains on investment securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(102
|
)
|
|
|
|
|
|
|
(102
|
)
|
Foreign currency translation adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
|
|
|
|
|
|
|
|
19
|
|
Defined benefit plans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
|
|
9
|
|
Change in fair value of derivative instruments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(56
|
)
|
|
|
1,036
|
|
|
|
980
|
|
Recapitalization repurchase of common stock
|
|
|
(411,957
|
)
|
|
|
(4
|
)
|
|
|
(5,005
|
)
|
|
|
|
|
|
|
(16,364
|
)
|
|
|
(21,373
|
)
|
Recapitalization equity contributions
|
|
|
92,218
|
|
|
|
1
|
|
|
|
4,476
|
|
|
|
|
|
|
|
|
|
|
|
4,477
|
|
Cash dividends declared
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(139
|
)
|
|
|
(139
|
)
|
Stock repurchases
|
|
|
(13,057
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(653
|
)
|
|
|
(653
|
)
|
Stock options exercised
|
|
|
3,970
|
|
|
|
|
|
|
|
163
|
|
|
|
|
|
|
|
|
|
|
|
163
|
|
Employee benefit plan issuances
|
|
|
3,531
|
|
|
|
|
|
|
|
366
|
|
|
|
|
|
|
|
|
|
|
|
366
|
|
Adjustment to initially apply FAS 158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(58
|
)
|
|
|
|
|
|
|
(58
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, December 31, 2006
|
|
|
92,218
|
|
|
|
1
|
|
|
|
|
|
|
|
16
|
|
|
|
(11,391
|
)
|
|
|
(11,374
|
)
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
874
|
|
|
|
874
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in net unrealized gains on investment securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
(2
|
)
|
Foreign currency translation adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15
|
)
|
|
|
|
|
|
|
(15
|
)
|
Defined benefit plans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
23
|
|
Change in fair value of derivative instruments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(194
|
)
|
|
|
|
|
|
|
(194
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(188
|
)
|
|
|
874
|
|
|
|
686
|
|
Equity contributions
|
|
|
1,961
|
|
|
|
|
|
|
|
60
|
|
|
|
|
|
|
|
|
|
|
|
60
|
|
Share-based benefit plans
|
|
|
|
|
|
|
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
24
|
|
Adjustment to initially apply FIN 48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38
|
|
|
|
38
|
|
Other
|
|
|
3
|
|
|
|
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, December 31, 2007
|
|
|
94,182
|
|
|
|
1
|
|
|
|
112
|
|
|
|
(172
|
)
|
|
|
(10,479
|
)
|
|
|
(10,538
|
)
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
673
|
|
|
|
673
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in net unrealized gains and losses on investment
securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(44
|
)
|
|
|
|
|
|
|
(44
|
)
|
Foreign currency translation adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(62
|
)
|
|
|
|
|
|
|
(62
|
)
|
Defined benefit plans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(62
|
)
|
|
|
|
|
|
|
(62
|
)
|
Change in fair value of derivative instruments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(264
|
)
|
|
|
|
|
|
|
(264
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(432
|
)
|
|
|
673
|
|
|
|
241
|
|
Share-based benefit plans
|
|
|
185
|
|
|
|
|
|
|
|
40
|
|
|
|
|
|
|
|
|
|
|
|
40
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
13
|
|
|
|
|
|
|
|
(11
|
)
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, December 31, 2008
|
|
|
94,367
|
|
|
$
|
1
|
|
|
$
|
165
|
|
|
$
|
(604
|
)
|
|
$
|
(9,817
|
)
|
|
$
|
(10,255
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
F-5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
673
|
|
|
$
|
874
|
|
|
$
|
1,036
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for doubtful accounts
|
|
|
3,409
|
|
|
|
3,130
|
|
|
|
2,660
|
|
Depreciation and amortization
|
|
|
1,416
|
|
|
|
1,426
|
|
|
|
1,391
|
|
Income taxes
|
|
|
(448
|
)
|
|
|
(105
|
)
|
|
|
(552
|
)
|
Gains on sales of facilities
|
|
|
(97
|
)
|
|
|
(471
|
)
|
|
|
(205
|
)
|
Impairment of long-lived assets
|
|
|
64
|
|
|
|
24
|
|
|
|
24
|
|
Amortization of deferred loan costs
|
|
|
79
|
|
|
|
78
|
|
|
|
18
|
|
Change in minority interests
|
|
|
36
|
|
|
|
40
|
|
|
|
58
|
|
Share-based compensation
|
|
|
32
|
|
|
|
24
|
|
|
|
324
|
|
Increase (decrease) in cash from operating assets and
liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(3,328
|
)
|
|
|
(3,345
|
)
|
|
|
(3,043
|
)
|
Inventories and other assets
|
|
|
159
|
|
|
|
(241
|
)
|
|
|
(12
|
)
|
Accounts payable and accrued expenses
|
|
|
(198
|
)
|
|
|
(29
|
)
|
|
|
115
|
|
Other
|
|
|
|
|
|
|
(9
|
)
|
|
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
1,797
|
|
|
|
1,396
|
|
|
|
1,845
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(1,600
|
)
|
|
|
(1,444
|
)
|
|
|
(1,865
|
)
|
Acquisition of hospitals and health care entities
|
|
|
(85
|
)
|
|
|
(32
|
)
|
|
|
(112
|
)
|
Disposal of hospitals and health care entities
|
|
|
193
|
|
|
|
767
|
|
|
|
651
|
|
Change in investments
|
|
|
21
|
|
|
|
207
|
|
|
|
26
|
|
Other
|
|
|
4
|
|
|
|
23
|
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(1,467
|
)
|
|
|
(479
|
)
|
|
|
(1,307
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuances of long-term debt
|
|
|
|
|
|
|
|
|
|
|
21,758
|
|
Net change in revolving bank credit facility
|
|
|
700
|
|
|
|
(520
|
)
|
|
|
(435
|
)
|
Repayment of long-term debt
|
|
|
(960
|
)
|
|
|
(750
|
)
|
|
|
(3,728
|
)
|
Issuances of common stock
|
|
|
|
|
|
|
100
|
|
|
|
108
|
|
Repurchases of common stock
|
|
|
|
|
|
|
|
|
|
|
(653
|
)
|
Recapitalization-repurchase of common stock
|
|
|
|
|
|
|
|
|
|
|
(20,364
|
)
|
Recapitalization-equity contributions
|
|
|
|
|
|
|
|
|
|
|
3,782
|
|
Payment of debt issuance costs
|
|
|
|
|
|
|
|
|
|
|
(586
|
)
|
Payment of cash dividends
|
|
|
|
|
|
|
|
|
|
|
(201
|
)
|
Other
|
|
|
2
|
|
|
|
12
|
|
|
|
79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities
|
|
|
(258
|
)
|
|
|
(1,158
|
)
|
|
|
(240
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
72
|
|
|
|
(241
|
)
|
|
|
298
|
|
Cash and cash equivalents at beginning of period
|
|
|
393
|
|
|
|
634
|
|
|
|
336
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
465
|
|
|
$
|
393
|
|
|
$
|
634
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest payments
|
|
$
|
1,979
|
|
|
$
|
2,163
|
|
|
$
|
893
|
|
Income tax payments, net of refunds
|
|
$
|
716
|
|
|
$
|
421
|
|
|
$
|
1,087
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
F-6
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
NOTE 1
|
ACCOUNTING
POLICIES
|
Merger,
Recapitalization and Reporting Entity
On November 17, 2006 HCA Inc. (the Company)
completed its merger (the Merger) with Hercules
Acquisition Corporation, pursuant to which the Company was
acquired by Hercules Holding II, LLC, a Delaware limited
liability company owned by a private investor group including
affiliates of Bain Capital Partners, Kohlberg Kravis
Roberts & Co., Merrill Lynch Global Private Equity
(each a Sponsor) and affiliates of HCA founder,
Dr. Thomas F. Frist Jr., (the Frist Entities,
and together with the Sponsors, the Investors), and
by members of management and certain other investors. The
Merger, the financing transactions related to the Merger and
other related transactions are collectively referred to in this
annual report as the Recapitalization. The Merger
was accounted for as a recapitalization in our financial
statements, with no adjustments to the historical basis of our
assets and liabilities. As a result of the Recapitalization, our
outstanding capital stock is owned by the Investors, certain
members of management and key employees and certain other
investors. On April 29, 2008, we registered our common
stock pursuant to Section 12(g) of the Securities Exchange
Act of 1934, thus subjecting us to the reporting requirements of
Section 13(a) of the Securities Exchange Act of 1934. Our
common stock is not traded on a national securities exchange.
HCA Inc. is a holding company whose affiliates own and operate
hospitals and related health care entities. The term
affiliates includes direct and indirect subsidiaries
of HCA Inc. and partnerships and joint ventures in which such
subsidiaries are partners. At December 31, 2008, these
affiliates owned and operated 158 hospitals, 97 freestanding
surgery centers and provided extensive outpatient and ancillary
services. Affiliates of HCA are also partners in joint ventures
that own and operate eight hospitals and eight freestanding
surgery centers, which are accounted for using the equity
method. The Companys facilities are located in
20 states and England. The terms HCA,
Company, we, our or
us, as used in this annual report on
Form 10-K,
refer to HCA Inc. and its affiliates unless otherwise stated or
indicated by context.
Basis of
Presentation
The preparation of financial statements in conformity with
generally accepted accounting principles requires management to
make estimates and assumptions that affect the amounts reported
in the consolidated financial statements and accompanying notes.
Actual results could differ from those estimates.
The consolidated financial statements include all subsidiaries
and entities controlled by HCA. We generally define
control as ownership of a majority of the voting
interest of an entity. The consolidated financial statements
include entities in which we absorb a majority of the
entitys expected losses, receive a majority of the
entitys expected residual returns, or both, as a result of
ownership, contractual or other financial interests in the
entity. Significant intercompany transactions have been
eliminated. Investments in entities that we do not control, but
in which we have a substantial ownership interest and can
exercise significant influence, are accounted for using the
equity method.
We have completed various acquisitions and joint venture
transactions. The accounts of these entities have been included
in our consolidated financial statements for periods subsequent
to our acquisition of controlling interests. The majority of our
expenses are cost of revenue items. Costs that could
be classified as general and administrative include our
corporate office costs, which were $174 million,
$169 million and $187 million for the years ended
December 31, 2008, 2007 and 2006, respectively.
Revenues
Revenues consist primarily of net patient service revenues that
are recorded based upon established billing rates less
allowances for contractual adjustments. Revenues are recorded
during the period the health care services are provided, based
upon the estimated amounts due from the patients and third-party
payers. Third-party payers include federal and state agencies
(under the Medicare and Medicaid programs), managed care health
plans,
F-7
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 1
|
ACCOUNTING
POLICIES (Continued)
|
Revenues
(Continued)
commercial insurance companies and employers. Estimates of
contractual allowances under managed care health plans are based
upon the payment terms specified in the related contractual
agreements. Contractual payment terms in managed care agreements
are generally based upon predetermined rates per diagnosis, per
diem rates or discounted fee-for-service rates.
Laws and regulations governing the Medicare and Medicaid
programs are complex and subject to interpretation. As a result,
there is at least a reasonable possibility that recorded
estimates will change by a material amount. The estimated
reimbursement amounts are adjusted in subsequent periods as cost
reports are prepared and filed and as final settlements are
determined (in relation to certain government programs,
primarily Medicare, this is generally referred to as the
cost report filing and settlement process). The
adjustments to estimated reimbursement amounts, which resulted
in net increases to revenues, related primarily to cost reports
filed during the respective year were $32 million,
$47 million and $55 million in 2008, 2007 and 2006,
respectively. The adjustments to estimated reimbursement
amounts, which resulted in net increases to revenues, related
primarily to cost reports filed during previous years were
$35 million, $83 million and $62 million in 2008,
2007 and 2006, respectively.
The Emergency Medical Treatment and Active Labor Act
(EMTALA) requires any hospital participating in the
Medicare program to conduct an appropriate medical screening
examination of every person who presents to the hospitals
emergency room for treatment and, if the individual is suffering
from an emergency medical condition, to either stabilize the
condition or make an appropriate transfer of the individual to a
facility able to handle the condition. The obligation to screen
and stabilize emergency medical conditions exists regardless of
an individuals ability to pay for treatment. Federal and
state laws and regulations, including but not limited to EMTALA,
require, and our commitment to providing quality patient care
encourages, us to provide services to patients who are
financially unable to pay for the health care services they
receive. Because we do not pursue collection of amounts
determined to qualify as charity care, they are not reported in
revenues. Patients treated at hospitals for nonelective care,
who have income at or below 200% of the federal poverty level,
are eligible for charity care. The federal poverty level is
established by the federal government and is based on income and
family size. We provide discounts to uninsured patients who do
not qualify for Medicaid or charity care. These discounts are
similar to those provided to many local managed care plans. In
implementing the discount policy, we first attempt to qualify
uninsured patients for Medicaid, other federal or state
assistance or charity care. If an uninsured patient does not
qualify for these programs, the uninsured discount is applied.
Cash and
Cash Equivalents
Cash and cash equivalents include highly liquid investments with
a maturity of three months or less when purchased. Our insurance
subsidiarys cash equivalent investments in excess of the
amounts required to pay estimated professional liability claims
during the next twelve months are not included in cash and cash
equivalents as these funds are not available for general
corporate purposes. Carrying values of cash and cash equivalents
approximate fair value due to the short-term nature of these
instruments.
Our cash management system provides for daily investment of
available balances and the funding of outstanding checks when
presented for payment. Outstanding, but unpresented, checks
totaling $382 million and $370 million at
December 31, 2008 and 2007, respectively, have been
included in accounts payable in the consolidated
balance sheets. Upon presentation for payment, these checks are
funded through available cash balances or our credit facility.
F-8
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 1
|
ACCOUNTING
POLICIES (Continued)
|
Accounts
Receivable
We receive payments for services rendered from federal and state
agencies (under the Medicare and Medicaid programs), managed
care health plans, commercial insurance companies, employers and
patients. During the years ended December 31, 2008, 2007
and 2006, 23%, 24% and 25%, respectively, of our revenues
related to patients participating in the fee-for-service
Medicare program and 6%, 5% and 5%, respectively, of our
revenues related to patients participating in managed Medicare
programs. We recognize that revenues and receivables from
government agencies are significant to our operations, but do
not believe there are significant credit risks associated with
these government agencies. We do not believe there are any other
significant concentrations of revenues from any particular payer
that would subject us to any significant credit risks in the
collection of our accounts receivable.
Additions to the allowance for doubtful accounts are made by
means of the provision for doubtful accounts. Accounts written
off as uncollectible are deducted from the allowance for
doubtful accounts and subsequent recoveries are added. The
amount of the provision for doubtful accounts is based upon
managements assessment of historical and expected net
collections, business and economic conditions, trends in
federal, state and private employer health care coverage and
other collection indicators. The provision for doubtful accounts
and the allowance for doubtful accounts relate primarily to
uninsured amounts (including copayment and
deductible amounts from patients who have health care coverage)
due directly from patients. Accounts are written off when all
reasonable internal and external collection efforts have been
performed. We consider the return of an account from the
secondary external collection agency to be the culmination of
our reasonable collection efforts and the timing basis for
writing off the account balance (prior to 2007, we wrote
accounts off upon their return from the primary external
agency). Writeoffs are based upon specific identification and
the writeoff process requires a writeoff adjustment entry to the
patient accounting system. Management relies on the results of
detailed reviews of historical writeoffs and recoveries at
facilities that represent a majority of our revenues and
accounts receivable (the hindsight analysis) as a
primary source of information to utilize in estimating the
collectibility of our accounts receivable. We perform the
hindsight analysis quarterly, utilizing rolling twelve-months
accounts receivable collection and writeoff data. At
December 31, 2008 and 2007, our allowance for doubtful
accounts represented approximately 93% and 89%, respectively, of
the $5.838 billion and $4.825 billion, respectively,
patient due accounts receivable balance, including accounts, net
of estimated contractual discounts, related to patients for
which eligibility for Medicaid coverage was being evaluated
(pending Medicaid accounts). Revenue days in
accounts receivable were 49 days, 53 days and
53 days at December 31, 2008, 2007 and 2006,
respectively. Adverse changes in general economic conditions,
patient accounting service center operations, payer mix or
trends in federal or state governmental health care coverage
could affect our collection of accounts receivable, cash flows
and results of operations.
Inventories
Inventories are stated at the lower of cost
(first-in,
first-out) or market.
Property
and Equipment and Amortizable Intangibles
Depreciation expense, computed using the straight-line method,
was $1.412 billion in 2008, $1.421 billion in 2007,
and $1.384 billion in 2006. Buildings and improvements are
depreciated over estimated useful lives ranging generally from
10 to 40 years. Estimated useful lives of equipment vary
generally from four to 10 years.
Debt issuance costs are amortized based upon the terms of the
respective debt obligations. The gross carrying amount of
deferred loan costs at December 31, 2008 and 2007 was
$650 million and $652 million, respectively, and
accumulated amortization was $192 million and
$113 million, respectively. Amortization of deferred loan
costs is included in interest expense and was $79 million,
$78 million and $18 million for 2008, 2007 and 2006,
respectively.
F-9
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 1
|
ACCOUNTING
POLICIES (Continued)
|
Property
and Equipment and Amortizable Intangibles (Continued)
When events, circumstances or operating results indicate the
carrying values of certain long-lived assets and related
identifiable intangible assets (excluding goodwill) expected to
be held and used, might be impaired, we prepare projections of
the undiscounted future cash flows expected to result from the
use of the assets and their eventual disposition. If the
projections indicate the recorded amounts are not expected to be
recoverable, such amounts are reduced to estimated fair value.
Fair value may be estimated based upon internal evaluations that
include quantitative analyses of revenues and cash flows,
reviews of recent sales of similar facilities and independent
appraisals.
Long-lived assets to be disposed of are reported at the lower of
their carrying amounts or fair value less costs to sell or
close. The estimates of fair value are usually based upon recent
sales of similar assets and market responses based upon
discussions with and offers received from potential buyers.
Investments
of Insurance Subsidiary
At December 31, 2008 and 2007, the investments of our
wholly-owned insurance subsidiary were classified as
available-for-sale as defined in Statement of
Financial Accounting Standards No. 115, Accounting
for Certain Investments in Debt and Equity Securities and
are recorded at fair value. The investment securities are held
for the purpose of providing the funding source to pay
professional liability claims covered by the insurance
subsidiary. We perform a quarterly assessment of individual
investment securities to determine whether declines in market
value are temporary or other-than-temporary. Our investment
securities evaluation process involves multiple subjective
judgments, often involves estimating the outcome of future
events, and requires a significant level of professional
judgment in determining whether an impairment has occurred. We
evaluate, among other things, the financial position and near
term prospects of the issuer, conditions in the issuers
industry, liquidity of the investment, changes in the amount or
timing of expected future cash flows from the investment, and
recent downgrades of the issuer by a rating agency, to determine
if, and when, a decline in the fair value of an investment below
amortized cost is considered other-than-temporary. The length of
time and extent to which the fair value of the investment is
less than amortized cost and our ability and intent to retain
the investment, to allow for any anticipated recovery of the
investments fair value, are important components of our
investment securities evaluation process.
Goodwill
Goodwill is not amortized, but is subject to annual impairment
tests. In addition to the annual impairment review, impairment
reviews are performed whenever circumstances indicate a possible
impairment may exist. Impairment testing for goodwill is done at
the reporting unit level. Reporting units are one level below
the business segment level, and our impairment testing is
performed at the operating division or market level. We compare
the fair value of the reporting unit assets to the carrying
amount, on at least an annual basis, to determine if there is
potential impairment. If the fair value of the reporting unit
assets is less than their carrying value, we compare the fair
value of the goodwill to its carrying value. If the fair value
of the goodwill is less than its carrying value, an impairment
loss is recognized. Fair value of goodwill is estimated based
upon internal evaluations of the related long-lived assets for
each reporting unit that include quantitative analyses of
revenues and cash flows and reviews of recent sales of similar
facilities. We recognized goodwill impairments of
$48 million during 2008. No goodwill impairments were
recognized during 2007 and 2006.
During 2008, goodwill increased by $43 million related to
acquisitions, decreased by $14 million related to facility
sales, decreased by $48 million related to impairments and
decreased by $30 million related to foreign currency
translation and other adjustments. During 2007, goodwill
increased by $44 million related to acquisitions, decreased
by $45 million related to facility sales and increased by
$29 million related to foreign currency translation and
other adjustments.
F-10
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 1
|
ACCOUNTING
POLICIES (Continued)
|
Physician
Recruiting Agreements
In order to recruit physicians to meet the needs of our
hospitals and the communities they serve, we enter into minimum
revenue guarantee arrangements to assist the recruited
physicians during the period they are relocating and
establishing their practices. A guarantor is required to
recognize, at the inception of a guarantee, a liability for the
fair value of the stand-ready obligation undertaken in issuing
the guarantee. We expense the total estimated guarantee
liability amount at the time the physician recruiting agreement
becomes effective as we are not able to justify recording a
contract-based asset based upon our analysis of the related
control, regulatory and legal considerations.
The physician recruiting liability amounts of $27 million
and $22 million at December 31, 2008 and 2007,
respectively, represent the amount of expense recognized in
excess of payments made through December 31, 2008 and 2007,
respectively. At December 31, 2008 the maximum amount of
all effective minimum revenue guarantees that could be paid
prospectively was $66 million.
Professional
Liability Claims
Reserves for professional liability risks were
$1.387 billion and $1.513 billion at December 31,
2008 and 2007, respectively. The current portion of the
reserves, $279 million and $280 million at
December 31, 2008 and 2007, respectively, is included in
other accrued expenses in the consolidated balance
sheet. Provisions for losses related to professional liability
risks were $175 million, $163 million and
$217 million for 2008, 2007 and 2006, respectively, and are
included in other operating expenses in our
consolidated income statement. Provisions for losses related to
professional liability risks are based upon actuarially
determined estimates. Loss and loss expense reserves represent
the estimated ultimate net cost of all reported and unreported
losses incurred through the respective consolidated balance
sheet dates. The reserves for unpaid losses and loss expenses
are estimated using individual case-basis valuations and
actuarial analyses. Those estimates are subject to the effects
of trends in loss severity and frequency. The estimates are
continually reviewed and adjustments are recorded as experience
develops or new information becomes known. Adjustments to the
estimated reserve amounts are included in current operating
results. The reserves for professional liability risks cover
approximately 2,800 and 2,600 individual claims at
December 31, 2008 and 2007, respectively, and estimates for
unreported potential claims. The time period required to resolve
these claims can vary depending upon the jurisdiction and
whether the claim is settled or litigated. During 2008 and 2007,
$314 million and $236 million, respectively, of net
payments were made for professional and general liability
claims. The estimation of the timing of payments beyond a year
can vary significantly. Although considerable variability is
inherent in professional liability reserve estimates, we believe
the reserves for losses and loss expenses are adequate; however,
there can be no assurance that the ultimate liability will not
exceed our estimates.
A portion of our professional liability risks is insured through
a wholly-owned insurance subsidiary. Subject to a
$5 million per occurrence self-insured retention (in place
since January 1, 2007), our facilities are insured by our
wholly-owned insurance subsidiary for losses up to
$50 million per occurrence. The insurance subsidiary has
obtained reinsurance for professional liability risks generally
above a retention level of $15 million per occurrence. We
also maintain professional liability insurance with unrelated
commercial carriers for losses in excess of amounts insured by
our insurance subsidiary.
The obligations covered by reinsurance contracts are included in
the reserves for professional liability risks, as the insurance
subsidiary remains liable to the extent the reinsurers do not
meet their obligations under the reinsurance contracts. The
amounts receivable under the reinsurance contracts include
$28 million and $14 million at December 31, 2008
and 2007, respectively, recorded in other assets and
$29 million and $30 million at December 31, 2008
and 2007, respectively, recorded in other current
assets.
F-11
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 1
|
ACCOUNTING
POLICIES (Continued)
|
Financial
Instruments
Derivative financial instruments are employed to manage risks,
including interest rate and foreign currency exposures, and are
not used for trading or speculative purposes. We recognize
derivative instruments, such as interest rate swap agreements
and foreign exchange contracts, in the consolidated balance
sheets at fair value. Changes in the fair value of derivatives
are recognized periodically either in earnings or in
stockholders equity, as a component of other comprehensive
income, depending on whether the derivative financial instrument
qualifies for hedge accounting, and if so, whether it qualifies
as a fair value hedge or a cash flow hedge. Generally, changes
in fair values of derivatives accounted for as fair value hedges
are recorded in earnings, along with the changes in the fair
value of the hedged items that relate to the hedged risk. Gains
and losses on derivatives designated as cash flow hedges, to the
extent they are effective, are recorded in other comprehensive
income, and subsequently reclassified to earnings to offset the
impact of the forecasted transactions when they occur. In the
event the forecasted transaction to which a cash flow hedge
relates is no longer likely, the amount in other comprehensive
income is recognized in earnings and generally the derivative is
terminated. Changes in the fair value of derivatives not
qualifying as hedges, and for any portion of a hedge that is
ineffective, are reported in earnings.
The net interest paid or received on interest rate swaps is
recognized as interest expense. Gains and losses resulting from
the early termination of interest rate swap agreements are
deferred and amortized as adjustments to interest expense over
the remaining term of the debt originally covered by the
terminated swap.
Minority
Interests in Consolidated Entities
The consolidated financial statements include all assets,
liabilities, revenues and expenses of less than 100% owned
entities that we control. Accordingly, we have recorded minority
interests in the earnings and equity of such entities.
Recent
Pronouncements
In December 2007, the Financial Accounting Standards Board (the
FASB) issued Statement of Financial Accounting
Standards No. 141(R), Business Combinations
(SFAS 141(R)). This new standard will change
the financial accounting and reporting of business combination
transactions in consolidated financial statements. SFAS 141(R)
replaces FASB Statement No. 141, Business
Combinations (SFAS 141). SFAS 141(R)
retains the fundamental requirements in SFAS 141 that the
acquisition method of accounting (which SFAS 141 called the
purchase method) be used for all business combinations and for
an acquirer to be identified for each business combination.
SFAS 141(R) defines the acquirer as the entity that obtains
control of one or more businesses in the business combination
and establishes the acquisition date as the date the acquirer
achieves control. The scope of SFAS 141(R) is broader than
that of SFAS 141, which applied only to business
combinations in which control was obtained by transferring
consideration. SFAS 141(R) applies the acquisition method
to all transactions and other events in which one entity obtains
control over one or more other businesses. SFAS 141(R) is
effective for business combination transactions for which the
acquisition date is on or after the beginning of the first
annual reporting period beginning on or after December 15,
2008.
In December 2007, the FASB issued Statement of Financial
Accounting Standards No. 160, Noncontrolling
Interests in Consolidated Financial Statements, an amendment of
ARB No. 51 (SFAS 160). This new
standard will change the financial accounting and reporting of
noncontrolling (or minority) interests in consolidated financial
statements. SFAS 160 applies to all entities that prepare
consolidated financial statements, except not-for-profit
organizations. SFAS 160 amends certain of ARB
No. 51s consolidation procedures to provide
consistency with the requirements of SFAS 141(R).
SFAS 160 is required to be adopted concurrently with
SFAS 141(R) and is effective for fiscal years and interim
periods beginning on or after December 15, 2008.
SFAS 160 will require retroactive restatement to provide
for consistent presentation of noncontrolling interests for all
periods presented.
F-12
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 1
|
ACCOUNTING
POLICIES (Continued)
|
Recent
Pronouncements (Continued)
We do not expect the adoption of SFAS 160 to have a
material effect on our financial position or results of
operations.
In March 2008, the FASB issued Statement of Financial Accounting
Standards No. 161, Disclosures about Derivative
Instruments and Hedging Activities, an amendment of FASB
Statement No. 133 (SFAS 161). This
new standard will require entities to provide enhanced
disclosures about (a) how and why an entity uses
derivatives instruments, (b) how derivative instruments and
related hedged items are accounted for and (c) how
derivative instruments and related hedged items affect an
entitys financial position, financial performance and cash
flows. SFAS 161 is effective for financial statements
issued for fiscal years and interim periods beginning after
November 15, 2008. We do not expect the adoption of
SFAS 161 to have a material effect on our financial
position or results of operations.
Reclassifications
Certain prior year amounts have been reclassified to conform to
the 2008 presentation.
|
|
NOTE 2
|
MERGER
AND RECAPITALIZATION
|
On July 24, 2006, we entered into an Agreement and Plan of
Merger (the Merger Agreement) with Hercules Holding
II, LLC, a Delaware limited liability company (Hercules
Holding), and Hercules Acquisition Corporation, a Delaware
corporation and a wholly-owned subsidiary of Hercules Holding
(Merger Sub). Our board of directors approved the
Merger Agreement on the unanimous recommendation of a special
committee comprised entirely of disinterested directors. The
Merger was approved by a majority of HCAs shareholders at
a special meeting of shareholders held on November 16, 2006.
On November 17, 2006, pursuant to the terms of the Merger
Agreement, the Investors consummated the acquisition of the
Company through the merger of Merger Sub with and into the
Company. The Company was the surviving corporation in the
Merger. At December 31, 2008, 97.3% of our common stock is
owned by the Investors and certain other investors, with the
remainder being owned by certain members of management and
employees of the Company.
Rollover
and Stockholder Agreements And Equity Securities with Contingent
Redemption Rights
In connection with the Merger, the Frist Entities and certain
members of our management entered into agreements with the
Company
and/or
Hercules Holding, pursuant to which they elected to invest in
the Company, as the surviving corporation in the Merger, through
a rollover of employee stock options, a rollover of shares of
common stock of the Company, or a combination thereof. Pursuant
to the rollover agreements the Frist Entities and management
team made rollover investments of $885 million and
$125 million, respectively.
The stockholder agreements, among other things, contain
agreements among the parties with respect to restrictions on the
transfer of shares, including tag along rights and drag along
rights, registration rights (including customary indemnification
provisions) and other rights. Pursuant to the management
stockholder agreements, the applicable employees can elect to
have the Company redeem their common stock and vested stock
options in the events of death or permanent disability, prior to
the consummation of the initial public offering of common stock
by the Company. At December 31, 2008, 1,698,400 common
shares and 2,937,000 vested stock options were subject to these
contingent redemption terms.
F-13
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 2
|
MERGER
AND RECAPITALIZATION (Continued)
|
Management
Agreement
Affiliates of the Investors entered into a management agreement
with us pursuant to which such affiliates will provide us with
management services. Under the management agreement, the
affiliates of the Investors are entitled to receive an aggregate
annual management fee of $15 million, which amount will
increase annually, beginning in 2008, at a rate equal to the
percentage increase in Adjusted EBITDA (as defined in the
Management Agreement) in the applicable year compared to the
preceding year, and reimbursement of out-of-pocket expenses
incurred in connection with the provision of services pursuant
to the agreement. The management agreement has an initial term
expiring on December 31, 2016, provided that the term will
be extended annually for one additional year unless we or the
Investors provide notice to the other of their desire not to
automatically extend the term. In addition, the management
agreement provides that the affiliates of the Investors are
entitled to receive a fee equal to 1% of the gross transaction
value in connection with certain financing, acquisition,
disposition, and change of control transactions, as well as a
termination fee based on the net present value of future payment
obligations under the management agreement in the event of an
initial public offering or under certain other circumstances.
The agreement also contains customary exculpation and
indemnification provisions in favor of the Investors and their
affiliates.
Recapitalization
Transaction Costs
For the year ended December 31, 2006, our results of
operations include the following expenses related to the
Recapitalization (dollars in millions):
|
|
|
|
|
Compensation expense related to accelerated vesting of stock
options and restricted stock, and other employee benefits
|
|
$
|
258
|
|
Consulting, legal, accounting and other transaction costs
|
|
|
131
|
|
Loss on extinguishment of debt
|
|
|
53
|
|
|
|
|
|
|
Total
|
|
$
|
442
|
|
|
|
|
|
|
In addition to these amounts, approximately $77 million of
transaction costs were recorded directly to shareholders
deficit, and an additional $568 million of transaction
costs were capitalized as deferred loan costs.
|
|
NOTE 3
|
SHARE-BASED
COMPENSATION
|
Effective January 1, 2006, we adopted Statement of
Financial Accounting Standards No. 123(R),
Share-Based Payment (SFAS 123(R)),
using the modified prospective application transition method.
Under this method, compensation cost is recognized, beginning
January 1, 2006, based on the requirements of
SFAS 123(R) for all share-based awards granted after the
effective date, and based on Statement of Financial Accounting
Standards No. 123, Accounting for Stock-Based
Compensation (SFAS 123), for all awards
granted to employees prior to January 1, 2006 that were
unvested on the effective date.
Upon consummation of the Merger, all outstanding stock options
(other than certain options held by certain rollover
shareholders) became fully vested, were cancelled and converted
into the right to receive a cash payment equal to the number of
shares underlying the options multiplied by the amount (if any)
by which $51.00 exceeded the option exercise price. The
acceleration of vesting of stock options resulted in the
recognition of $42 million of additional share-based
compensation expense for 2006.
Certain management holders of outstanding HCA stock options were
permitted to retain certain of their stock options (the
Rollover Options) in lieu of receiving the merger
consideration (the amount, if any, by which $51.00 exceeded the
option exercise price). The Rollover Options remain outstanding
in accordance with the terms of the governing stock incentive
plans and grant agreements pursuant to which the holder
originally received the stock
F-14
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 3
|
SHARE-BASED
COMPENSATION (Continued)
|
option grants, except the exercise price and number of shares
subject to the rollover option agreement were adjusted so that
the aggregate intrinsic value for each applicable option holder
was maintained and the exercise price for substantially all the
options was adjusted to $12.75 per option. Pursuant to the
rollover option agreement, 10,967,500 prerecapitalization HCA
stock options were converted into 2,285,200 Rollover Options, of
which 1,797,200 are outstanding and exercisable at
December 31, 2008.
SFAS 123(R) requires that the benefits of tax deductions in
excess of amounts recognized as compensation cost be reported as
a financing cash flow. Tax benefits of $7 million,
$1 million and $97 million from tax deductions in
excess of amounts recognized as compensation cost were reported
as financing cash flows in 2008, 2007 and 2006, respectively.
2006
Stock Incentive Plan
In connection with the Recapitalization, the 2006 Stock
Incentive Plan for Key Employees of HCA Inc. and its Affiliates
(the 2006 Plan) was established. The 2006 Plan is
designed to promote the long term financial interests and growth
of the Company and its subsidiaries by attracting and retaining
management and other personnel and key service providers and to
motivate management personnel by means of incentives to achieve
long range goals and further the alignment of interests of
participants with those of our stockholders through
opportunities for increased stock, or stock-based, ownership in
the Company. A portion of the options under the 2006 Plan vests
solely based upon continued employment over a specific period of
time, and a portion of the options vests based both upon
continued employment over a specific period of time and upon the
achievement of predetermined financial and Investor return
targets over time. We granted 357,500 and 9,328,000 options
under the 2006 Plan during 2008 and 2007, respectively. As of
December 31, 2008, 1,186,200 options granted under the 2006
Plan have vested, and there were 1,788,300 shares available
for future grants under the 2006 Plan.
2005
Equity Incentive Plan
Prior to the Recapitalization, the HCA 2005 Equity Incentive
Plan was the primary plan under which stock options and
restricted stock were granted to officers, employees and
directors. Upon consummation of the Recapitalization, all shares
of restricted stock became fully vested, were cancelled and
converted into the right to receive a cash payment of $51.00 per
restricted share. During 2006, we recognized $247 million
of compensation costs related to restricted share grants. The
acceleration of vesting of restricted stock resulted in the
recognition of $201 million of the total compensation
expense related to restricted stock for 2006.
A summary of restricted share activity during 2006 follows
(share amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
Number of
|
|
|
Grant Date Fair
|
|
|
|
Shares
|
|
|
Value
|
|
|
Restricted shares, December 31, 2005
|
|
|
3,748
|
|
|
$
|
43.42
|
|
Granted
|
|
|
2,979
|
|
|
|
49.11
|
|
Vested
|
|
|
(494
|
)
|
|
|
41.40
|
|
Cancelled
|
|
|
(232
|
)
|
|
|
45.98
|
|
Settled in Recapitalization
|
|
|
(6,001
|
)
|
|
|
46.31
|
|
|
|
|
|
|
|
|
|
|
Restricted shares, December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
Option Activity All Plans
The fair value of each stock option award is estimated on the
grant date, using option valuation models and the weighted
average assumptions indicated in the following table. Awards
under the 2006 Plan generally vest based on
F-15
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 3
|
SHARE-BASED
COMPENSATION (Continued)
|
Stock
Option Activity All Plans (Continued)
continued employment and based upon achievement of certain
financial and Investor return-based targets. Each grant is
valued as a single award with an expected term equal to the
average expected term of the component vesting tranches. We use
historical option exercise behavior data and other factors to
estimate the expected term of the options. The expected term of
the option is limited by the contractual term, and employee
post-vesting termination behavior is incorporated in the
historical option exercise behavior data. Compensation cost is
recognized on the straight-line attribution method. The
straight-line attribution method requires that total
compensation expense recognized must at least equal the vested
portion of the grant-date fair value. The expected volatility is
derived using historical stock price information of certain peer
group companies for a period of time equal to the expected
option term. The risk-free interest rate is the approximate
yield on United States Treasury Strips having a life equal to
the expected option life on the date of grant. The expected life
is an estimate of the number of years an option will be held
before it is exercised.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Risk-free interest rate
|
|
|
2.50
|
%
|
|
|
4.86
|
%
|
|
|
4.70
|
%
|
Expected volatility
|
|
|
30
|
%
|
|
|
30
|
%
|
|
|
24
|
%
|
Expected life, in years
|
|
|
4
|
|
|
|
5
|
|
|
|
5
|
|
Expected dividend yield
|
|
|
|
|
|
|
|
|
|
|
1.09
|
%
|
Information regarding stock option activity during 2008, 2007
and 2006 is summarized below (share amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Average
|
|
|
Aggregate
|
|
|
|
Stock
|
|
|
Exercise
|
|
|
Remaining
|
|
|
Intrinsic Value
|
|
|
|
Options
|
|
|
Price
|
|
|
Contractual Term
|
|
|
(dollars in millions)
|
|
|
Options outstanding, December 31, 2005
|
|
|
27,806
|
|
|
$
|
36.35
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
2,566
|
|
|
|
48.64
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(5,220
|
)
|
|
|
26.24
|
|
|
|
|
|
|
|
|
|
Cancelled
|
|
|
(1,008
|
)
|
|
|
49.76
|
|
|
|
|
|
|
|
|
|
Settled in Recapitalization
|
|
|
(13,177
|
)
|
|
|
36.22
|
|
|
|
|
|
|
|
|
|
Rolled over in Recapitalization existing
|
|
|
(10,967
|
)
|
|
|
42.98
|
|
|
|
|
|
|
|
|
|
Rolled over in Recapitalization new
|
|
|
2,285
|
|
|
|
12.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding, December 31, 2006
|
|
|
2,285
|
|
|
|
12.50
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
9,328
|
|
|
|
51.34
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(36
|
)
|
|
|
12.75
|
|
|
|
|
|
|
|
|
|
Cancelled
|
|
|
(405
|
)
|
|
|
51.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding, December 31, 2007
|
|
|
11,172
|
|
|
|
43.54
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
357
|
|
|
|
58.21
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(480
|
)
|
|
|
15.01
|
|
|
|
|
|
|
|
|
|
Cancelled
|
|
|
(412
|
)
|
|
|
51.14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding, December 31, 2008
|
|
|
10,637
|
|
|
|
45.02
|
|
|
|
7.5 years
|
|
|
$
|
115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercisable, December 31, 2008
|
|
|
2,937
|
|
|
$
|
27.55
|
|
|
|
5.6 years
|
|
|
$
|
83
|
|
F-16
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 3
|
SHARE-BASED
COMPENSATION (Continued)
|
Stock
Option Activity All Plans (Continued)
The weighted average fair values of stock options granted during
2008, 2007 and 2006 were $14.01, $16.01 and $10.76 per share,
respectively. The total intrinsic value of stock options
exercised in the year ended December 31, 2008 was
$20 million.
|
|
NOTE 4
|
ACQUISITIONS
AND DISPOSITIONS
|
During 2008, we paid $18 million to acquire one hospital
and $67 million to acquire other health care entities.
During 2007, we did not acquire any hospitals, but paid
$32 million for other health care entities. During 2006, we
paid $63 million to acquire three hospitals and
$49 million to acquire other health care entities. Purchase
price amounts have been allocated to the related assets acquired
and liabilities assumed based upon their respective fair values.
The purchase price paid in excess of the fair value of
identifiable net assets of acquired entities aggregated
$43 million, $44 million and $38 million in 2008,
2007 and 2006, respectively. The consolidated financial
statements include the accounts and operations of the acquired
entities subsequent to the respective acquisition dates. The pro
forma effects of the acquired entities on our results of
operations for periods prior to the respective acquisition dates
were not significant.
During 2008, we received proceeds of $143 million and
recognized a net pretax gain of $81 million
($48 million after tax) on the sales of two hospitals. We
also received proceeds of $50 million and recognized a net
pretax gain of $16 million ($10 million after tax)
from sales of other health care entities and real estate
investments. During 2007, we received proceeds of
$661 million and recognized a net pretax gain of
$443 million ($272 million after tax) from sales of
three hospitals. We also received proceeds of $106 million
and recognized a net pretax gain of $28 million
($18 million after tax) from sales of real estate
investments. During 2006, we received proceeds of
$560 million and recognized a net pretax gain of
$176 million ($85 million after tax) on the sales of
nine hospitals. We also received proceeds of $91 million
and recognized a net pretax gain of $29 million
($18 million after tax) from sales of real estate
investments and our equity investment in a hospital joint
venture.
|
|
NOTE 5
|
IMPAIRMENTS
OF LONG-LIVED ASSETS
|
During 2008, we recorded pretax charges of $64 million to
reduce the carrying value of identified assets to estimated fair
value. The $64 million asset impairment includes
$55 million related to other health care entity investments
in our Eastern Group and $9 million related to certain
hospital facilities in our Central Group. During 2007, we
recorded a pretax charge of $24 million to adjust the value
of a building in our Central Group to estimated fair value.
During 2006, the carrying value for a closed hospital was
reduced to fair value, based upon estimates of sales value,
resulting in a pretax charge of $16 million that affected
our Corporate and Other Group. During 2006, we also decided to
terminate a construction project and incurred a pretax charge of
$8 million that affected our Corporate and Other Group.
The asset impairment charges did not have a significant impact
on our operations or cash flows and are not expected to
significantly impact cash flows for future periods. The
impairment charges affected our property and equipment asset
category by $16 million, $24 million and
$24 million in 2008, 2007 and 2006, respectively.
F-17
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The provision for income taxes consists of the following
(dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
699
|
|
|
$
|
566
|
|
|
$
|
993
|
|
State
|
|
|
56
|
|
|
|
37
|
|
|
|
62
|
|
Foreign
|
|
|
25
|
|
|
|
32
|
|
|
|
35
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
(505
|
)
|
|
|
(391
|
)
|
|
|
(426
|
)
|
State
|
|
|
(29
|
)
|
|
|
(62
|
)
|
|
|
(43
|
)
|
Foreign
|
|
|
22
|
|
|
|
134
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
268
|
|
|
$
|
316
|
|
|
$
|
626
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of the federal statutory rate to the effective
income tax rate follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Federal statutory rate
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
State income taxes, net of federal tax benefit
|
|
|
3.7
|
|
|
|
0.2
|
|
|
|
0.4
|
|
Change in liability for uncertain tax positions
|
|
|
(7.4
|
)
|
|
|
(7.2
|
)
|
|
|
|
|
Nondeductible intangible assets
|
|
|
0.4
|
|
|
|
|
|
|
|
1.5
|
|
Tax exempt interest income
|
|
|
(2.5
|
)
|
|
|
(2.1
|
)
|
|
|
(1.1
|
)
|
Other items, net
|
|
|
(0.7
|
)
|
|
|
0.7
|
|
|
|
1.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective income tax rate
|
|
|
28.5
|
%
|
|
|
26.6
|
%
|
|
|
37.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As a result of a settlement reached with the Appeals Division of
the Internal Revenue Service (the IRS) and the
revision of a proposed IRS adjustment related to prior taxable
years, we reduced our provision for income taxes by
$69 million in 2008. Our 2007 provision for income taxes
was reduced by $85 million, principally based on new
information received related to tax positions taken in a prior
taxable year, and by an additional $39 million to adjust
2006 state tax accruals to the amounts reported on completed tax
returns and based upon an analysis of the Recapitalization costs.
A summary of the items comprising the deferred tax assets and
liabilities at December 31 follows (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Depreciation and fixed asset basis differences
|
|
$
|
|
|
|
$
|
324
|
|
|
$
|
|
|
|
$
|
329
|
|
Allowances for professional liability and other risks
|
|
|
244
|
|
|
|
|
|
|
|
197
|
|
|
|
|
|
Accounts receivable
|
|
|
1,263
|
|
|
|
|
|
|
|
884
|
|
|
|
|
|
Compensation
|
|
|
201
|
|
|
|
|
|
|
|
156
|
|
|
|
|
|
Other
|
|
|
786
|
|
|
|
287
|
|
|
|
633
|
|
|
|
259
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,494
|
|
|
$
|
611
|
|
|
$
|
1,870
|
|
|
$
|
588
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2008, state net operating loss
carryforwards (expiring in years 2009 through
2028) available to offset future taxable income
approximated $145 million. Utilization of net operating
loss carryforwards in any
F-18
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 6
|
INCOME
TAXES (Continued)
|
one year may be limited and, in certain cases, result in an
adjustment to intangible assets. Net deferred tax assets related
to such carryforwards are not significant.
We are currently contesting before the IRS Appeals Division
certain claimed deficiencies and adjustments proposed by the IRS
in connection with its examination of the 2003 and 2004 federal
income tax returns for HCA and 17 affiliates that are treated as
partnerships for federal income tax purposes (affiliated
partnerships). The disputed items include the timing of
recognition of certain patient service revenues and our method
for calculating the tax allowance for doubtful accounts.
Eight taxable periods of HCA and its predecessors ended in 1995
through 2002 and the 2002 taxable year for 13 affiliated
partnerships, for which the primary remaining issue is the
computation of the tax allowance for doubtful accounts, are
pending before the IRS Examination Division or the United States
Tax Court as of December 31, 2008. The IRS began an audit
of the 2005 and 2006 federal income tax returns for HCA and
seven affiliated partnerships during 2008.
Effective January 1, 2007, we adopted FASB Interpretation
No. 48, Accounting for Uncertainty in Income
Taxes (FIN 48). FIN 48 creates a
single model to address uncertainty in income tax positions and
clarifies the accounting for income taxes by prescribing the
minimum recognition threshold a tax position is required to meet
before being recognized in the financial statements. FIN 48
applies to all tax positions related to income taxes subject to
FASB Statement No. 109, Accounting for Income
Taxes. The provision for income taxes reflects a
$20 million ($12 million net of tax) reduction in
interest related to taxing authority examinations for the year
ended December 31, 2008 and interest expense of
$17 million ($11 million net of tax) for the year
ended December 31, 2007.
The following table summarizes the activity related to our
unrecognized tax benefits (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Balance at January 1
|
|
$
|
622
|
|
|
$
|
555
|
|
Additions based on tax positions related to the current year
|
|
|
32
|
|
|
|
70
|
|
Additions for tax positions of prior years
|
|
|
55
|
|
|
|
112
|
|
Reductions for tax positions of prior years
|
|
|
(57
|
)
|
|
|
(101
|
)
|
Settlements
|
|
|
(162
|
)
|
|
|
2
|
|
Lapse of applicable statutes of limitations
|
|
|
(8
|
)
|
|
|
(16
|
)
|
|
|
|
|
|
|
|
|
|
Balance at December 31
|
|
$
|
482
|
|
|
$
|
622
|
|
|
|
|
|
|
|
|
|
|
During 2008, we reached a settlement with the IRS Appeals
Division relating to the deductibility of the 2001 government
settlement payment, the timing of recognition of certain patient
service revenues for 2001 and 2002, and the amount of insurance
expense deducted in 2001 and 2002. As a result of the
settlement, $111 million of the $215 million
refundable deposit made in 2006 has been applied to tax and
interest due for the 2001 and 2002 taxable years.
Our liability for unrecognized tax benefits was
$625 million, including accrued interest of
$156 million and excluding $13 million that was
recorded as reductions of the related deferred tax assets, as of
December 31, 2008 ($828 million, $218 million and
$12 million, respectively, as of December 31, 2007).
Unrecognized tax benefits of $264 million
($489 million as of December 31, 2007) would
affect the effective rate, if recognized. The liability for
unrecognized tax benefits does not reflect deferred tax assets
related to deductible interest and state income taxes or the
balance of a refundable deposit we made in 2006, which is
recorded in noncurrent assets.
Depending on the resolution of the IRS disputes, the completion
of examinations by federal, state or international taxing
authorities, or the expiration of statutes of limitation for
specific taxing jurisdictions, we
F-19
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 6
|
INCOME
TAXES (Continued)
|
believe it is reasonably possible that our liability for
unrecognized tax benefits may significantly increase or decrease
within the next twelve months. However, we are currently unable
to estimate the range of any possible change.
|
|
NOTE 7
|
INVESTMENTS
OF INSURANCE SUBSIDIARY
|
A summary of the insurance subsidiarys investments at
December 31 follows (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
Unrealized
|
|
|
|
|
|
|
Amortized
|
|
|
Amounts
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Value
|
|
|
Debt securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
States and municipalities
|
|
$
|
808
|
|
|
$
|
20
|
|
|
$
|
(23
|
)
|
|
$
|
805
|
|
Auction rate securities
|
|
|
576
|
|
|
|
|
|
|
|
(40
|
)
|
|
|
536
|
|
Asset-backed securities
|
|
|
51
|
|
|
|
1
|
|
|
|
(5
|
)
|
|
|
47
|
|
Money market funds
|
|
|
226
|
|
|
|
|
|
|
|
|
|
|
|
226
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,661
|
|
|
|
21
|
|
|
|
(68
|
)
|
|
|
1,614
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stocks
|
|
|
6
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
5
|
|
Common stocks and other equities
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,670
|
|
|
$
|
21
|
|
|
$
|
(69
|
)
|
|
|
1,622
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts classified as current assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(200
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment carrying value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,422
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-20
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 7
|
INVESTMENTS
OF INSURANCE SUBSIDIARY (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
|
|
|
Unrealized
|
|
|
|
|
|
|
Amortized
|
|
|
Amounts
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Value
|
|
|
Debt securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
States and municipalities
|
|
$
|
944
|
|
|
$
|
23
|
|
|
$
|
(2
|
)
|
|
$
|
965
|
|
Auction rate securities
|
|
|
731
|
|
|
|
|
|
|
|
|
|
|
|
731
|
|
Asset-backed securities
|
|
|
59
|
|
|
|
1
|
|
|
|
|
|
|
|
60
|
|
Corporate
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
Money market funds
|
|
|
109
|
|
|
|
|
|
|
|
|
|
|
|
109
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,845
|
|
|
|
24
|
|
|
|
(2
|
)
|
|
|
1,867
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stocks
|
|
|
26
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
25
|
|
Common stocks and other equities
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,878
|
|
|
$
|
24
|
|
|
$
|
(3
|
)
|
|
|
1,899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts classified as current assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(230
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment carrying value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,669
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2008 and 2007 the investments of our
insurance subsidiary were classified as
available-for-sale. Changes in temporary unrealized
gains and losses are recorded as adjustments to other
comprehensive income. At December 31, 2008 and 2007,
$119 million and $106 million, respectively, of our
investments were subject to the restrictions included in
insurance bond collateralization and assumed reinsurance
contracts.
Scheduled maturities of investments in debt securities at
December 31, 2008 were as follows (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Value
|
|
|
Due in one year or less
|
|
$
|
313
|
|
|
$
|
314
|
|
Due after one year through five years
|
|
|
305
|
|
|
|
311
|
|
Due after five years through ten years
|
|
|
252
|
|
|
|
254
|
|
Due after ten years
|
|
|
164
|
|
|
|
152
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,034
|
|
|
|
1,031
|
|
Auction rate securities
|
|
|
576
|
|
|
|
536
|
|
Asset-backed securities
|
|
|
51
|
|
|
|
47
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,661
|
|
|
$
|
1,614
|
|
|
|
|
|
|
|
|
|
|
The average expected maturity of the investments in debt
securities at December 31, 2008 was 3.9 years,
compared to the average scheduled maturity of 12.8 years.
Expected and scheduled maturities may differ because the issuers
of certain securities have the right to call, prepay or
otherwise redeem such obligations prior to their scheduled
maturity date. The average expected maturities for our auction
rate and asset-backed securities were derived from valuation
models of expected cash flows and involved managements
judgment. The average expected
F-21
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 7
|
INVESTMENTS
OF INSURANCE SUBSIDIARY (Continued)
|
maturities for our auction rate and asset-backed securities at
December 31, 2008 were 5.5 years and 6.9 years,
respectively, compared to average scheduled maturities of
25.5 years and 26.2 years, respectively.
The cost of securities sold is based on the specific
identification method. Sales of securities for the years ended
December 31 are summarized below (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
2007
|
|
2006
|
|
Debt securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash proceeds
|
|
$
|
23
|
|
|
$
|
272
|
|
|
$
|
401
|
|
Gross realized gains
|
|
|
|
|
|
|
8
|
|
|
|
1
|
|
Gross realized losses
|
|
|
|
|
|
|
1
|
|
|
|
2
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash proceeds
|
|
$
|
4
|
|
|
$
|
87
|
|
|
$
|
1,509
|
|
Gross realized gains
|
|
|
2
|
|
|
|
1
|
|
|
|
256
|
|
Gross realized losses
|
|
|
2
|
|
|
|
|
|
|
|
12
|
|
|
|
NOTE 8
|
FINANCIAL
INSTRUMENTS
|
Interest
Rate Swap Agreements
We have entered into interest rate swap agreements to manage our
exposure to fluctuations in interest rates. These swap
agreements involve the exchange of fixed and variable rate
interest payments between two parties based on common notional
principal amounts and maturity dates. Pay-fixed interest rate
swaps effectively convert LIBOR indexed variable rate
instruments to fixed interest rate obligations. The net interest
payments, based on the notional amounts in these agreements,
generally match the timing of the related liabilities. The
notional amounts of the swap agreements represent amounts used
to calculate the exchange of cash flows and are not our assets
or liabilities. Our credit risk related to these agreements is
considered low because the swap agreements are with creditworthy
financial institutions. The interest payments under these
agreements are settled on a net basis.
The following table sets forth our interest rate swap
agreements, which have been designated as cash flow hedges, at
December 31, 2008 (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional
|
|
|
|
Fair
|
|
|
Amount
|
|
Termination Date
|
|
Value
|
|
Pay-fixed interest rate swap
|
|
$
|
4,000
|
|
|
|
November 2011
|
|
|
$
|
(327
|
)
|
Pay-fixed interest rate swap
|
|
|
4,000
|
|
|
|
November 2011
|
|
|
|
(301
|
)
|
Pay-fixed interest rate swap
|
|
|
500
|
|
|
|
March 2011
|
|
|
|
(15
|
)
|
Pay-fixed interest rate swap
|
|
|
500
|
|
|
|
March 2011
|
|
|
|
(14
|
)
|
The fair value of the interest rate swaps at December 31,
2008 represents the estimated amounts we would pay upon
termination of these agreements.
Cross
Currency Swaps
The Company and certain subsidiaries have incurred obligations
and entered into various intercompany transactions where such
obligations are denominated in currencies (Great Britain
Pound and Euro), other than the functional currencies (United
States Dollar and Great Britain Pound) of the parties executing
the trade. In order to better match the cash flows of our
obligations and intercompany transactions with cash flows from
operations, we entered into various cross currency swaps. Our
credit risk related to these agreements is considered low
because the swap agreements are with creditworthy financial
institutions.
F-22
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 8
|
FINANCIAL
INSTRUMENTS (Continued)
|
Cross
Currency Swaps (Continued)
Certain of our cross currency swaps were not designated as
hedges, and changes in fair value are recognized in results of
operations. The following table sets forth these cross currency
swap agreements at December 31, 2008 (amounts in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional
|
|
|
|
Fair
|
|
|
Amount
|
|
Termination Date
|
|
Value
|
|
Euro United States Dollar Currency Swap
|
|
|
557 Euro
|
|
|
|
December 2011
|
|
|
$
|
81
|
|
Euro Great Britain Pound (GBP) Currency Swap
|
|
|
27 GBP
|
|
|
|
December 2011
|
|
|
|
16
|
|
The following table sets forth our cross currency swap
agreements, which have been designated as cash flow hedges, at
December 31, 2008 (amounts in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional
|
|
|
|
Fair
|
|
|
Amount
|
|
Termination Date
|
|
Value
|
|
GBP United States Dollar Currency Swap
|
|
|
50 GBP
|
|
|
|
November 2010
|
|
|
$
|
(13
|
)
|
GBP United States Dollar Currency Swap
|
|
|
50 GBP
|
|
|
|
November 2010
|
|
|
|
(13
|
)
|
The fair value of the cross currency swaps at December 31,
2008 represents the estimated amounts we would receive (pay)
upon termination of these agreements.
|
|
NOTE 9
|
ASSETS
AND LIABILITIES MEASURED AT FAIR VALUE
|
On January 1, 2008, we adopted Statement of Financial
Accounting Standards No. 157, Fair Value
Measurements (SFAS 157). SFAS 157
defines fair value, establishes a framework for measuring fair
value, and expands disclosures about fair value measurements.
SFAS 157 applies to reported balances that are required or
permitted to be measured at fair value under existing accounting
pronouncements.
SFAS 157 emphasizes that fair value is a market-based
measurement, not an entity-specific measurement. Therefore, a
fair value measurement should be determined based on the
assumptions that market participants would use in pricing the
asset or liability. As a basis for considering market
participant assumptions in fair value measurements,
SFAS 157 establishes a fair value hierarchy that
distinguishes between market participant assumptions based on
market data obtained from sources independent of the reporting
entity (observable inputs that are classified within
Levels 1 and 2 of the hierarchy) and the reporting
entitys own assumptions about market participant
assumptions (unobservable inputs classified within Level 3
of the hierarchy).
Level 1 inputs utilize quoted prices (unadjusted) in active
markets for identical assets or liabilities. Level 2 inputs
are inputs other than quoted prices included in Level 1
that are observable for the asset or liability, either directly
or indirectly. Level 2 inputs may include quoted prices for
similar assets and liabilities in active markets, as well as
inputs that are observable for the asset or liability (other
than quoted prices), such as interest rates, foreign exchange
rates, and yield curves that are observable at commonly quoted
intervals. Level 3 inputs are unobservable inputs for the
asset or liability, which are typically based on an
entitys own assumptions, as there is little, if any,
related market activity. In instances where the determination of
the fair value measurement is based on inputs from different
levels of the fair value hierarchy, the level in the fair value
hierarchy within which the entire fair value measurement falls
is based on the lowest level input that is significant to the
fair value measurement in its entirety. Our assessment of the
significance of a particular input to the fair value measurement
in its entirety requires judgment, and considers factors
specific to the asset or liability.
Cash
Traded Investments
Our cash traded investments are generally classified within
Level 1 or Level 2 of the fair value hierarchy because
they are valued using quoted market prices, broker or dealer
quotations, or alternative pricing sources with
F-23
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 9
|
ASSETS
AND LIABILITIES MEASURED AT FAIR VALUE (Continued)
|
Cash
Traded Investments (Continued)
reasonable levels of price transparency. Certain types of cash
traded instruments are classified within Level 3 of the
fair value hierarchy because they trade infrequently and
therefore have little or no price transparency. Such instruments
include auction rate securities (ARS) and limited
partnership investments. The transaction price is initially used
as the best estimate of fair value.
Our wholly-owned insurance subsidiary had investments in
municipal, tax-exempt ARS, that are backed by student loans
substantially guaranteed by the federal government, of
$536 million ($573 million par value) at
December 31, 2008. We do not currently intend to attempt to
sell the ARS as the liquidity needs of our insurance subsidiary
are expected to be met by other investments in its investment
portfolio. These securities continue to accrue and pay interest
semi-annually based on the failed auction maximum rate formulas
stated in their respective Official Statements. During 2008,
certain issuers of our ARS redeemed $93 million of our
securities at par value. The valuation of these securities
involved managements judgment, after consideration of
market factors and the absence of market transparency, market
liquidity and observable inputs. Our valuation models derived a
fair market value compared to tax-equivalent yields of other
student loan backed variable rate securities of similar credit
worthiness.
Derivative
Financial Instruments
We have entered into interest rate and cross currency swap
agreements to manage our exposure to fluctuations in interest
rates and foreign currency risks. The valuation of these
instruments is determined using widely accepted valuation
techniques, including discounted cash flow analysis on the
expected cash flows of each derivative. This analysis reflects
the contractual terms of the derivatives, including the period
to maturity, and uses observable market-based inputs, including
interest rate curves, foreign exchange rates and implied
volatilities. To comply with the provisions of SFAS 157, we
incorporate credit valuation adjustments to reflect both our own
nonperformance risk and the respective counterpartys
nonperformance risk in the fair value measurements.
Although we have determined that the majority of the inputs used
to value our derivatives fall within Level 2 of the fair
value hierarchy, the credit valuation adjustments associated
with our derivatives utilize Level 3 inputs, such as
estimates of current credit spreads to evaluate the likelihood
of default by us and our counterparties. We have assessed the
significance of the impact of the credit valuation adjustments
on the overall valuation of our derivative positions and have
determined that the credit valuation adjustments are significant
to the overall valuation of our derivatives. As a result, we
have determined that our derivative valuations in their entirety
are classified in Level 3 of the fair value hierarchy at
December 31, 2008.
F-24
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 9
|
ASSETS
AND LIABILITIES MEASURED AT FAIR VALUE (Continued)
|
Derivative
Financial Instruments (Continued)
The following table summarizes our assets and liabilities
measured at fair value on a recurring basis as of
December 31, 2008, aggregated by the level in the fair
value hierarchy within which those measurements fall (dollars in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements Using
|
|
|
|
|
|
|
Quoted Prices in
|
|
|
|
|
|
|
|
|
|
|
|
|
Active Markets for
|
|
|
|
|
|
|
|
|
|
|
|
|
Identical Assets
|
|
|
Significant Other
|
|
|
Significant
|
|
|
|
|
|
|
and Liabilities
|
|
|
Observable Inputs
|
|
|
Unobservable Inputs
|
|
|
|
Fair Value
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments of insurance subsidiary
|
|
$
|
1,622
|
|
|
$
|
227
|
|
|
$
|
857
|
|
|
$
|
538
|
|
Less amounts classified as current assets
|
|
|
(200
|
)
|
|
|
(200
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,422
|
|
|
|
27
|
|
|
|
857
|
|
|
|
538
|
|
Cross currency swaps (Other assets)
|
|
|
97
|
|
|
|
|
|
|
|
|
|
|
|
97
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps (Income taxes and other liabilities)
|
|
|
657
|
|
|
|
|
|
|
|
|
|
|
|
657
|
|
Cross currency swaps (Income taxes and other liabilities)
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
|
26
|
|
The following table summarizes the activity related to the
investments of our insurance subsidiary and our cross currency
and interest rate swaps which have fair value measurements based
on significant unobservable inputs (Level 3) during
the year ended December 31, 2008 (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments
|
|
|
Cross
|
|
|
Interest
|
|
|
|
of Insurance
|
|
|
Currency
|
|
|
Rate
|
|
|
|
Subsidiary
|
|
|
Swaps (net)
|
|
|
Swaps
|
|
|
Balance at December 31, 2007
|
|
$
|
4
|
|
|
$
|
|
|
|
$
|
|
|
Realized gains and losses included in earnings
|
|
|
2
|
|
|
|
|
|
|
|
|
|
Unrealized gains and losses included in other comprehensive
income
|
|
|
(41
|
)
|
|
|
|
|
|
|
|
|
Purchases, issuances and settlements
|
|
|
(95
|
)
|
|
|
|
|
|
|
|
|
Transfers into Level 3
|
|
|
668
|
|
|
|
71
|
|
|
|
657
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
538
|
|
|
$
|
71
|
|
|
$
|
657
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-25
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
A summary of long-term debt at December 31, including
related interest rates at December 31, 2008, follows
(dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Senior secured asset-based revolving credit facility (effective
interest rate of 2.8%)
|
|
$
|
2,000
|
|
|
$
|
1,350
|
|
Senior secured revolving credit facility (effective interest
rate of 2.7%)
|
|
|
50
|
|
|
|
|
|
Senior secured term loan facilities (effective interest rate of
6.0%)
|
|
|
12,002
|
|
|
|
12,317
|
|
Other senior secured debt (effective interest rate of 6.8%)
|
|
|
406
|
|
|
|
427
|
|
|
|
|
|
|
|
|
|
|
First lien debt
|
|
|
14,458
|
|
|
|
14,094
|
|
|
|
|
|
|
|
|
|
|
Senior secured cash-pay notes (effective interest rate of 9.6%)
|
|
|
4,200
|
|
|
|
4,200
|
|
Senior secured toggle notes (effective interest rate of 10.0%)
|
|
|
1,500
|
|
|
|
1,500
|
|
|
|
|
|
|
|
|
|
|
Second lien debt
|
|
|
5,700
|
|
|
|
5,700
|
|
|
|
|
|
|
|
|
|
|
Senior unsecured notes payable through 2095 (effective interest
rate of 7.2%)
|
|
|
6,831
|
|
|
|
7,514
|
|
|
|
|
|
|
|
|
|
|
Total debt (average life of six years, rates averaging 6.9%)
|
|
|
26,989
|
|
|
|
27,308
|
|
Less amounts due within one year
|
|
|
404
|
|
|
|
308
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
26,585
|
|
|
$
|
27,000
|
|
|
|
|
|
|
|
|
|
|
Senior
Secured Credit Facilities
In connection with the Recapitalization, we entered into
(i) a $2.000 billion senior secured asset-based
revolving credit facility with a borrowing base of 85% of
eligible accounts receivable, subject to customary reserves and
eligibility criteria (fully utilized at December 31, 2008)
(the ABL credit facility) and (ii) a senior
secured credit agreement (the cash flow credit
facility and, together with the ABL credit facility, the
senior secured credit facilities), consisting of a
$2.000 billion revolving credit facility
($1.858 billion available at December 31, 2008 after
giving effect to certain outstanding letters of credit), a
$2.750 billion term loan A ($2.525 billion outstanding
at December 31, 2008), a $8.800 billion term loan B
($8.624 billion outstanding at December 31,
2008) and a 1.000 billion European term loan
(611 million, or $853 million, outstanding at
December 31, 2008) under which one of our European
subsidiaries is the borrower.
Borrowings under the senior secured credit facilities bear
interest at a rate equal to, as determined by the type of
borrowing, either an applicable margin plus, at our option,
either (a) a base rate determined by reference to the
higher of (1) the federal funds rate plus
1/2
of 1% or (2) the prime rate of Bank of America or
(b) a LIBOR rate for the currency of such borrowing for the
relevant interest period, plus, in each case, an applicable
margin. The applicable margin for borrowings under the senior
secured credit facilities, with the exception of term loan B
where the margin is static, may be reduced subject to attaining
certain leverage ratios.
The ABL facility and the $2.000 billion revolving credit
facility portion of the cash flow credit facility expire
November 2012. The term loan facilities require quarterly
installment payments. The final payment under term loan A is in
November 2012. The final payments under term loan B and the
European term loan are in November 2013. The senior secured
credit facilities contain a number of covenants that restrict,
subject to certain exceptions, our (and some or all of our
subsidiaries) ability to incur additional indebtedness,
repay subordinated indebtedness, create liens on assets, sell
assets, make investments, loans or advances, engage in certain
transactions with affiliates, pay dividends and distributions,
and enter into sale and leaseback transactions. In addition, we
are required to satisfy and maintain a maximum total leverage
ratio covenant under the cash flow facility and, in certain
situations under the ABL credit facility, a minimum interest
coverage ratio covenant.
F-26
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 10
|
LONG-TERM
DEBT (Continued)
|
Senior
Secured Credit Facilities (Continued)
We use interest rate swap agreements to manage the floating rate
exposure of our debt portfolio. We entered into interest rate
swap agreements, in a total notional amount of $9 billion,
in order to hedge a portion of our exposure to variable rate
interest payments associated with the senior secured credit
facility. The effect of the interest rate swaps is reflected in
the effective interest rate for the senior secured credit
facilities.
Senior
Secured Notes
In November 2006, we issued $4.200 billion of senior
secured notes (comprised of $1.000 billion of
91/8% notes
due 2014 and $3.200 billion of
91/4% notes
due 2016), and $1.500 billion of
95/8%
cash/103/8%
in-kind senior secured toggle notes (which allow us, at our
option, to pay interest in-kind during the first five years) due
2016, which are subject to certain standard covenants. In
November 2008, we elected to make an interest payment for the
interest period ending in May 2009 by paying in-kind instead of
paying interest in cash.
General
Information
The senior secured credit facilities and senior secured notes
are fully and unconditionally guaranteed by substantially all
existing and future, direct and indirect, wholly-owned material
domestic subsidiaries that are Unrestricted
Subsidiaries under our Indenture dated December 16,
1993 (except for certain special purpose subsidiaries that only
guarantee and pledge their assets under our ABL credit
facility). In addition, borrowings under the European term loan
are guaranteed by all material, wholly-owned European
subsidiaries.
Maturities of long-term debt in years 2010 through 2013 are
$1.144 billion, $896 million, $4.707 billion and
$10.095 billion, respectively.
The estimated fair value of our long-term debt was
$20.225 billion and $26.127 billion at
December 31, 2008 and 2007, respectively, compared to
carrying amounts aggregating $26.989 billion and
$27.308 billion, respectively. The estimates of fair value
are generally based upon the quoted market prices for the same
or similar issues of long-term debt with the same maturities.
We operate in a highly regulated and litigious industry. As a
result, various lawsuits, claims and legal and regulatory
proceedings have been and can be expected to be instituted or
asserted against us. The resolution of any such lawsuits, claims
or legal and regulatory proceedings could have a material,
adverse affect on our results of operations or financial
position in a given period.
We are subject to claims and suits arising in the ordinary
course of business, including claims for personal injuries or
wrongful restriction of, or interference with, physicians
staff privileges. In certain of these actions the claimants may
seek punitive damages against us which may not be covered by
insurance. It is managements opinion that the ultimate
resolution of these pending claims and legal proceedings will
not have a material, adverse effect on our results of operations
or financial position.
|
|
NOTE 12
|
CAPITAL
STOCK AND STOCK REPURCHASES
|
Capital
Stock
The Companys certificate of incorporation and by-laws were
amended and restated, effective March 27, 2008 and
March 26, 2008, respectively. The amended and restated
certificate of incorporation authorizes the Company to issue up
to 125,000,000 shares of common stock, and the amended and
restated by-laws set the number of directors constituting the
board of directors of the Company at not less than one nor more
than 15.
F-27
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 12
|
CAPITAL
STOCK AND STOCK REPURCHASES (Continued)
|
Stock
Repurchase Program
In 2005, we announced the authorization of a modified
Dutch auction tender offer to purchase up to
$2.500 billion of our common stock. During 2006, we
repurchased 13.0 million shares of our common stock for
$653 million, through open market purchases, which
completed this authorization.
|
|
NOTE 13
|
EMPLOYEE
BENEFIT PLANS
|
We maintained a noncontributory, defined contribution retirement
plan which covered substantially all employees. Benefits were
determined as a percentage of a participants salary and
vest over specified periods of employee service. Retirement plan
expense was $46 million for 2008, $203 million for
2007 and $190 million for 2006. Amounts approximately equal
to retirement plan expense are funded annually. Effective
April 1, 2008, the noncontributory plan and the related
participant account balances were merged into the contributory
HCA 401(k) Plan.
We maintain contributory, defined contribution benefit plans
that are available to employees who meet certain minimum
requirements. Certain of the plans require that we match
specified percentages of participant contributions up to certain
maximum levels (generally, 100% of the first 3% to 9%, depending
upon years of vesting service, of compensation deferred by
participants for periods subsequent to March 31, 2008, and
50% of the first 3% of compensation deferred by participants for
periods prior to April 1, 2008). The cost of these plans
totaled $233 million for 2008, $86 million for 2007
and $71 million for 2006. Our contributions are funded
periodically during each year.
We maintain a Supplemental Executive Retirement Plan
(SERP) for certain executives. The plan is designed
to ensure that upon retirement the participant receives the
value of a prescribed life annuity from the combination of the
SERP and our other benefit plans. Compensation expense under the
plan was $20 million for 2008, $20 million for 2007
and $15 million for 2006. Accrued benefits liabilities
under this plan totaled $133 million at December 31,
2008 and $109 million at December 31, 2007.
We maintain defined benefit pension plans which resulted from
certain hospital acquisitions in prior years. Compensation
expense under these plans was $24 million for 2008,
$27 million for 2007, and $31 million for 2006.
Accrued benefits liabilities under these plans totaled
$142 million at December 31, 2008 and $48 million
at December 31, 2007.
|
|
NOTE 14
|
SEGMENT
AND GEOGRAPHIC INFORMATION
|
We operate in one line of business, which is operating hospitals
and related health care entities. During the years ended
December 31, 2008, 2007 and 2006, approximately 23%, 24%
and 25%, respectively, of our revenues related to patients
participating in the fee-for-service Medicare program.
Our operations are structured into three geographically
organized groups: the Eastern Group includes 48 consolidating
hospitals located in the Eastern United States, the Central
Group includes 51 consolidating hospitals located in the Central
United States and the Western Group includes 53 consolidating
hospitals located in the Western United States. We also operate
six consolidating hospitals in England, and these facilities are
included in the Corporate and other group.
Adjusted segment EBITDA is defined as income before depreciation
and amortization, interest expense, gains on sales of
facilities, impairment of long-lived assets, transaction costs,
minority interests and income taxes. We use adjusted segment
EBITDA as an analytical indicator for purposes of allocating
resources to geographic areas and assessing their performance.
Adjusted segment EBITDA is commonly used as an analytical
indicator within the health care industry, and also serves as a
measure of leverage capacity and debt service ability. Adjusted
segment EBITDA should not be considered as a measure of
financial performance under generally accepted accounting
F-28
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 14
|
SEGMENT
AND GEOGRAPHIC INFORMATION (Continued)
|
principles, and the items excluded from adjusted segment EBITDA
are significant components in understanding and assessing
financial performance. Because adjusted segment EBITDA is not a
measurement determined in accordance with generally accepted
accounting principles and is thus susceptible to varying
calculations, adjusted segment EBITDA, as presented, may not be
comparable to other similarly titled measures of other
companies. The geographic distributions of our revenues, equity
in earnings of affiliates, adjusted segment EBITDA, depreciation
and amortization, assets and goodwill are summarized in the
following table (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Eastern Group
|
|
$
|
8,570
|
|
|
$
|
8,204
|
|
|
$
|
7,775
|
|
Central Group
|
|
|
6,740
|
|
|
|
6,302
|
|
|
|
5,917
|
|
Western Group
|
|
|
12,118
|
|
|
|
11,378
|
|
|
|
10,495
|
|
Corporate and other
|
|
|
946
|
|
|
|
974
|
|
|
|
1,290
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
28,374
|
|
|
$
|
26,858
|
|
|
$
|
25,477
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in earnings of affiliates:
|
|
|
|
|
|
|
|
|
|
|
|
|
Eastern Group
|
|
$
|
(2
|
)
|
|
$
|
(2
|
)
|
|
$
|
(6
|
)
|
Central Group
|
|
|
(2
|
)
|
|
|
8
|
|
|
|
(3
|
)
|
Western Group
|
|
|
(219
|
)
|
|
|
(212
|
)
|
|
|
(187
|
)
|
Corporate and other
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(223
|
)
|
|
$
|
(206
|
)
|
|
$
|
(197
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted segment EBITDA:
|
|
|
|
|
|
|
|
|
|
|
|
|
Eastern Group
|
|
$
|
1,288
|
|
|
$
|
1,268
|
|
|
$
|
1,196
|
|
Central Group
|
|
|
1,061
|
|
|
|
1,082
|
|
|
|
975
|
|
Western Group
|
|
|
2,270
|
|
|
|
2,196
|
|
|
|
2,088
|
|
Corporate and other
|
|
|
(45
|
)
|
|
|
46
|
|
|
|
211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
4,574
|
|
|
$
|
4,592
|
|
|
$
|
4,470
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
|
|
|
|
Eastern Group
|
|
$
|
358
|
|
|
$
|
369
|
|
|
$
|
363
|
|
Central Group
|
|
|
359
|
|
|
|
364
|
|
|
|
329
|
|
Western Group
|
|
|
552
|
|
|
|
529
|
|
|
|
492
|
|
Corporate and other
|
|
|
147
|
|
|
|
164
|
|
|
|
207
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,416
|
|
|
$
|
1,426
|
|
|
$
|
1,391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted segment EBITDA
|
|
$
|
4,574
|
|
|
$
|
4,592
|
|
|
$
|
4,470
|
|
Depreciation and amortization
|
|
|
1,416
|
|
|
|
1,426
|
|
|
|
1,391
|
|
Interest expense
|
|
|
2,021
|
|
|
|
2,215
|
|
|
|
955
|
|
Gains on sales of facilities
|
|
|
(97
|
)
|
|
|
(471
|
)
|
|
|
(205
|
)
|
Impairment of long-lived assets
|
|
|
64
|
|
|
|
24
|
|
|
|
24
|
|
Transaction costs
|
|
|
|
|
|
|
|
|
|
|
442
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before minority interests and income taxes
|
|
$
|
1,170
|
|
|
$
|
1,398
|
|
|
$
|
1,863
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-29
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 14
|
SEGMENT
AND GEOGRAPHIC INFORMATION (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
Eastern Group
|
|
$
|
4,906
|
|
|
$
|
4,928
|
|
Central Group
|
|
|
5,251
|
|
|
|
5,157
|
|
Western Group
|
|
|
8,597
|
|
|
|
8,152
|
|
Corporate and other
|
|
|
5,526
|
|
|
|
5,788
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
24,280
|
|
|
$
|
24,025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Eastern
|
|
|
Central
|
|
|
Western
|
|
|
Corporate
|
|
|
|
|
|
|
Group
|
|
|
Group
|
|
|
Group
|
|
|
and Other
|
|
|
Total
|
|
|
Goodwill:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007
|
|
$
|
628
|
|
|
$
|
1,015
|
|
|
$
|
749
|
|
|
$
|
237
|
|
|
$
|
2,629
|
|
Acquisitions
|
|
|
38
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
43
|
|
Sales
|
|
|
(14
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(14
|
)
|
Impairments
|
|
|
(48
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(48
|
)
|
Foreign currency translation and other
|
|
|
(2
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
(26
|
)
|
|
|
(30
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
602
|
|
|
$
|
1,013
|
|
|
$
|
754
|
|
|
$
|
211
|
|
|
$
|
2,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-30
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 15
|
OTHER
COMPREHENSIVE INCOME (LOSS)
|
The components of accumulated other comprehensive income (loss)
are as follows (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
Unrealized
|
|
|
Foreign
|
|
|
|
|
|
in Fair
|
|
|
|
|
|
|
Gains (Losses) on
|
|
|
Currency
|
|
|
Defined
|
|
|
Value of
|
|
|
|
|
|
|
Available-for-Sale
|
|
|
Translation
|
|
|
Benefit
|
|
|
Derivative
|
|
|
|
|
|
|
Securities
|
|
|
Adjustments
|
|
|
Plans
|
|
|
Instruments
|
|
|
Total
|
|
|
Balances at December 31, 2005
|
|
$
|
118
|
|
|
$
|
30
|
|
|
$
|
(18
|
)
|
|
$
|
|
|
|
$
|
130
|
|
Unrealized gains on available-for-sale securities, net of $30 of
income taxes
|
|
|
53
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53
|
|
Gains reclassified into earnings from other comprehensive
income, net of $88 of income taxes
|
|
|
(155
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(155
|
)
|
Foreign currency translation adjustments, net of $10 of income
taxes
|
|
|
|
|
|
|
19
|
|
|
|
|
|
|
|
|
|
|
|
19
|
|
Defined benefit plans, net of $30 income tax benefit
|
|
|
|
|
|
|
|
|
|
|
(49
|
)
|
|
|
|
|
|
|
(49
|
)
|
Change in fair value of derivative instruments, net of $10 of
income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2006
|
|
|
16
|
|
|
|
49
|
|
|
|
(67
|
)
|
|
|
18
|
|
|
|
16
|
|
Unrealized gains on available-for-sale securities, net of $1 of
income taxes
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
Foreign currency translation adjustments, net of $3 income tax
benefit
|
|
|
|
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
(7
|
)
|
Gains reclassified into earnings from other comprehensive
income, net of $3 and $5, respectively, of income taxes
|
|
|
(5
|
)
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
(13
|
)
|
Defined benefit plans, net of $14 of income taxes
|
|
|
|
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
23
|
|
Change in fair value of derivative instruments, net of $112
income tax benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(194
|
)
|
|
|
(194
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2007
|
|
|
14
|
|
|
|
34
|
|
|
|
(44
|
)
|
|
|
(176
|
)
|
|
|
(172
|
)
|
Unrealized losses on available-for-sale securities, net of $25
income tax benefit
|
|
|
(44
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(44
|
)
|
Foreign currency translation adjustments, net of $33 income tax
benefit
|
|
|
|
|
|
|
(62
|
)
|
|
|
|
|
|
|
|
|
|
|
(62
|
)
|
Defined benefit plans, net of $36 income tax benefit
|
|
|
|
|
|
|
|
|
|
|
(62
|
)
|
|
|
|
|
|
|
(62
|
)
|
Change in fair value of derivative instruments, net of $152
income tax benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(264
|
)
|
|
|
(264
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2008
|
|
$
|
(30
|
)
|
|
$
|
(28
|
)
|
|
$
|
(106
|
)
|
|
$
|
(440
|
)
|
|
$
|
(604
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-31
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 16
|
ACCRUED
EXPENSES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
|
A summary of other accrued expenses at December 31 follows
(dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Professional liability risks
|
|
$
|
279
|
|
|
$
|
280
|
|
Interest
|
|
|
212
|
|
|
|
223
|
|
Employee benefit plans
|
|
|
89
|
|
|
|
217
|
|
Income taxes
|
|
|
224
|
|
|
|
190
|
|
Taxes other than income
|
|
|
189
|
|
|
|
139
|
|
Other
|
|
|
289
|
|
|
|
342
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,282
|
|
|
$
|
1,391
|
|
|
|
|
|
|
|
|
|
|
A summary of activity for the allowance of doubtful accounts
follows (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision
|
|
|
Accounts
|
|
|
|
|
|
|
Balance at
|
|
|
for
|
|
|
Written off,
|
|
|
Balance
|
|
|
|
Beginning
|
|
|
Doubtful
|
|
|
Net of
|
|
|
at End
|
|
|
|
of Year
|
|
|
Accounts
|
|
|
Recoveries
|
|
|
of Year
|
|
|
Allowance for doubtful accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2006
|
|
$
|
2,897
|
|
|
$
|
2,660
|
|
|
$
|
(2,129
|
)
|
|
$
|
3,428
|
|
Year ended December 31, 2007
|
|
|
3,428
|
|
|
|
3,130
|
|
|
|
(2,269
|
)
|
|
|
4,289
|
|
Year ended December 31, 2008
|
|
|
4,289
|
|
|
|
3,409
|
|
|
|
(2,263
|
)
|
|
|
5,435
|
|
|
|
NOTE 17
|
SUPPLEMENTAL
CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER
COLLATERAL-RELATED INFORMATION
|
The senior secured credit facilities and senior secured notes
described in Note 10 are fully and unconditionally
guaranteed by substantially all existing and future, direct and
indirect, wholly-owned material domestic subsidiaries that are
Unrestricted Subsidiaries under our Indenture dated
December 16, 1993 (except for certain special purpose
subsidiaries that only guarantee and pledge their assets under
our ABL credit facility).
Our condensed consolidating balance sheets at December 31,
2008 and 2007 and condensed consolidating statements of income
and cash flows for each of the three years in the period ended
December 31, 2008, segregating the parent company issuer,
the subsidiary guarantors, the subsidiary non-guarantors and
eliminations, follow.
F-32
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 17
|
SUPPLEMENTAL
CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER
COLLATERAL-RELATED INFORMATION (Continued)
|
HCA
INC.
CONDENSED CONSOLIDATING INCOME STATEMENT
For The Year Ended December 31, 2008
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
|
|
|
Condensed
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
Revenues
|
|
$
|
|
|
|
$
|
16,507
|
|
|
$
|
11,867
|
|
|
$
|
|
|
|
$
|
28,374
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
|
|
|
|
6,846
|
|
|
|
4,594
|
|
|
|
|
|
|
|
11,440
|
|
Supplies
|
|
|
|
|
|
|
2,671
|
|
|
|
1,949
|
|
|
|
|
|
|
|
4,620
|
|
Other operating expenses
|
|
|
(6
|
)
|
|
|
2,444
|
|
|
|
2,116
|
|
|
|
|
|
|
|
4,554
|
|
Provision for doubtful accounts
|
|
|
|
|
|
|
2,073
|
|
|
|
1,336
|
|
|
|
|
|
|
|
3,409
|
|
Equity in earnings of affiliates
|
|
|
(2,100
|
)
|
|
|
(82
|
)
|
|
|
(141
|
)
|
|
|
2,100
|
|
|
|
(223
|
)
|
Gains on investments
|
|
|
|
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
|
776
|
|
|
|
640
|
|
|
|
|
|
|
|
1,416
|
|
Interest expense
|
|
|
2,190
|
|
|
|
(328
|
)
|
|
|
159
|
|
|
|
|
|
|
|
2,021
|
|
Gains on sales of facilities
|
|
|
|
|
|
|
(5
|
)
|
|
|
(92
|
)
|
|
|
|
|
|
|
(97
|
)
|
Impairment of long-lived assets
|
|
|
|
|
|
|
|
|
|
|
64
|
|
|
|
|
|
|
|
64
|
|
Management fees
|
|
|
|
|
|
|
(426
|
)
|
|
|
426
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
84
|
|
|
|
13,970
|
|
|
|
11,050
|
|
|
|
2,100
|
|
|
|
27,204
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before minority interests and income taxes
|
|
|
(84
|
)
|
|
|
2,537
|
|
|
|
817
|
|
|
|
(2,100
|
)
|
|
|
1,170
|
|
Minority interests in earnings of consolidated entities
|
|
|
|
|
|
|
53
|
|
|
|
176
|
|
|
|
|
|
|
|
229
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
(84
|
)
|
|
|
2,484
|
|
|
|
641
|
|
|
|
(2,100
|
)
|
|
|
941
|
|
Provision for income taxes
|
|
|
(757
|
)
|
|
|
803
|
|
|
|
222
|
|
|
|
|
|
|
|
268
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
673
|
|
|
$
|
1,681
|
|
|
$
|
419
|
|
|
$
|
(2,100
|
)
|
|
$
|
673
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-33
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 17
|
SUPPLEMENTAL
CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER
COLLATERAL-RELATED INFORMATION (Continued)
|
HCA
INC.
CONDENSED CONSOLIDATING INCOME STATEMENT
For The Year Ended December 31, 2007
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
|
|
|
Condensed
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
Revenues
|
|
$
|
|
|
|
$
|
15,598
|
|
|
$
|
11,260
|
|
|
$
|
|
|
|
$
|
26,858
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
|
|
|
|
6,441
|
|
|
|
4,273
|
|
|
|
|
|
|
|
10,714
|
|
Supplies
|
|
|
|
|
|
|
2,549
|
|
|
|
1,846
|
|
|
|
|
|
|
|
4,395
|
|
Other operating expenses
|
|
|
(2
|
)
|
|
|
2,279
|
|
|
|
1,964
|
|
|
|
|
|
|
|
4,241
|
|
Provision for doubtful accounts
|
|
|
|
|
|
|
1,942
|
|
|
|
1,188
|
|
|
|
|
|
|
|
3,130
|
|
Equity in earnings of affiliates
|
|
|
(2,245
|
)
|
|
|
(90
|
)
|
|
|
(116
|
)
|
|
|
2,245
|
|
|
|
(206
|
)
|
Gains on investments
|
|
|
|
|
|
|
|
|
|
|
(8
|
)
|
|
|
|
|
|
|
(8
|
)
|
Depreciation and amortization
|
|
|
|
|
|
|
779
|
|
|
|
647
|
|
|
|
|
|
|
|
1,426
|
|
Interest expense
|
|
|
2,161
|
|
|
|
(95
|
)
|
|
|
149
|
|
|
|
|
|
|
|
2,215
|
|
Gains on sales of facilities
|
|
|
|
|
|
|
(3
|
)
|
|
|
(468
|
)
|
|
|
|
|
|
|
(471
|
)
|
Impairment of long-lived assets
|
|
|
|
|
|
|
|
|
|
|
24
|
|
|
|
|
|
|
|
24
|
|
Management fees
|
|
|
|
|
|
|
(392
|
)
|
|
|
392
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(86
|
)
|
|
|
13,410
|
|
|
|
9,891
|
|
|
|
2,245
|
|
|
|
25,460
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before minority interests and income taxes
|
|
|
86
|
|
|
|
2,188
|
|
|
|
1,369
|
|
|
|
(2,245
|
)
|
|
|
1,398
|
|
Minority interests in earnings of consolidated entities
|
|
|
|
|
|
|
28
|
|
|
|
180
|
|
|
|
|
|
|
|
208
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
86
|
|
|
|
2,160
|
|
|
|
1,189
|
|
|
|
(2,245
|
)
|
|
|
1,190
|
|
Provision for income taxes
|
|
|
(788
|
)
|
|
|
712
|
|
|
|
392
|
|
|
|
|
|
|
|
316
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
874
|
|
|
$
|
1,448
|
|
|
$
|
797
|
|
|
$
|
(2,245
|
)
|
|
$
|
874
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-34
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 17
|
SUPPLEMENTAL
CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER
COLLATERAL-RELATED INFORMATION (Continued)
|
HCA
INC.
CONDENSED CONSOLIDATING INCOME STATEMENT
For The Year Ended December 31, 2006
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
|
|
|
Condensed
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
Revenues
|
|
$
|
|
|
|
$
|
14,913
|
|
|
$
|
10,564
|
|
|
$
|
|
|
|
$
|
25,477
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
|
|
|
|
6,319
|
|
|
|
4,090
|
|
|
|
|
|
|
|
10,409
|
|
Supplies
|
|
|
|
|
|
|
2,487
|
|
|
|
1,835
|
|
|
|
|
|
|
|
4,322
|
|
Other operating expenses
|
|
|
|
|
|
|
2,253
|
|
|
|
1,803
|
|
|
|
|
|
|
|
4,056
|
|
Provision for doubtful accounts
|
|
|
|
|
|
|
1,652
|
|
|
|
1,008
|
|
|
|
|
|
|
|
2,660
|
|
Equity in earnings of affiliates
|
|
|
(1,995
|
)
|
|
|
(79
|
)
|
|
|
(118
|
)
|
|
|
1,995
|
|
|
|
(197
|
)
|
Gains on investments
|
|
|
|
|
|
|
|
|
|
|
(243
|
)
|
|
|
|
|
|
|
(243
|
)
|
Depreciation and amortization
|
|
|
|
|
|
|
755
|
|
|
|
636
|
|
|
|
|
|
|
|
1,391
|
|
Interest expense
|
|
|
895
|
|
|
|
(99
|
)
|
|
|
159
|
|
|
|
|
|
|
|
955
|
|
Gains on sales of facilities
|
|
|
|
|
|
|
7
|
|
|
|
(212
|
)
|
|
|
|
|
|
|
(205
|
)
|
Impairment of long-lived assets
|
|
|
|
|
|
|
5
|
|
|
|
19
|
|
|
|
|
|
|
|
24
|
|
Transaction costs
|
|
|
429
|
|
|
|
25
|
|
|
|
(12
|
)
|
|
|
|
|
|
|
442
|
|
Management fees
|
|
|
|
|
|
|
(377
|
)
|
|
|
377
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(671
|
)
|
|
|
12,948
|
|
|
|
9,342
|
|
|
|
1,995
|
|
|
|
23,614
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before minority interests and income taxes
|
|
|
671
|
|
|
|
1,965
|
|
|
|
1,222
|
|
|
|
(1,995
|
)
|
|
|
1,863
|
|
Minority interests in earnings of consolidated entities
|
|
|
|
|
|
|
21
|
|
|
|
180
|
|
|
|
|
|
|
|
201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
671
|
|
|
|
1,944
|
|
|
|
1,042
|
|
|
|
(1,995
|
)
|
|
|
1,662
|
|
Provision for income taxes
|
|
|
(365
|
)
|
|
|
612
|
|
|
|
379
|
|
|
|
|
|
|
|
626
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
1,036
|
|
|
$
|
1,332
|
|
|
$
|
663
|
|
|
$
|
(1,995
|
)
|
|
$
|
1,036
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-35
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 17
|
SUPPLEMENTAL
CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER
COLLATERAL-RELATED INFORMATION (Continued)
|
HCA
INC.
CONDENSED CONSOLIDATING BALANCE SHEET
DECEMBER 31, 2008
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
|
|
|
Condensed
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
|
|
|
$
|
134
|
|
|
$
|
331
|
|
|
$
|
|
|
|
$
|
465
|
|
Accounts receivable, net
|
|
|
|
|
|
|
2,214
|
|
|
|
1,566
|
|
|
|
|
|
|
|
3,780
|
|
Inventories
|
|
|
|
|
|
|
455
|
|
|
|
282
|
|
|
|
|
|
|
|
737
|
|
Deferred income taxes
|
|
|
914
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
914
|
|
Other
|
|
|
|
|
|
|
140
|
|
|
|
265
|
|
|
|
|
|
|
|
405
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
914
|
|
|
|
2,943
|
|
|
|
2,444
|
|
|
|
|
|
|
|
6,301
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
|
|
|
|
7,122
|
|
|
|
4,407
|
|
|
|
|
|
|
|
11,529
|
|
Investments of insurance subsidiary
|
|
|
|
|
|
|
|
|
|
|
1,422
|
|
|
|
|
|
|
|
1,422
|
|
Investments in and advances to affiliates
|
|
|
|
|
|
|
243
|
|
|
|
599
|
|
|
|
|
|
|
|
842
|
|
Goodwill
|
|
|
|
|
|
|
1,643
|
|
|
|
937
|
|
|
|
|
|
|
|
2,580
|
|
Deferred loan costs
|
|
|
458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
458
|
|
Investments in and advances to subsidiaries
|
|
|
19,290
|
|
|
|
|
|
|
|
|
|
|
|
(19,290
|
)
|
|
|
|
|
Other
|
|
|
1,050
|
|
|
|
31
|
|
|
|
67
|
|
|
|
|
|
|
|
1,148
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
21,712
|
|
|
$
|
11,982
|
|
|
$
|
9,876
|
|
|
$
|
(19,290
|
)
|
|
$
|
24,280
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS (DEFICIT) EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
|
|
|
$
|
881
|
|
|
$
|
489
|
|
|
$
|
|
|
|
$
|
1,370
|
|
Accrued salaries
|
|
|
|
|
|
|
549
|
|
|
|
305
|
|
|
|
|
|
|
|
854
|
|
Other accrued expenses
|
|
|
435
|
|
|
|
284
|
|
|
|
563
|
|
|
|
|
|
|
|
1,282
|
|
Long-term debt due within one year
|
|
|
355
|
|
|
|
|
|
|
|
49
|
|
|
|
|
|
|
|
404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
790
|
|
|
|
1,714
|
|
|
|
1,406
|
|
|
|
|
|
|
|
3,910
|
|
Long-term debt
|
|
|
26,089
|
|
|
|
99
|
|
|
|
397
|
|
|
|
|
|
|
|
26,585
|
|
Intercompany balances
|
|
|
3,663
|
|
|
|
(8,136
|
)
|
|
|
4,473
|
|
|
|
|
|
|
|
|
|
Professional liability risks
|
|
|
|
|
|
|
|
|
|
|
1,108
|
|
|
|
|
|
|
|
1,108
|
|
Income taxes and other liabilities
|
|
|
1,270
|
|
|
|
379
|
|
|
|
133
|
|
|
|
|
|
|
|
1,782
|
|
Minority interests in equity of consolidated entities
|
|
|
|
|
|
|
138
|
|
|
|
857
|
|
|
|
|
|
|
|
995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,812
|
|
|
|
(5,806
|
)
|
|
|
8,374
|
|
|
|
|
|
|
|
34,380
|
|
Equity securities with contingent redemption rights
|
|
|
155
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
155
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders (deficit) equity
|
|
|
(10,255
|
)
|
|
|
17,788
|
|
|
|
1,502
|
|
|
|
(19,290
|
)
|
|
|
(10,255
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
21,712
|
|
|
$
|
11,982
|
|
|
$
|
9,876
|
|
|
$
|
(19,290
|
)
|
|
$
|
24,280
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-36
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 17
|
SUPPLEMENTAL
CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER
COLLATERAL-RELATED INFORMATION (Continued)
|
HCA
INC.
CONDENSED CONSOLIDATING BALANCE SHEET
DECEMBER 31, 2007
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
|
|
|
Condensed
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
|
|
|
$
|
165
|
|
|
$
|
228
|
|
|
$
|
|
|
|
$
|
393
|
|
Accounts receivable, net
|
|
|
|
|
|
|
2,248
|
|
|
|
1,647
|
|
|
|
|
|
|
|
3,895
|
|
Inventories
|
|
|
|
|
|
|
432
|
|
|
|
278
|
|
|
|
|
|
|
|
710
|
|
Deferred income taxes
|
|
|
592
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
592
|
|
Other
|
|
|
|
|
|
|
123
|
|
|
|
492
|
|
|
|
|
|
|
|
615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
592
|
|
|
|
2,968
|
|
|
|
2,645
|
|
|
|
|
|
|
|
6,205
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
|
|
|
|
6,960
|
|
|
|
4,482
|
|
|
|
|
|
|
|
11,442
|
|
Investments of insurance subsidiary
|
|
|
|
|
|
|
|
|
|
|
1,669
|
|
|
|
|
|
|
|
1,669
|
|
Investments in and advances to affiliates
|
|
|
|
|
|
|
221
|
|
|
|
467
|
|
|
|
|
|
|
|
688
|
|
Goodwill
|
|
|
|
|
|
|
1,644
|
|
|
|
985
|
|
|
|
|
|
|
|
2,629
|
|
Deferred loan costs
|
|
|
539
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
539
|
|
Investments in and advances to subsidiaries
|
|
|
17,190
|
|
|
|
|
|
|
|
|
|
|
|
(17,190
|
)
|
|
|
|
|
Other
|
|
|
798
|
|
|
|
18
|
|
|
|
37
|
|
|
|
|
|
|
|
853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
19,119
|
|
|
$
|
11,811
|
|
|
$
|
10,285
|
|
|
$
|
(17,190
|
)
|
|
$
|
24,025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS (DEFICIT) EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
|
|
|
$
|
883
|
|
|
$
|
487
|
|
|
$
|
|
|
|
$
|
1,370
|
|
Accrued salaries
|
|
|
|
|
|
|
515
|
|
|
|
265
|
|
|
|
|
|
|
|
780
|
|
Other accrued expenses
|
|
|
411
|
|
|
|
372
|
|
|
|
608
|
|
|
|
|
|
|
|
1,391
|
|
Long-term debt due within one year
|
|
|
271
|
|
|
|
|
|
|
|
37
|
|
|
|
|
|
|
|
308
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
682
|
|
|
|
1,770
|
|
|
|
1,397
|
|
|
|
|
|
|
|
3,849
|
|
Long-term debt
|
|
|
26,439
|
|
|
|
103
|
|
|
|
458
|
|
|
|
|
|
|
|
27,000
|
|
Intercompany balances
|
|
|
1,368
|
|
|
|
(6,524
|
)
|
|
|
5,156
|
|
|
|
|
|
|
|
|
|
Professional liability risks
|
|
|
|
|
|
|
|
|
|
|
1,233
|
|
|
|
|
|
|
|
1,233
|
|
Income taxes and other liabilities
|
|
|
1,004
|
|
|
|
238
|
|
|
|
137
|
|
|
|
|
|
|
|
1,379
|
|
Minority interests in equity of consolidated entities
|
|
|
|
|
|
|
117
|
|
|
|
821
|
|
|
|
|
|
|
|
938
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29,493
|
|
|
|
(4,296
|
)
|
|
|
9,202
|
|
|
|
|
|
|
|
34,399
|
|
Equity securities with contingent redemption rights
|
|
|
164
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
164
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders (deficit) equity
|
|
|
(10,538
|
)
|
|
|
16,107
|
|
|
|
1,083
|
|
|
|
(17,190
|
)
|
|
|
(10,538
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
19,119
|
|
|
$
|
11,811
|
|
|
$
|
10,285
|
|
|
$
|
(17,190
|
)
|
|
$
|
24,025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-37
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 17
|
SUPPLEMENTAL
CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER
COLLATERAL-RELATED INFORMATION (Continued)
|
HCA
INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For The Year Ended December 31, 2008
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
|
|
|
Condensed
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
673
|
|
|
$
|
1,681
|
|
|
$
|
419
|
|
|
$
|
(2,100
|
)
|
|
$
|
673
|
|
Adjustments to reconcile net income to net cash provided by
(used in) operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for doubtful accounts
|
|
|
|
|
|
|
2,073
|
|
|
|
1,336
|
|
|
|
|
|
|
|
3,409
|
|
Depreciation and amortization
|
|
|
|
|
|
|
776
|
|
|
|
640
|
|
|
|
|
|
|
|
1,416
|
|
Income taxes
|
|
|
(448
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(448
|
)
|
Gains on sales of facilities
|
|
|
|
|
|
|
(5
|
)
|
|
|
(92
|
)
|
|
|
|
|
|
|
(97
|
)
|
Impairment of long-lived assets
|
|
|
|
|
|
|
|
|
|
|
64
|
|
|
|
|
|
|
|
64
|
|
Amortization of deferred loan costs
|
|
|
79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
79
|
|
Change in minority interests
|
|
|
|
|
|
|
21
|
|
|
|
15
|
|
|
|
|
|
|
|
36
|
|
Share-based compensation
|
|
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32
|
|
Equity in earnings of affiliates
|
|
|
(2,100
|
)
|
|
|
|
|
|
|
|
|
|
|
2,100
|
|
|
|
|
|
Decrease in cash from operating assets and liabilities
|
|
|
(11
|
)
|
|
|
(2,085
|
)
|
|
|
(1,271
|
)
|
|
|
|
|
|
|
(3,367
|
)
|
Other
|
|
|
|
|
|
|
(19
|
)
|
|
|
19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
|
(1,775
|
)
|
|
|
2,442
|
|
|
|
1,130
|
|
|
|
|
|
|
|
1,797
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
|
|
|
|
(927
|
)
|
|
|
(673
|
)
|
|
|
|
|
|
|
(1,600
|
)
|
Acquisition of hospitals and health care entities
|
|
|
|
|
|
|
(34
|
)
|
|
|
(51
|
)
|
|
|
|
|
|
|
(85
|
)
|
Disposal of hospitals and health care entities
|
|
|
|
|
|
|
27
|
|
|
|
166
|
|
|
|
|
|
|
|
193
|
|
Change in investments
|
|
|
|
|
|
|
(26
|
)
|
|
|
47
|
|
|
|
|
|
|
|
21
|
|
Other
|
|
|
|
|
|
|
(4
|
)
|
|
|
8
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
|
|
|
|
(964
|
)
|
|
|
(503
|
)
|
|
|
|
|
|
|
(1,467
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in revolving bank credit facility
|
|
|
700
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
700
|
|
Repayment of long-term debt
|
|
|
(851
|
)
|
|
|
(4
|
)
|
|
|
(105
|
)
|
|
|
|
|
|
|
(960
|
)
|
Changes in intercompany balances with affiliates, net
|
|
|
1,935
|
|
|
|
(1,505
|
)
|
|
|
(430
|
)
|
|
|
|
|
|
|
|
|
Other
|
|
|
(9
|
)
|
|
|
|
|
|
|
11
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
1,775
|
|
|
|
(1,509
|
)
|
|
|
(524
|
)
|
|
|
|
|
|
|
(258
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
|
|
|
|
(31
|
)
|
|
|
103
|
|
|
|
|
|
|
|
72
|
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
|
165
|
|
|
|
228
|
|
|
|
|
|
|
|
393
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
|
|
|
$
|
134
|
|
|
$
|
331
|
|
|
$
|
|
|
|
$
|
465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-38
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 17
|
SUPPLEMENTAL
CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER
COLLATERAL-RELATED INFORMATION (Continued)
|
HCA
INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For The Year Ended December 31, 2007
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
|
|
|
Condensed
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
874
|
|
|
$
|
1,448
|
|
|
$
|
797
|
|
|
$
|
(2,245
|
)
|
|
$
|
874
|
|
Adjustments to reconcile net income to net cash provided by
(used in) operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for doubtful accounts
|
|
|
|
|
|
|
1,942
|
|
|
|
1,188
|
|
|
|
|
|
|
|
3,130
|
|
Depreciation and amortization
|
|
|
|
|
|
|
779
|
|
|
|
647
|
|
|
|
|
|
|
|
1,426
|
|
Income taxes
|
|
|
(105
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(105
|
)
|
Gains on sales of facilities
|
|
|
|
|
|
|
(3
|
)
|
|
|
(468
|
)
|
|
|
|
|
|
|
(471
|
)
|
Impairment of long-lived assets
|
|
|
|
|
|
|
|
|
|
|
24
|
|
|
|
|
|
|
|
24
|
|
Amortization of deferred loan costs
|
|
|
78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
78
|
|
Change in minority interests
|
|
|
|
|
|
|
16
|
|
|
|
24
|
|
|
|
|
|
|
|
40
|
|
Share-based compensation
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24
|
|
Equity in earnings of affiliates
|
|
|
(2,245
|
)
|
|
|
|
|
|
|
|
|
|
|
2,245
|
|
|
|
|
|
Decrease in cash from operating assets and liabilities
|
|
|
(6
|
)
|
|
|
(2,127
|
)
|
|
|
(1,482
|
)
|
|
|
|
|
|
|
(3,615
|
)
|
Other
|
|
|
7
|
|
|
|
18
|
|
|
|
(34
|
)
|
|
|
|
|
|
|
(9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
|
(1,373
|
)
|
|
|
2,073
|
|
|
|
696
|
|
|
|
|
|
|
|
1,396
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
|
|
|
|
(640
|
)
|
|
|
(804
|
)
|
|
|
|
|
|
|
(1,444
|
)
|
Acquisition of hospitals and health care entities
|
|
|
|
|
|
|
(11
|
)
|
|
|
(21
|
)
|
|
|
|
|
|
|
(32
|
)
|
Disposal of hospitals and health care entities
|
|
|
|
|
|
|
24
|
|
|
|
743
|
|
|
|
|
|
|
|
767
|
|
Change in investments
|
|
|
|
|
|
|
3
|
|
|
|
204
|
|
|
|
|
|
|
|
207
|
|
Other
|
|
|
|
|
|
|
(8
|
)
|
|
|
31
|
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities
|
|
|
|
|
|
|
(632
|
)
|
|
|
153
|
|
|
|
|
|
|
|
(479
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in revolving bank credit facility
|
|
|
(520
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(520
|
)
|
Repayment of long-term debt
|
|
|
(255
|
)
|
|
|
(4
|
)
|
|
|
(491
|
)
|
|
|
|
|
|
|
(750
|
)
|
Issuances of common stock
|
|
|
100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100
|
|
Changes in intercompany balances with affiliates, net
|
|
|
2,059
|
|
|
|
(1,554
|
)
|
|
|
(505
|
)
|
|
|
|
|
|
|
|
|
Other
|
|
|
(11
|
)
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
1,373
|
|
|
|
(1,558
|
)
|
|
|
(973
|
)
|
|
|
|
|
|
|
(1,158
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
|
|
|
|
(117
|
)
|
|
|
(124
|
)
|
|
|
|
|
|
|
(241
|
)
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
|
282
|
|
|
|
352
|
|
|
|
|
|
|
|
634
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
|
|
|
$
|
165
|
|
|
$
|
228
|
|
|
$
|
|
|
|
$
|
393
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-39
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 17
|
SUPPLEMENTAL
CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER
COLLATERAL-RELATED INFORMATION (Continued)
|
HCA
INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For The Year Ended December 31, 2006
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
Parent
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
|
|
|
Condensed
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,036
|
|
|
$
|
1,332
|
|
|
$
|
663
|
|
|
$
|
(1,995
|
)
|
|
$
|
1,036
|
|
Adjustments to reconcile net income to net cash provided by
(used in) operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for doubtful accounts
|
|
|
|
|
|
|
1,652
|
|
|
|
1,008
|
|
|
|
|
|
|
|
2,660
|
|
Depreciation and amortization
|
|
|
|
|
|
|
755
|
|
|
|
636
|
|
|
|
|
|
|
|
1,391
|
|
Income taxes
|
|
|
(552
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(552
|
)
|
Gains on sales of facilities
|
|
|
|
|
|
|
7
|
|
|
|
(212
|
)
|
|
|
|
|
|
|
(205
|
)
|
Impairment of long-lived assets
|
|
|
|
|
|
|
5
|
|
|
|
19
|
|
|
|
|
|
|
|
24
|
|
Amortization of deferred loan costs
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18
|
|
Change in minority interests
|
|
|
|
|
|
|
18
|
|
|
|
40
|
|
|
|
|
|
|
|
58
|
|
Share-based compensation
|
|
|
324
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
324
|
|
Equity in earnings of affiliates
|
|
|
(1,995
|
)
|
|
|
|
|
|
|
|
|
|
|
1,995
|
|
|
|
|
|
Increase (decrease) in cash from operating assets and liabilities
|
|
|
78
|
|
|
|
(1,552
|
)
|
|
|
(1,466
|
)
|
|
|
|
|
|
|
(2,940
|
)
|
Other
|
|
|
56
|
|
|
|
2
|
|
|
|
(27
|
)
|
|
|
|
|
|
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
|
(1,035
|
)
|
|
|
2,219
|
|
|
|
661
|
|
|
|
|
|
|
|
1,845
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
|
|
|
|
(1,058
|
)
|
|
|
(807
|
)
|
|
|
|
|
|
|
(1,865
|
)
|
Acquisition of hospitals and health care entities
|
|
|
|
|
|
|
(29
|
)
|
|
|
(83
|
)
|
|
|
|
|
|
|
(112
|
)
|
Disposal of hospitals and health care entities
|
|
|
|
|
|
|
108
|
|
|
|
543
|
|
|
|
|
|
|
|
651
|
|
Change in investments
|
|
|
|
|
|
|
13
|
|
|
|
13
|
|
|
|
|
|
|
|
26
|
|
Other
|
|
|
|
|
|
|
(4
|
)
|
|
|
(3
|
)
|
|
|
|
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
|
|
|
|
(970
|
)
|
|
|
(337
|
)
|
|
|
|
|
|
|
(1,307
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuances of long-term debt
|
|
|
21,207
|
|
|
|
|
|
|
|
551
|
|
|
|
|
|
|
|
21,758
|
|
Net change in revolving bank credit facility
|
|
|
(435
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(435
|
)
|
Repayment of long-term debt
|
|
|
(3,621
|
)
|
|
|
(3
|
)
|
|
|
(104
|
)
|
|
|
|
|
|
|
(3,728
|
)
|
Issuances of common stock
|
|
|
108
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
108
|
|
Repurchases of common stock
|
|
|
(653
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(653
|
)
|
Recapitalization-repurchase of common stock
|
|
|
(20,364
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(20,364
|
)
|
Recapitalization-equity contributions
|
|
|
3,782
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,782
|
|
Payment of debt issuance costs
|
|
|
(586
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(586
|
)
|
Payment of cash dividends
|
|
|
(201
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(201
|
)
|
Changes in intercompany balances with affiliates, net
|
|
|
1,719
|
|
|
|
(1,095
|
)
|
|
|
(624
|
)
|
|
|
|
|
|
|
|
|
Other
|
|
|
79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
1,035
|
|
|
|
(1,098
|
)
|
|
|
(177
|
)
|
|
|
|
|
|
|
(240
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
|
|
|
|
151
|
|
|
|
147
|
|
|
|
|
|
|
|
298
|
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
|
131
|
|
|
|
205
|
|
|
|
|
|
|
|
336
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
|
|
|
$
|
282
|
|
|
$
|
352
|
|
|
$
|
|
|
|
$
|
634
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthtrust, Inc. The Hospital Company
(Healthtrust) is the first-tier subsidiary of HCA
Inc. The common stock of Healthtrust has been pledged as
collateral for the senior secured credit facilities and senior
secured notes described in Note 10.
Rule 3-16
of
Regulation S-X
under the Securities Act requires the filing of separate
financial
F-40
HCA
INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 17
|
SUPPLEMENTAL
CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER
COLLATERAL-RELATED INFORMATION (Continued)
|
statements for any affiliate of the registrant whose securities
constitute a substantial portion of the collateral for any class
of securities registered or being registered. We believe the
separate financial statements requirement applies to Healthtrust
due to the pledge of its common stock as collateral for the
senior secured notes. Due to the corporate structure
relationship of HCA and Healthtrust, HCAs operating
subsidiaries are also the operating subsidiaries of Healthtrust.
The corporate structure relationship, combined with the
application of push-down accounting in Healthtrusts
consolidated financial statements related to HCAs debt and
financial instruments, results in the consolidated financial
statements of Healthtrust being substantially identical to the
consolidated financial statements of HCA. The consolidated
financial statements of HCA and Healthtrust present the
identical amounts for revenues, expenses, net income, assets,
liabilities, total stockholders (deficit) equity, net cash
provided by operating activities, net cash used in investing
activities and net cash used in financing activities. Certain
individual line items in the HCA consolidated statements of
stockholders (deficit) equity and cash flows are combined
into one line item in the Healthtrust consolidated statements of
stockholders (deficit) equity and cash flows.
Reconciliations of the HCA Inc. Consolidated Statements of
Stockholders (Deficit) Equity and Consolidated Statements
of Cash Flows presentations to the Healthtrust, Inc.
The Hospital Company Consolidated Statements of
Stockholders (Deficit) Equity and Consolidated Statements
of Cash Flows presentations for the years ended
December 31, 2008, 2007 and 2006 are as follows (dollars in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Presentation in HCA Inc. Consolidated Statements of
Stockholders (Deficit) Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
Recapitalization-repurchase of common stock
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(21,373
|
)
|
Recapitalization-equity contribution
|
|
|
|
|
|
|
|
|
|
|
4,477
|
|
Cash dividends declared
|
|
|
|
|
|
|
|
|
|
|
(139
|
)
|
Stock repurchases
|
|
|
|
|
|
|
|
|
|
|
(653
|
)
|
Stock options exercised
|
|
|
|
|
|
|
|
|
|
|
163
|
|
Employee benefit plan issuances
|
|
|
|
|
|
|
|
|
|
|
366
|
|
Equity contributions
|
|
|
|
|
|
|
60
|
|
|
|
|
|
Share-based benefit plans
|
|
|
40
|
|
|
|
24
|
|
|
|
|
|
Other
|
|
|
2
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Presentation in Healthtrust, Inc. The Hospital
Company Consolidated Statements of Stockholders (Deficit)
Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions from (to) HCA Inc., net of contributions to (from)
HCA Inc.
|
|
$
|
42
|
|
|
$
|
112
|
|
|
$
|
(17,159
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Presentation in HCA Inc. Consolidated Statements of Cash Flows
(cash flows from financing activities):
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuances of common stock
|
|
$
|
|
|
|
$
|
100
|
|
|
$
|
108
|
|
Repurchases of common stock
|
|
|
|
|
|
|
|
|
|
|
(653
|
)
|
Recapitalization-repurchase of common stock
|
|
|
|
|
|
|
|
|
|
|
(20,364
|
)
|
Recapitalization-equity contributions
|
|
|
|
|
|
|
|
|
|
|
3,782
|
|
Payment of cash dividends
|
|
|
|
|
|
|
|
|
|
|
(201
|
)
|
Other
|
|
|
(9
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Presentation in Healthtrust Inc. The Hospital
Company Consolidated Statements of Cash Flows (cash flows from
financing activities):
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash distributions from (to) HCA Inc.
|
|
$
|
(9
|
)
|
|
$
|
98
|
|
|
$
|
(17,328
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Due to the consolidated financial statements of Healthtrust
being substantially identical to the consolidated financial
statements of HCA, except for the items presented in the tables
above, the separate consolidated financial statements of
Healthtrust are not presented.
F-41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
First
|
|
Second
|
|
Third
|
|
Fourth
|
|
Revenues
|
|
$
|
7,127
|
|
|
$
|
6,980
|
|
|
$
|
7,002
|
|
|
$
|
7,265
|
|
Net income
|
|
$
|
170
|
(a)
|
|
$
|
141
|
(b)
|
|
$
|
86
|
(c)
|
|
$
|
276
|
(d)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
First
|
|
Second
|
|
Third
|
|
Fourth
|
|
Revenues
|
|
$
|
6,677
|
|
|
$
|
6,729
|
|
|
$
|
6,569
|
|
|
$
|
6,883
|
|
Net income
|
|
$
|
180
|
(e)
|
|
$
|
116
|
(f)
|
|
$
|
300
|
(g)
|
|
$
|
278
|
(h)
|
|
|
|
(a)
|
|
First quarter results include
$30 million of gains on sales of facilities (See
NOTE 4 of the notes to consolidated financial statements).
|
|
(b)
|
|
Second quarter results include
$6 million of losses on sales of facilities (See
NOTE 4 of the notes to consolidated financial statements)
and $6 million of costs related to the impairment of
long-lived assets (See NOTE 5 of the notes to consolidated
financial statements).
|
|
(c)
|
|
Third quarter results include
$29 million of gains on sales of facilities (See
NOTE 4 of the notes to consolidated financial statements)
and $28 million of costs related to the impairment of
long-lived assets (See NOTE 5 of the notes to consolidated
financial statements).
|
|
(d)
|
|
Fourth quarter results include
$5 million of gains on sales of facilities (See NOTE 4
of the notes to consolidated financial statements) and
$6 million of costs related to the impairment of long-lived
assets (See NOTE 5 of the notes to consolidated financial
statements).
|
|
(e)
|
|
First quarter results include
$2 million of gains on sales of facilities (See NOTE 4
of the notes to consolidated financial statements).
|
|
(f)
|
|
Second quarter results include
$7 million of gains on sales of facilities (See NOTE 4
of the notes to consolidated financial statements) and
$15 million of costs related to the impairment of
long-lived assets (See NOTE 5 of the notes to consolidated
financial statements).
|
|
(g)
|
|
Third quarter results include
$193 million of gains on sales of facilities (See
NOTE 4 of the notes to consolidated financial statements).
|
|
(h)
|
|
Fourth quarter results include
$88 million of gains on sales of facilities (See
NOTE 4 of the notes to consolidated financial statements).
|
F-42